data_1ovq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ovq _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.569 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' ILE . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.545 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.742 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.638 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' HD11 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.742 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' CB ' HD12 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 8' ' ' PHE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.476 ' CG ' ' O ' ' A' ' 61' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.318 0.58 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.418 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.405 ' NE2' ' OG ' ' A' ' 132' ' ' SER . 10.4 t-160 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.403 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.503 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' ALA . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 133' ' ' TYR 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.405 ' OG ' ' NE2' ' A' ' 94' ' ' HIS . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.41 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 68.6 m -143.29 147.03 34.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.079 -1.247 . . . . 0.0 111.699 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.566 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -126.79 142.08 51.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.128 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -130.09 144.82 51.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 130' ' ' LEU . . . -153.8 126.01 7.93 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.889 -1.132 . . . . 0.0 110.319 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 1.9 m-85 -123.67 136.5 54.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.305 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 12.8 t70 -106.14 96.68 6.64 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.9 p90 -174.16 -159.68 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.55 ' CA ' ' CE2' ' A' ' 79' ' ' PHE . . . -166.26 -148.03 5.41 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.057 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.9 p -37.52 -91.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.655 -0.909 . . . . 0.0 113.098 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.45 49.51 0.94 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.679 -1.263 . . . . 0.0 111.473 -178.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.94 134.25 27.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 110.373 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.734 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 32.9 mm -126.39 94.96 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . -125.42 103.94 0.74 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 103.349 -3.901 . . . . 0.0 103.349 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -141.0 164.79 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.79 -174.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' HB2' ' CA ' ' A' ' 127' ' ' VAL . . . -125.68 129.97 50.62 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 ' HG ' ' A' ' 48' ' ' LEU . 10.9 t -102.48 125.89 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -120.59 146.49 17.64 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 118.251 -1.928 . . . . 0.0 112.31 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 21' ' ' GLN . 7.0 pt20 -95.86 121.44 37.59 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.43 ' CD ' ' OH ' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -89.87 31.43 0.96 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.698 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.57 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.97 -32.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.406 ' OG1' HD12 ' A' ' 23' ' ' ILE . 86.2 m -115.92 -17.33 11.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.63 34.43 9.25 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.659 -1.258 . . . . 0.0 109.959 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 161.59 20.4 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.946 -1.326 . . . . 0.0 110.583 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -134.59 135.04 41.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.925 -1.11 . . . . 0.0 112.422 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -98.91 153.72 37.69 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -91.61 134.71 1.59 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.292 1.154 . . . . 0.0 112.094 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HG ' ' HD2' ' A' ' 31' ' ' PRO . 1.6 tt -99.44 141.26 22.51 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.36 167.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.811 2.341 . . . . 0.0 116.223 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.56 144.84 56.92 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.053 1.406 . . . . 0.0 114.284 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.734 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.23 55.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 112.976 -1.92 . . . . 0.0 115.835 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 37.5 tptt -133.73 96.78 3.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.852 -1.155 . . . . 0.0 109.81 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.95 161.14 16.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.411 ' O ' ' HB ' ' A' ' 39' ' ' THR . 42.7 mt-30 -85.24 120.97 27.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.214 -0.929 . . . . 0.0 111.498 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.26 27.34 1.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.046 -1.034 . . . . 0.0 110.278 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.08 16.82 55.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 23.1 m -94.8 109.39 43.57 Favored Pre-proline 0 C--N 1.306 -1.284 0 O-C-N 121.082 -1.246 . . . . 0.0 109.789 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.448 ' CB ' HD13 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -68.88 155.92 67.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.572 1.301 . . . . 0.0 109.165 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 3.2 m-20 -63.71 91.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.976 -1.077 . . . . 0.0 108.87 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 13.4 t90 -91.95 -21.6 20.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.74 -37.97 26.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.947 . . . . 0.0 109.889 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -73.12 -50.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.736 -0.602 . . . . 0.0 110.045 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 20.6 mt -70.34 -49.32 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.952 -1.092 . . . . 0.0 111.025 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -54.06 -32.94 56.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.67 -1.269 . . . . 0.0 109.815 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -61.02 -47.21 87.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.309 -0.87 . . . . 0.0 109.37 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD1' ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.52 -27.07 31.94 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 109.03 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -66.16 -54.64 22.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 111.221 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -74.84 -25.82 59.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.941 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -81.26 -38.3 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 0.0 110.771 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -109.71 -20.56 12.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.074 -1.016 . . . . 0.0 111.109 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER 56.52 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 46.8 Cg_endo -72.04 134.53 23.5 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.8 1.421 . . . . 0.0 111.117 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.92 -35.8 23.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 110.725 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.58 144.85 50.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 5.0 mp -130.02 137.75 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.527 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -124.54 114.28 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 83' ' ' ILE . 1.1 p -134.67 151.29 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.229 -1.544 . . . . 0.0 114.008 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.16 140.5 3.18 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.297 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 3.4 ttm180 -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -56.04 -32.14 63.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.666 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 7.6 m-30 -57.83 -47.72 81.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.026 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 59' ' ' VAL . . . -55.34 -34.69 64.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -80.29 -24.07 40.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 109.198 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 79' ' ' PHE . 2.1 mtt180 -77.3 -56.71 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 91' ' ' VAL . 16.2 pt -62.14 -38.88 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 109.412 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.441 ' N ' HG13 ' A' ' 83' ' ' ILE . 1.9 t60 -58.6 -42.14 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.496 -0.753 . . . . 0.0 109.901 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.72 -16.81 80.41 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -44.82 23.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -1.222 . . . . 0.0 110.433 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.6 -13.15 9.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.01 -1.057 . . . . 0.0 110.881 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 82.24 32.76 27.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.14 153.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.485 -1.009 . . . . 0.0 110.686 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 81.69 6.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.756 . . . . 0.0 110.531 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 8.7 p -100.31 152.3 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 153.85 29.78 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -92.66 138.64 31.32 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.027 -1.046 . . . . 0.0 108.907 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.482 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 8.1 t60 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.786 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 121.052 0.453 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HA ' ' CG1' ' A' ' 127' ' ' VAL . . . -48.57 -29.68 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 0.0 110.9 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.4 p -54.7 -33.39 60.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 111.526 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -77.71 -55.77 5.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.151 . . . . 0.0 109.266 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -53.47 -24.3 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.456 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.3 mp -76.76 -46.01 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.455 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 17.0 mt -53.73 -27.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -67.55 -39.81 84.98 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.894 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -34.18 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -32.35 67.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.566 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 t80 -75.11 -54.46 7.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.68 -0.638 . . . . 0.0 109.754 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.532 ' CZ ' HD13 ' A' ' 130' ' ' LEU . 25.2 m-85 -52.18 -28.98 20.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.074 -1.016 . . . . 0.0 109.558 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.486 -0.759 . . . . 0.0 109.677 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.7 m -147.5 138.34 23.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.968 -1.313 . . . . 0.0 112.209 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' CB ' HD23 ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.481 ' CA ' HG13 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.737 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 8' ' ' PHE . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' CD ' HD13 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.688 0.756 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.4 28.75 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.553 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -128.03 126.7 41.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.124 -0.985 . . . . 0.0 111.155 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.518 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.1 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 138.01 58.19 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 123.004 1.383 . . . . 0.0 113.772 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.035 -1.893 . . . . 0.0 115.73 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.05 159.76 17.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.374 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.02 123.92 33.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -0.883 . . . . 0.0 110.821 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -0.93 . . . . 0.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 13' ' ' LYS . . . 90.33 18.94 47.59 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 17.2 m -92.81 107.7 26.46 Favored Pre-proline 0 C--N 1.307 -1.275 0 O-C-N 121.06 -1.259 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.468 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.24 157.62 56.71 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.641 1.337 . . . . 0.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 32.4 m-20 -64.47 90.79 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.55 -20.45 54.1 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.359 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -30.89 30.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.837 -0.539 . . . . 0.0 111.764 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 52' ' ' TRP . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.42 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.83 -51.63 8.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.907 -1.121 . . . . 0.0 112.281 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HD22 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.775 -1.203 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.173 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 46.9 Cg_endo -73.74 136.86 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.735 1.387 . . . . 0.0 111.422 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.79 -45.18 37.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 110.074 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -133.86 140.3 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.067 . . . . 0.0 109.606 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 3.8 mp -117.7 137.89 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.002 . . . . 0.0 111.856 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -121.29 122.42 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 60' ' ' GLY . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -57.02 4.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.442 HD13 HG11 ' A' ' 59' ' ' VAL . 23.5 pt -57.78 -25.75 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.068 . . . . 0.0 109.798 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.68 62.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.81 -16.26 75.62 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 68.7 m-85 -119.1 -11.92 9.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 110.322 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.97 31.62 42.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.17 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.682 -0.893 . . . . 0.0 110.773 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.29 125.83 40.19 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.887 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.254 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.208 0.528 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.553 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -21.62 64.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 109.281 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CE2' HD13 ' A' ' 130' ' ' LEU . 4.0 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.96 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.6 m -142.63 134.84 27.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.965 -1.315 . . . . 0.0 112.505 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.604 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -126.31 140.6 52.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -135.03 134.32 40.3 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.481 -1.387 . . . . 0.0 110.772 179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.526 ' O ' HG11 ' A' ' 17' ' ' VAL . . . -118.33 122.96 44.17 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 33.6 m-85 -109.04 131.95 54.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.52 -0.738 . . . . 0.0 111.764 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 18.1 t70 -113.34 93.2 4.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.0 p90 -177.65 -164.57 0.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.244 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.56 168.56 33.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 55.7 p -60.01 77.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.89 -1.359 . . . . 0.0 111.654 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' GLY . 3.7 mttp 162.67 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.528 -0.733 . . . . 0.0 110.678 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -137.84 142.29 40.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -178.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.609 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 36.5 mm -122.92 102.22 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' HG21 ' A' ' 17' ' ' VAL . . . -129.5 103.9 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 104.126 -3.59 . . . . 0.0 104.126 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 30' ' ' LEU . 39.8 t -135.75 167.13 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 116.713 -1.995 . . . . 0.0 114.091 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.52 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -128.67 131.64 48.03 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.544 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 68.5 t -101.08 135.88 35.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.85 -1.156 . . . . 0.0 108.091 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -111.71 141.03 16.45 Favored Glycine 0 N--CA 1.484 1.85 0 C-N-CA 119.047 -1.549 . . . . 0.0 111.352 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -95.87 112.85 24.47 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -87.58 21.49 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.582 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.573 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.81 -32.66 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.412 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -117.73 -17.37 9.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.61 34.74 11.19 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.92 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 158.48 26.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.738 -1.448 . . . . 0.0 110.909 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.86 119.44 30.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.844 -1.16 . . . . 0.0 111.737 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' VAL . 31.8 ttm105 -86.98 154.54 55.24 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.0 Cg_endo -91.53 137.36 1.98 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.134 1.071 . . . . 0.0 112.151 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 1.2 tt -99.74 141.23 22.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.508 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 22.2 Cg_endo -43.25 169.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.839 2.359 . . . . 0.0 116.086 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ILE . . . -65.41 150.3 48.56 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 123.528 1.632 . . . . 0.0 115.069 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.609 ' HA ' ' C ' ' A' ' 15' ' ' ILE 0.279 0.9 OUTLIER -51.22 -126.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.462 -2.153 . . . . 0.0 112.783 179.838 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' H ' ' CG1' ' A' ' 33' ' ' ILE . 0.7 OUTLIER 34.87 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.211 -0.931 . . . . 0.0 112.468 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.9 160.48 17.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.932 -1.105 . . . . 0.0 109.752 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.09 115.21 26.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 111.419 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.3 25.79 0.95 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.849 . . . . 0.0 110.372 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.76 17.23 42.21 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.1 m -94.98 106.94 28.3 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 120.999 -1.295 . . . . 0.0 109.993 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.44 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.4 Cg_endo -72.22 162.53 41.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.575 1.303 . . . . 0.0 109.734 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -64.27 92.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.001 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.428 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 31.3 t90 -90.45 -17.23 27.53 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.457 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.8 m-20 -81.65 -35.4 29.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.811 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -82.4 -48.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.854 -0.529 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 18.5 mt -70.75 -33.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.155 -0.966 . . . . 0.0 111.16 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.3 OUTLIER -76.8 -45.22 29.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.924 -1.11 . . . . 0.0 110.427 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CD ' ' O ' ' A' ' 43' ' ' ASN . 1.9 mtt180 -52.44 -41.46 63.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.473 ' CD1' ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.28 -28.71 34.58 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.107 -0.996 . . . . 0.0 109.066 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.13 -49.78 76.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -1.0 . . . . 0.0 110.48 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -72.43 -32.35 66.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 111.053 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.85 -42.53 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.103 . . . . 0.0 111.221 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 49.0 m95 -111.01 -27.5 8.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.899 -1.125 . . . . 0.0 111.562 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.7 mt-30 59.48 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.022 -1.049 . . . . 0.0 109.487 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 46.8 Cg_endo -71.37 129.61 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.605 1.319 . . . . 0.0 111.44 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -80.34 -40.21 27.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 110.58 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -132.9 155.16 49.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 109.879 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 57' ' ' ILE . 4.9 mp -133.15 137.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 112.695 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.64 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.476 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 74.0 t -131.82 150.73 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.975 -1.703 . . . . 0.0 113.065 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 170.14 121.13 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.245 -0.978 . . . . 0.0 110.833 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 120.891 -1.358 . . . . 0.0 109.535 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -48.44 81.77 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -25.24 62.8 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.995 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -63.13 -45.51 91.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.44 70.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.463 -0.773 . . . . 0.0 109.104 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -67.15 -23.25 65.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -56.93 4.04 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 110.45 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' CD1' HG11 ' A' ' 59' ' ' VAL . 16.2 pt -56.16 -28.82 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.473 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 32.5 t-80 -70.2 -50.99 34.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.345 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.81 -15.55 79.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -74.66 -44.27 51.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.918 -1.342 . . . . 0.0 110.5 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -113.64 -11.09 13.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.394 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.62 48.22 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.49 153.91 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.636 -0.92 . . . . 0.0 110.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.55 88.5 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.676 . . . . 0.0 109.768 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.417 ' CG2' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -88.87 151.05 3.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.087 0.946 . . . . 0.0 111.48 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.36 39.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -101.58 127.4 48.31 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.024 -1.048 . . . . 0.0 109.342 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.409 ' N ' HD21 ' A' ' 93' ' ' LEU . 42.7 t-80 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.309 0.576 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.438 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -79.06 -40.07 32.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.5 m -52.91 -23.13 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.966 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.84 -55.3 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.065 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.52 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.14 -24.36 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -72.08 -45.53 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 68.0 mt -62.43 -41.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.548 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -56.55 -48.1 78.04 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.195 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -21.59 40.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 0.0 109.965 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 p -70.31 -50.62 37.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.751 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.604 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.29 -40.99 78.93 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.139 -0.976 . . . . 0.0 110.111 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -53.45 -31.22 44.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.831 -1.168 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.491 -0.755 . . . . 0.0 109.946 179.531 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.985 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.8 m -150.37 135.1 17.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.34 . . . . 0.0 112.427 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.581 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -126.7 143.87 51.1 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -135.72 134.3 38.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.435 -1.416 . . . . 0.0 110.521 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -118.56 123.32 44.77 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.573 ' HA ' HG12 ' A' ' 17' ' ' VAL . 29.0 m-85 -108.83 129.95 55.4 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.57 0.7 . . . . 0.0 111.789 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 21.8 t70 -112.65 91.99 3.85 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -173.89 -172.93 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.48 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -144.66 -177.18 19.3 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.474 ' N ' ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -71.47 63.36 0.39 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.117 -1.225 . . . . 0.0 111.598 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 12' ' ' THR . 4.4 ptmt 171.57 -27.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.233 -0.917 . . . . 0.0 110.61 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.593 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -125.44 143.44 50.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.0 108.756 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.702 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 33.5 mm -124.78 97.12 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -125.55 104.06 0.74 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 104.244 -3.543 . . . . 0.0 104.244 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 8' ' ' PHE . 38.3 t -134.85 165.8 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 116.623 -2.031 . . . . 0.0 113.688 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -129.7 131.72 46.42 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 28' ' ' ARG . 73.7 t -101.51 137.43 29.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 108.082 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.61 136.82 13.87 Favored Glycine 0 N--CA 1.485 1.928 0 O-C-N 120.507 -1.371 . . . . 0.0 110.589 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.64 117.41 30.41 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.161 -1.2 . . . . 0.0 108.04 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HG3' ' CB ' ' A' ' 5' ' ' LEU . 2.5 mtm180 -90.08 24.51 2.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.343 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -32.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -16.82 10.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.486 -0.759 . . . . 0.0 109.99 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 33.54 22.31 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.09 161.55 21.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.982 -1.305 . . . . 0.0 110.807 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.04 122.5 39.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.868 -1.145 . . . . 0.0 112.068 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' VAL . 11.6 ttm180 -87.3 153.11 53.53 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.3 Cg_endo -91.43 139.37 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.132 1.069 . . . . 0.0 112.364 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.82 142.47 24.68 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.29 167.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.846 2.364 . . . . 0.0 115.993 -174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.89 143.49 57.91 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 123.234 1.492 . . . . 0.0 114.834 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.702 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.7 50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 112.916 -1.947 . . . . 0.0 115.623 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.6 mmtt -131.63 97.43 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.864 -1.147 . . . . 0.0 109.654 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.61 161.09 16.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 110.251 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -85.71 120.57 27.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.876 . . . . 0.0 111.218 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 48.72 25.46 1.01 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -0.979 . . . . 0.0 110.495 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.7 17.28 42.19 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 21.4 m -98.72 115.72 65.66 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 121.141 -1.211 . . . . 0.0 110.03 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.444 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -69.79 157.7 59.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.433 1.228 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.429 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -64.54 91.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.942 -1.099 . . . . 0.0 109.177 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 26.9 t90 -90.94 -16.9 27.29 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -80.38 -34.53 36.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.432 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mp -81.99 -55.13 8.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.699 -0.625 . . . . 0.0 109.768 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 32.1 mt -59.62 -37.81 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 2.1 tm-20 -72.9 -31.18 64.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.944 -1.097 . . . . 0.0 109.962 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -64.92 -50.66 65.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -73.69 -25.02 60.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 109.959 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.46 -53.75 50.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.104 . . . . 0.0 110.504 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.44 -23.52 63.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.44 -41.22 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 111.346 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -109.08 -17.54 13.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.836 -1.165 . . . . 0.0 111.359 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' LEU . 5.7 mt-30 54.08 97.24 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.15 -0.969 . . . . 0.0 109.835 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.3 Cg_endo -71.56 125.41 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.664 1.349 . . . . 0.0 110.971 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -73.52 -41.91 62.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -138.24 157.87 45.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.031 -1.043 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 57' ' ' ILE . 4.7 mp -132.68 137.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 112.244 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.496 HG21 HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.86 122.13 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 60' ' ' GLY . 76.7 t -133.94 150.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 120.147 -1.596 . . . . 0.0 113.088 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 172.66 118.22 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 3.8 pp . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HA ' HD21 ' A' ' 93' ' ' LEU . 8.7 mtt180 -68.13 -48.19 66.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.364 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -25.41 65.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.0 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.507 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 37.3 t80 -59.33 -47.25 86.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.431 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -57.87 -31.81 67.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.09 -27.62 67.16 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.539 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -75.88 -57.89 3.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 20.7 pt -57.4 -32.13 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.176 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 88' ' ' GLY . 24.9 t-80 -65.8 -51.56 58.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.245 -0.91 . . . . 0.0 110.144 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.56 -15.63 73.3 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -71.49 -44.55 64.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.31 . . . . 0.0 110.511 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 -10.73 9.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 74.58 38.82 42.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.24 153.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.593 -0.946 . . . . 0.0 110.785 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -74.86 85.66 2.22 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.636 -0.665 . . . . 0.0 109.681 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.443 ' CG2' HG22 ' A' ' 59' ' ' VAL . 1.2 p -88.34 151.54 3.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -120.83 158.66 27.11 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.431 HD23 ' CB ' ' A' ' 80' ' ' ALA . 8.8 mt -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.403 ' HB2' HG22 ' A' ' 129' ' ' ILE . 29.2 t60 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -66.87 -38.88 87.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 110.303 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 129' ' ' ILE . 28.8 t -53.51 -32.7 51.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.389 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.73 -55.73 9.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.529 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.56 -23.87 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 124' ' ' ALA . 1.1 mp -73.3 -44.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.465 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 71.9 mt -60.79 -36.54 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.531 ' CD1' ' CE2' ' A' ' 134' ' ' PHE 0.256 0.4 OUTLIER -64.91 -54.3 32.97 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.414 178.485 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -56.21 -21.78 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 110.039 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -33.08 26.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.581 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -59.04 -38.95 80.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 76.1 m-85 -55.0 -40.45 70.14 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.245 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 38.9 m -150.35 141.32 22.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.886 -1.361 . . . . 0.0 112.31 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.556 ' CD1' ' CE1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.83 163.36 25.39 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.437 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.523 HD13 ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -144.92 145.22 31.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.192 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -137.73 124.37 21.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.109 -0.994 . . . . 0.0 108.727 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.523 ' CE1' HD13 ' A' ' 6' ' ' LEU . 73.7 m-85 -120.66 142.5 49.4 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.71 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t0 -106.54 91.35 3.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.481 ' HB3' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -97.34 134.96 39.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.1 160.84 28.56 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 p -47.69 112.24 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.058 -1.26 . . . . 0.0 110.514 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 mtmt 55.29 46.48 23.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.285 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.474 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.48 120.94 14.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.743 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -116.66 93.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 CA-C-O 122.467 1.127 . . . . 0.0 113.924 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -124.23 104.89 0.84 Allowed Glycine 0 C--N 1.287 -2.169 0 N-CA-C 103.626 -3.79 . . . . 0.0 103.626 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 30' ' ' LEU . 81.5 t -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 116.49 -2.084 . . . . 0.0 112.819 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -134.35 138.36 44.85 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' CG1' ' HG ' ' A' ' 48' ' ' LEU . 33.6 t -100.91 130.45 50.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -112.76 136.71 13.69 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.856 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 117.68 34.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 3.2 tpt180 -91.83 35.11 0.97 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.79 0.805 . . . . 0.0 109.967 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' ' 24' ' ' THR . 1.0 OUTLIER -113.66 -35.07 2.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.482 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -118.81 -17.19 9.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.716 . . . . 0.0 109.976 178.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 34.08 7.53 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.13 161.41 21.05 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.996 -1.296 . . . . 0.0 111.221 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -138.45 127.3 23.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 111.161 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 19' ' ' VAL . 8.0 mmm180 -88.04 154.65 52.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.412 -0.805 . . . . 0.0 109.041 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.26 136.75 2.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.471 1.248 . . . . 0.0 111.356 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -99.17 144.61 28.55 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 17.9 Cg_endo -39.67 165.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.772 2.315 . . . . 0.0 115.756 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.86 142.07 58.56 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.157 1.456 . . . . 0.0 114.355 -175.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.743 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -55.53 51.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.449 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.0 tptm -133.34 98.62 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.75 -1.219 . . . . 0.0 108.96 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.15 161.6 16.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 110.819 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.77 119.43 24.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.832 . . . . 0.0 111.08 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.18 25.71 1.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' HA2' ' CG ' ' A' ' 13' ' ' LYS . . . 93.62 14.59 52.69 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.428 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 11.7 m -91.25 111.12 47.05 Favored Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 120.944 -1.327 . . . . 0.0 109.776 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.482 ' CB ' HD12 ' A' ' 15' ' ' ILE . 43.4 Cg_endo -70.37 155.87 62.97 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.639 1.336 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -63.76 91.67 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.897 -1.127 . . . . 0.0 108.579 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.434 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 15.1 t90 -92.41 -22.49 19.62 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.88 -39.28 21.76 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.096 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.9 mp -70.56 -55.0 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 49' ' ' LEU . 5.9 mt -68.31 -43.02 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.691 -1.256 . . . . 0.0 110.591 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tm-20 -54.63 -30.79 55.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.717 -1.239 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.8 mtp180 -66.57 -44.01 83.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.345 -0.847 . . . . 0.0 109.362 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.468 ' HG ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -82.63 -27.14 31.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.303 -0.873 . . . . 0.0 109.285 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.447 ' CD1' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -66.74 -53.37 33.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.972 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -80.01 -26.99 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.154 -0.966 . . . . 0.0 111.345 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 25.8 tt0 -79.1 -41.16 29.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.964 -1.085 . . . . 0.0 110.978 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -103.58 -14.69 16.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.059 -1.026 . . . . 0.0 111.112 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 51.96 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.951 -1.093 . . . . 0.0 110.112 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.5 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.739 1.389 . . . . 0.0 111.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 2.3 m-20 -76.77 -43.52 36.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' CB ' HD21 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -132.31 136.82 47.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp -129.98 137.43 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.052 -1.03 . . . . 0.0 111.869 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.21 126.0 74.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.479 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 10.0 p -132.91 150.12 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.579 -1.325 . . . . 0.0 112.289 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.02 3.03 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.909 -1.139 . . . . 0.0 110.377 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 1.6 pt? . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.102 -1.234 . . . . 0.0 110.111 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' CB ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -56.42 -48.94 75.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -24.66 64.92 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.147 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 10' ' ' PHE . 5.7 t80 -61.03 -49.73 76.21 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . . . -57.29 -33.05 67.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.463 -0.773 . . . . 0.0 109.146 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.47 -23.45 63.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 110.12 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -70.51 -51.6 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.06 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -68.06 -23.75 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.708 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 89' ' ' VAL . 1.5 t-80 -59.07 -57.8 11.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -0.814 . . . . 0.0 110.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.82 -15.63 80.76 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.42 -44.33 91.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.288 . . . . 0.0 110.198 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.13 -14.01 11.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.71 31.06 30.76 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.476 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 34.2 m -95.52 153.2 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -1.039 . . . . 0.0 110.617 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.13 72.66 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 110.255 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 83' ' ' ILE . 4.8 p -89.51 152.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.999 0.904 . . . . 0.0 111.12 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 162.27 27.82 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.89 143.24 45.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.753 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.463 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.259 0.552 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -78.97 -31.1 44.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.7 p -54.23 -30.85 51.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.333 -0.854 . . . . 0.0 111.482 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.03 -56.22 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 109.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.501 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -55.87 -24.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 124' ' ' ALA . 4.5 mm -71.13 -44.67 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.481 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 36.3 mt -61.41 -42.0 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.572 HD13 ' CE2' ' A' ' 133' ' ' TYR . 1.0 OUTLIER -57.7 -58.06 10.01 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.739 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.0 -21.76 65.12 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 108.994 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -58.03 -40.86 81.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.548 -0.72 . . . . 0.0 110.985 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.572 ' CE2' HD13 ' A' ' 130' ' ' LEU . 4.5 p90 -81.64 -32.64 31.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.317 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.5 m-85 -52.62 -31.8 38.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.985 . . . . 0.0 110.121 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.5 m -147.49 138.32 23.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.326 . . . . 0.0 112.243 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' CB ' HD23 ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.586 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.481 ' CA ' HG13 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.737 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 8' ' ' PHE . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' CD ' HD13 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.695 0.759 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.38 28.79 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.553 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -128.02 126.73 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.146 -0.971 . . . . 0.0 111.143 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.518 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.2 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.4 138.01 58.19 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 123.025 1.393 . . . . 0.0 113.715 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.73 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.03 159.75 17.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.97 . . . . 0.0 110.43 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.08 123.96 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.803 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 13' ' ' LYS . . . 90.33 18.96 47.51 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 17.2 m -92.87 107.71 26.6 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.099 -1.236 . . . . 0.0 110.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.468 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.23 157.62 56.75 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.572 1.301 . . . . 0.0 109.082 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 32.4 m-20 -64.47 90.77 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.52 -20.46 54.18 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.371 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -30.94 30.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.67 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.83 -0.543 . . . . 0.0 111.764 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 52' ' ' TRP . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.41 64.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.81 -51.65 8.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 112.302 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HD22 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.755 -1.216 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.822 -1.174 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 46.9 Cg_endo -73.71 136.86 23.94 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.72 1.379 . . . . 0.0 111.439 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.82 -45.1 37.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.403 -0.811 . . . . 0.0 110.103 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -133.88 140.35 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.068 . . . . 0.0 109.591 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 3.8 mp -117.74 137.83 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 111.856 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -121.21 122.46 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 60' ' ' GLY . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -56.99 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.442 HD13 HG11 ' A' ' 59' ' ' VAL . 23.5 pt -57.84 -25.71 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.974 -1.079 . . . . 0.0 109.792 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.71 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.75 -16.29 75.69 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 68.8 m-85 -119.08 -11.97 9.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.94 31.66 42.79 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.19 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.905 . . . . 0.0 110.773 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.3 125.86 40.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.861 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 110.445 -179.272 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.208 0.528 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.553 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -21.63 64.49 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CE2' HD13 ' A' ' 130' ' ' LEU . 4.1 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.569 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' ILE . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.545 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.742 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.638 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.503 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' HD11 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.742 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' CB ' HD12 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 8' ' ' PHE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.476 ' CG ' ' O ' ' A' ' 61' ' ' LEU . 1.7 pp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.318 0.58 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.418 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.405 ' NE2' ' OG ' ' A' ' 132' ' ' SER . 10.4 t-160 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.403 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.503 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' ALA . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 133' ' ' TYR 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.405 ' OG ' ' NE2' ' A' ' 94' ' ' HIS . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.005 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.59 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB1' HD23 ' A' ' 130' ' ' LEU . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.722 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 17' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.722 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.441 ' CB ' HD13 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.432 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' O ' HD21 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 59' ' ' VAL . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.331 0.586 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 10' ' ' PHE . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.411 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.43 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.333 0.587 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.549 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.576 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.59 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.969 -1.312 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.553 ' CD2' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.58 127.81 34.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.991 -1.3 . . . . 0.0 112.151 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.724 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 18' ' ' ALA . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 17' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.83 29.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -90.56 32.8 0.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.744 0.783 . . . . 0.0 110.038 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.559 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.424 ' OG1' ' CD1' ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.724 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.504 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 10.6 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.6 70.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 5.7 mp -76.65 -53.05 8.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.897 -1.127 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 5' ' ' LEU . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.7 mp -124.47 137.6 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.999 -1.063 . . . . 0.0 112.088 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.061 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' CA ' HD21 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CZ ' ' CE2' ' A' ' 10' ' ' PHE . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -22.71 67.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.021 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.428 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.34 16.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.32 40.0 41.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.65 154.12 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.565 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 84.71 7.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.495 -0.753 . . . . 0.0 110.246 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 HD21 ' CA ' ' A' ' 77' ' ' ARG . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.279 0.561 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.534 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.486 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.569 HD12 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 130' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.005 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.59 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB1' HD23 ' A' ' 130' ' ' LEU . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.722 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 17' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.423 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.722 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.441 ' CB ' HD13 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.432 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' O ' HD21 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 59' ' ' VAL . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.331 0.586 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 10' ' ' PHE . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.411 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.43 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.333 0.587 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.549 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.576 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.59 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 130' ' ' LEU . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CG ' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.494 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.745 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 ' HB ' ' CB ' ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.569 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.404 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.408 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.404 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.535 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.434 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.745 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 41' ' ' ASP . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 53' ' ' GLN . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.45 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 HG21 ' CG2' ' A' ' 91' ' ' VAL . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.476 ' CD1' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 4.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.444 0.64 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.442 ' CG2' HG21 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.436 HD21 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.436 ' N ' HD21 ' A' ' 93' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.297 0.57 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.535 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.454 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.552 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.601 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.552 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.551 ' CD1' ' CE1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CG ' ' HB ' ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.479 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.753 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 28' ' ' ARG . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.429 ' HB3' ' N ' ' A' ' 3' ' ' GLY . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.753 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 36' ' ' GLN . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' GLN . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' CG1' ' CG2' ' A' ' 91' ' ' VAL . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 79' ' ' PHE . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.437 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 91' ' ' VAL . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.434 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.337 0.589 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.506 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.551 ' CE1' ' CD1' ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.587 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' HD22 ' A' ' 130' ' ' LEU . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.718 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' CA ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.543 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.574 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.718 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.434 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD2' ' CG2' ' A' ' 15' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' CD1' HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' O ' HD22 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.36 0.6 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.453 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.436 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.4 ' HB2' HG11 ' A' ' 89' ' ' VAL . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 83' ' ' ILE . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 HD21 ' CB ' ' A' ' 80' ' ' ALA . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.431 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.538 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.005 -1.291 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.553 ' CD2' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.6 127.83 34.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.3 . . . . 0.0 112.196 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.724 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 18' ' ' ALA . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 17' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.87 29.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -90.61 32.78 0.94 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.559 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.424 ' OG1' ' CD1' ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.724 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.504 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 10.7 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.58 70.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 5.7 mp -76.69 -53.06 8.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.858 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.89 -1.131 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 5' ' ' LEU . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.7 mp -124.51 137.64 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.999 -1.063 . . . . 0.0 112.044 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.085 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' CA ' HD21 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CZ ' ' CE2' ' A' ' 10' ' ' PHE . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -22.79 67.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 108.996 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 110.428 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.36 16.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 40.03 41.61 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.66 154.09 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.594 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.81 84.71 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 HD21 ' CA ' ' A' ' 77' ' ' ARG . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.279 0.561 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.534 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.486 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.569 HD12 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 130' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 130' ' ' LEU . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CG ' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.494 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.745 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 ' HB ' ' CB ' ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.569 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.404 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.408 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.404 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.535 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.434 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.745 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 41' ' ' ASP . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 53' ' ' GLN . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.45 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 HG21 ' CG2' ' A' ' 91' ' ' VAL . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.476 ' CD1' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 4.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.444 0.64 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.442 ' CG2' HG21 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.436 HD21 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.436 ' N ' HD21 ' A' ' 93' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.297 0.57 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.535 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.454 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.552 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.601 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.552 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.551 ' CD1' ' CE1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CG ' ' HB ' ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.479 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.753 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.506 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 28' ' ' ARG . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.429 ' HB3' ' N ' ' A' ' 3' ' ' GLY . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.753 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 36' ' ' GLN . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' GLN . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' CG1' ' CG2' ' A' ' 91' ' ' VAL . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 79' ' ' PHE . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.437 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 91' ' ' VAL . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.434 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.337 0.589 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.506 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.551 ' CE1' ' CD1' ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.587 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' HD22 ' A' ' 130' ' ' LEU . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.718 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' CA ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.543 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.574 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.718 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.434 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD2' ' CG2' ' A' ' 15' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.442 ' CD1' HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' O ' HD22 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.36 0.6 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.453 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.436 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.4 ' HB2' HG11 ' A' ' 89' ' ' VAL . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 83' ' ' ILE . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 HD21 ' CB ' ' A' ' 80' ' ' ALA . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.431 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.538 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.605 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 130' ' ' LEU . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 17' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.719 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.587 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.482 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.568 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.719 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 36' ' ' GLN . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.411 ' N ' ' O ' ' A' ' 40' ' ' PRO . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' C ' ' CD1' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.448 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' HD22 ' A' ' 5' ' ' LEU . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.442 ' CG1' HG22 ' A' ' 91' ' ' VAL . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 59' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.441 HD12 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.429 ' N ' HD11 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 ' CG1' ' A' ' 59' ' ' VAL . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.482 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.493 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.605 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.605 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 130' ' ' LEU . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 17' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.719 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.587 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.482 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.568 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.719 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 36' ' ' GLN . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.411 ' N ' ' O ' ' A' ' 40' ' ' PRO . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.439 ' C ' ' CD1' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.448 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' HD22 ' A' ' 5' ' ' LEU . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.493 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.442 ' CG1' HG22 ' A' ' 91' ' ' VAL . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 59' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.441 HD12 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.429 ' N ' HD11 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 ' CG1' ' A' ' 59' ' ' VAL . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.482 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.493 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.605 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.12 113.9 4.26 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.595 -1.532 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.591 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 130' ' ' LEU . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.25 -179.88 30.73 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.28 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.85 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.91 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.938 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.727 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.523 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -113.82 112.27 23.12 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.424 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.53 48.36 1.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.411 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.727 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.94 5.68 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.09 162.24 16.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -0.802 . . . . 0.0 109.861 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.77 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.68 25.77 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.371 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.405 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.63 61.08 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.106 -1.232 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.69 155.9 58.09 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.642 1.338 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 1.7 m-20 -65.97 91.72 0.15 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.719 -1.238 . . . . 0.0 109.117 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.5 -17.85 35.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -32.66 33.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.86 29.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.335 0.588 . . . . 0.0 110.291 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.11 -47.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 110.416 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' CD1' HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.79 25.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.8 -5.41 15.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.693 -1.254 . . . . 0.0 111.94 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 52' ' ' TRP . 79.3 mt-30 57.58 109.91 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.352 -0.843 . . . . 0.0 109.446 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.9 Cg_endo -71.06 111.52 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.208 1.11 . . . . 0.0 111.522 -177.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.455 ' O ' HD22 ' A' ' 5' ' ' LEU . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.479 0.657 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -62.89 -48.66 78.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.04 -25.14 64.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.807 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 83' ' ' ILE . . . -59.46 -35.06 73.36 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -22.52 62.03 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.518 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -69.91 -57.19 5.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.773 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.491 ' CD1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 pp -59.71 -28.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.959 -1.088 . . . . 0.0 110.218 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.431 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -67.05 -58.56 4.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.22 -15.85 61.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.26 4.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 4.8 p -95.68 152.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.175 0.988 . . . . 0.0 112.071 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.34 46.8 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.18 128.38 41.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.02 -1.05 . . . . 0.0 108.855 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m170 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 0.0 110.843 -179.063 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.254 0.55 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 127' ' ' VAL . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.523 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' ALA . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.54 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.591 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.568 -0.707 . . . . 0.0 111.231 -179.847 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.597 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.93 130.42 56.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.592 ' HA ' HG12 ' A' ' 17' ' ' VAL . 5.2 m-85 -115.93 134.69 54.72 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.373 -0.829 . . . . 0.0 111.894 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.0 t70 -113.99 92.66 4.05 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.494 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.635 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.725 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 8' ' ' PHE . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB2' ' CA ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.619 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.4 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.94 23.74 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.61 164.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.679 2.253 . . . . 0.0 115.414 -174.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.7 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.71 28.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.98 30.52 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.55 17.46 66.16 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 39.7 m -86.91 108.87 20.4 Favored Pre-proline 0 C--N 1.307 -1.256 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.505 1.266 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.4 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.38 -36.5 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.805 178.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.7 mp -77.48 -52.74 15.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 109.729 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.84 -43.83 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.995 -1.066 . . . . 0.0 110.488 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.0 tt0 -53.07 -42.8 66.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.953 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.89 -38.27 72.57 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.553 178.983 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD2' ' CG ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.08 133.26 28.32 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.067 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.58 -34.17 60.64 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.664 -0.648 . . . . 0.0 109.848 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 5' ' ' LEU . 5.0 mt-10 -141.31 157.58 45.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.018 -1.051 . . . . 0.0 110.668 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.446 ' CD1' ' O ' ' A' ' 56' ' ' GLU . 8.0 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.496 ' CD1' ' CD2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 8' ' ' PHE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 166.65 127.04 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 3.5 pp . . . . . 0 N--CA 1.494 1.749 0 O-C-N 120.934 -1.333 . . . . 0.0 109.778 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.378 0.609 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.429 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.31 -48.4 81.52 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.475 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -26.27 65.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.805 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.12 94.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.35 -16.53 71.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.516 ' CG ' ' CD2' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -98.64 153.84 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.39 78.91 8.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.747 . . . . 0.0 110.794 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.429 ' HG ' ' CG ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.115 0.483 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.463 ' CA ' ' HB2' ' A' ' 9' ' ' ASP . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 9' ' ' ASP . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.567 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.597 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.59 -38.69 72.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.617 -179.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.6 m-85 -55.71 -33.55 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 109.001 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ASP . 92.0 m -150.82 140.47 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -1.226 . . . . 0.0 112.702 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.619 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.4 136.77 52.31 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.449 -0.782 . . . . 0.0 108.951 178.239 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.518 HD11 ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -120.22 144.26 47.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.961 -1.087 . . . . 0.0 108.883 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.532 ' HB2' HD22 ' A' ' 130' ' ' LEU . . . -145.32 124.33 12.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 3.1 m-85 -117.95 149.95 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.841 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.3 t0 -121.16 93.8 4.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.1 p90 -174.26 -155.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.113 -1.435 . . . . 0.0 113.705 -177.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . 159.04 159.12 9.47 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p 45.68 -143.78 0.23 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.055 . . . . 0.0 111.394 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 18.9 mttt -81.96 51.99 1.86 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.04 -1.038 . . . . 0.0 111.389 -178.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -142.02 131.49 23.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.682 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.728 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 31.8 mm -124.62 96.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.16 103.66 0.77 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 103.393 -3.883 . . . . 0.0 103.393 176.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.523 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.48 170.44 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 C-N-CA 116.144 -2.223 . . . . 0.0 114.406 -174.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB1' ' CA ' ' A' ' 127' ' ' VAL . . . -127.66 136.89 52.23 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.306 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.491 ' HA ' HD13 ' A' ' 6' ' ' LEU . 13.9 t -106.76 125.04 62.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.83 135.73 13.08 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 118.714 -1.708 . . . . 0.0 111.277 -177.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -96.74 120.57 37.3 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -91.09 36.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.454 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.585 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 178.171 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.402 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.52 -16.52 10.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 178.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.61 35.83 7.68 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.089 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.75 161.21 20.5 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.855 -1.379 . . . . 0.0 111.064 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -124.88 123.29 39.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.046 -1.034 . . . . 0.0 112.375 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HG3' ' HD2' ' A' ' 29' ' ' PRO . 24.6 ttt-85 -88.19 146.12 37.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 50.5 Cg_endo -90.74 141.1 3.09 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 O-C-N 122.792 0.891 . . . . 0.0 112.89 -176.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -99.55 139.65 21.04 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.031 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 21.7 Cg_endo -42.65 169.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.013 2.475 . . . . 0.0 115.965 -174.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.62 143.79 57.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.827 -176.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.728 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.87 53.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.495 -1.684 . . . . 0.0 115.53 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.98 96.24 3.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.829 -1.17 . . . . 0.0 109.273 176.133 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.85 160.86 16.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.577 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -83.81 116.64 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.083 -1.011 . . . . 0.0 111.336 -178.609 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 48.2 27.75 1.37 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 94.81 12.33 55.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 20.5 m -95.47 110.52 51.28 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.022 -1.281 . . . . 0.0 109.631 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.45 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.9 Cg_endo -73.53 159.18 46.69 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.472 1.248 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.2 m-20 -63.39 91.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.923 -1.111 . . . . 0.0 108.118 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.45 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 11.4 t-105 -87.69 -16.8 33.31 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.224 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -80.02 -35.07 37.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.8 mp -74.49 -50.05 28.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.725 -0.61 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 49' ' ' LEU . 12.1 mt -71.23 -43.58 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.907 -1.121 . . . . 0.0 110.466 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 33.8 tp10 -49.2 -43.0 42.0 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.166 -0.959 . . . . 0.0 109.26 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -57.57 -48.22 79.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' GLN . 2.6 mt -59.61 -24.95 64.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.856 178.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.453 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -84.1 -46.8 11.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.621 -0.674 . . . . 0.0 112.136 -178.408 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -50.72 9.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 112.286 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -84.22 -30.63 25.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.046 . . . . 0.0 112.162 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -109.12 -30.74 7.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 0.0 111.74 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 54.2 97.07 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.083 -1.011 . . . . 0.0 109.477 -178.589 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -68.6 124.2 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.446 1.235 . . . . 0.0 110.614 -179.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' THR . 3.9 t0 -71.31 -39.0 71.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.53 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' HD21 ' A' ' 5' ' ' LEU . 12.9 tt0 -135.28 154.37 51.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.2 mp -133.94 136.83 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.799 -1.188 . . . . 0.0 112.682 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -120.2 113.92 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.073 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 83' ' ' ILE . 2.3 t -134.08 151.58 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.173 -1.579 . . . . 0.0 112.993 -177.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.44 141.32 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.661 177.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.328 0.585 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.77 -45.93 90.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.189 -0.944 . . . . 0.0 109.784 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -56.97 -30.99 64.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.169 -0.957 . . . . 0.0 109.401 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.497 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 74.4 t80 -61.6 -38.61 88.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.931 178.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 93' ' ' LEU . . . -56.72 -33.28 66.34 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -68.89 -22.87 64.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.905 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.67 6.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.445 ' CD1' HG12 ' A' ' 59' ' ' VAL . 34.7 pt -59.69 -30.12 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.853 -1.154 . . . . 0.0 109.151 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.9 t-160 -64.37 -58.32 6.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 109.754 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.43 -16.19 42.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -71.78 -44.82 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -1.225 . . . . 0.0 110.669 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 -10.62 9.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 110.842 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 42.56 16.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.412 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.7 m -104.53 153.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -1.047 . . . . 0.0 110.715 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.07 83.89 2.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 0.0 111.225 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 57' ' ' ILE . 2.8 p -90.76 151.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -121.28 155.29 35.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.92 -0.488 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 80' ' ' ALA . 21.2 mt -92.28 142.68 27.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.041 -1.037 . . . . 0.0 110.621 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.5 ' CG ' HG12 ' A' ' 129' ' ' ILE . 16.4 t-160 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.14 0.495 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.49 60.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.222 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 1.5 m -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.807 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.41 -50.68 8.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.878 -1.139 . . . . 0.0 109.222 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.41 -23.15 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.332 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 128' ' ' ILE . 12.4 mm -70.13 -41.64 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 174.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 38.3 mt -63.92 -35.16 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 176.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.561 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -67.08 -34.61 78.03 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.147 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -20.33 64.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.852 -1.155 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -48.56 26.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -58.15 -40.41 81.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.889 -1.132 . . . . 0.0 109.642 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.4 m-85 -52.61 -45.64 66.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.071 -1.018 . . . . 0.0 109.616 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.98 179.37 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.11 113.87 4.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.554 -1.557 . . . . 0.0 111.027 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.591 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 130' ' ' LEU . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.27 -179.86 30.74 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.27 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.825 -179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.88 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.115 -0.99 . . . . 0.0 110.938 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.727 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.523 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -113.83 112.33 23.2 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.39 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.56 48.36 1.53 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.411 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.727 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.89 5.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.02 162.24 16.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 109.898 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.71 20.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.156 -0.965 . . . . 0.0 111.154 -178.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.75 25.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.405 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.64 61.05 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.077 -1.249 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.7 155.94 57.99 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.586 1.308 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 1.7 m-20 -66.04 91.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.734 -1.229 . . . . 0.0 109.098 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.47 -17.92 35.1 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.22 -32.66 33.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.95 28.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.317 0.58 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.04 -47.63 67.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.477 -0.765 . . . . 0.0 110.453 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 ' CD1' HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.82 25.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.77 -5.37 15.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.702 -1.249 . . . . 0.0 111.95 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 52' ' ' TRP . 79.3 mt-30 57.59 109.94 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.9 Cg_endo -71.09 111.52 3.09 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.276 1.145 . . . . 0.0 111.522 -177.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.455 ' O ' HD22 ' A' ' 5' ' ' LEU . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.479 0.657 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -62.89 -48.69 77.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.0 -25.17 64.37 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 108.815 178.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 83' ' ' ILE . . . -59.46 -35.07 73.38 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -22.46 62.01 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.56 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -69.91 -57.21 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.491 ' CD1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 pp -59.68 -28.83 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.934 -1.104 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.431 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -67.06 -58.57 4.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.123 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.2 -15.85 61.51 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.27 4.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 4.8 p -95.75 152.52 3.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 122.202 1.001 . . . . 0.0 112.018 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.35 46.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.13 128.37 41.91 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.999 -1.063 . . . . 0.0 108.854 -179.798 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m170 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 110.843 -179.088 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.254 0.55 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 127' ' ' VAL . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.523 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' ALA . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.54 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.591 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.262 -179.853 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.597 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.93 130.47 56.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.592 ' HA ' HG12 ' A' ' 17' ' ' VAL . 5.2 m-85 -115.99 134.63 54.76 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.357 -0.84 . . . . 0.0 111.863 -178.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.1 t70 -113.92 92.65 4.05 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.494 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.635 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.725 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 8' ' ' PHE . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB2' ' CA ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.619 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.5 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.563 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.89 23.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.51 164.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.668 2.245 . . . . 0.0 115.462 -174.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.72 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.72 28.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.97 30.51 4.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 110.147 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.56 17.42 66.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 40.2 m -86.83 108.83 20.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.145 -1.209 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.502 1.264 . . . . 0.0 109.475 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.5 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.4 -36.44 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.834 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.7 mp -77.52 -52.74 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.809 -0.557 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.89 -43.77 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.995 -1.066 . . . . 0.0 110.518 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 4.9 tt0 -53.07 -42.84 66.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.918 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.86 -38.27 72.48 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.553 179.007 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD2' ' CG ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.057 -1.027 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.448 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.06 133.25 28.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.083 -178.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.59 -34.17 60.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.724 -0.61 . . . . 0.0 109.848 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 5' ' ' LEU . 5.0 mt-10 -141.3 157.57 45.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.018 -1.051 . . . . 0.0 110.623 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.446 ' CD1' ' O ' ' A' ' 56' ' ' GLU . 7.9 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.496 ' CD1' ' CD2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 8' ' ' PHE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 166.65 127.06 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 3.5 pp . . . . . 0 N--CA 1.494 1.77 0 O-C-N 120.969 -1.313 . . . . 0.0 109.779 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.378 0.609 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.429 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.37 -48.36 81.61 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.469 179.671 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -26.23 65.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.765 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . 0.446 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.15 94.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.3 -16.51 71.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.516 ' CG ' ' CD2' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -98.62 153.85 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.533 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 78.91 8.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.714 . . . . 0.0 110.794 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.429 ' HG ' ' CG ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.115 0.483 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.463 ' CA ' ' HB2' ' A' ' 9' ' ' ASP . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 9' ' ' ASP . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.567 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.597 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.56 -38.72 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.629 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.6 m-85 -55.69 -33.55 64.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.001 179.022 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -152.21 138.71 18.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 22' ' ' ARG . . . -163.72 81.31 0.12 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.569 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' ILE . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.545 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.742 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.638 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' HD11 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.742 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' CB ' HD12 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 8' ' ' PHE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.476 ' CG ' ' O ' ' A' ' 61' ' ' LEU . 1.7 pp -104.61 107.69 58.75 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -88.43 113.41 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 109.488 -1.004 . . . . 0.0 109.488 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 131.51 42.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.956 -1.09 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.99 123.97 29.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.691 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 tpt -84.53 -44.28 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.891 -1.131 . . . . 0.0 109.668 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.42 -2.27 20.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 110.477 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 -25.73 19.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.89 -160.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -1.023 . . . . 0.0 109.742 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.13 163.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.151 -0.968 . . . . 0.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.05 107.37 4.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.94 -6.58 19.4 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.596 1.314 . . . . 0.0 110.754 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -25.08 64.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 0.0 110.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.93 -19.06 5.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.301 -0.875 . . . . 0.0 111.412 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.31 -35.39 7.89 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 109.88 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -74.67 -27.87 60.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.392 -0.818 . . . . 0.0 109.119 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -66.79 -50.85 61.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.426 -0.796 . . . . 0.0 109.949 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.418 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.405 ' NE2' ' OG ' ' A' ' 132' ' ' SER . 10.4 t-160 -83.34 120.72 26.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.95 143.24 28.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.29 -0.881 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -74.17 82.93 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.013 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -19.42 39.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.755 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -25.33 64.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.205 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -115.61 88.23 2.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.918 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 m -138.04 -52.14 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.648 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.48 152.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.59 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.63 -45.49 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.805 . . . . 0.0 110.051 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 170.62 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.142 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -117.61 64.5 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 15.43 25.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.96 -76.36 0.67 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 93.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -44.98 5.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -75.39 96.38 3.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -55.98 -28.19 56.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.026 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -98.09 115.15 5.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.98 160.73 10.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 66.8 t80 53.71 35.67 21.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 0.0 110.013 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -61.64 165.43 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.258 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.39 110.6 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.09 107.24 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -170.36 125.65 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -25.89 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.93 77.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -101.19 146.38 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -1.133 . . . . 0.0 110.066 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.16 24.9 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.405 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -87.75 58.24 4.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.995 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.403 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m 55.04 29.33 12.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 110.481 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.503 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' ALA . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 133' ' ' TYR 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.405 ' OG ' ' NE2' ' A' ' 94' ' ' HIS . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.26 -27.46 42.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 -18.91 43.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.915 . . . . 0.0 110.109 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.51 51.64 56.62 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.155 -1.203 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.26 0.552 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 1.8 m 58.28 109.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.41 -92.06 0.09 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.41 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 68.6 m -143.29 147.03 34.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.079 -1.247 . . . . 0.0 111.699 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.566 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -126.79 142.08 51.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.128 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' CD1' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -130.09 144.82 51.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' CB ' ' CD2' ' A' ' 130' ' ' LEU . . . -153.8 126.01 7.93 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.889 -1.132 . . . . 0.0 110.319 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 1.9 m-85 -123.67 136.5 54.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.305 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 12.8 t70 -106.14 96.68 6.64 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.605 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.9 p90 -174.16 -159.68 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.55 ' CA ' ' CE2' ' A' ' 79' ' ' PHE . . . -166.26 -148.03 5.41 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.057 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 78.9 p -37.52 -91.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.655 -0.909 . . . . 0.0 113.098 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.45 49.51 0.94 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.679 -1.263 . . . . 0.0 111.473 -178.203 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.94 134.25 27.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 110.373 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.734 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 32.9 mm -126.39 94.96 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . -125.42 103.94 0.74 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 103.349 -3.901 . . . . 0.0 103.349 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -141.0 164.79 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.79 -174.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' HB2' ' CA ' ' A' ' 127' ' ' VAL . . . -125.68 129.97 50.62 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG12 ' HG ' ' A' ' 48' ' ' LEU . 10.9 t -102.48 125.89 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -120.59 146.49 17.64 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 118.251 -1.928 . . . . 0.0 112.31 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 21' ' ' GLN . 7.0 pt20 -95.86 121.44 37.59 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.43 ' CD ' ' OH ' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -89.87 31.43 0.96 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.698 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.57 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.97 -32.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.406 ' OG1' HD12 ' A' ' 23' ' ' ILE . 86.2 m -115.92 -17.33 11.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.63 34.43 9.25 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.659 -1.258 . . . . 0.0 109.959 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 161.59 20.4 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.946 -1.326 . . . . 0.0 110.583 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -134.59 135.04 41.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.925 -1.11 . . . . 0.0 112.422 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -98.91 153.72 37.69 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -91.61 134.71 1.59 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.292 1.154 . . . . 0.0 112.094 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' HG ' ' HD2' ' A' ' 31' ' ' PRO . 1.6 tt -99.44 141.26 22.51 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.36 167.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.811 2.341 . . . . 0.0 116.223 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.56 144.84 56.92 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.053 1.406 . . . . 0.0 114.284 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.734 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.23 55.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 112.976 -1.92 . . . . 0.0 115.835 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 37.5 tptt -133.73 96.78 3.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.852 -1.155 . . . . 0.0 109.81 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.95 161.14 16.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.411 ' O ' ' HB ' ' A' ' 39' ' ' THR . 42.7 mt-30 -85.24 120.97 27.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.214 -0.929 . . . . 0.0 111.498 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.26 27.34 1.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.046 -1.034 . . . . 0.0 110.278 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.08 16.82 55.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 23.1 m -94.8 109.39 43.57 Favored Pre-proline 0 C--N 1.306 -1.284 0 O-C-N 121.082 -1.246 . . . . 0.0 109.789 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.448 ' CB ' HD13 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -68.88 155.92 67.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.572 1.301 . . . . 0.0 109.165 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 3.2 m-20 -63.71 91.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.976 -1.077 . . . . 0.0 108.87 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 13.4 t90 -91.95 -21.6 20.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.74 -37.97 26.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.947 . . . . 0.0 109.889 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -73.12 -50.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.736 -0.602 . . . . 0.0 110.045 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 20.6 mt -70.34 -49.32 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.952 -1.092 . . . . 0.0 111.025 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -54.06 -32.94 56.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.67 -1.269 . . . . 0.0 109.815 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -61.02 -47.21 87.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.309 -0.87 . . . . 0.0 109.37 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD1' ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.52 -27.07 31.94 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 109.03 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -66.16 -54.64 22.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 111.221 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -74.84 -25.82 59.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.941 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -81.26 -38.3 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 0.0 110.771 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -109.71 -20.56 12.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.074 -1.016 . . . . 0.0 111.109 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER 56.52 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 46.8 Cg_endo -72.04 134.53 23.5 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.8 1.421 . . . . 0.0 111.117 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.92 -35.8 23.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 110.725 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.58 144.85 50.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 5.0 mp -130.02 137.75 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.527 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -124.54 114.28 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 83' ' ' ILE . 1.1 p -134.67 151.29 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.229 -1.544 . . . . 0.0 114.008 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 151.16 140.5 3.18 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.297 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -103.47 127.21 30.09 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' N ' HD21 ' A' ' 61' ' ' LEU . 53.5 Cg_endo -90.82 115.63 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.15 1.079 . . . . 0.0 110.695 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD23 ' CD2' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -130.98 132.7 45.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.924 -1.11 . . . . 0.0 110.863 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -81.86 129.53 34.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.192 -0.942 . . . . 0.0 110.228 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.4 tpp -83.7 -45.75 13.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.982 -1.074 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -11.24 15.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.451 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.88 -49.18 0.81 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 t -111.45 -176.61 2.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -1.014 . . . . 0.0 109.506 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' OE1' ' NH2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 48.91 -155.84 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.417 ' NE2' ' HB3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -176.98 77.02 0.25 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 0.0 110.548 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 -10.15 25.37 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.865 1.455 . . . . 0.0 110.404 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.17 -23.85 37.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.177 -0.952 . . . . 0.0 110.354 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.457 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -53.93 -21.13 7.23 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 111.334 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.05 -40.29 30.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.873 -1.142 . . . . 0.0 108.548 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.71 71.31 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . . . -58.47 -37.39 75.4 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.233 -0.917 . . . . 0.0 108.538 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 3.4 ttm180 -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -56.04 -32.14 63.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.666 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 7.6 m-30 -57.83 -47.72 81.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.026 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 59' ' ' VAL . . . -55.34 -34.69 64.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -80.29 -24.07 40.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 109.198 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.4 ' HB2' ' HA ' ' A' ' 79' ' ' PHE . 2.1 mtt180 -77.3 -56.71 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 91' ' ' VAL . 16.2 pt -62.14 -38.88 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 109.412 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.441 ' N ' HG13 ' A' ' 83' ' ' ILE . 1.9 t60 -58.6 -42.14 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.496 -0.753 . . . . 0.0 109.901 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.72 -16.81 80.41 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -44.82 23.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -1.222 . . . . 0.0 110.433 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -119.6 -13.15 9.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.01 -1.057 . . . . 0.0 110.881 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 82.24 32.76 27.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.4 m -91.14 153.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.485 -1.009 . . . . 0.0 110.686 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 81.69 6.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.756 . . . . 0.0 110.531 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.497 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 8.7 p -100.31 152.3 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 153.85 29.78 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -92.66 138.64 31.32 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.027 -1.046 . . . . 0.0 108.907 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.482 ' N ' ' CD2' ' A' ' 93' ' ' LEU . 8.1 t60 -80.31 103.31 10.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.786 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.26 145.58 29.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 0.0 110.726 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.417 ' HB3' ' NE2' ' A' ' 70' ' ' GLN . 25.6 mm-40 -129.61 32.79 4.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.405 ' NH2' ' OE1' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -73.08 -4.82 34.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 110.789 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -22.35 63.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.71 63.82 4.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.125 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.4 m -94.2 -12.17 28.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.635 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -55.53 151.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.064 . . . . 0.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.74 -49.36 4.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.415 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 48.61 68.98 0.61 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.897 . . . . 0.0 110.479 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.57 62.83 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.257 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 t -100.93 4.94 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.73 113.21 0.53 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -130.23 136.15 48.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -1.16 . . . . 0.0 109.94 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 1.5 m-85 -145.58 100.14 3.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.336 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -92.78 20.66 6.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -114.88 165.9 12.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.267 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.11 -91.63 0.1 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.95 126.31 1.1 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -96.09 123.71 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.119 . . . . 0.0 110.148 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -154.62 71.12 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.25 -166.04 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.0 mt 53.44 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.63 171.77 17.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.239 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 162.96 20.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.115 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -120.5 142.61 15.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -116.21 134.1 55.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.154 . . . . 0.0 110.407 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.07 111.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -65.62 -158.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.377 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.06 -60.21 0.37 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 0.0 111.127 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HA ' ' CG1' ' A' ' 127' ' ' VAL . . . -48.57 -29.68 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 0.0 110.9 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.4 p -54.7 -33.39 60.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 111.526 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.561 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -77.71 -55.77 5.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.151 . . . . 0.0 109.266 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -53.47 -24.3 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.456 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.3 mp -76.76 -46.01 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.455 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 17.0 mt -53.73 -27.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -67.55 -39.81 84.98 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.894 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -34.18 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -32.35 67.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.566 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 t80 -75.11 -54.46 7.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.68 -0.638 . . . . 0.0 109.754 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.532 ' CZ ' HD13 ' A' ' 130' ' ' LEU . 25.2 m-85 -52.18 -28.98 20.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.074 -1.016 . . . . 0.0 109.558 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -22.55 40.52 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.486 -0.759 . . . . 0.0 109.677 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -79.54 -11.13 59.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.203 -0.936 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.49 -57.86 3.48 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.307 -1.114 . . . . 0.0 110.207 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.213 0.53 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.446 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 69.1 p -154.99 122.61 5.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 110.044 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.25 -92.43 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.7 m -147.5 138.34 23.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.968 -1.313 . . . . 0.0 112.209 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' CB ' HD23 ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.481 ' CA ' HG13 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.737 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 8' ' ' PHE . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' CD ' HD13 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.688 0.756 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.4 28.75 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.553 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -128.03 126.7 41.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.124 -0.985 . . . . 0.0 111.155 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.518 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.1 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 138.01 58.19 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 123.004 1.383 . . . . 0.0 113.772 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.035 -1.893 . . . . 0.0 115.73 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.05 159.76 17.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.374 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.02 123.92 33.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -0.883 . . . . 0.0 110.821 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -0.93 . . . . 0.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 13' ' ' LYS . . . 90.33 18.94 47.59 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 17.2 m -92.81 107.7 26.46 Favored Pre-proline 0 C--N 1.307 -1.275 0 O-C-N 121.06 -1.259 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.468 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.24 157.62 56.71 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.641 1.337 . . . . 0.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 32.4 m-20 -64.47 90.79 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.55 -20.45 54.1 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.359 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -30.89 30.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.837 -0.539 . . . . 0.0 111.764 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 52' ' ' TRP . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.42 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.83 -51.63 8.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.907 -1.121 . . . . 0.0 112.281 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HD22 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.775 -1.203 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.173 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 46.9 Cg_endo -73.74 136.86 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.735 1.387 . . . . 0.0 111.422 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.79 -45.18 37.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 110.074 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -133.86 140.3 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.067 . . . . 0.0 109.606 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 3.8 mp -117.7 137.89 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.002 . . . . 0.0 111.856 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -121.29 122.42 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 60' ' ' GLY . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -118.3 113.46 37.06 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.07 115.86 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.375 1.197 . . . . 0.0 110.555 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.56 133.59 46.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 110.284 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -80.46 131.4 35.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.207 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -44.9 14.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.031 . . . . 0.0 110.027 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.48 -11.28 15.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.334 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.2 -51.07 0.77 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 6.4 t -105.3 -165.15 1.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.382 -1.069 . . . . 0.0 109.523 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 68' ' ' THR . 19.1 pt-20 37.87 -157.12 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.165 0.507 . . . . 0.0 111.47 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.8 67.12 0.22 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 -30.08 14.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.925 1.487 . . . . 0.0 110.089 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.08 -30.01 68.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.88 -19.57 18.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.875 . . . . 0.0 111.237 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.28 -33.39 5.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 109.646 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -80.05 -30.3 39.4 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -65.09 -45.05 86.78 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 108.908 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -57.02 4.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.442 HD13 HG11 ' A' ' 59' ' ' VAL . 23.5 pt -57.78 -25.75 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.068 . . . . 0.0 109.798 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.68 62.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.81 -16.26 75.62 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 68.7 m-85 -119.1 -11.92 9.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 110.322 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.97 31.62 42.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.17 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.682 -0.893 . . . . 0.0 110.773 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.29 125.83 40.19 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.887 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -87.95 101.66 13.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.35 143.88 50.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.821 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -79.59 57.57 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -63.49 -29.61 70.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 0.0 110.213 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -18.65 65.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.892 . . . . 0.0 110.209 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 t -56.88 92.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.38 127.73 6.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.165 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.8 152.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.184 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.31 -22.9 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 62.14 135.1 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.402 -0.811 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.42 39.74 31.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 p -114.21 19.45 16.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.905 . . . . 0.0 110.26 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.82 -140.69 12.61 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.99 137.51 39.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 110.272 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.57 39.73 3.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -95.91 -59.17 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -75.75 -60.6 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 110.295 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.08 -53.97 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.82 -94.64 0.09 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 56.0 m-85 -125.77 79.86 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.213 -1.169 . . . . 0.0 110.333 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 51.73 57.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.61 173.48 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.14 -46.04 0.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.187 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.56 158.04 27.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.149 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -153.81 80.34 1.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.18 141.73 10.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -167.86 147.62 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -1.055 . . . . 0.0 110.082 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.26 139.48 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 110.363 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -173.24 -37.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.908 . . . . 0.0 110.129 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.89 21.62 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.553 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -21.62 64.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 109.281 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CE2' HD13 ' A' ' 130' ' ' LEU . 4.0 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -24.36 39.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -13.18 32.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.35 -21.35 59.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.181 -1.188 . . . . 0.0 110.163 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.311 0.577 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.77 128.13 13.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.92 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.6 m -142.63 134.84 27.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.965 -1.315 . . . . 0.0 112.505 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.604 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -126.31 140.6 52.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -135.03 134.32 40.3 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.481 -1.387 . . . . 0.0 110.772 179.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.526 ' O ' HG11 ' A' ' 17' ' ' VAL . . . -118.33 122.96 44.17 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.535 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 33.6 m-85 -109.04 131.95 54.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.52 -0.738 . . . . 0.0 111.764 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 18.1 t70 -113.34 93.2 4.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.626 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.0 p90 -177.65 -164.57 0.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.244 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.56 168.56 33.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 55.7 p -60.01 77.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.89 -1.359 . . . . 0.0 111.654 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' GLY . 3.7 mttp 162.67 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.528 -0.733 . . . . 0.0 110.678 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -137.84 142.29 40.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -178.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.609 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 36.5 mm -122.92 102.22 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' HG21 ' A' ' 17' ' ' VAL . . . -129.5 103.9 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 104.126 -3.59 . . . . 0.0 104.126 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 30' ' ' LEU . 39.8 t -135.75 167.13 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 116.713 -1.995 . . . . 0.0 114.091 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.52 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -128.67 131.64 48.03 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.544 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 68.5 t -101.08 135.88 35.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.85 -1.156 . . . . 0.0 108.091 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -111.71 141.03 16.45 Favored Glycine 0 N--CA 1.484 1.85 0 C-N-CA 119.047 -1.549 . . . . 0.0 111.352 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -95.87 112.85 24.47 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -87.58 21.49 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.582 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.573 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.81 -32.66 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.412 HG21 ' CD1' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -117.73 -17.37 9.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.61 34.74 11.19 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.92 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 158.48 26.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.738 -1.448 . . . . 0.0 110.909 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.86 119.44 30.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.844 -1.16 . . . . 0.0 111.737 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 19' ' ' VAL . 31.8 ttm105 -86.98 154.54 55.24 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.0 Cg_endo -91.53 137.36 1.98 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.134 1.071 . . . . 0.0 112.151 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.542 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 1.2 tt -99.74 141.23 22.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.508 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 22.2 Cg_endo -43.25 169.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.839 2.359 . . . . 0.0 116.086 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ILE . . . -65.41 150.3 48.56 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 123.528 1.632 . . . . 0.0 115.069 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.609 ' HA ' ' C ' ' A' ' 15' ' ' ILE 0.279 0.9 OUTLIER -51.22 -126.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.462 -2.153 . . . . 0.0 112.783 179.838 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' H ' ' CG1' ' A' ' 33' ' ' ILE . 0.7 OUTLIER 34.87 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.211 -0.931 . . . . 0.0 112.468 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.9 160.48 17.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.932 -1.105 . . . . 0.0 109.752 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.09 115.21 26.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 111.419 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.3 25.79 0.95 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.849 . . . . 0.0 110.372 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.76 17.23 42.21 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.1 m -94.98 106.94 28.3 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 120.999 -1.295 . . . . 0.0 109.993 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.4 Cg_endo -72.22 162.53 41.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.575 1.303 . . . . 0.0 109.734 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -64.27 92.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.001 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.428 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 31.3 t90 -90.45 -17.23 27.53 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.457 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.8 m-20 -81.65 -35.4 29.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.811 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.452 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -82.4 -48.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.854 -0.529 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 18.5 mt -70.75 -33.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.155 -0.966 . . . . 0.0 111.16 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.3 OUTLIER -76.8 -45.22 29.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.924 -1.11 . . . . 0.0 110.427 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CD ' ' O ' ' A' ' 43' ' ' ASN . 1.9 mtt180 -52.44 -41.46 63.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.473 ' CD1' ' C ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.28 -28.71 34.58 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.107 -0.996 . . . . 0.0 109.066 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.13 -49.78 76.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -1.0 . . . . 0.0 110.48 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -72.43 -32.35 66.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 111.053 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.85 -42.53 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.103 . . . . 0.0 111.221 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.443 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 49.0 m95 -111.01 -27.5 8.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.899 -1.125 . . . . 0.0 111.562 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.7 mt-30 59.48 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.022 -1.049 . . . . 0.0 109.487 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 46.8 Cg_endo -71.37 129.61 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.605 1.319 . . . . 0.0 111.44 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -80.34 -40.21 27.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 110.58 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -132.9 155.16 49.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 109.879 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 ' N ' HD13 ' A' ' 57' ' ' ILE . 4.9 mp -133.15 137.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 112.695 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.64 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.476 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 74.0 t -131.82 150.73 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.975 -1.703 . . . . 0.0 113.065 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 170.14 121.13 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.245 -0.978 . . . . 0.0 110.833 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.08 149.19 97.18 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.891 -1.358 . . . . 0.0 109.535 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.457 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 44.2 Cg_endo -71.89 135.12 24.95 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.278 1.146 . . . . 0.0 111.323 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' CD2' HD12 ' A' ' 61' ' ' LEU . 3.9 mm? -90.03 164.35 14.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -50.89 126.11 15.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.355 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 79.5 mmm -80.98 -43.42 19.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.291 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.43 15.8 26.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 110.315 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.441 ' O ' ' CG2' ' A' ' 68' ' ' THR . . . -124.88 45.78 1.14 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 67' ' ' GLY . 11.0 t 36.57 -153.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.07 -0.665 . . . . 0.0 111.784 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.36 160.39 14.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 110.256 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.43 155.46 31.67 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.314 -0.866 . . . . 0.0 110.409 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 -6.64 19.48 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.766 1.403 . . . . 0.0 111.22 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -24.56 5.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.7 -19.72 6.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 111.127 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.54 -28.87 2.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.932 -1.105 . . . . 0.0 109.822 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -29.02 50.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 108.919 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -64.57 -45.35 87.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.637 -0.665 . . . . 0.0 109.786 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -48.44 81.77 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -25.24 62.8 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.995 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.487 ' CE2' ' O ' ' A' ' 10' ' ' PHE . 0.8 OUTLIER -63.13 -45.51 91.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.34 -29.44 70.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.463 -0.773 . . . . 0.0 109.104 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -67.15 -23.25 65.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -56.93 4.04 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 110.45 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.434 ' CD1' HG11 ' A' ' 59' ' ' VAL . 16.2 pt -56.16 -28.82 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.473 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.41 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 32.5 t-80 -70.2 -50.99 34.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.345 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.81 -15.55 79.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -74.66 -44.27 51.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.918 -1.342 . . . . 0.0 110.5 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -113.64 -11.09 13.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.394 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.62 48.22 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.49 153.91 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.636 -0.92 . . . . 0.0 110.949 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.55 88.5 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.676 . . . . 0.0 109.768 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.417 ' CG2' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -88.87 151.05 3.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.087 0.946 . . . . 0.0 111.48 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.36 39.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.427 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -101.58 127.4 48.31 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.024 -1.048 . . . . 0.0 109.342 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.409 ' N ' HD21 ' A' ' 93' ' ' LEU . 42.7 t-80 -87.32 108.91 19.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.77 138.15 34.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.34 30.7 7.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.177 -0.952 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -83.75 -21.18 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.115 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.32 -18.53 48.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.262 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 t -54.22 164.36 0.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.083 -1.01 . . . . 0.0 110.499 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -141.09 178.72 7.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.02 152.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.083 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -38.16 90.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.88 99.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.538 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.33 153.69 44.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 p -94.05 17.09 13.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.478 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.64 169.62 11.31 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.83 120.32 8.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -1.188 . . . . 0.0 110.33 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 t80 53.04 35.35 19.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.75 139.11 33.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.17 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.04 95.63 2.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.71 78.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.04 -112.91 0.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -173.37 -176.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -1.222 . . . . 0.0 110.173 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -156.65 73.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 110.37 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.33 61.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 110.343 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -24.52 35.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.77 -173.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.096 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -97.28 -26.06 15.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.189 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 142.38 -115.96 1.0 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER 54.33 -173.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -1.092 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 120' ' ' LYS . 98.8 t 56.57 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 110.627 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 18.3 p-10 -121.29 158.56 27.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.091 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.07 26.79 5.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.438 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -79.06 -40.07 32.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.5 m -52.91 -23.13 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.966 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.84 -55.3 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.065 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.52 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.14 -24.36 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.432 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -72.08 -45.53 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.468 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 68.0 mt -62.43 -41.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.548 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.4 OUTLIER -56.55 -48.1 78.04 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.195 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -21.59 40.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 0.0 109.965 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 p -70.31 -50.62 37.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.751 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.604 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.29 -40.99 78.93 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.139 -0.976 . . . . 0.0 110.111 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -53.45 -31.22 44.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.831 -1.168 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.23 -20.95 43.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.491 -0.755 . . . . 0.0 109.946 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.18 -9.87 22.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -132.5 55.26 0.76 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.202 -1.175 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -86.05 -75.05 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 110.179 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.29 -79.09 0.14 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.8 m -150.37 135.1 17.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.34 . . . . 0.0 112.427 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.581 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -126.7 143.87 51.1 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -135.72 134.3 38.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.435 -1.416 . . . . 0.0 110.521 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -118.56 123.32 44.77 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.573 ' HA ' HG12 ' A' ' 17' ' ' VAL . 29.0 m-85 -108.83 129.95 55.4 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.57 0.7 . . . . 0.0 111.789 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 21.8 t70 -112.65 91.99 3.85 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -173.89 -172.93 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.48 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.507 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -144.66 -177.18 19.3 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.474 ' N ' ' CE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -71.47 63.36 0.39 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.117 -1.225 . . . . 0.0 111.598 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 12' ' ' THR . 4.4 ptmt 171.57 -27.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.233 -0.917 . . . . 0.0 110.61 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.593 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -125.44 143.44 50.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.0 108.756 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.702 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 33.5 mm -124.78 97.12 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -125.55 104.06 0.74 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 104.244 -3.543 . . . . 0.0 104.244 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 8' ' ' PHE . 38.3 t -134.85 165.8 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 116.623 -2.031 . . . . 0.0 113.688 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -129.7 131.72 46.42 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 28' ' ' ARG . 73.7 t -101.51 137.43 29.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 108.082 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.61 136.82 13.87 Favored Glycine 0 N--CA 1.485 1.928 0 O-C-N 120.507 -1.371 . . . . 0.0 110.589 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.64 117.41 30.41 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.161 -1.2 . . . . 0.0 108.04 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HG3' ' CB ' ' A' ' 5' ' ' LEU . 2.5 mtm180 -90.08 24.51 2.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.343 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -32.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -16.82 10.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.486 -0.759 . . . . 0.0 109.99 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 33.54 22.31 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.09 161.55 21.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.982 -1.305 . . . . 0.0 110.807 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.497 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.04 122.5 39.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.868 -1.145 . . . . 0.0 112.068 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' VAL . 11.6 ttm180 -87.3 153.11 53.53 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.3 Cg_endo -91.43 139.37 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.132 1.069 . . . . 0.0 112.364 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.82 142.47 24.68 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.29 167.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.846 2.364 . . . . 0.0 115.993 -174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.89 143.49 57.91 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 123.234 1.492 . . . . 0.0 114.834 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.702 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.7 50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 112.916 -1.947 . . . . 0.0 115.623 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.6 mmtt -131.63 97.43 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.864 -1.147 . . . . 0.0 109.654 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.61 161.09 16.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 110.251 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -85.71 120.57 27.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.876 . . . . 0.0 111.218 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 48.72 25.46 1.01 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -0.979 . . . . 0.0 110.495 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 93.7 17.28 42.19 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 21.4 m -98.72 115.72 65.66 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 121.141 -1.211 . . . . 0.0 110.03 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.444 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -69.79 157.7 59.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.433 1.228 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.429 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -64.54 91.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.942 -1.099 . . . . 0.0 109.177 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 26.9 t90 -90.94 -16.9 27.29 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -80.38 -34.53 36.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.432 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.6 mp -81.99 -55.13 8.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.699 -0.625 . . . . 0.0 109.768 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 32.1 mt -59.62 -37.81 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 2.1 tm-20 -72.9 -31.18 64.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.944 -1.097 . . . . 0.0 109.962 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -64.92 -50.66 65.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' CD1' HD11 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -73.69 -25.02 60.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 109.959 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.46 -53.75 50.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.104 . . . . 0.0 110.504 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.44 -23.52 63.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.44 -41.22 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 111.346 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -109.08 -17.54 13.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.836 -1.165 . . . . 0.0 111.359 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' LEU . 5.7 mt-30 54.08 97.24 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.15 -0.969 . . . . 0.0 109.835 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.3 Cg_endo -71.56 125.41 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.664 1.349 . . . . 0.0 110.971 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -73.52 -41.91 62.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' O ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -138.24 157.87 45.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.031 -1.043 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 57' ' ' ILE . 4.7 mp -132.68 137.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 112.244 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 HG21 HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -113.86 122.13 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 60' ' ' GLY . 76.7 t -133.94 150.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 120.147 -1.596 . . . . 0.0 113.088 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 172.66 118.22 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 3.8 pp -63.66 148.39 94.32 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.09 137.68 45.03 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.582 1.306 . . . . 0.0 110.506 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 64' ' ' ASN . 62.7 tp -95.11 163.98 13.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 0.0 110.355 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.429 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -49.41 139.78 11.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.897 . . . . 0.0 110.43 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.8 tpt -83.11 -43.18 16.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 110.334 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.8 19.27 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.47 55.33 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -1.125 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.32 32.06 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 109.781 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -97.05 112.22 60.07 Favored Pre-proline 0 C--N 1.303 -1.413 0 O-C-N 121.456 -0.777 . . . . 0.0 109.826 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.38 -6.52 19.1 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.555 1.292 . . . . 0.0 110.411 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tt -53.05 -29.2 28.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.77 -21.25 18.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 111.01 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.05 -30.48 6.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.97 -1.082 . . . . 0.0 109.095 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -78.02 -30.31 49.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -57.54 -40.43 78.82 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.526 -0.734 . . . . 0.0 109.403 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HA ' HD21 ' A' ' 93' ' ' LEU . 8.7 mtt180 -68.13 -48.19 66.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.364 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -25.41 65.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.0 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.507 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 37.3 t80 -59.33 -47.25 86.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.431 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -57.87 -31.81 67.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.09 -27.62 67.16 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.539 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -75.88 -57.89 3.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 20.7 pt -57.4 -32.13 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.176 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 88' ' ' GLY . 24.9 t-80 -65.8 -51.56 58.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.245 -0.91 . . . . 0.0 110.144 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.56 -15.63 73.3 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -71.49 -44.55 64.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.31 . . . . 0.0 110.511 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 -10.73 9.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.479 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 74.58 38.82 42.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.24 153.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.593 -0.946 . . . . 0.0 110.785 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -74.86 85.66 2.22 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.636 -0.665 . . . . 0.0 109.681 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.443 ' CG2' HG22 ' A' ' 59' ' ' VAL . 1.2 p -88.34 151.54 3.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -120.83 158.66 27.11 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.431 HD23 ' CB ' ' A' ' 80' ' ' ALA . 8.8 mt -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' HB2' HG22 ' A' ' 129' ' ' ILE . 29.2 t60 -83.09 112.09 19.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.77 141.75 34.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -80.5 82.88 6.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -76.0 -29.02 58.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.349 -0.844 . . . . 0.0 110.671 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.13 -41.04 87.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.27 120.11 37.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.068 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.6 t -155.21 69.34 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 0.0 110.729 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 t -94.33 144.34 9.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -96.93 -40.76 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.654 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 54.53 -148.92 0.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.103 -0.998 . . . . 0.0 109.933 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.13 -43.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 110.321 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -112.92 -23.35 10.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.374 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.94 171.55 28.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 47.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 46.06 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -15.0 51.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.901 . . . . 0.0 110.674 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 107.62 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 110.357 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.54 143.26 26.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.33 155.39 26.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -122.84 34.73 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -128.84 -155.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.74 150.48 30.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -176.2 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.24 -154.08 0.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.968 . . . . 0.0 110.312 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt 55.91 56.37 6.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -159.55 28.41 0.38 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.3 177.35 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -1.116 . . . . 0.0 110.163 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -102.85 154.85 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 110.305 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.282 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.5 m -158.39 24.78 0.24 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -66.87 -38.88 87.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 110.303 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.42 ' O ' HG13 ' A' ' 129' ' ' ILE . 28.8 t -53.51 -32.7 51.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.389 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.73 -55.73 9.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.529 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.56 -23.87 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 124' ' ' ALA . 1.1 mp -73.3 -44.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.465 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 71.9 mt -60.79 -36.54 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.531 ' CD1' ' CE2' ' A' ' 134' ' ' PHE 0.256 0.4 OUTLIER -64.91 -54.3 32.97 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.414 178.485 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -56.21 -21.78 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 110.039 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -33.08 26.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.581 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -59.04 -38.95 80.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 76.1 m-85 -55.0 -40.45 70.14 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.245 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -23.37 40.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -84.35 -16.75 41.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.389 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.07 -58.82 4.55 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.19 -1.182 . . . . 0.0 110.322 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.313 0.578 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.7 p -128.64 179.4 5.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.175 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 137.49 -64.1 0.56 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.493 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 38.9 m -150.35 141.32 22.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.886 -1.361 . . . . 0.0 112.31 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.556 ' CD1' ' CE1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.83 163.36 25.39 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.437 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.523 HD13 ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -144.92 145.22 31.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.192 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.476 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -137.73 124.37 21.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.109 -0.994 . . . . 0.0 108.727 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.523 ' CE1' HD13 ' A' ' 6' ' ' LEU . 73.7 m-85 -120.66 142.5 49.4 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.71 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t0 -106.54 91.35 3.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' HB3' ' CE2' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -97.34 134.96 39.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.1 160.84 28.56 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 p -47.69 112.24 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.058 -1.26 . . . . 0.0 110.514 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 mtmt 55.29 46.48 23.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.285 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.474 ' HB2' ' CG1' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.48 120.94 14.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.743 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -116.66 93.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 CA-C-O 122.467 1.127 . . . . 0.0 113.924 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -124.23 104.89 0.84 Allowed Glycine 0 C--N 1.287 -2.169 0 N-CA-C 103.626 -3.79 . . . . 0.0 103.626 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 30' ' ' LEU . 81.5 t -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 116.49 -2.084 . . . . 0.0 112.819 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -134.35 138.36 44.85 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' CG1' ' HG ' ' A' ' 48' ' ' LEU . 33.6 t -100.91 130.45 50.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -112.76 136.71 13.69 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.856 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 117.68 34.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 3.2 tpt180 -91.83 35.11 0.97 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.79 0.805 . . . . 0.0 109.967 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' ' 24' ' ' THR . 1.0 OUTLIER -113.66 -35.07 2.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.482 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -118.81 -17.19 9.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.716 . . . . 0.0 109.976 178.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 34.08 7.53 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.13 161.41 21.05 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.996 -1.296 . . . . 0.0 111.221 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -138.45 127.3 23.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 111.161 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 19' ' ' VAL . 8.0 mmm180 -88.04 154.65 52.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.412 -0.805 . . . . 0.0 109.041 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.26 136.75 2.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.471 1.248 . . . . 0.0 111.356 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.54 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -99.17 144.61 28.55 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 17.9 Cg_endo -39.67 165.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.772 2.315 . . . . 0.0 115.756 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.86 142.07 58.56 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.157 1.456 . . . . 0.0 114.355 -175.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.743 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -55.53 51.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.449 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.0 tptm -133.34 98.62 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.75 -1.219 . . . . 0.0 108.96 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.15 161.6 16.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 110.819 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.77 119.43 24.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.832 . . . . 0.0 111.08 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.18 25.71 1.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' HA2' ' CG ' ' A' ' 13' ' ' LYS . . . 93.62 14.59 52.69 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.428 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 11.7 m -91.25 111.12 47.05 Favored Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 120.944 -1.327 . . . . 0.0 109.776 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.482 ' CB ' HD12 ' A' ' 15' ' ' ILE . 43.4 Cg_endo -70.37 155.87 62.97 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.639 1.336 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -63.76 91.67 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.897 -1.127 . . . . 0.0 108.579 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.434 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 15.1 t90 -92.41 -22.49 19.62 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.88 -39.28 21.76 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.096 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.9 mp -70.56 -55.0 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' A' ' 49' ' ' LEU . 5.9 mt -68.31 -43.02 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.691 -1.256 . . . . 0.0 110.591 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tm-20 -54.63 -30.79 55.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.717 -1.239 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.8 mtp180 -66.57 -44.01 83.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.345 -0.847 . . . . 0.0 109.362 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.468 ' HG ' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -82.63 -27.14 31.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.303 -0.873 . . . . 0.0 109.285 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.447 ' CD1' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -66.74 -53.37 33.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.972 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -80.01 -26.99 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.154 -0.966 . . . . 0.0 111.345 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 25.8 tt0 -79.1 -41.16 29.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.964 -1.085 . . . . 0.0 110.978 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -103.58 -14.69 16.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.059 -1.026 . . . . 0.0 111.112 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 51.96 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.951 -1.093 . . . . 0.0 110.112 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.5 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.739 1.389 . . . . 0.0 111.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 2.3 m-20 -76.77 -43.52 36.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' CB ' HD21 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -132.31 136.82 47.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 2.7 mp -129.98 137.43 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.052 -1.03 . . . . 0.0 111.869 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.21 126.0 74.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.479 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 10.0 p -132.91 150.12 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.579 -1.325 . . . . 0.0 112.289 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.02 3.03 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.909 -1.139 . . . . 0.0 110.377 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 1.6 pt? -65.61 148.44 98.13 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.102 -1.234 . . . . 0.0 110.111 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.87 143.31 60.42 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.619 1.326 . . . . 0.0 109.869 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HG ' ' N ' ' A' ' 64' ' ' ASN . 8.8 tp -90.65 154.72 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.419 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 24.5 p30 -52.04 152.19 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -12.17 59.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 110.624 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -75.07 -11.33 60.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.069 -1.019 . . . . 0.0 110.539 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.59 46.67 73.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 t -103.08 -161.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.004 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.5 147.64 50.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.038 -1.039 . . . . 0.0 110.285 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.97 68.03 5.38 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.31 -11.32 28.49 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.908 1.478 . . . . 0.0 110.716 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.25 -24.57 57.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.868 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.6 -19.89 6.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 111.532 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -31.41 4.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.829 -1.169 . . . . 0.0 109.536 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.62 63.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -58.03 -46.34 85.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -56.42 -48.94 75.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -24.66 64.92 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.147 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 10' ' ' PHE . 5.7 t80 -61.03 -49.73 76.21 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . . . -57.29 -33.05 67.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.463 -0.773 . . . . 0.0 109.146 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.47 -23.45 63.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 110.12 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -70.51 -51.6 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.06 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -68.06 -23.75 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.708 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.476 ' CE1' ' O ' ' A' ' 89' ' ' VAL . 1.5 t-80 -59.07 -57.8 11.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -0.814 . . . . 0.0 110.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.82 -15.63 80.76 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.405 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.42 -44.33 91.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.288 . . . . 0.0 110.198 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.13 -14.01 11.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.71 31.06 30.76 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.476 ' O ' ' CE1' ' A' ' 84' ' ' HIS . 34.2 m -95.52 153.2 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -1.039 . . . . 0.0 110.617 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.13 72.66 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 110.255 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.43 ' CG2' HD13 ' A' ' 83' ' ' ILE . 4.8 p -89.51 152.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.999 0.904 . . . . 0.0 111.12 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 162.27 27.82 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.89 143.24 45.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.753 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -82.47 104.93 13.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.463 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.6 144.33 49.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.084 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -79.8 56.26 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.24 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -78.07 -33.57 50.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.994 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 100' ' ' THR . 10.0 mp -88.64 -40.56 13.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.25 -82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.462 -0.774 . . . . 0.0 110.62 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' LEU . 58.8 p -105.46 112.72 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.297 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.95 152.09 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.009 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 104' ' ' ARG . 22.2 mt-10 -94.88 -24.04 17.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -0.849 . . . . 0.0 110.567 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 54.94 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.498 -0.751 . . . . 0.0 110.341 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -138.11 129.47 27.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.943 -1.098 . . . . 0.0 110.243 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.3 m -109.53 -5.56 15.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.898 . . . . 0.0 110.815 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.14 -64.06 4.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.91 92.39 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -1.164 . . . . 0.0 110.409 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -81.62 149.57 28.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -88.77 122.75 32.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -81.33 158.76 24.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.985 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.83 -171.64 34.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.34 92.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.08 20.81 8.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.123 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -170.36 117.14 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.49 120.65 15.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.86 96.67 6.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.001 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -166.06 145.39 6.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.378 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -154.02 -68.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.2 167.66 18.76 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.0 mtpp -137.12 149.45 47.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -1.121 . . . . 0.0 110.318 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 120' ' ' LYS . 93.7 t 55.62 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.453 -0.779 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.88 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.46 25.36 4.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.221 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.433 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -78.97 -31.1 44.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.7 p -54.23 -30.85 51.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.333 -0.854 . . . . 0.0 111.482 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.03 -56.22 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 109.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.501 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -55.87 -24.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 124' ' ' ALA . 4.5 mm -71.13 -44.67 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.481 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 36.3 mt -61.41 -42.0 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.572 HD13 ' CE2' ' A' ' 133' ' ' TYR . 1.0 OUTLIER -57.7 -58.06 10.01 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.739 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.0 -21.76 65.12 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 108.994 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -58.03 -40.86 81.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.548 -0.72 . . . . 0.0 110.985 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.572 ' CE2' HD13 ' A' ' 130' ' ' LEU . 4.5 p90 -81.64 -32.64 31.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.317 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.5 m-85 -52.62 -31.8 38.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.985 . . . . 0.0 110.121 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -27.13 38.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -13.84 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.403 -0.811 . . . . 0.0 110.625 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.3 -14.66 73.68 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.049 -1.265 . . . . 0.0 110.201 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.213 0.53 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.445 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 69.4 p -154.99 122.61 5.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 110.044 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.25 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.742 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.5 m -147.49 138.32 23.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.326 . . . . 0.0 112.243 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' CB ' HD23 ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.586 ' CD1' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HG2' ' CA ' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.481 ' CA ' HG13 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.737 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.518 HG13 ' CD2' ' A' ' 8' ' ' PHE . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.512 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' CD ' HD13 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.695 0.759 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.38 28.79 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.553 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -128.02 126.73 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.146 -0.971 . . . . 0.0 111.143 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.518 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.2 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.4 138.01 58.19 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 123.025 1.393 . . . . 0.0 113.715 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.737 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.73 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.03 159.75 17.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.97 . . . . 0.0 110.43 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.08 123.96 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.803 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' CA ' ' HG2' ' A' ' 13' ' ' LYS . . . 90.33 18.96 47.51 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 17.2 m -92.87 107.71 26.6 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.099 -1.236 . . . . 0.0 110.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.468 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.23 157.62 56.75 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.572 1.301 . . . . 0.0 109.082 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.45 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 32.4 m-20 -64.47 90.77 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.52 -20.46 54.18 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.371 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -30.94 30.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.67 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.83 -0.543 . . . . 0.0 111.764 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD22 ' CD1' ' A' ' 52' ' ' TRP . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.441 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.41 64.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.81 -51.65 8.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 112.302 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.465 ' CD1' HD22 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.755 -1.216 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.822 -1.174 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.462 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 46.9 Cg_endo -73.71 136.86 23.94 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.72 1.379 . . . . 0.0 111.439 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.82 -45.1 37.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.403 -0.811 . . . . 0.0 110.103 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -133.88 140.35 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.068 . . . . 0.0 109.591 178.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 3.8 mp -117.74 137.83 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 111.856 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -121.21 122.46 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 60' ' ' GLY . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.5 OUTLIER -118.3 113.46 37.06 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.07 115.86 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.375 1.197 . . . . 0.0 110.555 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 52.3 tp -130.56 133.59 46.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 110.284 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -80.47 131.42 35.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.188 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -44.9 14.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 110.027 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.48 -11.28 15.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.334 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.2 -51.07 0.77 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 6.4 t -105.31 -165.14 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.382 -1.069 . . . . 0.0 109.572 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 68' ' ' THR . 19.1 pt-20 37.87 -157.12 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.165 0.507 . . . . 0.0 111.47 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -176.8 67.12 0.22 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 -30.08 14.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.921 1.485 . . . . 0.0 110.089 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -60.08 -30.01 68.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.88 -19.57 18.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.875 . . . . 0.0 111.237 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.28 -33.39 5.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 109.646 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -80.05 -30.3 39.4 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -65.09 -45.05 86.78 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 108.908 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -56.99 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.442 HD13 HG11 ' A' ' 59' ' ' VAL . 23.5 pt -57.84 -25.71 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.974 -1.079 . . . . 0.0 109.792 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.71 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.75 -16.29 75.69 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 87' ' ' PHE . 68.8 m-85 -119.08 -11.97 9.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.94 31.66 42.79 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 29.1 m -94.19 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.905 . . . . 0.0 110.773 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.438 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.3 125.86 40.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.861 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -87.97 101.7 14.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 110.445 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.41 143.92 49.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -79.59 57.59 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -63.52 -29.59 70.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 0.0 110.21 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -18.65 65.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.892 . . . . 0.0 110.209 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.5 t -56.88 92.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.38 127.73 6.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.165 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.8 152.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.184 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -97.31 -22.9 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 62.14 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.402 -0.811 . . . . 0.0 110.448 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.44 39.75 31.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 17.9 p -114.21 19.41 16.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.905 . . . . 0.0 110.26 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.84 -140.64 12.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.99 137.51 39.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 110.272 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.61 39.81 3.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -95.95 -59.17 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -75.75 -60.6 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 110.295 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.06 -53.93 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.84 -94.64 0.09 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 56.0 m-85 -125.75 79.79 1.85 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -1.174 . . . . 0.0 110.362 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 51.78 57.4 6.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.313 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.63 173.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.24 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.15 -46.04 0.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.53 158.06 27.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -153.83 80.35 1.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.18 141.73 10.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -167.86 147.62 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -1.055 . . . . 0.0 110.082 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.32 139.52 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.336 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -173.24 -37.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.89 21.62 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.439 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.553 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.464 HG23 HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.582 HD13 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -21.63 64.49 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.582 ' CE2' HD13 ' A' ' 130' ' ' LEU . 4.1 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -24.36 39.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -13.18 32.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.35 -21.35 59.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.181 -1.188 . . . . 0.0 110.126 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -152.21 138.71 18.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 22' ' ' ARG . . . -163.72 81.31 0.12 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.569 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' ILE . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.545 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.574 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.574 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.742 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.638 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.503 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' HD11 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.477 HD11 ' N ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.742 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' CB ' HD12 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.482 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 8' ' ' PHE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.409 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.476 ' CG ' ' O ' ' A' ' 61' ' ' LEU . 1.7 pp -104.61 107.69 58.75 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -88.43 113.41 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 109.488 -1.004 . . . . 0.0 109.488 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.99 131.51 42.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.956 -1.09 . . . . 0.0 110.63 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.99 123.97 29.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.691 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 tpt -84.53 -44.28 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.891 -1.131 . . . . 0.0 109.668 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.42 -2.27 20.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 110.477 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 -25.73 19.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.89 -160.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -1.023 . . . . 0.0 109.742 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.13 163.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.151 -0.968 . . . . 0.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.05 107.37 4.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.94 -6.58 19.4 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.596 1.314 . . . . 0.0 110.754 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -25.08 64.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 0.0 110.572 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.467 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.93 -19.06 5.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.301 -0.875 . . . . 0.0 111.412 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.31 -35.39 7.89 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 109.88 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -74.67 -27.87 60.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.392 -0.818 . . . . 0.0 109.119 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -66.79 -50.85 61.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.426 -0.796 . . . . 0.0 109.949 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.418 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.471 ' CD1' HG23 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.413 ' HB3' ' CG1' ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.405 ' NE2' ' OG ' ' A' ' 132' ' ' SER . 10.4 t-160 -83.34 120.72 26.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.95 143.24 28.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.29 -0.881 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -74.17 82.93 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.013 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -19.42 39.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.755 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -25.33 64.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.205 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -115.61 88.23 2.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.918 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 m -138.04 -52.14 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.648 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.48 152.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.59 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.63 -45.49 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.805 . . . . 0.0 110.051 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 170.62 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.142 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -117.61 64.5 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 15.43 25.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.96 -76.36 0.67 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 93.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -44.98 5.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -75.39 96.38 3.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -55.98 -28.19 56.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.026 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -98.09 115.15 5.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.98 160.73 10.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 66.8 t80 53.71 35.67 21.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 0.0 110.013 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -61.64 165.43 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.258 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.39 110.6 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -53.09 107.24 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -170.36 125.65 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -25.89 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.93 77.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -101.19 146.38 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -1.133 . . . . 0.0 110.066 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.16 24.9 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.405 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -87.75 58.24 4.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.995 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.403 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m 55.04 29.33 12.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 110.481 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' A' ' 127' ' ' VAL . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.638 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.503 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 126' ' ' ALA . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 133' ' ' TYR 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.405 ' OG ' ' NE2' ' A' ' 94' ' ' HIS . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.26 -27.46 42.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 -18.91 43.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.915 . . . . 0.0 110.109 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.51 51.64 56.62 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.155 -1.203 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.228 0.537 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER 179.9 -45.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 0.0 109.988 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.62 -79.6 0.09 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.59 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB1' HD23 ' A' ' 130' ' ' LEU . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.722 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 17' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 2' ' ' SER . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.722 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.441 ' CB ' HD13 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.435 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.432 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' O ' HD21 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 59' ' ' VAL . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -64.81 143.05 98.72 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD2' ' HG ' ' A' ' 61' ' ' LEU . 42.9 Cg_endo -68.6 148.84 73.22 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.612 1.322 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.21 163.57 12.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.386 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.14 148.67 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -24.3 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -84.49 -11.58 55.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.9 62.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 t -68.97 -172.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -1.195 . . . . 0.0 110.183 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -61.23 125.6 24.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 110.075 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.09 78.65 3.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.689 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.82 -7.69 20.39 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.719 1.379 . . . . 0.0 110.566 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -27.81 12.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.028 -1.045 . . . . 0.0 110.644 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -57.76 -22.08 45.0 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.102 -0.999 . . . . 0.0 110.892 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.75 -30.4 5.58 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.004 -1.06 . . . . 0.0 108.849 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -82.46 -31.49 29.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -59.93 -48.68 80.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.404 -0.81 . . . . 0.0 109.536 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 10' ' ' PHE . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.411 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.43 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -91.23 115.28 27.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.11 144.27 55.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -99.06 45.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -87.83 -22.82 24.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.078 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.45 -23.75 62.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.437 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -98.76 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 m -154.86 63.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -72.52 152.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -86.42 -43.34 12.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.61 111.19 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -152.91 -166.02 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.12 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -25.06 9.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.23 108.26 2.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.24 -161.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.325 -1.103 . . . . 0.0 110.666 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -151.94 175.59 12.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.35 -0.843 . . . . 0.0 110.271 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.89 -64.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -105.64 153.48 21.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.812 . . . . 0.0 110.142 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.76 119.87 0.79 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.72 23.83 11.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -125.32 -38.54 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 0.0 110.086 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -143.93 110.57 5.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CD1' ' A' ' 116' ' ' LEU . . . -102.49 -25.28 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -158.75 99.47 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.326 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.9 t30 -158.29 -152.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 120' ' ' LYS . 16.1 mttt 58.02 -84.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.514 -0.742 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' ASN . . . -70.15 66.07 0.71 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 118' ' ' LYS . 29.3 tttt -124.92 -48.33 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.107 . . . . 0.0 110.002 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.19 75.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.1 142.33 58.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t -176.07 -37.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.549 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.576 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.59 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.96 -22.7 42.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -87.57 12.65 11.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.618 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.67 21.07 3.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.133 -1.216 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.149 0.5 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 0.9 OUTLIER 54.36 -173.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.19 -0.944 . . . . 0.0 110.182 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.05 -61.72 0.65 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.969 -1.312 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.553 ' CD2' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.58 127.81 34.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.991 -1.3 . . . . 0.0 112.151 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.724 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 18' ' ' ALA . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 17' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.83 29.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -90.56 32.8 0.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.744 0.783 . . . . 0.0 110.038 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.559 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.424 ' OG1' ' CD1' ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.724 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.504 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 10.6 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.6 70.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 5.7 mp -76.65 -53.05 8.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.897 -1.127 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 5' ' ' LEU . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.7 mp -124.47 137.6 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.999 -1.063 . . . . 0.0 112.088 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -99.62 114.34 65.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.061 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HG3' ' CD2' ' A' ' 94' ' ' HIS . 51.0 Cg_endo -94.17 112.37 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.164 1.086 . . . . 0.0 109.465 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' O ' ' NE2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -132.85 133.13 42.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 110.342 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.442 ' HB3' ' N ' ' A' ' 68' ' ' THR . 26.3 m120 -80.81 125.25 29.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.298 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.3 tpt -82.83 -45.61 14.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 110.214 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -108.09 15.71 24.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.93 19.03 25.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.442 ' N ' ' HB3' ' A' ' 64' ' ' ASN . 6.2 t -165.4 -147.41 0.1 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -1.194 . . . . 0.0 110.057 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.89 165.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 0.0 110.866 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -164.41 131.71 2.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 109.643 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.02 -12.08 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.316 1.166 . . . . 0.0 110.932 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.49 -27.83 40.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.022 -1.049 . . . . 0.0 110.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.91 -19.7 13.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.18 -0.95 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.89 -34.94 5.88 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -30.78 26.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -61.74 -51.48 68.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.78 . . . . 0.0 109.493 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' CA ' HD21 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CZ ' ' CE2' ' A' ' 10' ' ' PHE . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -22.71 67.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.021 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.428 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.34 16.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.32 40.0 41.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.65 154.12 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.565 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 84.71 7.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.495 -0.753 . . . . 0.0 110.246 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 HD21 ' CA ' ' A' ' 77' ' ' ARG . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 -82.73 117.12 22.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.37 138.48 31.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.006 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.36 28.42 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.367 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -79.69 -41.02 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.803 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 -26.42 21.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.697 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 m 52.92 177.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.492 -0.755 . . . . 0.0 110.493 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.9 p -85.94 130.12 34.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.86 . . . . 0.0 110.106 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.17 152.43 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -91.42 -35.74 14.19 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.032 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 54.25 -150.72 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -112.15 68.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 p -83.82 -19.74 34.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.354 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.65 129.5 1.54 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.41 59.85 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -1.143 . . . . 0.0 109.922 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 108' ' ' PHE . 79.4 t80 -151.79 64.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.36 -157.65 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.76 -169.57 3.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.57 89.2 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.4 149.3 43.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -103.48 49.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -1.134 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.46 -58.32 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.51 62.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.64 100.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.08 87.77 7.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -122.27 -33.21 3.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.25 -30.2 57.34 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -94.75 -78.14 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -1.067 . . . . 0.0 110.026 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 t 58.31 162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.322 -0.861 . . . . 0.0 110.141 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.79 40.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.417 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m -144.5 -42.85 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.351 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.534 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.486 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.569 HD12 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 130' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -80.3 -20.65 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -91.76 -21.48 20.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.339 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.25 26.58 64.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.14 -1.212 . . . . 0.0 110.341 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.228 0.537 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER 179.9 -45.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 0.0 109.988 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 171.62 -79.6 0.09 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.158 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.442 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.59 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.554 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB1' HD23 ' A' ' 130' ' ' LEU . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.554 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.528 ' HB2' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.722 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.482 ' N ' ' CG2' ' A' ' 17' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.554 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 2' ' ' SER . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG11 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.722 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.441 ' CB ' HD13 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.435 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.432 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 4' ' ' THR . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' O ' HD21 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.487 HG23 HD12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.466 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' HG11 ' A' ' 59' ' ' VAL . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -64.81 143.05 98.72 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD2' ' HG ' ' A' ' 61' ' ' LEU . 42.9 Cg_endo -68.6 148.84 73.22 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.612 1.322 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.21 163.57 12.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.386 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.14 148.67 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -24.3 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -84.49 -11.58 55.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.9 62.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 t -68.97 -172.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -1.195 . . . . 0.0 110.183 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -61.23 125.6 24.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 110.075 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.09 78.65 3.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.689 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.82 -7.69 20.39 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.719 1.379 . . . . 0.0 110.566 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -27.81 12.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.028 -1.045 . . . . 0.0 110.644 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -57.76 -22.08 45.0 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.102 -0.999 . . . . 0.0 110.892 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.75 -30.4 5.58 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.004 -1.06 . . . . 0.0 108.849 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -82.46 -31.49 29.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -59.93 -48.68 80.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.404 -0.81 . . . . 0.0 109.536 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.483 ' CE1' ' CZ ' ' A' ' 10' ' ' PHE . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.466 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.411 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.43 ' HA ' ' HB ' ' A' ' 57' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -91.23 115.28 27.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.11 144.27 55.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -99.06 45.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -87.83 -22.82 24.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.078 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.45 -23.75 62.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.437 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -98.76 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 m -154.86 63.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -72.52 152.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -86.42 -43.34 12.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.164 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.61 111.19 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.123 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -152.91 -166.02 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.12 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -25.06 9.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.23 108.26 2.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.24 -161.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.325 -1.103 . . . . 0.0 110.666 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -151.94 175.59 12.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.35 -0.843 . . . . 0.0 110.271 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.89 -64.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -105.64 153.48 21.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.812 . . . . 0.0 110.142 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.76 119.87 0.79 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.72 23.83 11.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -125.32 -38.54 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 0.0 110.086 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -143.93 110.57 5.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.415 ' O ' ' CD1' ' A' ' 116' ' ' LEU . . . -102.49 -25.28 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.415 ' CD1' ' O ' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -158.75 99.47 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.326 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.9 t30 -158.29 -152.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 120' ' ' LYS . 16.1 mttt 58.02 -84.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.514 -0.742 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' ASN . . . -70.15 66.07 0.71 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 118' ' ' LYS . 29.3 tttt -124.92 -48.33 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.107 . . . . 0.0 110.002 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.19 75.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.089 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.1 142.33 58.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t -176.07 -37.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.43 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.549 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.576 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.59 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.59 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.96 -22.7 42.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -87.57 12.65 11.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.618 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.67 21.07 3.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.133 -1.216 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.218 0.532 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.25 119.93 25.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.17 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . -165.84 -89.62 0.07 OUTLIER Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 130' ' ' LEU . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CG ' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.494 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.745 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 ' HB ' ' CB ' ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.569 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.404 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.408 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.404 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.745 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 41' ' ' ASP . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 53' ' ' GLN . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.45 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 HG21 ' CG2' ' A' ' 91' ' ' VAL . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.476 ' CD1' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 4.3 pp -65.47 149.7 96.84 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.91 147.15 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.595 1.313 . . . . 0.0 110.66 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.2 164.75 13.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 110.281 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -50.64 141.89 11.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.17 -25.97 48.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -4.79 55.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.9 31.71 61.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -179.32 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -1.099 . . . . 0.0 110.21 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.99 119.33 10.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.809 . . . . 0.0 109.927 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.36 91.17 5.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 110.002 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.99 -9.24 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.699 1.368 . . . . 0.0 110.457 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -24.08 8.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 110.154 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.09 -21.12 7.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.275 -0.89 . . . . 0.0 110.661 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.53 7.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 108.697 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -78.34 -33.01 49.42 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -57.06 -46.15 82.7 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.345 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.442 ' CG2' HG21 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.436 HD21 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.436 ' N ' HD21 ' A' ' 93' ' ' LEU . 2.1 t-80 -82.08 110.79 17.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 128.43 34.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.295 -0.878 . . . . 0.0 110.31 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -126.59 48.85 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.979 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -72.91 -30.82 64.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.478 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -78.23 -21.7 49.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.156 -0.965 . . . . 0.0 110.188 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.433 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 1.2 m 49.35 70.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.93 . . . . 0.0 110.728 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m 55.84 103.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.882 . . . . 0.0 110.499 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.46 151.78 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.923 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 104' ' ' ARG . 3.5 tt0 -90.18 -21.45 22.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 55.53 -87.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 110.298 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -83.62 114.55 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -96.27 -7.41 35.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.57 106.86 2.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -173.37 4.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -1.109 . . . . 0.0 110.018 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.71 154.66 17.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -47.1 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.275 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.32 124.51 40.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.38 56.81 2.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.69 -146.98 20.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -72.71 65.79 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -1.127 . . . . 0.0 110.215 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 53.32 -178.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.95 24.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pp -164.74 152.14 11.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.133 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.68 -81.83 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -149.07 145.77 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.56 40.56 1.2 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.04 147.52 32.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -1.13 . . . . 0.0 110.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.69 19.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.446 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -86.57 64.44 8.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t 52.2 33.42 12.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.535 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.454 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.552 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.601 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.552 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -80.39 -20.95 42.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -78.85 -6.76 56.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 0.0 110.777 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.63 -43.6 3.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.217 -1.167 . . . . 0.0 110.313 -179.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.248 0.547 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 10.2 p -172.4 -168.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . 109.33 -46.42 1.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.551 ' CD1' ' CE1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CG ' ' HB ' ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.479 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.753 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 28' ' ' ARG . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' HB3' ' N ' ' A' ' 3' ' ' GLY . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.753 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 36' ' ' GLN . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' GLN . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' CG1' ' CG2' ' A' ' 91' ' ' VAL . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.67 120.07 33.39 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.64 118.09 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 120.756 0.97 . . . . 0.0 110.528 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.4 133.47 47.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.145 -0.972 . . . . 0.0 110.64 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.7 125.71 30.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.2 tpt -83.74 -43.79 15.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.62 19.99 19.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.454 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.66 -39.7 2.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -124.79 -175.19 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.563 -0.963 . . . . 0.0 109.353 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 48.72 -166.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.098 -1.001 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 74.48 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.25 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.05 -24.87 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 110.311 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.2 tp -67.56 -24.91 65.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 0.0 110.648 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.48 -20.59 7.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.147 -0.971 . . . . 0.0 111.254 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.38 -34.22 10.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.989 -1.069 . . . . 0.0 109.324 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -57.63 -47.36 82.42 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 79' ' ' PHE . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.437 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 91' ' ' VAL . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -83.68 100.18 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -99.12 145.65 26.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.264 -0.898 . . . . 0.0 111.287 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.1 55.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.357 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.22 -17.01 38.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 110.987 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -32.48 73.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.068 -1.02 . . . . 0.0 110.371 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.3 t 55.03 171.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.32 -0.863 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 m -122.73 111.24 16.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 151.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 110.108 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -75.98 -43.74 43.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.238 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.63 89.44 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -144.91 -56.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -110.08 -20.79 12.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.38 70.62 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 53.14 -172.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -102.93 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.141 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 164.75 17.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 110.163 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.47 -158.65 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.44 -109.9 0.76 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.65 95.16 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 -64.14 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.204 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -109.43 -178.95 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.159 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.15 123.64 31.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -54.92 41.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.89 163.55 25.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.871 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.79 -43.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.71 124.25 1.35 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 55.76 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -1.08 . . . . 0.0 109.858 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.17 -65.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.85 139.63 13.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.43 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t 54.88 31.3 15.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -0.825 . . . . 0.0 110.477 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.506 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.551 ' CE1' ' CD1' ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -72.82 -20.41 61.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.45 -18.45 54.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.533 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -178.81 77.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.447 ' OXT' ' CD1' ' A' ' 138' ' ' TYR . 10.7 t80 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.235 -1.156 . . . . 0.0 109.91 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.109 0.48 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.458 ' CB ' ' HG2' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -129.32 -44.71 1.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.372 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.51 -79.65 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.413 -1.375 . . . . 0.0 110.22 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.587 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' HD22 ' A' ' 130' ' ' LEU . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.718 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' CA ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.543 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.574 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.718 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.434 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD2' ' CG2' ' A' ' 15' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' CD1' HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' O ' HD22 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -65.03 147.62 98.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.23 148.61 44.27 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.895 1.471 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -96.34 160.69 14.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -0.837 . . . . 0.0 109.995 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -75.08 135.53 41.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.164 -0.96 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 -43.35 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.62 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.32 14.31 29.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.77 30.45 9.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.87 -158.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -1.076 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 172.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -160.0 80.98 2.41 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.368 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.22 -13.99 31.28 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.679 1.357 . . . . 0.0 110.313 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.92 -25.38 63.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.26 -20.35 10.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 111.629 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -36.88 12.31 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.914 -1.116 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -75.33 -27.88 59.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.411 -0.806 . . . . 0.0 108.867 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -61.28 -45.71 93.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.566 -0.709 . . . . 0.0 109.872 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.453 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.436 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.4 ' HB2' HG11 ' A' ' 89' ' ' VAL . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 83' ' ' ILE . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 HD21 ' CB ' ' A' ' 80' ' ' ALA . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.431 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 -89.45 113.87 25.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.3 144.79 56.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.411 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.47 86.92 6.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.65 52.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.608 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -18.72 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.428 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -63.49 -178.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -113.75 161.62 17.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.26 152.71 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.24 -37.8 84.39 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.053 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.95 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.87 . . . . 0.0 110.511 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -73.85 0.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.995 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -98.54 -20.78 16.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.66 58.78 12.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 102.99 4.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.69 115.73 30.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.947 . . . . 0.0 110.108 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 -54.81 19.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.548 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.78 172.02 19.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.282 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 101.22 91.05 2.11 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.37 103.55 1.68 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -56.84 -39.56 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.237 . . . . 0.0 110.167 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.92 146.21 2.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -169.84 141.17 2.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.21 106.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.29 161.92 0.83 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.409 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 174.11 9.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.17 -108.22 3.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -140.72 47.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 7.9 p -151.45 111.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 110.288 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -106.32 16.79 24.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -78.13 -24.18 47.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.538 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -79.43 -17.83 53.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -79.27 -1.55 37.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 110.971 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.05 45.05 0.59 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 25.3 p90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.159 . . . . 0.0 110.242 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.149 0.5 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 0.9 OUTLIER 54.36 -173.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.19 -0.944 . . . . 0.0 110.182 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.05 -61.72 0.65 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.005 -1.291 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.553 ' CD2' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' HG ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.608 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.6 127.83 34.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.3 . . . . 0.0 112.196 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.402 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.724 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 18' ' ' ALA . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' N ' HG13 ' A' ' 17' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.87 29.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -90.61 32.78 0.94 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.559 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.424 ' OG1' ' CD1' ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.492 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.724 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD12 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.504 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 10.7 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.504 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' CD2' ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.58 70.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.444 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 5.7 mp -76.69 -53.06 8.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.858 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.89 -1.131 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' HB3' HD21 ' A' ' 5' ' ' LEU . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.7 mp -124.51 137.64 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.999 -1.063 . . . . 0.0 112.044 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.482 HG21 ' CD1' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.5 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -99.62 114.3 65.52 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.085 178.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.475 ' HG3' ' CD2' ' A' ' 94' ' ' HIS . 51.0 Cg_endo -94.14 112.37 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.225 1.119 . . . . 0.0 109.465 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' O ' ' NE2' ' A' ' 70' ' ' GLN . 0.2 OUTLIER -132.85 133.13 42.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 110.342 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.442 ' HB3' ' N ' ' A' ' 68' ' ' THR . 26.4 m120 -80.81 125.25 29.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.298 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.3 tpt -82.83 -45.61 14.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 110.214 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -108.09 15.71 24.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.93 19.03 25.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.442 ' N ' ' HB3' ' A' ' 64' ' ' ASN . 6.2 t -165.4 -147.41 0.1 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -1.194 . . . . 0.0 110.057 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.89 165.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 0.0 110.866 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -164.41 131.71 2.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 109.643 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.02 -12.08 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.316 1.166 . . . . 0.0 110.932 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.5 -27.84 40.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 110.165 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.91 -19.7 13.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.18 -0.95 . . . . 0.0 110.918 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.89 -34.94 5.88 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -30.78 26.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -61.74 -51.48 68.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.78 . . . . 0.0 109.493 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' CA ' HD21 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CZ ' ' CE2' ' A' ' 10' ' ' PHE . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.419 ' CB ' HD23 ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -22.79 67.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 108.996 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 110.428 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.36 16.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 40.03 41.61 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.66 154.09 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.594 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.81 84.71 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 HD21 ' CA ' ' A' ' 77' ' ' ARG . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 -82.73 117.12 22.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.37 138.48 31.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.006 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.36 28.42 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.367 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -79.69 -41.02 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.803 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.98 -26.46 21.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.793 . . . . 0.0 109.684 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 m 52.94 177.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.493 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.9 p -85.94 130.12 34.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.86 . . . . 0.0 110.106 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.19 152.46 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.172 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -91.42 -35.74 14.19 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 54.28 -150.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -112.17 68.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 p -83.8 -19.77 34.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.63 129.49 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.36 59.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 0.0 109.953 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 108' ' ' PHE . 79.4 t80 -151.77 64.39 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.335 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.31 -157.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.74 -169.52 3.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.209 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.57 89.2 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.39 149.26 42.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -103.47 49.81 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.091 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.46 -58.32 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.51 62.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.64 100.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.08 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.08 87.77 7.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -122.25 -33.25 3.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.286 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.23 -30.2 57.38 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -94.75 -78.14 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -1.067 . . . . 0.0 110.026 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 t 58.31 162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.322 -0.861 . . . . 0.0 110.141 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.79 40.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.417 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m -144.5 -42.85 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.351 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.534 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.486 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.569 HD12 ' CE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.569 ' CE2' HD12 ' A' ' 130' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -80.3 -20.65 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -91.76 -21.48 20.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.339 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.23 26.61 64.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.14 -1.212 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.218 0.532 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.25 119.93 25.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.17 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . -165.84 -89.62 0.07 OUTLIER Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.601 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' A' ' 130' ' ' LEU . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.577 ' CG ' ' CE1' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.494 ' HB3' ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.745 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 ' HB ' ' CB ' ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.569 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.404 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.408 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.404 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.514 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.434 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.745 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.434 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 41' ' ' ASP . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.434 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 53' ' ' GLN . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.45 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.404 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.444 ' O ' HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 HG21 ' CG2' ' A' ' 91' ' ' VAL . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.476 ' CD1' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' N ' HG13 ' A' ' 59' ' ' VAL . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 10' ' ' PHE . 4.3 pp -65.47 149.7 96.84 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.91 147.15 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.595 1.313 . . . . 0.0 110.66 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.2 164.75 13.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 110.281 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -50.64 141.89 11.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.17 -25.97 48.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -4.79 55.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.9 31.71 61.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -179.32 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -1.099 . . . . 0.0 110.21 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.99 119.33 10.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.809 . . . . 0.0 109.927 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.36 91.17 5.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 110.002 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.99 -9.24 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.699 1.368 . . . . 0.0 110.457 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -24.08 8.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 110.154 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.09 -21.12 7.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.275 -0.89 . . . . 0.0 110.661 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.53 7.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 108.697 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -78.34 -33.01 49.42 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -57.06 -46.15 82.7 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.345 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.4 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.415 ' O ' ' N ' ' A' ' 88' ' ' GLY . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.442 ' CG2' HG21 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.436 HD21 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.436 ' N ' HD21 ' A' ' 93' ' ' LEU . 2.1 t-80 -82.08 110.79 17.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 128.43 34.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.295 -0.878 . . . . 0.0 110.31 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -126.59 48.85 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.979 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -72.91 -30.82 64.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.478 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -78.23 -21.7 49.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.156 -0.965 . . . . 0.0 110.188 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.433 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 1.2 m 49.35 70.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.93 . . . . 0.0 110.728 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m 55.84 103.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.882 . . . . 0.0 110.499 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.46 151.78 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.923 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 104' ' ' ARG . 3.5 tt0 -90.18 -21.45 22.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 55.53 -87.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 110.298 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -83.62 114.55 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -96.27 -7.41 35.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.57 106.86 2.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -173.37 4.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -1.109 . . . . 0.0 110.018 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.71 154.66 17.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -47.1 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.275 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.32 124.51 40.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.38 56.81 2.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.69 -146.98 20.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -72.71 65.79 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -1.127 . . . . 0.0 110.215 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 53.32 -178.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.95 24.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pp -164.74 152.14 11.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.133 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.68 -81.83 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -149.07 145.77 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.56 40.56 1.2 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.04 147.52 32.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -1.13 . . . . 0.0 110.076 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.69 19.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.446 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -86.57 64.44 8.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t 52.2 33.42 12.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.414 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.535 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.454 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.552 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.601 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.552 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -80.39 -20.95 42.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -78.85 -6.76 56.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 0.0 110.777 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.63 -43.6 3.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.217 -1.167 . . . . 0.0 110.313 -179.909 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.248 0.547 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 10.2 p -172.4 -168.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . 109.33 -46.42 1.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.551 ' CD1' ' CE1' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' A' ' 130' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CG ' ' HB ' ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.576 ' CD1' ' CZ ' ' A' ' 79' ' ' PHE . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.479 ' HB3' ' CG1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.753 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.506 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 28' ' ' ARG . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' HB3' ' N ' ' A' ' 3' ' ' GLY . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.456 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.753 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.443 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 36' ' ' GLN . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.445 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.435 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' GLN . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 ' CG1' ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' CG1' ' CG2' ' A' ' 91' ' ' VAL . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.67 120.07 33.39 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.64 118.09 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 120.756 0.97 . . . . 0.0 110.528 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.4 133.47 47.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.145 -0.972 . . . . 0.0 110.64 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.7 125.71 30.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.2 tpt -83.74 -43.79 15.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.62 19.99 19.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.454 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.66 -39.7 2.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -124.79 -175.19 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.563 -0.963 . . . . 0.0 109.353 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 48.72 -166.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.098 -1.001 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 74.48 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.25 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.05 -24.87 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 110.311 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.2 tp -67.56 -24.91 65.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 0.0 110.648 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.48 -20.59 7.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.147 -0.971 . . . . 0.0 111.254 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.38 -34.22 10.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.989 -1.069 . . . . 0.0 109.324 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -57.63 -47.36 82.42 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 79' ' ' PHE . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.437 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 91' ' ' VAL . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 ' C ' ' CD1' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -83.68 100.18 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -99.12 145.65 26.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.264 -0.898 . . . . 0.0 111.287 -179.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.1 55.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.357 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.22 -17.01 38.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 110.987 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -32.48 73.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.068 -1.02 . . . . 0.0 110.371 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.3 t 55.03 171.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.32 -0.863 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 m -122.73 111.24 16.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 151.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 110.108 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -75.98 -43.74 43.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.238 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.63 89.44 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -144.91 -56.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -110.08 -20.79 12.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.38 70.62 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 53.14 -172.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -102.93 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.141 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 164.75 17.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 110.163 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.47 -158.65 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.44 -109.9 0.76 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.65 95.16 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 -64.14 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.204 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -109.43 -178.95 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.159 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.15 123.64 31.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -54.92 41.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.89 163.55 25.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.871 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.79 -43.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.71 124.25 1.35 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 55.76 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -1.08 . . . . 0.0 109.858 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.17 -65.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.431 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.85 139.63 13.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.43 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t 54.88 31.3 15.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -0.825 . . . . 0.0 110.477 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.506 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 128' ' ' ILE . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.496 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.551 ' CE1' ' CD1' ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -72.82 -20.41 61.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.45 -18.45 54.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.533 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -178.81 77.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.447 ' OXT' ' CD1' ' A' ' 138' ' ' TYR . 10.7 t80 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.235 -1.156 . . . . 0.0 109.91 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.109 0.48 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.458 ' CB ' ' HG2' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -129.32 -44.71 1.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.372 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.51 -79.65 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.413 -1.375 . . . . 0.0 110.22 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.587 ' HG ' ' CZ ' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' HB3' HD22 ' A' ' 130' ' ' LEU . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.526 ' HA ' ' HB ' ' A' ' 17' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.718 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB3' ' CA ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.543 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' HG2' ' CB ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.574 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.538 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.509 ' HB3' HG11 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.718 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 36' ' ' GLN . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.434 ' CB ' HD12 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' OD2' ' CG2' ' A' ' 15' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.426 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.442 ' CD1' HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.438 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' O ' HD22 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.469 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.457 ' CG2' ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CA ' ' O ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -65.03 147.62 98.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.23 148.61 44.27 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.895 1.471 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.7 tp -96.34 160.69 14.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -0.837 . . . . 0.0 109.995 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -75.08 135.53 41.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.164 -0.96 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 -43.35 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.62 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.32 14.31 29.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.77 30.45 9.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.87 -158.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -1.076 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 172.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -160.0 80.98 2.41 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.368 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.22 -13.99 31.28 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.679 1.357 . . . . 0.0 110.313 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.92 -25.38 63.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.26 -20.35 10.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 111.629 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -36.88 12.31 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.914 -1.116 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -75.33 -27.88 59.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.411 -0.806 . . . . 0.0 108.867 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -61.28 -45.71 93.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.566 -0.709 . . . . 0.0 109.872 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' CB ' HD21 ' A' ' 93' ' ' LEU . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.453 HD13 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.436 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.4 ' HB2' HG11 ' A' ' 89' ' ' VAL . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG2' HD13 ' A' ' 83' ' ' ILE . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 HD21 ' CB ' ' A' ' 80' ' ' ALA . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.431 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 -89.45 113.87 25.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.3 144.79 56.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.411 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.47 86.92 6.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.65 52.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.608 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -18.72 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.428 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -63.49 -178.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -113.75 161.62 17.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.26 152.71 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.24 -37.8 84.39 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.053 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.95 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.87 . . . . 0.0 110.511 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -73.85 0.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.995 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -98.54 -20.78 16.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.66 58.78 12.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 102.99 4.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.69 115.73 30.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.947 . . . . 0.0 110.108 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 -54.81 19.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.548 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.78 172.02 19.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.282 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 101.22 91.05 2.11 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.37 103.55 1.68 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -56.84 -39.56 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.237 . . . . 0.0 110.167 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.92 146.21 2.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -169.84 141.17 2.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.21 106.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.29 161.92 0.83 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.409 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 174.11 9.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.17 -108.22 3.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -140.72 47.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 121' ' ' VAL . 7.9 p -151.45 111.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 110.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -106.32 16.79 24.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -78.13 -24.18 47.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.538 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.469 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -79.43 -17.83 53.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -79.27 -1.55 37.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 110.971 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.05 45.05 0.59 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 25.3 p90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.159 . . . . 0.0 110.242 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.559 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 5.4 m -53.93 135.87 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.63 -91.6 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.122 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.605 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 130' ' ' LEU . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 17' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.719 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.587 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.482 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.568 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.719 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 36' ' ' GLN . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.411 ' N ' ' O ' ' A' ' 40' ' ' PRO . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' C ' ' CD1' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.448 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' HD22 ' A' ' 5' ' ' LEU . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.442 ' CG1' HG22 ' A' ' 91' ' ' VAL . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -64.13 149.15 94.56 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 39.9 Cg_endo -65.31 149.13 88.74 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.235 1.124 . . . . 0.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.32 164.82 14.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.343 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -47.42 125.83 8.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.857 . . . . 0.0 110.557 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 tpp -72.56 -11.42 60.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 110.661 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -6.37 48.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.072 . . . . 0.0 110.945 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.87 -32.12 6.35 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.43 138.66 9.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.223 -1.163 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -83.88 171.35 13.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.58 128.66 0.66 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.46 -6.24 18.67 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.429 1.226 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -25.17 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.085 -1.009 . . . . 0.0 110.802 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.91 -21.56 11.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.044 -1.035 . . . . 0.0 110.677 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.72 -29.63 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.082 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -31.75 34.13 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -58.02 -45.71 86.47 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.263 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 59' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.441 HD12 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.429 ' N ' HD11 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 ' CG1' ' A' ' 59' ' ' VAL . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.01 113.76 27.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 19.4 p-10 -97.29 126.39 42.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.729 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 51.39 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 110.723 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -88.1 -15.04 37.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.411 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -23.17 55.24 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.107 -0.996 . . . . 0.0 110.506 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -63.16 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.2 m -106.02 52.64 0.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.897 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.3 152.07 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.299 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.17 -28.27 64.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 56.29 169.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -129.67 22.75 5.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -111.79 2.99 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.43 153.8 17.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -40.92 17.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -1.163 . . . . 0.0 110.189 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -63.13 94.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.954 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.39 140.79 57.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -168.78 117.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.984 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -127.43 153.95 19.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.55 -65.18 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -86.26 91.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.147 . . . . 0.0 110.007 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 118.05 28.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.49 138.06 19.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.38 145.52 20.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 52.72 88.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.823 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -131.01 178.99 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.052 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.0 165.91 12.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -133.4 50.16 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 0.0 110.128 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 m -61.19 -26.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.27 -162.26 0.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.398 -0.814 . . . . 0.0 110.394 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p -84.52 52.47 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.032 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.482 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.493 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.605 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.15 44.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 7.66 45.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.956 . . . . 0.0 110.814 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -145.81 54.39 0.55 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.239 -1.154 . . . . 0.0 110.327 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.559 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.4 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 5.4 m -53.93 135.87 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.63 -91.6 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.122 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.605 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 130' ' ' LEU . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 17' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.603 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.719 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.587 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.482 ' CB ' ' CA ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.568 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.719 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 36' ' ' GLN . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.411 ' N ' ' O ' ' A' ' 40' ' ' PRO . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.439 ' C ' ' CD1' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.419 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.448 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HA ' ' HB ' ' A' ' 4' ' ' THR . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' HD22 ' A' ' 5' ' ' LEU . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.493 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.442 ' CG1' HG22 ' A' ' 91' ' ' VAL . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -64.13 149.15 94.56 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.453 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 39.9 Cg_endo -65.31 149.13 88.74 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.235 1.124 . . . . 0.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.32 164.82 14.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.343 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -47.42 125.83 8.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.857 . . . . 0.0 110.557 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 tpp -72.56 -11.42 60.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 110.661 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -6.37 48.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.072 . . . . 0.0 110.945 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.87 -32.12 6.35 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.43 138.66 9.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.223 -1.163 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -83.88 171.35 13.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.58 128.66 0.66 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.46 -6.24 18.67 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.429 1.226 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -25.17 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.085 -1.009 . . . . 0.0 110.802 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.91 -21.56 11.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.044 -1.035 . . . . 0.0 110.677 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.72 -29.63 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.082 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -31.75 34.13 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -58.02 -45.71 86.47 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.263 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' CG1' ' A' ' 59' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.441 HD12 ' CG2' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.429 ' N ' HD11 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 ' CG1' ' A' ' 59' ' ' VAL . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.01 113.76 27.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 19.4 p-10 -97.29 126.39 42.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.729 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 51.39 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 110.723 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -88.1 -15.04 37.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.411 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -23.17 55.24 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.107 -0.996 . . . . 0.0 110.506 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -63.16 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.2 m -106.02 52.64 0.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.897 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.3 152.07 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.299 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.17 -28.27 64.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.483 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 56.29 169.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -129.67 22.75 5.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -111.79 2.99 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.43 153.8 17.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -40.92 17.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -1.163 . . . . 0.0 110.189 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -63.13 94.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.954 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.39 140.79 57.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -168.78 117.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.984 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -127.43 153.95 19.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.55 -65.18 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -86.26 91.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.147 . . . . 0.0 110.007 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 118.05 28.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.49 138.06 19.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.38 145.52 20.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 52.72 88.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.823 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -131.01 178.99 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.052 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.0 165.91 12.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -133.4 50.16 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 0.0 110.128 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 m -61.19 -26.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.27 -162.26 0.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.398 -0.814 . . . . 0.0 110.394 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p -84.52 52.47 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.032 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' O ' ' CD1' ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.482 ' CA ' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.493 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.549 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.605 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.549 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.15 44.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 7.66 45.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.956 . . . . 0.0 110.814 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -145.81 54.39 0.55 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.239 -1.154 . . . . 0.0 110.327 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.241 0.543 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -161.65 147.97 14.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.103 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -172.1 88.42 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.12 113.9 4.26 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.595 -1.532 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.591 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 130' ' ' LEU . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.25 -179.88 30.73 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.28 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.85 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.91 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.938 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.727 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.523 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -113.82 112.27 23.12 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.424 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.53 48.36 1.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.411 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.727 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.94 5.68 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.09 162.24 16.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -0.802 . . . . 0.0 109.861 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.77 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.68 25.77 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.371 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.405 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.63 61.08 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.106 -1.232 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.69 155.9 58.09 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.642 1.338 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 1.7 m-20 -65.97 91.72 0.15 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.719 -1.238 . . . . 0.0 109.117 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.5 -17.85 35.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -32.66 33.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.86 29.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.335 0.588 . . . . 0.0 110.291 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.1 mt -70.11 -47.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 110.416 -179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' CD1' HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.79 25.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.8 -5.41 15.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.693 -1.254 . . . . 0.0 111.94 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.439 ' O ' ' O ' ' A' ' 52' ' ' TRP . 79.3 mt-30 57.58 109.91 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.352 -0.843 . . . . 0.0 109.446 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.9 Cg_endo -71.06 111.52 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.208 1.11 . . . . 0.0 111.522 -177.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.455 ' O ' HD22 ' A' ' 5' ' ' LEU . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -64.98 149.32 96.86 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.14 149.34 76.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.816 1.43 . . . . 0.0 110.445 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.38 164.74 14.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.53 150.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.441 -0.787 . . . . 0.0 110.787 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -15.93 63.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.14 -11.45 59.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 110.624 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.59 49.01 81.4 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 -166.22 1.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.226 -1.161 . . . . 0.0 110.239 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.71 114.04 26.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -131.37 120.69 18.08 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.876 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.48 -7.71 21.9 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.481 1.253 . . . . 0.0 111.258 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.86 -26.79 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.969 -1.082 . . . . 0.0 110.232 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.27 -20.71 19.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.305 -0.872 . . . . 0.0 111.091 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.59 -32.87 8.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.989 -1.069 . . . . 0.0 109.17 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' PHE . 2.1 ttt-85 -75.76 -29.9 58.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -58.71 -43.19 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 178.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -62.89 -48.66 78.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.04 -25.14 64.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.807 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 83' ' ' ILE . . . -59.46 -35.06 73.36 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -22.52 62.03 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.518 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -69.91 -57.19 5.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.773 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.491 ' CD1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 pp -59.71 -28.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.959 -1.088 . . . . 0.0 110.218 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.431 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -67.05 -58.56 4.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.22 -15.85 61.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.26 4.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 4.8 p -95.68 152.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.175 0.988 . . . . 0.0 112.071 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.34 46.8 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.18 128.38 41.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.02 -1.05 . . . . 0.0 108.855 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -92.65 132.35 36.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 0.0 110.843 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.52 145.54 54.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.29 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -87.16 -141.57 0.11 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.261 -0.9 . . . . 0.0 109.693 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -11.88 46.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.704 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -17.63 40.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.04 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.82 65.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 110.28 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -143.31 159.59 42.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.18 152.2 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 110.137 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.0 -32.51 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.5 111.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.38 144.84 42.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 t -91.09 -23.86 20.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.23 -20.96 67.82 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.74 107.94 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -1.194 . . . . 0.0 110.357 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -121.49 116.02 23.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.93 160.33 3.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -103.0 -52.56 3.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.93 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.07 -112.8 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.92 -112.3 3.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 53.86 46.63 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -1.086 . . . . 0.0 110.439 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -176.16 160.71 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.328 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.07 -57.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp 53.82 64.7 1.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.88 . . . . 0.0 110.172 -179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -109.72 49.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.161 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -90.96 79.33 5.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.62 67.21 0.3 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -69.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.134 . . . . 0.0 110.161 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 11.8 p -172.82 31.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.413 -0.804 . . . . 0.0 110.169 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -111.02 -178.95 3.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p -109.28 64.93 0.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 127' ' ' VAL . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.523 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' ALA . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.54 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.591 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.28 -17.88 47.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.568 -0.707 . . . . 0.0 111.231 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.444 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -75.14 -20.24 59.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.727 -1.233 . . . . 0.0 111.2 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.81 41.58 0.2 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.033 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.158 -1.201 . . . . 0.0 110.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -172.62 160.35 4.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -161.45 84.88 0.11 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.597 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.93 130.42 56.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.592 ' HA ' HG12 ' A' ' 17' ' ' VAL . 5.2 m-85 -115.93 134.69 54.72 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.373 -0.829 . . . . 0.0 111.894 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.0 t70 -113.99 92.66 4.05 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.494 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.635 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.725 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 8' ' ' PHE . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB2' ' CA ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.619 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.4 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.94 23.74 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.61 164.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.679 2.253 . . . . 0.0 115.414 -174.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.7 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.71 28.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.98 30.52 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.55 17.46 66.16 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 39.7 m -86.91 108.87 20.4 Favored Pre-proline 0 C--N 1.307 -1.256 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.505 1.266 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.4 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.38 -36.5 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.805 178.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.7 mp -77.48 -52.74 15.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 109.729 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.84 -43.83 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.995 -1.066 . . . . 0.0 110.488 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.0 tt0 -53.07 -42.8 66.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.953 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.89 -38.27 72.57 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.553 178.983 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD2' ' CG ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.08 133.26 28.32 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.067 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.58 -34.17 60.64 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.664 -0.648 . . . . 0.0 109.848 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 5' ' ' LEU . 5.0 mt-10 -141.31 157.58 45.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.018 -1.051 . . . . 0.0 110.668 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.446 ' CD1' ' O ' ' A' ' 56' ' ' GLU . 8.0 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' CD1' ' CD2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 8' ' ' PHE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 166.65 127.04 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 3.5 pp -63.19 149.63 90.66 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.934 -1.333 . . . . 0.0 109.778 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.14 145.82 89.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.655 1.345 . . . . 0.0 111.378 -178.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.7 164.28 12.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -49.05 149.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.213 -0.93 . . . . 0.0 110.398 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -28.49 69.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.195 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.24 -11.37 59.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.49 27.89 66.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -165.94 0.63 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.081 -1.247 . . . . 0.0 109.912 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.82 154.08 26.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 110.352 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -157.28 85.12 2.85 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.23 -7.75 22.01 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.712 1.375 . . . . 0.0 110.821 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 72' ' ' LEU . 2.3 mm? -79.57 -24.21 42.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.29 -21.78 10.18 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 111.009 -178.859 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.88 -29.01 4.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 0.0 108.959 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -81.65 -31.82 32.14 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -58.42 -48.41 80.79 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.429 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.31 -48.4 81.52 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.475 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -26.27 65.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.805 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.12 94.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.35 -16.53 71.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.516 ' CG ' ' CD2' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -98.64 153.84 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.512 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.39 78.91 8.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.747 . . . . 0.0 110.794 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.429 ' HG ' ' CG ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -82.68 102.38 11.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.66 144.49 30.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.96 . . . . 0.0 110.095 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.36 79.16 9.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.379 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -83.28 -10.75 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.208 -0.932 . . . . 0.0 110.39 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -17.47 61.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.505 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -50.77 -30.69 14.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.481 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.6 m -72.0 93.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 110.047 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.13 152.6 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.53 -24.49 20.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.388 -0.82 . . . . 0.0 110.356 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -161.34 -52.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -167.8 130.05 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.11 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -114.06 15.58 18.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.02 -175.87 32.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 14.6 mt -61.03 -177.02 0.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -1.164 . . . . 0.0 110.404 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -129.28 144.22 51.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.405 -0.809 . . . . 0.0 109.948 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -153.93 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.467 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -171.8 -41.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.33 -143.67 21.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ARG . . . 102.02 -165.46 17.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 55.3 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.961 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -143.56 -60.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.856 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.32 84.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.81 156.55 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.1 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 110.783 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -89.04 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.05 -129.66 1.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -162.39 161.88 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -1.151 . . . . 0.0 110.229 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.03 127.68 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -101.39 -158.91 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -101.19 16.5 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.463 ' CA ' ' HB2' ' A' ' 9' ' ' ASP . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 9' ' ' ASP . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.567 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.597 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.59 -38.69 72.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.617 -179.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.6 m-85 -55.71 -33.55 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 109.001 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -80.69 -32.14 36.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -78.71 -10.6 59.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 110.615 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.42 -58.71 12.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.112 179.815 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.243 0.544 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 -73.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.75 -86.08 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ASP . 92.0 m -150.82 140.47 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -1.226 . . . . 0.0 112.702 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.619 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -127.4 136.77 52.31 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.449 -0.782 . . . . 0.0 108.951 178.239 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.518 HD11 ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -120.22 144.26 47.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.961 -1.087 . . . . 0.0 108.883 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.532 ' HB2' HD22 ' A' ' 130' ' ' LEU . . . -145.32 124.33 12.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 3.1 m-85 -117.95 149.95 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.841 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.3 t0 -121.16 93.8 4.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.1 p90 -174.26 -155.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.113 -1.435 . . . . 0.0 113.705 -177.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . 159.04 159.12 9.47 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p 45.68 -143.78 0.23 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.055 . . . . 0.0 111.394 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 18.9 mttt -81.96 51.99 1.86 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.04 -1.038 . . . . 0.0 111.389 -178.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -142.02 131.49 23.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.682 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.728 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 31.8 mm -124.62 96.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.16 103.66 0.77 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 103.393 -3.883 . . . . 0.0 103.393 176.349 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.523 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.48 170.44 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 C-N-CA 116.144 -2.223 . . . . 0.0 114.406 -174.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB1' ' CA ' ' A' ' 127' ' ' VAL . . . -127.66 136.89 52.23 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.306 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.491 ' HA ' HD13 ' A' ' 6' ' ' LEU . 13.9 t -106.76 125.04 62.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.83 135.73 13.08 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 118.714 -1.708 . . . . 0.0 111.277 -177.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -96.74 120.57 37.3 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -91.09 36.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.454 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.585 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 178.171 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.402 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.52 -16.52 10.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 178.948 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.61 35.83 7.68 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.089 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.75 161.21 20.5 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.855 -1.379 . . . . 0.0 111.064 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.539 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -124.88 123.29 39.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.046 -1.034 . . . . 0.0 112.375 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HG3' ' HD2' ' A' ' 29' ' ' PRO . 24.6 ttt-85 -88.19 146.12 37.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 50.5 Cg_endo -90.74 141.1 3.09 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 O-C-N 122.792 0.891 . . . . 0.0 112.89 -176.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.523 ' HB3' HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -99.55 139.65 21.04 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.031 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 21.7 Cg_endo -42.65 169.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.013 2.475 . . . . 0.0 115.965 -174.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.62 143.79 57.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.827 -176.181 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.728 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -53.87 53.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.495 -1.684 . . . . 0.0 115.53 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.98 96.24 3.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.829 -1.17 . . . . 0.0 109.273 176.133 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.85 160.86 16.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.577 -179.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -83.81 116.64 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.083 -1.011 . . . . 0.0 111.336 -178.609 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 48.2 27.75 1.37 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 94.81 12.33 55.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 36' ' ' GLN . 20.5 m -95.47 110.52 51.28 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.022 -1.281 . . . . 0.0 109.631 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.45 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.9 Cg_endo -73.53 159.18 46.69 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.472 1.248 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 1.2 m-20 -63.39 91.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.923 -1.111 . . . . 0.0 108.118 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.45 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 11.4 t-105 -87.69 -16.8 33.31 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.224 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -80.02 -35.07 37.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.8 mp -74.49 -50.05 28.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.725 -0.61 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 49' ' ' LEU . 12.1 mt -71.23 -43.58 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.907 -1.121 . . . . 0.0 110.466 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 33.8 tp10 -49.2 -43.0 42.0 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.166 -0.959 . . . . 0.0 109.26 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -57.57 -48.22 79.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 53' ' ' GLN . 2.6 mt -59.61 -24.95 64.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.856 178.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.453 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -84.1 -46.8 11.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.621 -0.674 . . . . 0.0 112.136 -178.408 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -50.72 9.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 112.286 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -84.22 -30.63 25.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.046 . . . . 0.0 112.162 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -109.12 -30.74 7.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 0.0 111.74 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 54.2 97.07 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.083 -1.011 . . . . 0.0 109.477 -178.589 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -68.6 124.2 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.446 1.235 . . . . 0.0 110.614 -179.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' THR . 3.9 t0 -71.31 -39.0 71.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.53 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' O ' HD21 ' A' ' 5' ' ' LEU . 12.9 tt0 -135.28 154.37 51.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.2 mp -133.94 136.83 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.799 -1.188 . . . . 0.0 112.682 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -120.2 113.92 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.073 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 83' ' ' ILE . 2.3 t -134.08 151.58 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.173 -1.579 . . . . 0.0 112.993 -177.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.44 141.32 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.661 177.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -110.21 108.74 58.81 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.539 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -90.29 113.99 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.216 1.114 . . . . 0.0 110.048 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.3 tp -131.74 132.08 43.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 110.594 179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -82.1 125.35 30.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 109.531 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.4 tpp -83.54 -44.81 14.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 110.319 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.69 17.51 22.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.198 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.65 30.61 66.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 t -166.35 -148.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.38 -1.071 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 150.62 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 109.894 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -159.1 98.53 1.63 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.0 110.609 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.0 -8.27 23.24 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.71 1.374 . . . . 0.0 110.524 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -24.12 67.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.144 -0.973 . . . . 0.0 110.531 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -54.24 -19.97 6.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.509 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.73 -26.85 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.019 -1.051 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -33.94 54.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -62.93 -50.15 71.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.583 -0.698 . . . . 0.0 109.748 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -62.77 -45.93 90.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.189 -0.944 . . . . 0.0 109.784 179.636 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -56.97 -30.99 64.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.169 -0.957 . . . . 0.0 109.401 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.497 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 74.4 t80 -61.6 -38.61 88.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.931 178.553 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 93' ' ' LEU . . . -56.72 -33.28 66.34 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -68.89 -22.87 64.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.905 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.67 6.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.445 ' CD1' HG12 ' A' ' 59' ' ' VAL . 34.7 pt -59.69 -30.12 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.853 -1.154 . . . . 0.0 109.151 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.9 t-160 -64.37 -58.32 6.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 109.754 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.43 -16.19 42.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -71.78 -44.82 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -1.225 . . . . 0.0 110.669 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.35 -10.62 9.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 110.842 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 42.56 16.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.412 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.7 m -104.53 153.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -1.047 . . . . 0.0 110.715 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.07 83.89 2.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 0.0 111.225 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.432 HG22 ' CG2' ' A' ' 57' ' ' ILE . 2.8 p -90.76 151.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -121.28 155.29 35.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.92 -0.488 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 80' ' ' ALA . 21.2 mt -92.28 142.68 27.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.041 -1.037 . . . . 0.0 110.621 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.5 ' CG ' HG12 ' A' ' 129' ' ' ILE . 16.4 t-160 -80.76 106.77 13.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.94 144.7 44.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.6 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.8 76.97 0.46 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.875 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -84.32 -4.56 58.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.231 -0.918 . . . . 0.0 110.978 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -28.14 68.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.128 . . . . 0.0 110.579 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 p -62.5 95.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -83.25 -167.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.897 . . . . 0.0 110.457 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.09 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -21.29 46.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.481 -0.762 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.66 135.34 53.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 0.0 110.209 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.15 167.51 10.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.418 ' OG ' ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -91.33 -12.67 34.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 110.596 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.97 107.91 2.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -107.16 80.97 1.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -1.145 . . . . 0.0 110.584 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.24 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 110.639 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -59.59 160.46 7.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 109.639 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -53.39 39.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.23 150.25 0.25 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.5 87.97 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.418 ' CE2' ' OG ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -175.81 92.9 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.261 -1.14 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.77 66.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -98.79 -36.18 9.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -0.952 . . . . 0.0 110.261 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 57.17 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.28 -0.888 . . . . 0.0 110.546 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.59 151.85 25.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.124 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -62.37 1.56 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.96 -125.33 6.42 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt 54.97 174.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.6 167.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 109.989 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.75 85.0 2.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.977 . . . . 0.0 110.546 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 m -72.81 -10.06 59.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.342 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.49 60.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.222 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 1.5 m -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.807 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.41 -50.68 8.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.878 -1.139 . . . . 0.0 109.222 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.41 -23.15 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.332 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 128' ' ' ILE . 12.4 mm -70.13 -41.64 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 174.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 38.3 mt -63.92 -35.16 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 176.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.561 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -67.08 -34.61 78.03 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.147 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -20.33 64.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.852 -1.155 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -48.56 26.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -58.15 -40.41 81.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.889 -1.132 . . . . 0.0 109.642 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.561 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.4 m-85 -52.61 -45.64 66.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.071 -1.018 . . . . 0.0 109.616 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -80.69 -18.71 47.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.98 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -98.38 11.88 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.28 -42.23 98.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.351 -1.088 . . . . 0.0 110.093 179.886 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.241 0.543 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -161.65 147.97 14.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.103 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -172.1 88.42 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.11 113.87 4.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.554 -1.557 . . . . 0.0 111.027 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.591 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB2' HD21 ' A' ' 130' ' ' LEU . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.515 ' CE2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.602 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.27 -179.86 30.74 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.27 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.825 -179.059 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.88 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.115 -0.99 . . . . 0.0 110.938 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.727 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.569 ' HA ' ' CB ' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.523 ' CB ' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.514 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -113.83 112.33 23.2 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.39 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.56 48.36 1.53 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.411 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 ' N ' HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 ' HB3' HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.727 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.89 5.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -89.02 162.24 16.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 109.898 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.71 20.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.156 -0.965 . . . . 0.0 111.154 -178.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.75 25.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.405 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.64 61.05 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.077 -1.249 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.454 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.7 155.94 57.99 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.586 1.308 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB3' ' CG1' ' A' ' 44' ' ' ILE . 1.7 m-20 -66.04 91.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.734 -1.229 . . . . 0.0 109.098 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.47 -17.92 35.1 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.22 -32.66 33.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.479 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.95 28.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.317 0.58 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.0 mt -70.04 -47.63 67.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.477 -0.765 . . . . 0.0 110.453 -179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' CD1' HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.82 25.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.77 -5.37 15.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.702 -1.249 . . . . 0.0 111.95 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.44 ' O ' ' O ' ' A' ' 52' ' ' TRP . 79.3 mt-30 57.59 109.94 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.9 Cg_endo -71.09 111.52 3.09 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.276 1.145 . . . . 0.0 111.522 -177.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.455 ' O ' HD22 ' A' ' 5' ' ' LEU . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 91' ' ' VAL . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 129' ' ' ILE . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.485 ' CB ' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -64.98 149.32 96.86 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.14 149.34 76.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.816 1.43 . . . . 0.0 110.445 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.36 164.77 14.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.23 -179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -46.56 150.43 0.68 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.377 -0.827 . . . . 0.0 110.787 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -15.93 63.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.14 -11.45 59.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 110.624 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.56 49.04 80.99 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 -166.22 1.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.226 -1.161 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.68 114.01 26.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -131.35 120.69 18.1 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.48 -7.71 21.9 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.481 1.253 . . . . 0.0 111.258 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.84 -26.79 15.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 110.293 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.27 -20.71 19.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 111.091 -179.838 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.59 -32.87 8.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.989 -1.069 . . . . 0.0 109.17 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' PHE . 2.1 ttt-85 -75.76 -29.9 58.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.215 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -58.71 -43.19 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -62.89 -48.69 77.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.0 -25.17 64.37 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 108.815 178.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 83' ' ' ILE . . . -59.46 -35.07 73.38 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -22.46 62.01 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.56 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -69.91 -57.21 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.491 ' CD1' ' CG2' ' A' ' 91' ' ' VAL . 2.7 pp -59.68 -28.83 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.934 -1.104 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.431 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 0.8 OUTLIER -67.06 -58.57 4.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.123 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.2 -15.85 61.51 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' ND1' ' A' ' 84' ' ' HIS . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.27 4.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 4.8 p -95.75 152.52 3.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 122.202 1.001 . . . . 0.0 112.018 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.35 46.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.13 128.37 41.91 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.999 -1.063 . . . . 0.0 108.854 -179.798 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -92.68 132.35 36.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 110.843 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.52 145.51 54.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.29 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -87.12 -141.6 0.11 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -11.84 46.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.704 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -17.59 40.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.82 65.64 1.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -143.31 159.59 42.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.081 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.18 152.2 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 110.137 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.0 -32.51 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.49 111.55 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.046 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.43 144.84 42.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 t -91.09 -23.86 20.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.27 -20.88 67.82 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.79 107.94 13.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -121.49 116.02 23.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.95 160.34 3.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.597 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -103.04 -52.53 3.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.04 -112.86 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.86 -112.29 3.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 53.86 46.63 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -1.081 . . . . 0.0 110.439 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -176.17 160.71 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.363 179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.09 -57.47 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp 53.82 64.69 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.88 . . . . 0.0 110.172 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -109.7 49.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.169 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -90.96 79.33 5.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.63 67.22 0.3 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 -69.27 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -1.134 . . . . 0.0 110.188 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 11.8 p -172.82 31.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.413 -0.804 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.0 -178.94 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 110.51 -179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p -109.3 64.93 0.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 127' ' ' VAL . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.523 ' N ' ' CB ' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 128' ' ' ILE . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 126' ' ' ALA . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.54 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.591 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -81.25 -17.92 47.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.262 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.444 ' CG ' ' O ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -75.14 -20.24 59.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.727 -1.233 . . . . 0.0 111.2 -178.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.81 41.58 0.2 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.033 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.185 -1.185 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -172.62 160.35 4.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -161.45 84.88 0.11 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.597 ' CD1' ' CE2' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 17' ' ' VAL . . . -112.93 130.47 56.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.592 ' HA ' HG12 ' A' ' 17' ' ' VAL . 5.2 m-85 -115.99 134.63 54.76 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.357 -0.84 . . . . 0.0 111.863 -178.221 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.1 t70 -113.92 92.65 4.05 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.635 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.494 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' LYS . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.635 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.725 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.592 HG12 ' HA ' ' A' ' 8' ' ' PHE . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' HB2' ' CA ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.619 ' HA ' ' HG ' ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.5 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.563 ' CD1' ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.448 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.89 23.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.488 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.51 164.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.668 2.245 . . . . 0.0 115.462 -174.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.72 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.725 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.72 28.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.97 30.51 4.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 110.147 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.56 17.42 66.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 40.2 m -86.83 108.83 20.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.145 -1.209 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.447 ' HA ' ' CG1' ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.502 1.264 . . . . 0.0 109.475 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.5 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.4 -36.44 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.834 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 1.7 mp -77.52 -52.74 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.809 -0.557 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.89 -43.77 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.995 -1.066 . . . . 0.0 110.518 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 4.9 tt0 -53.07 -42.84 66.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.918 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.86 -38.27 72.48 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.553 179.007 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 52' ' ' TRP . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' CD2' ' CG ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.057 -1.027 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.06 133.25 28.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.083 -178.381 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.59 -34.17 60.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.724 -0.61 . . . . 0.0 109.848 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 5' ' ' LEU . 5.0 mt-10 -141.3 157.57 45.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.018 -1.051 . . . . 0.0 110.623 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.446 ' CD1' ' O ' ' A' ' 56' ' ' GLU . 7.9 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' CD1' ' CD2' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.478 HG22 ' CD1' ' A' ' 8' ' ' PHE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 59' ' ' VAL . . . 166.65 127.06 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 76' ' ' ALA . 3.5 pp -63.23 149.67 90.71 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.969 -1.313 . . . . 0.0 109.779 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.14 145.82 89.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.655 1.345 . . . . 0.0 111.378 -178.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -98.7 164.28 12.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -49.05 149.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.213 -0.93 . . . . 0.0 110.398 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -28.49 69.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.195 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.24 -11.37 59.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.49 27.89 66.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -165.94 0.63 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.046 -1.267 . . . . 0.0 109.912 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.82 154.08 26.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 110.352 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.29 85.14 2.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.962 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.23 -7.75 22.01 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.712 1.375 . . . . 0.0 110.821 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' N ' HD21 ' A' ' 72' ' ' LEU . 2.3 mm? -79.57 -24.21 42.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.31 -21.76 10.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 110.99 -178.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.89 -29.01 4.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.017 -1.052 . . . . 0.0 108.959 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -81.63 -31.89 32.18 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -58.38 -48.38 80.82 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.469 -0.769 . . . . 0.0 109.494 179.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.429 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.37 -48.36 81.61 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.469 179.671 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.494 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -26.23 65.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.765 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CD1' HG23 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.446 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.15 94.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.3 -16.51 71.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.516 ' CG ' ' CD2' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 m -98.62 153.85 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.533 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 78.91 8.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.714 . . . . 0.0 110.794 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.446 ' CG1' ' HB2' ' A' ' 84' ' ' HIS . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.429 ' HG ' ' CG ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -82.68 102.38 11.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.66 144.49 30.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.96 . . . . 0.0 110.095 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.36 79.16 9.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.379 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -83.28 -10.74 58.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.208 -0.932 . . . . 0.0 110.39 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.83 -17.5 61.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 110.483 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -50.77 -30.69 14.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.481 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.6 m -72.0 93.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 110.047 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.17 152.58 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 110.465 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.53 -24.49 20.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 110.356 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -161.34 -52.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -167.8 130.05 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.11 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 p -114.06 15.58 18.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.02 -175.87 32.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 14.6 mt -61.03 -177.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -1.164 . . . . 0.0 110.404 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -129.28 144.19 51.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -153.93 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.467 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -171.8 -41.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.33 -143.67 21.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ARG . . . 102.02 -165.46 17.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 55.3 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.961 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -143.56 -60.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.32 84.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.81 156.55 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.1 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 110.783 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -89.04 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.05 -129.66 1.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -162.41 161.9 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 110.171 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.03 127.68 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -101.39 -158.91 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -101.19 16.5 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.463 ' CA ' ' HB2' ' A' ' 9' ' ' ASP . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 9' ' ' ASP . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.567 ' CD1' ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.597 ' CE2' ' CD1' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.56 -38.72 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.629 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.567 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 7.6 m-85 -55.69 -33.55 64.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.001 179.022 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -80.69 -32.14 36.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -78.71 -10.61 59.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 110.615 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.4 -58.75 12.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.112 179.815 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.318 0.58 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.44 ' HB2' HG11 ' A' ' 91' ' ' VAL . 1.2 t-80 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 68.6 m -143.29 147.03 34.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.079 -1.247 . . . . 0.0 111.699 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -126.79 142.08 51.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.128 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -130.09 144.82 51.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 58' ' ' ILE . . . -153.8 126.01 7.93 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.889 -1.132 . . . . 0.0 110.319 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.905 ' HB2' HG23 ' A' ' 59' ' ' VAL . 1.9 m-85 -123.67 136.5 54.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.305 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 129' ' ' ILE . 12.8 t70 -106.14 96.68 6.64 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.9 p90 -174.16 -159.68 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.55 ' CA ' ' CE2' ' A' ' 79' ' ' PHE . . . -166.26 -148.03 5.41 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.057 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 12' ' ' THR . 78.9 p -37.52 -91.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.655 -0.909 . . . . 0.0 113.098 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.45 49.51 0.94 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.679 -1.263 . . . . 0.0 111.473 -178.203 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.78 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.94 134.25 27.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 110.373 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 40' ' ' PRO . 32.9 mm -126.39 94.96 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.42 103.94 0.74 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 103.349 -3.901 . . . . 0.0 103.349 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.989 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.0 164.79 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.79 -174.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.806 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.68 129.97 50.62 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.609 HG11 ' HG ' ' A' ' 48' ' ' LEU . 10.9 t -102.48 125.89 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.729 ' HA3' HD12 ' A' ' 5' ' ' LEU . . . -120.59 146.49 17.64 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 118.251 -1.928 . . . . 0.0 112.31 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 21' ' ' GLN . 13.8 pt20 -95.86 121.44 37.59 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.43 ' CD ' ' OH ' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -89.87 31.43 0.96 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.698 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.886 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.97 -32.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -115.92 -17.33 11.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.63 34.43 9.25 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.659 -1.258 . . . . 0.0 109.959 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 161.59 20.4 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.946 -1.326 . . . . 0.0 110.583 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . . . -134.59 135.04 41.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.925 -1.11 . . . . 0.0 112.422 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -98.91 153.72 37.69 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.4 Cg_endo -91.61 134.71 1.59 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.292 1.154 . . . . 0.0 112.094 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.989 HD22 HG13 ' A' ' 17' ' ' VAL . 1.6 tt -99.44 141.26 22.51 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.36 167.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.811 2.341 . . . . 0.0 116.223 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.56 144.84 56.92 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.053 1.406 . . . . 0.0 114.284 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.23 55.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 112.976 -1.92 . . . . 0.0 115.835 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 37.5 tptt -133.73 96.78 3.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.852 -1.155 . . . . 0.0 109.81 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.95 161.14 16.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 39' ' ' THR . 42.7 mt-30 -85.24 120.97 27.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.214 -0.929 . . . . 0.0 111.498 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.26 27.34 1.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.046 -1.034 . . . . 0.0 110.278 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.08 16.82 55.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.796 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.1 m -94.8 109.39 43.57 Favored Pre-proline 0 C--N 1.306 -1.284 0 O-C-N 121.082 -1.246 . . . . 0.0 109.789 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.717 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -68.88 155.92 67.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.572 1.301 . . . . 0.0 109.165 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 45' ' ' ILE . 3.2 m-20 -63.71 91.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.976 -1.077 . . . . 0.0 108.87 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 13.4 t90 -91.95 -21.6 20.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.74 -37.97 26.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.947 . . . . 0.0 109.889 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -73.12 -50.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.736 -0.602 . . . . 0.0 110.045 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 41' ' ' ASP . 20.6 mt -70.34 -49.32 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.952 -1.092 . . . . 0.0 111.025 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -54.06 -32.94 56.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.67 -1.269 . . . . 0.0 109.815 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -61.02 -47.21 87.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.309 -0.87 . . . . 0.0 109.37 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.945 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.52 -27.07 31.94 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 109.03 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.875 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -66.16 -54.64 22.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 111.221 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -74.84 -25.82 59.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.941 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -81.26 -38.3 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 0.0 110.771 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.518 ' HB2' HD22 ' A' ' 48' ' ' LEU . 33.9 m95 -109.71 -20.56 12.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.074 -1.016 . . . . 0.0 111.109 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER 56.52 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 46.8 Cg_endo -72.04 134.53 23.5 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.8 1.421 . . . . 0.0 111.117 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.92 -35.8 23.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 110.725 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.58 144.85 50.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 91' ' ' VAL . 5.0 mp -130.02 137.75 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.527 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.54 114.28 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.905 HG23 ' HB2' ' A' ' 8' ' ' PHE . 1.1 p -134.67 151.29 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.229 -1.544 . . . . 0.0 114.008 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 151.16 140.5 3.18 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.297 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.442 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 3.4 ttm180 -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -56.04 -32.14 63.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.666 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 7.6 m-30 -57.83 -47.72 81.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.026 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' HIS . . . -55.34 -34.69 64.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -80.29 -24.07 40.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 109.198 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 79' ' ' PHE . 2.1 mtt180 -77.3 -56.71 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 91' ' ' VAL . 16.2 pt -62.14 -38.88 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 109.412 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.462 ' N ' HG13 ' A' ' 83' ' ' ILE . 1.9 t60 -58.6 -42.14 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.496 -0.753 . . . . 0.0 109.901 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.72 -16.81 80.41 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -44.82 23.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -1.222 . . . . 0.0 110.433 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.6 -13.15 9.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.01 -1.057 . . . . 0.0 110.881 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 82.24 32.76 27.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.4 m -91.14 153.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.485 -1.009 . . . . 0.0 110.686 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 81.69 6.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.756 . . . . 0.0 110.531 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 57' ' ' ILE . 8.7 p -100.31 152.3 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 153.85 29.78 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.003 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -92.66 138.64 31.32 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.027 -1.046 . . . . 0.0 108.907 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 1.003 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t60 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.786 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 121.052 0.453 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -48.57 -29.68 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 0.0 110.9 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.4 p -54.7 -33.39 60.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 111.526 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -77.71 -55.77 5.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.151 . . . . 0.0 109.266 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.806 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -53.47 -24.3 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -76.76 -46.01 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 9' ' ' ASP . 17.0 mt -53.73 -27.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.961 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -67.55 -39.81 84.98 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.894 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -34.18 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -32.35 67.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 t80 -75.11 -54.46 7.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.68 -0.638 . . . . 0.0 109.754 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.961 ' CE2' HD12 ' A' ' 130' ' ' LEU . 25.2 m-85 -52.18 -28.98 20.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.074 -1.016 . . . . 0.0 109.558 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.486 -0.759 . . . . 0.0 109.677 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.7 m -147.5 138.34 23.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.968 -1.313 . . . . 0.0 112.209 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.02 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.02 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HB2' HD12 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.688 0.756 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.4 28.75 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.03 126.7 41.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.124 -0.985 . . . . 0.0 111.155 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.1 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 138.01 58.19 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 123.004 1.383 . . . . 0.0 113.772 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.035 -1.893 . . . . 0.0 115.73 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.05 159.76 17.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.374 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.02 123.92 33.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -0.883 . . . . 0.0 110.821 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -0.93 . . . . 0.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.94 47.59 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.81 107.7 26.46 Favored Pre-proline 0 C--N 1.307 -1.275 0 O-C-N 121.06 -1.259 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.24 157.62 56.71 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.641 1.337 . . . . 0.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.79 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.55 -20.45 54.1 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.359 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -30.89 30.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.837 -0.539 . . . . 0.0 111.764 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.42 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.83 -51.63 8.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.907 -1.121 . . . . 0.0 112.281 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.775 -1.203 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.173 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.74 136.86 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.735 1.387 . . . . 0.0 111.422 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.79 -45.18 37.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 110.074 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 140.3 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.067 . . . . 0.0 109.606 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.7 137.89 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.002 . . . . 0.0 111.856 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.736 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.29 122.42 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -57.02 4.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.78 -25.75 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.068 . . . . 0.0 109.798 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.68 62.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.81 -16.26 75.62 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.7 m-85 -119.1 -11.92 9.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 110.322 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.97 31.62 42.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.17 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.682 -0.893 . . . . 0.0 110.773 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.29 125.83 40.19 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.887 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.208 0.528 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.764 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -21.62 64.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 109.281 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.0 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.96 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.6 m -142.63 134.84 27.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.965 -1.315 . . . . 0.0 112.505 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.073 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -126.31 140.6 52.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.942 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -135.03 134.32 40.3 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.481 -1.387 . . . . 0.0 110.772 179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -118.33 122.96 44.17 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.761 ' HE1' HG23 ' A' ' 57' ' ' ILE . 33.6 m-85 -109.04 131.95 54.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.52 -0.738 . . . . 0.0 111.764 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 18.1 t70 -113.34 93.2 4.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.0 p90 -177.65 -164.57 0.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.244 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.56 168.56 33.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 55.7 p -60.01 77.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.89 -1.359 . . . . 0.0 111.654 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 3.7 mttp 162.67 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.528 -0.733 . . . . 0.0 110.678 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -137.84 142.29 40.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -178.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 40' ' ' PRO . 36.5 mm -122.92 102.22 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.5 103.9 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 104.126 -3.59 . . . . 0.0 104.126 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.898 ' CG1' HD13 ' A' ' 30' ' ' LEU . 39.8 t -135.75 167.13 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 116.713 -1.995 . . . . 0.0 114.091 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.67 131.64 48.03 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.652 HG13 HD11 ' A' ' 6' ' ' LEU . 68.5 t -101.08 135.88 35.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.85 -1.156 . . . . 0.0 108.091 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -111.71 141.03 16.45 Favored Glycine 0 N--CA 1.484 1.85 0 C-N-CA 119.047 -1.549 . . . . 0.0 111.352 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -95.87 112.85 24.47 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -87.58 21.49 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.582 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.891 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.81 -32.66 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.753 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -117.73 -17.37 9.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.61 34.74 11.19 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.92 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 158.48 26.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.738 -1.448 . . . . 0.0 110.909 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.86 119.44 30.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.844 -1.16 . . . . 0.0 111.737 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' VAL . 31.8 ttm105 -86.98 154.54 55.24 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.0 Cg_endo -91.53 137.36 1.98 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.134 1.071 . . . . 0.0 112.151 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.898 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.2 tt -99.74 141.23 22.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 22.2 Cg_endo -43.25 169.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.839 2.359 . . . . 0.0 116.086 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ILE . . . -65.41 150.3 48.56 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 123.528 1.632 . . . . 0.0 115.069 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 14' ' ' SER 0.279 0.9 OUTLIER -51.22 -126.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.462 -2.153 . . . . 0.0 112.783 179.838 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.589 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.7 OUTLIER 34.87 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.211 -0.931 . . . . 0.0 112.468 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -88.9 160.48 17.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.932 -1.105 . . . . 0.0 109.752 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.09 115.21 26.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 111.419 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.3 25.79 0.95 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.849 . . . . 0.0 110.372 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.76 17.23 42.21 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.1 m -94.98 106.94 28.3 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 120.999 -1.295 . . . . 0.0 109.993 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.781 ' HB3' HD11 ' A' ' 15' ' ' ILE . 46.4 Cg_endo -72.22 162.53 41.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.575 1.303 . . . . 0.0 109.734 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.914 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -64.27 92.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.001 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.428 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 31.3 t90 -90.45 -17.23 27.53 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.457 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.8 m-20 -81.65 -35.4 29.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.811 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.0 mp -82.4 -48.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.854 -0.529 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 41' ' ' ASP . 18.5 mt -70.75 -33.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.155 -0.966 . . . . 0.0 111.16 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -76.8 -45.22 29.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.924 -1.11 . . . . 0.0 110.427 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CD ' ' O ' ' A' ' 43' ' ' ASN . 1.9 mtt180 -52.44 -41.46 63.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.943 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.28 -28.71 34.58 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.107 -0.996 . . . . 0.0 109.066 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.931 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.13 -49.78 76.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -1.0 . . . . 0.0 110.48 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -72.43 -32.35 66.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 111.053 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.85 -42.53 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.103 . . . . 0.0 111.221 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 49.0 m95 -111.01 -27.5 8.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.899 -1.125 . . . . 0.0 111.562 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.7 mt-30 59.48 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.022 -1.049 . . . . 0.0 109.487 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.482 ' HB3' HD13 ' A' ' 6' ' ' LEU . 46.8 Cg_endo -71.37 129.61 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.605 1.319 . . . . 0.0 111.44 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -80.34 -40.21 27.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 110.58 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -132.9 155.16 49.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 109.879 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.761 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.9 mp -133.15 137.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 112.695 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.64 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.916 HG11 ' CD1' ' A' ' 83' ' ' ILE . 74.0 t -131.82 150.73 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.975 -1.703 . . . . 0.0 113.065 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 170.14 121.13 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.245 -0.978 . . . . 0.0 110.833 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 120.891 -1.358 . . . . 0.0 109.535 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -48.44 81.77 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -25.24 62.8 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.995 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -63.13 -45.51 91.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -62.34 -29.44 70.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.463 -0.773 . . . . 0.0 109.104 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -67.15 -23.25 65.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -56.93 4.04 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 110.45 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.916 ' CD1' HG11 ' A' ' 59' ' ' VAL . 16.2 pt -56.16 -28.82 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.473 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.458 ' HB2' HG11 ' A' ' 91' ' ' VAL . 32.5 t-80 -70.2 -50.99 34.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.345 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.81 -15.55 79.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -74.66 -44.27 51.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.918 -1.342 . . . . 0.0 110.5 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -113.64 -11.09 13.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.394 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.62 48.22 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 89' ' ' VAL . 35.4 m -109.49 153.91 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.636 -0.92 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.55 88.5 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.676 . . . . 0.0 109.768 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.743 HG21 ' CD1' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -88.87 151.05 3.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.087 0.946 . . . . 0.0 111.48 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.36 39.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.892 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -101.58 127.4 48.31 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.024 -1.048 . . . . 0.0 109.342 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.838 ' N ' HD22 ' A' ' 93' ' ' LEU . 42.7 t-80 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.309 0.576 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.06 -40.07 32.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.5 m -52.91 -23.13 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.966 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -83.84 -55.3 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.065 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.677 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.14 -24.36 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -72.08 -45.53 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.673 HG22 ' HB ' ' A' ' 58' ' ' ILE . 68.0 mt -62.43 -41.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.557 HD22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -56.55 -48.1 78.04 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.195 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -21.59 40.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 0.0 109.965 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 p -70.31 -50.62 37.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.751 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.29 -40.99 78.93 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.139 -0.976 . . . . 0.0 110.111 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -53.45 -31.22 44.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.831 -1.168 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.491 -0.755 . . . . 0.0 109.946 179.531 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.985 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.8 m -150.37 135.1 17.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.34 . . . . 0.0 112.427 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.069 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -126.7 143.87 51.1 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.912 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -135.72 134.3 38.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.435 -1.416 . . . . 0.0 110.521 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -118.56 123.32 44.77 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HA ' HG22 ' A' ' 17' ' ' VAL . 29.0 m-85 -108.83 129.95 55.4 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.57 0.7 . . . . 0.0 111.789 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.8 t70 -112.65 91.99 3.85 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.895 ' CD2' HD13 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -173.89 -172.93 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.48 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.504 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -144.66 -177.18 19.3 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.618 HG23 ' HE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -71.47 63.36 0.39 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.117 -1.225 . . . . 0.0 111.598 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 12' ' ' THR . 4.4 ptmt 171.57 -27.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.233 -0.917 . . . . 0.0 110.61 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -125.44 143.44 50.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.0 108.756 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.895 HD13 ' CD2' ' A' ' 10' ' ' PHE . 33.5 mm -124.78 97.12 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.55 104.06 0.74 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 104.244 -3.543 . . . . 0.0 104.244 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.92 ' CG1' HD13 ' A' ' 30' ' ' LEU . 38.3 t -134.85 165.8 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 116.623 -2.031 . . . . 0.0 113.688 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.7 131.72 46.42 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.668 HG22 ' CD2' ' A' ' 6' ' ' LEU . 73.7 t -101.51 137.43 29.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 108.082 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.61 136.82 13.87 Favored Glycine 0 N--CA 1.485 1.928 0 O-C-N 120.507 -1.371 . . . . 0.0 110.589 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.64 117.41 30.41 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.161 -1.2 . . . . 0.0 108.04 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' CB ' ' A' ' 5' ' ' LEU . 2.5 mtm180 -90.08 24.51 2.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.343 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.878 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -32.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.407 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.43 -16.82 10.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.486 -0.759 . . . . 0.0 109.99 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 33.54 22.31 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.09 161.55 21.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.982 -1.305 . . . . 0.0 110.807 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.04 122.5 39.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.868 -1.145 . . . . 0.0 112.068 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' VAL . 11.6 ttm180 -87.3 153.11 53.53 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.3 Cg_endo -91.43 139.37 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.132 1.069 . . . . 0.0 112.364 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.92 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.82 142.47 24.68 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.29 167.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.846 2.364 . . . . 0.0 115.993 -174.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.89 143.49 57.91 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 123.234 1.492 . . . . 0.0 114.834 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.7 50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 112.916 -1.947 . . . . 0.0 115.623 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.6 mmtt -131.63 97.43 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.864 -1.147 . . . . 0.0 109.654 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.61 161.09 16.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 110.251 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -85.71 120.57 27.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.876 . . . . 0.0 111.218 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 48.72 25.46 1.01 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -0.979 . . . . 0.0 110.495 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.7 17.28 42.19 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.821 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 21.4 m -98.72 115.72 65.66 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 121.141 -1.211 . . . . 0.0 110.03 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.861 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -69.79 157.7 59.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.433 1.228 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -64.54 91.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.942 -1.099 . . . . 0.0 109.177 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 26.9 t90 -90.94 -16.9 27.29 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -80.38 -34.53 36.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.432 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 mp -81.99 -55.13 8.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.699 -0.625 . . . . 0.0 109.768 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 32.1 mt -59.62 -37.81 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 2.1 tm-20 -72.9 -31.18 64.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.944 -1.097 . . . . 0.0 109.962 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -64.92 -50.66 65.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.952 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.69 -25.02 60.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 109.959 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.944 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.46 -53.75 50.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.104 . . . . 0.0 110.504 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.44 -23.52 63.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.44 -41.22 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 111.346 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CE3' HD23 ' A' ' 48' ' ' LEU . 48.9 m0 -109.08 -17.54 13.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.836 -1.165 . . . . 0.0 111.359 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' LEU . 5.7 mt-30 54.08 97.24 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.15 -0.969 . . . . 0.0 109.835 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.3 Cg_endo -71.56 125.41 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.664 1.349 . . . . 0.0 110.971 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -73.52 -41.91 62.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -138.24 157.87 45.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.031 -1.043 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.724 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.7 mp -132.68 137.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 112.244 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.069 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.86 122.13 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.904 HG21 HD12 ' A' ' 83' ' ' ILE . 76.7 t -133.94 150.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 120.147 -1.596 . . . . 0.0 113.088 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.66 118.22 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.608 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.8 pp . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU . 8.7 mtt180 -68.13 -48.19 66.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.364 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -25.41 65.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.0 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.618 ' HE1' HG23 ' A' ' 12' ' ' THR . 37.3 t80 -59.33 -47.25 86.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -57.87 -31.81 67.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.09 -27.62 67.16 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.539 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -75.88 -57.89 3.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.904 HD12 HG21 ' A' ' 59' ' ' VAL . 20.7 pt -57.4 -32.13 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.176 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 88' ' ' GLY . 24.9 t-80 -65.8 -51.56 58.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.245 -0.91 . . . . 0.0 110.144 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.56 -15.63 73.3 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -71.49 -44.55 64.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.31 . . . . 0.0 110.511 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.691 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -119.17 -10.73 9.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.479 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 74.58 38.82 42.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.8 m -99.24 153.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.593 -0.946 . . . . 0.0 110.785 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -74.86 85.66 2.22 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.636 -0.665 . . . . 0.0 109.681 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.2 p -88.34 151.54 3.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -120.83 158.66 27.11 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 77' ' ' ARG . 8.8 mt -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.539 ' CD2' ' HA ' ' A' ' 129' ' ' ILE . 50.5 t-80 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.602 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -66.87 -38.88 87.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 110.303 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 28.8 t -53.51 -32.7 51.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.389 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -69.73 -55.73 9.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.652 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.56 -23.87 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.1 mp -73.3 -44.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 9' ' ' ASP . 71.9 mt -60.79 -36.54 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 5' ' ' LEU 0.256 0.4 OUTLIER -64.91 -54.3 32.97 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.414 178.485 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -56.21 -21.78 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 110.039 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -33.08 26.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.635 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -59.04 -38.95 80.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 76.1 m-85 -55.0 -40.45 70.14 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.245 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' ASP . 38.9 m -150.35 141.32 22.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.886 -1.361 . . . . 0.0 112.31 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.83 163.36 25.39 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.437 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.118 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.92 145.22 31.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.192 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.73 124.37 21.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.109 -0.994 . . . . 0.0 108.727 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.777 ' HB2' HG23 ' A' ' 59' ' ' VAL . 73.7 m-85 -120.66 142.5 49.4 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.71 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t0 -106.54 91.35 3.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.669 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -97.34 134.96 39.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.1 160.84 28.56 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 p -47.69 112.24 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.058 -1.26 . . . . 0.0 110.514 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 mtmt 55.29 46.48 23.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.285 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.754 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.48 120.94 14.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.707 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -116.66 93.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 CA-C-O 122.467 1.127 . . . . 0.0 113.924 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.23 104.89 0.84 Allowed Glycine 0 C--N 1.287 -2.169 0 N-CA-C 103.626 -3.79 . . . . 0.0 103.626 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.91 ' CG1' HD13 ' A' ' 30' ' ' LEU . 81.5 t -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 116.49 -2.084 . . . . 0.0 112.819 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.782 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -134.35 138.36 44.85 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 48' ' ' LEU . 33.6 t -100.91 130.45 50.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.584 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.76 136.71 13.69 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.856 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 117.68 34.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.641 ' HB2' HD12 ' A' ' 5' ' ' LEU . 3.2 tpt180 -91.83 35.11 0.97 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.79 0.805 . . . . 0.0 109.967 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.745 ' C ' HD12 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -113.66 -35.07 2.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -118.81 -17.19 9.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.716 . . . . 0.0 109.976 178.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 34.08 7.53 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.13 161.41 21.05 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.996 -1.296 . . . . 0.0 111.221 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -138.45 127.3 23.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 111.161 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 8.0 mmm180 -88.04 154.65 52.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.412 -0.805 . . . . 0.0 109.041 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.26 136.75 2.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.471 1.248 . . . . 0.0 111.356 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.91 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -99.17 144.61 28.55 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' CD ' HD23 ' A' ' 30' ' ' LEU . 17.9 Cg_endo -39.67 165.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.772 2.315 . . . . 0.0 115.756 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.86 142.07 58.56 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.157 1.456 . . . . 0.0 114.355 -175.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.754 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -55.53 51.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.449 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.0 tptm -133.34 98.62 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.75 -1.219 . . . . 0.0 108.96 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.851 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.15 161.6 16.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 110.819 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.77 119.43 24.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.832 . . . . 0.0 111.08 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.18 25.71 1.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 13' ' ' LYS . . . 93.62 14.59 52.69 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.851 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 11.7 m -91.25 111.12 47.05 Favored Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 120.944 -1.327 . . . . 0.0 109.776 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.679 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.4 Cg_endo -70.37 155.87 62.97 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.639 1.336 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.979 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -63.76 91.67 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.897 -1.127 . . . . 0.0 108.579 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.1 t90 -92.41 -22.49 19.62 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.88 -39.28 21.76 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.096 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -70.56 -55.0 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.979 HD12 ' O ' ' A' ' 41' ' ' ASP . 5.9 mt -68.31 -43.02 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.691 -1.256 . . . . 0.0 110.591 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 1.3 tm-20 -54.63 -30.79 55.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.717 -1.239 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.8 mtp180 -66.57 -44.01 83.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.345 -0.847 . . . . 0.0 109.362 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.118 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.63 -27.14 31.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.303 -0.873 . . . . 0.0 109.285 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.74 -53.37 33.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.972 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -80.01 -26.99 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.154 -0.966 . . . . 0.0 111.345 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 25.8 tt0 -79.1 -41.16 29.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.964 -1.085 . . . . 0.0 110.978 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 48' ' ' LEU . 73.4 m95 -103.58 -14.69 16.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.059 -1.026 . . . . 0.0 111.112 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 4' ' ' THR . 2.9 mt-30 51.96 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.951 -1.093 . . . . 0.0 110.112 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.5 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.739 1.389 . . . . 0.0 111.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 4' ' ' THR . 2.3 m-20 -76.77 -43.52 36.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.31 136.82 47.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.661 ' C ' HD13 ' A' ' 58' ' ' ILE . 2.7 mp -129.98 137.43 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.052 -1.03 . . . . 0.0 111.869 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.704 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.21 126.0 74.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' A' ' 8' ' ' PHE . 10.0 p -132.91 150.12 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.579 -1.325 . . . . 0.0 112.289 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.02 3.03 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.909 -1.139 . . . . 0.0 110.377 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 76' ' ' ALA . 1.6 pt? . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.102 -1.234 . . . . 0.0 110.111 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.55 ' CB ' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -56.42 -48.94 75.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -24.66 64.92 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.147 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 10' ' ' PHE . 5.7 t80 -61.03 -49.73 76.21 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB2' HG13 ' A' ' 59' ' ' VAL . . . -57.29 -33.05 67.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.463 -0.773 . . . . 0.0 109.146 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.47 -23.45 63.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 110.12 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -70.51 -51.6 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.06 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -68.06 -23.75 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.708 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.848 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.5 t-80 -59.07 -57.8 11.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -0.814 . . . . 0.0 110.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.82 -15.63 80.76 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.42 -44.33 91.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.288 . . . . 0.0 110.198 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.693 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -116.13 -14.01 11.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.71 31.06 30.76 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.2 m -95.52 153.2 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -1.039 . . . . 0.0 110.617 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.13 72.66 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 110.255 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -89.51 152.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.999 0.904 . . . . 0.0 111.12 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 162.27 27.82 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.89 143.24 45.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.753 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.485 ' CE1' HG23 ' A' ' 129' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.463 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.259 0.552 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.628 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -78.97 -31.1 44.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.7 p -54.23 -30.85 51.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.333 -0.854 . . . . 0.0 111.482 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.608 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.03 -56.22 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 109.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.782 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -55.87 -24.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.559 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 124' ' ' ALA . 4.5 mm -71.13 -44.67 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 126' ' ' ALA . 36.3 mt -61.41 -42.0 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.0 OUTLIER -57.7 -58.06 10.01 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.739 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.0 -21.76 65.12 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 108.994 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -58.03 -40.86 81.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.548 -0.72 . . . . 0.0 110.985 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 1.051 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.5 p90 -81.64 -32.64 31.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.317 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.5 m-85 -52.62 -31.8 38.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.985 . . . . 0.0 110.121 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.5 m -147.49 138.32 23.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.326 . . . . 0.0 112.243 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB2' HD12 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.695 0.759 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.38 28.79 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.02 126.73 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.146 -0.971 . . . . 0.0 111.143 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.2 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.4 138.01 58.19 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 123.025 1.393 . . . . 0.0 113.715 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.73 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.03 159.75 17.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.97 . . . . 0.0 110.43 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.08 123.96 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.803 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.96 47.51 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.87 107.71 26.6 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.099 -1.236 . . . . 0.0 110.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.23 157.62 56.75 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.572 1.301 . . . . 0.0 109.082 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.77 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.52 -20.46 54.18 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.371 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -30.94 30.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.67 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.83 -0.543 . . . . 0.0 111.764 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.41 64.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.81 -51.65 8.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 112.302 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.755 -1.216 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.822 -1.174 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.71 136.86 23.94 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.72 1.379 . . . . 0.0 111.439 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.82 -45.1 37.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.403 -0.811 . . . . 0.0 110.103 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 140.35 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.068 . . . . 0.0 109.591 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.74 137.83 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 111.856 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.21 122.46 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -56.99 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.84 -25.71 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.974 -1.079 . . . . 0.0 109.792 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.71 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.75 -16.29 75.69 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.8 m-85 -119.08 -11.97 9.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.94 31.66 42.79 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.19 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.905 . . . . 0.0 110.773 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.3 125.86 40.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.861 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 110.445 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.208 0.528 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.765 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -21.63 64.49 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.318 0.58 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.44 ' HB2' HG11 ' A' ' 91' ' ' VAL . 1.2 t-80 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.005 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.331 0.586 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.452 ' CD2' HG12 ' A' ' 91' ' ' VAL . 2.0 t-80 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.333 0.587 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.969 -1.312 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.58 127.81 34.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.991 -1.3 . . . . 0.0 112.151 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.83 29.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.748 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.56 32.8 0.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.744 0.783 . . . . 0.0 110.038 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.6 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.6 70.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.65 -53.05 8.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.897 -1.127 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.47 137.6 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.999 -1.063 . . . . 0.0 112.088 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.061 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -22.71 67.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.021 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.428 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.408 ' N ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.34 16.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.32 40.0 41.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.65 154.12 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.565 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 84.71 7.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.495 -0.753 . . . . 0.0 110.246 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.279 0.561 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.005 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.331 0.586 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.452 ' CD2' HG12 ' A' ' 91' ' ' VAL . 2.0 t-80 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.333 0.587 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.444 0.64 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.297 0.57 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 69.6 t60 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.337 0.589 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HD2' ' OH ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.36 0.6 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.005 -1.291 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.6 127.83 34.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.3 . . . . 0.0 112.196 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.402 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.87 29.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.747 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.61 32.78 0.94 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.7 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.58 70.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.69 -53.06 8.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.858 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.89 -1.131 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.51 137.64 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.999 -1.063 . . . . 0.0 112.044 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.085 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -22.79 67.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 108.996 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 110.428 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.408 ' N ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.36 16.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 40.03 41.61 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.66 154.09 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.594 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.81 84.71 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.279 0.561 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.444 0.64 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.297 0.57 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 69.6 t60 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.337 0.589 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HD2' ' OH ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.36 0.6 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.12 113.9 4.26 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.595 -1.532 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.25 -179.88 30.73 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.28 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.85 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.91 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.938 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.82 112.27 23.12 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.424 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.53 48.36 1.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.411 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.886 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.94 5.68 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.09 162.24 16.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -0.802 . . . . 0.0 109.861 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.77 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.68 25.77 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.371 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.8 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.63 61.08 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.106 -1.232 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.69 155.9 58.09 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.642 1.338 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -65.97 91.72 0.15 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.719 -1.238 . . . . 0.0 109.117 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.5 -17.85 35.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -32.66 33.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.86 29.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.335 0.588 . . . . 0.0 110.291 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.1 mt -70.11 -47.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 110.416 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.79 25.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.8 -5.41 15.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.693 -1.254 . . . . 0.0 111.94 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.58 109.91 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.352 -0.843 . . . . 0.0 109.446 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.06 111.52 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.208 1.11 . . . . 0.0 111.522 -177.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.479 0.657 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -62.89 -48.66 78.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.04 -25.14 64.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.807 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.06 73.36 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -22.52 62.03 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.518 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -69.91 -57.19 5.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.773 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.71 -28.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.959 -1.088 . . . . 0.0 110.218 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.05 -58.56 4.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.22 -15.85 61.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.26 4.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.68 152.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.175 0.988 . . . . 0.0 112.071 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.34 46.8 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.18 128.38 41.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.02 -1.05 . . . . 0.0 108.855 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 0.0 110.843 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.254 0.55 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.568 -0.707 . . . . 0.0 111.231 -179.847 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.42 56.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.93 134.69 54.72 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.373 -0.829 . . . . 0.0 111.894 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.0 t70 -113.99 92.66 4.05 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.438 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.4 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.94 23.74 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.61 164.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.679 2.253 . . . . 0.0 115.414 -174.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.7 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.877 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.71 28.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.98 30.52 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.55 17.46 66.16 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.877 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -86.91 108.87 20.4 Favored Pre-proline 0 C--N 1.307 -1.256 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.505 1.266 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.4 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.38 -36.5 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.805 178.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.48 -52.74 15.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 109.729 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.84 -43.83 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.995 -1.066 . . . . 0.0 110.488 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.0 tt0 -53.07 -42.8 66.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.953 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.89 -38.27 72.57 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.553 178.983 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.08 133.26 28.32 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.067 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.58 -34.17 60.64 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.664 -0.648 . . . . 0.0 109.848 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.31 157.58 45.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.018 -1.051 . . . . 0.0 110.668 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 8.0 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.04 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp . . . . . 0 N--CA 1.494 1.749 0 O-C-N 120.934 -1.333 . . . . 0.0 109.778 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.378 0.609 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.31 -48.4 81.52 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.475 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -26.27 65.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.805 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.12 94.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.35 -16.53 71.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.64 153.84 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.512 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.39 78.91 8.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.747 . . . . 0.0 110.794 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.115 0.483 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.59 -38.69 72.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.617 -179.495 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.71 -33.55 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 109.001 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ASP . 92.0 m -150.82 140.47 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -1.226 . . . . 0.0 112.702 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.127 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.4 136.77 52.31 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.449 -0.782 . . . . 0.0 108.951 178.239 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.02 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.22 144.26 47.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.961 -1.087 . . . . 0.0 108.883 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.579 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . . . -145.32 124.33 12.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 59' ' ' VAL . 3.1 m-85 -117.95 149.95 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.841 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.843 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.3 t0 -121.16 93.8 4.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.1 p90 -174.26 -155.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.113 -1.435 . . . . 0.0 113.705 -177.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . 159.04 159.12 9.47 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p 45.68 -143.78 0.23 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.055 . . . . 0.0 111.394 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 18.9 mttt -81.96 51.99 1.86 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.04 -1.038 . . . . 0.0 111.389 -178.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -142.02 131.49 23.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.682 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.96 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.8 mm -124.62 96.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.16 103.66 0.77 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 103.393 -3.883 . . . . 0.0 103.393 176.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.967 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.48 170.44 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 C-N-CA 116.144 -2.223 . . . . 0.0 114.406 -174.646 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.71 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.66 136.89 52.23 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.306 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 48' ' ' LEU . 13.9 t -106.76 125.04 62.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.83 135.73 13.08 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 118.714 -1.708 . . . . 0.0 111.277 -177.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -96.74 120.57 37.3 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HG2' ' OH ' ' A' ' 133' ' ' TYR . 11.3 mtp180 -91.09 36.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.454 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.89 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 178.171 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.52 -16.52 10.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 178.948 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.61 35.83 7.68 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.089 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.75 161.21 20.5 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.855 -1.379 . . . . 0.0 111.064 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -124.88 123.29 39.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.046 -1.034 . . . . 0.0 112.375 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 29' ' ' PRO . 24.6 ttt-85 -88.19 146.12 37.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 50.5 Cg_endo -90.74 141.1 3.09 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 O-C-N 122.792 0.891 . . . . 0.0 112.89 -176.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -99.55 139.65 21.04 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.031 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 21.7 Cg_endo -42.65 169.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.013 2.475 . . . . 0.0 115.965 -174.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.62 143.79 57.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.827 -176.181 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.87 53.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.495 -1.684 . . . . 0.0 115.53 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.98 96.24 3.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.829 -1.17 . . . . 0.0 109.273 176.133 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.85 160.86 16.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.577 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -83.81 116.64 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.083 -1.011 . . . . 0.0 111.336 -178.609 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 48.2 27.75 1.37 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 94.81 12.33 55.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 20.5 m -95.47 110.52 51.28 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.022 -1.281 . . . . 0.0 109.631 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HB3' HD11 ' A' ' 15' ' ' ILE . 45.9 Cg_endo -73.53 159.18 46.69 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.472 1.248 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.2 m-20 -63.39 91.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.923 -1.111 . . . . 0.0 108.118 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.45 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 11.4 t-105 -87.69 -16.8 33.31 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.224 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -80.02 -35.07 37.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -74.49 -50.05 28.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.725 -0.61 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 41' ' ' ASP . 12.1 mt -71.23 -43.58 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.907 -1.121 . . . . 0.0 110.466 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 33.8 tp10 -49.2 -43.0 42.0 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.166 -0.959 . . . . 0.0 109.26 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -57.57 -48.22 79.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 6' ' ' LEU . 2.6 mt -59.61 -24.95 64.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.856 178.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -84.1 -46.8 11.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.621 -0.674 . . . . 0.0 112.136 -178.408 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -50.72 9.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 112.286 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -84.22 -30.63 25.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.046 . . . . 0.0 112.162 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 57.9 m95 -109.12 -30.74 7.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 0.0 111.74 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 54.2 97.07 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.083 -1.011 . . . . 0.0 109.477 -178.589 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -68.6 124.2 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.446 1.235 . . . . 0.0 110.614 -179.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' THR . 3.9 t0 -71.31 -39.0 71.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.53 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HB3' HD23 ' A' ' 5' ' ' LEU . 12.9 tt0 -135.28 154.37 51.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.2 mp -133.94 136.83 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.799 -1.188 . . . . 0.0 112.682 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.127 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.2 113.92 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.073 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 8' ' ' PHE . 2.3 t -134.08 151.58 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.173 -1.579 . . . . 0.0 112.993 -177.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.44 141.32 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.661 177.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.328 0.585 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.543 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.0 mpt_? -62.77 -45.93 90.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.189 -0.944 . . . . 0.0 109.784 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -56.97 -30.99 64.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.169 -0.957 . . . . 0.0 109.401 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 74.4 t80 -61.6 -38.61 88.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.931 178.553 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -56.72 -33.28 66.34 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -68.89 -22.87 64.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.905 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.67 6.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 91' ' ' VAL . 34.7 pt -59.69 -30.12 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.853 -1.154 . . . . 0.0 109.151 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.441 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -64.37 -58.32 6.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 109.754 179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.43 -16.19 42.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -71.78 -44.82 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -1.225 . . . . 0.0 110.669 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -119.35 -10.62 9.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 110.842 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 42.56 16.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.7 m -104.53 153.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -1.047 . . . . 0.0 110.715 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.07 83.89 2.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 0.0 111.225 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 83' ' ' ILE . 2.8 p -90.76 151.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -121.28 155.29 35.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.92 -0.488 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 77' ' ' ARG . 21.2 mt -92.28 142.68 27.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.041 -1.037 . . . . 0.0 110.621 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.517 ' CG ' HG12 ' A' ' 129' ' ' ILE . 16.4 t-160 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.14 0.495 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.49 60.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.222 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 129' ' ' ILE . 1.5 m -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.807 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.62 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.41 -50.68 8.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.878 -1.139 . . . . 0.0 109.222 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.71 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -60.41 -23.15 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.332 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 128' ' ' ILE . 12.4 mm -70.13 -41.64 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 174.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.843 HD12 ' HB2' ' A' ' 9' ' ' ASP . 38.3 mt -63.92 -35.16 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 176.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.686 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -67.08 -34.61 78.03 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.147 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -20.33 64.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.852 -1.155 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -48.56 26.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -58.15 -40.41 81.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.889 -1.132 . . . . 0.0 109.642 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.61 -45.64 66.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.071 -1.018 . . . . 0.0 109.616 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.98 179.37 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.11 113.87 4.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.554 -1.557 . . . . 0.0 111.027 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.27 -179.86 30.74 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.27 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.825 -179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.88 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.115 -0.99 . . . . 0.0 110.938 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.742 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.83 112.33 23.2 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.39 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.56 48.36 1.53 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.411 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.885 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.89 5.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.02 162.24 16.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 109.898 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.71 20.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.156 -0.965 . . . . 0.0 111.154 -178.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.75 25.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.798 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.64 61.05 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.077 -1.249 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.7 155.94 57.99 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.586 1.308 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -66.04 91.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.734 -1.229 . . . . 0.0 109.098 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.47 -17.92 35.1 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.22 -32.66 33.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.95 28.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.317 0.58 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.0 mt -70.04 -47.63 67.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.477 -0.765 . . . . 0.0 110.453 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.82 25.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.77 -5.37 15.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.702 -1.249 . . . . 0.0 111.95 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.59 109.94 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.09 111.52 3.09 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.276 1.145 . . . . 0.0 111.522 -177.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.479 0.657 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -62.89 -48.69 77.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.0 -25.17 64.37 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 108.815 178.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.07 73.38 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -22.46 62.01 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.56 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -69.91 -57.21 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.68 -28.83 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.934 -1.104 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.06 -58.57 4.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.123 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.2 -15.85 61.51 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.478 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.27 4.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.75 152.52 3.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 122.202 1.001 . . . . 0.0 112.018 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.35 46.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.13 128.37 41.91 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.999 -1.063 . . . . 0.0 108.854 -179.798 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 110.843 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.254 0.55 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.262 -179.853 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.47 56.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.99 134.63 54.76 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.357 -0.84 . . . . 0.0 111.863 -178.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.1 t70 -113.92 92.65 4.05 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.5 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.89 23.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.51 164.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.668 2.245 . . . . 0.0 115.462 -174.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.72 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.72 28.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.97 30.51 4.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 110.147 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.56 17.42 66.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.876 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 40.2 m -86.83 108.83 20.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.145 -1.209 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.502 1.264 . . . . 0.0 109.475 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.5 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.4 -36.44 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.834 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.52 -52.74 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.809 -0.557 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.89 -43.77 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.995 -1.066 . . . . 0.0 110.518 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 4.9 tt0 -53.07 -42.84 66.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.918 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.86 -38.27 72.48 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.553 179.007 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.057 -1.027 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.06 133.25 28.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.083 -178.381 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.59 -34.17 60.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.724 -0.61 . . . . 0.0 109.848 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.3 157.57 45.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.018 -1.051 . . . . 0.0 110.623 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.9 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.06 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp . . . . . 0 N--CA 1.494 1.77 0 O-C-N 120.969 -1.313 . . . . 0.0 109.779 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.378 0.609 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.37 -48.36 81.61 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.469 179.671 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -26.23 65.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.765 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.15 94.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.3 -16.51 71.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.62 153.85 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.533 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 78.91 8.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.714 . . . . 0.0 110.794 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.115 0.483 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.56 -38.72 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.629 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.69 -33.55 64.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.001 179.022 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -152.21 138.71 18.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -163.72 81.31 0.12 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp -104.61 107.69 58.75 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -88.43 113.41 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 109.488 -1.004 . . . . 0.0 109.488 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -131.99 131.51 42.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.956 -1.09 . . . . 0.0 110.63 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.99 123.97 29.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.691 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 tpt -84.53 -44.28 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.891 -1.131 . . . . 0.0 109.668 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.42 -2.27 20.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 110.477 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 -25.73 19.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.89 -160.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -1.023 . . . . 0.0 109.742 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.13 163.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.151 -0.968 . . . . 0.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.05 107.37 4.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.94 -6.58 19.4 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.596 1.314 . . . . 0.0 110.754 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -25.08 64.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 0.0 110.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.93 -19.06 5.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.301 -0.875 . . . . 0.0 111.412 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . . . -47.31 -35.39 7.89 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -74.67 -27.87 60.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.392 -0.818 . . . . 0.0 109.119 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.79 -50.85 61.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.426 -0.796 . . . . 0.0 109.949 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 74' ' ' ALA . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.44 ' HB2' HG11 ' A' ' 91' ' ' VAL . 1.2 t-80 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 -83.34 120.72 26.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.95 143.24 28.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.29 -0.881 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -74.17 82.93 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.013 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -19.42 39.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.755 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -25.33 64.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.205 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -115.61 88.23 2.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.918 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 m -138.04 -52.14 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.648 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.48 152.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.59 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.63 -45.49 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.805 . . . . 0.0 110.051 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 170.62 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.142 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -117.61 64.5 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 15.43 25.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.96 -76.36 0.67 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 93.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -44.98 5.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -75.39 96.38 3.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -55.98 -28.19 56.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.026 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -98.09 115.15 5.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.98 160.73 10.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 66.8 t80 53.71 35.67 21.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 0.0 110.013 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -61.64 165.43 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.258 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.39 110.6 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 116' ' ' LEU . 2.8 mm? -53.09 107.24 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -170.36 125.65 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -25.89 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.93 77.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -101.19 146.38 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -1.133 . . . . 0.0 110.066 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.16 24.9 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.405 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -87.75 58.24 4.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.995 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m 55.04 29.33 12.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 110.481 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.26 -27.46 42.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 -18.91 43.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.915 . . . . 0.0 110.109 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.51 51.64 56.62 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.155 -1.203 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.26 0.552 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 1.8 m 58.28 109.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.41 -92.06 0.09 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 68.6 m -143.29 147.03 34.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.079 -1.247 . . . . 0.0 111.699 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -126.79 142.08 51.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.128 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -130.09 144.82 51.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 58' ' ' ILE . . . -153.8 126.01 7.93 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.889 -1.132 . . . . 0.0 110.319 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.905 ' HB2' HG23 ' A' ' 59' ' ' VAL . 1.9 m-85 -123.67 136.5 54.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.305 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 129' ' ' ILE . 12.8 t70 -106.14 96.68 6.64 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.9 p90 -174.16 -159.68 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.55 ' CA ' ' CE2' ' A' ' 79' ' ' PHE . . . -166.26 -148.03 5.41 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.057 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 12' ' ' THR . 78.9 p -37.52 -91.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.655 -0.909 . . . . 0.0 113.098 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.45 49.51 0.94 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.679 -1.263 . . . . 0.0 111.473 -178.203 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.78 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.94 134.25 27.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 110.373 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 40' ' ' PRO . 32.9 mm -126.39 94.96 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.42 103.94 0.74 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 103.349 -3.901 . . . . 0.0 103.349 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.989 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.0 164.79 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.79 -174.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.806 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.68 129.97 50.62 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.609 HG11 ' HG ' ' A' ' 48' ' ' LEU . 10.9 t -102.48 125.89 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.729 ' HA3' HD12 ' A' ' 5' ' ' LEU . . . -120.59 146.49 17.64 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 118.251 -1.928 . . . . 0.0 112.31 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 21' ' ' GLN . 13.8 pt20 -95.86 121.44 37.59 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -89.87 31.43 0.96 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.698 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.886 HD13 ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.97 -32.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -115.92 -17.33 11.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.63 34.43 9.25 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.659 -1.258 . . . . 0.0 109.959 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 161.59 20.4 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.946 -1.326 . . . . 0.0 110.583 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . . . -134.59 135.04 41.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.925 -1.11 . . . . 0.0 112.422 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -98.91 153.72 37.69 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.4 Cg_endo -91.61 134.71 1.59 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.292 1.154 . . . . 0.0 112.094 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.989 HD22 HG13 ' A' ' 17' ' ' VAL . 1.6 tt -99.44 141.26 22.51 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.36 167.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.811 2.341 . . . . 0.0 116.223 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.56 144.84 56.92 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.053 1.406 . . . . 0.0 114.284 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.23 55.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 112.976 -1.92 . . . . 0.0 115.835 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 37.5 tptt -133.73 96.78 3.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.852 -1.155 . . . . 0.0 109.81 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.95 161.14 16.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 39' ' ' THR . 42.7 mt-30 -85.24 120.97 27.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.214 -0.929 . . . . 0.0 111.498 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.26 27.34 1.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.046 -1.034 . . . . 0.0 110.278 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.08 16.82 55.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.796 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.1 m -94.8 109.39 43.57 Favored Pre-proline 0 C--N 1.306 -1.284 0 O-C-N 121.082 -1.246 . . . . 0.0 109.789 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.717 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -68.88 155.92 67.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.572 1.301 . . . . 0.0 109.165 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 45' ' ' ILE . 3.2 m-20 -63.71 91.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.976 -1.077 . . . . 0.0 108.87 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 13.4 t90 -91.95 -21.6 20.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.74 -37.97 26.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.947 . . . . 0.0 109.889 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -73.12 -50.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.736 -0.602 . . . . 0.0 110.045 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 41' ' ' ASP . 20.6 mt -70.34 -49.32 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.952 -1.092 . . . . 0.0 111.025 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -54.06 -32.94 56.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.67 -1.269 . . . . 0.0 109.815 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -61.02 -47.21 87.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.309 -0.87 . . . . 0.0 109.37 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.945 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.52 -27.07 31.94 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 109.03 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.875 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -66.16 -54.64 22.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 111.221 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -74.84 -25.82 59.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.941 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -81.26 -38.3 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 0.0 110.771 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.518 ' HB2' HD22 ' A' ' 48' ' ' LEU . 33.9 m95 -109.71 -20.56 12.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.074 -1.016 . . . . 0.0 111.109 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER 56.52 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 46.8 Cg_endo -72.04 134.53 23.5 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.8 1.421 . . . . 0.0 111.117 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.92 -35.8 23.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 110.725 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.58 144.85 50.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 91' ' ' VAL . 5.0 mp -130.02 137.75 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.527 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.54 114.28 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.905 HG23 ' HB2' ' A' ' 8' ' ' PHE . 1.1 p -134.67 151.29 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.229 -1.544 . . . . 0.0 114.008 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 151.16 140.5 3.18 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.297 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.049 HD21 HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -103.47 127.21 30.09 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.817 ' N ' HD22 ' A' ' 61' ' ' LEU . 53.5 Cg_endo -90.82 115.63 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.15 1.079 . . . . 0.0 110.695 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.049 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -130.98 132.7 45.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.924 -1.11 . . . . 0.0 110.863 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.3 m-20 -81.86 129.53 34.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.192 -0.942 . . . . 0.0 110.228 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.4 tpp -83.7 -45.75 13.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.982 -1.074 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -11.24 15.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.451 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.88 -49.18 0.81 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 t -111.45 -176.61 2.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -1.014 . . . . 0.0 109.506 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' OE1' ' NH2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 48.91 -155.84 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' NE2' ' HB3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -176.98 77.02 0.25 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 0.0 110.548 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 -10.15 25.37 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.865 1.455 . . . . 0.0 110.404 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -81.17 -23.85 37.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.177 -0.952 . . . . 0.0 110.354 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.56 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -53.93 -21.13 7.23 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 111.334 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.05 -40.29 30.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.873 -1.142 . . . . 0.0 108.548 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.71 71.31 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . . . -58.47 -37.39 75.4 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.233 -0.917 . . . . 0.0 108.538 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.442 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 3.4 ttm180 -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -56.04 -32.14 63.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.666 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 7.6 m-30 -57.83 -47.72 81.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.026 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' HIS . . . -55.34 -34.69 64.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -80.29 -24.07 40.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 109.198 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 79' ' ' PHE . 2.1 mtt180 -77.3 -56.71 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 91' ' ' VAL . 16.2 pt -62.14 -38.88 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 109.412 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.462 ' N ' HG13 ' A' ' 83' ' ' ILE . 1.9 t60 -58.6 -42.14 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.496 -0.753 . . . . 0.0 109.901 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.72 -16.81 80.41 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -44.82 23.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -1.222 . . . . 0.0 110.433 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.6 -13.15 9.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.01 -1.057 . . . . 0.0 110.881 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 82.24 32.76 27.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.4 m -91.14 153.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.485 -1.009 . . . . 0.0 110.686 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 81.69 6.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.756 . . . . 0.0 110.531 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 57' ' ' ILE . 8.7 p -100.31 152.3 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 153.85 29.78 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.003 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -92.66 138.64 31.32 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.027 -1.046 . . . . 0.0 108.907 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 1.003 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t60 -80.31 103.31 10.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.786 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.26 145.58 29.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 0.0 110.726 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB3' ' NE2' ' A' ' 70' ' ' GLN . 25.6 mm-40 -129.61 32.79 4.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.405 ' NH2' ' OE1' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -73.08 -4.82 34.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 110.789 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -22.35 63.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.71 63.82 4.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.125 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.4 m -94.2 -12.17 28.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.635 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -55.53 151.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.064 . . . . 0.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.74 -49.36 4.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.415 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 48.61 68.98 0.61 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.897 . . . . 0.0 110.479 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.57 62.83 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.257 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 t -100.93 4.94 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.73 113.21 0.53 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -130.23 136.15 48.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -1.16 . . . . 0.0 109.94 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 1.5 m-85 -145.58 100.14 3.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.336 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -92.78 20.66 6.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -114.88 165.9 12.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.267 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.11 -91.63 0.1 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.95 126.31 1.1 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -96.09 123.71 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.119 . . . . 0.0 110.148 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -154.62 71.12 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.25 -166.04 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.0 mt 53.44 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.63 171.77 17.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.239 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 162.96 20.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.115 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -120.5 142.61 15.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -116.21 134.1 55.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.154 . . . . 0.0 110.407 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.07 111.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ALA . 25.3 m-20 -65.62 -158.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.377 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.06 -60.21 0.37 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 0.0 111.127 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -48.57 -29.68 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 0.0 110.9 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.4 p -54.7 -33.39 60.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 111.526 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -77.71 -55.77 5.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.151 . . . . 0.0 109.266 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.806 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -53.47 -24.3 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -76.76 -46.01 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 9' ' ' ASP . 17.0 mt -53.73 -27.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.961 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -67.55 -39.81 84.98 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.894 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -34.18 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -32.35 67.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 t80 -75.11 -54.46 7.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.68 -0.638 . . . . 0.0 109.754 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.961 ' CE2' HD12 ' A' ' 130' ' ' LEU . 25.2 m-85 -52.18 -28.98 20.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.074 -1.016 . . . . 0.0 109.558 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -22.55 40.52 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.486 -0.759 . . . . 0.0 109.677 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -79.54 -11.13 59.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.203 -0.936 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.49 -57.86 3.48 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.307 -1.114 . . . . 0.0 110.207 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.213 0.53 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 69.1 p -154.99 122.61 5.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 110.044 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -158.25 -92.43 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.742 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.7 m -147.5 138.34 23.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.968 -1.313 . . . . 0.0 112.209 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.02 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.02 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.688 0.756 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.4 28.75 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.03 126.7 41.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.124 -0.985 . . . . 0.0 111.155 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.1 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 138.01 58.19 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 123.004 1.383 . . . . 0.0 113.772 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.035 -1.893 . . . . 0.0 115.73 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.05 159.76 17.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.374 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.02 123.92 33.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -0.883 . . . . 0.0 110.821 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -0.93 . . . . 0.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.94 47.59 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.81 107.7 26.46 Favored Pre-proline 0 C--N 1.307 -1.275 0 O-C-N 121.06 -1.259 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.24 157.62 56.71 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.641 1.337 . . . . 0.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.79 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.55 -20.45 54.1 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.359 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -30.89 30.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.837 -0.539 . . . . 0.0 111.764 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.42 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.83 -51.63 8.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.907 -1.121 . . . . 0.0 112.281 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.775 -1.203 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.173 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.74 136.86 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.735 1.387 . . . . 0.0 111.422 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.79 -45.18 37.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 110.074 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 140.3 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.067 . . . . 0.0 109.606 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.7 137.89 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.002 . . . . 0.0 111.856 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.736 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.29 122.42 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -118.3 113.46 37.06 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.609 ' N ' HD22 ' A' ' 61' ' ' LEU . 50.2 Cg_endo -84.07 115.86 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.375 1.197 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' LEU . 52.3 tp -130.56 133.59 46.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -80.46 131.4 35.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.207 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.761 ' HG2' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.27 -44.9 14.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.031 . . . . 0.0 110.027 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.48 -11.28 15.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.334 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.2 -51.07 0.77 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 6.4 t -105.3 -165.15 1.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.382 -1.069 . . . . 0.0 109.523 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 68' ' ' THR . 19.1 pt-20 37.87 -157.12 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.165 0.507 . . . . 0.0 111.47 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -176.8 67.12 0.22 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 -30.08 14.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.925 1.487 . . . . 0.0 110.089 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 65' ' ' MET . 1.1 tp -60.08 -30.01 68.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.88 -19.57 18.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.875 . . . . 0.0 111.237 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.28 -33.39 5.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 109.646 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -80.05 -30.3 39.4 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -65.09 -45.05 86.78 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 108.908 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -57.02 4.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.78 -25.75 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.068 . . . . 0.0 109.798 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.68 62.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.81 -16.26 75.62 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.7 m-85 -119.1 -11.92 9.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 110.322 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.97 31.62 42.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.17 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.682 -0.893 . . . . 0.0 110.773 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.29 125.83 40.19 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.887 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 -87.95 101.66 13.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.35 143.88 50.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.821 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -79.59 57.57 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -63.49 -29.61 70.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 0.0 110.213 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -18.65 65.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.892 . . . . 0.0 110.209 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 100' ' ' THR . 32.5 t -56.88 92.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -157.38 127.73 6.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.165 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.8 152.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.184 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 mt-10 -97.31 -22.9 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 62.14 135.1 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.402 -0.811 . . . . 0.0 110.448 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.42 39.74 31.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 17.9 p -114.21 19.45 16.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.905 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.82 -140.69 12.61 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.99 137.51 39.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 110.272 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.57 39.73 3.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -95.91 -59.17 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -75.75 -60.6 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 110.295 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.08 -53.97 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.82 -94.64 0.09 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 56.0 m-85 -125.77 79.86 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.213 -1.169 . . . . 0.0 110.333 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 51.73 57.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.61 173.48 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.14 -46.04 0.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.187 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.56 158.04 27.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.149 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -153.81 80.34 1.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.18 141.73 10.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -167.86 147.62 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -1.055 . . . . 0.0 110.082 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.26 139.48 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 110.363 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -173.24 -37.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.908 . . . . 0.0 110.129 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.89 21.62 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.764 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -21.62 64.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 109.281 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.0 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -24.36 39.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -13.18 32.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.35 -21.35 59.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.181 -1.188 . . . . 0.0 110.163 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.311 0.577 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -147.77 128.13 13.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.92 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.6 m -142.63 134.84 27.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.965 -1.315 . . . . 0.0 112.505 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.073 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -126.31 140.6 52.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.942 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -135.03 134.32 40.3 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.481 -1.387 . . . . 0.0 110.772 179.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -118.33 122.96 44.17 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.761 ' HE1' HG23 ' A' ' 57' ' ' ILE . 33.6 m-85 -109.04 131.95 54.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.52 -0.738 . . . . 0.0 111.764 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 18.1 t70 -113.34 93.2 4.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.0 p90 -177.65 -164.57 0.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.244 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.56 168.56 33.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 55.7 p -60.01 77.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.89 -1.359 . . . . 0.0 111.654 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 3.7 mttp 162.67 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.528 -0.733 . . . . 0.0 110.678 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -137.84 142.29 40.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -178.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 40' ' ' PRO . 36.5 mm -122.92 102.22 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.5 103.9 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 104.126 -3.59 . . . . 0.0 104.126 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.898 ' CG1' HD13 ' A' ' 30' ' ' LEU . 39.8 t -135.75 167.13 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 116.713 -1.995 . . . . 0.0 114.091 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.67 131.64 48.03 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.652 HG13 HD11 ' A' ' 6' ' ' LEU . 68.5 t -101.08 135.88 35.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.85 -1.156 . . . . 0.0 108.091 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -111.71 141.03 16.45 Favored Glycine 0 N--CA 1.484 1.85 0 C-N-CA 119.047 -1.549 . . . . 0.0 111.352 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -95.87 112.85 24.47 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 1.1 ttp180 -87.58 21.49 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.582 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.891 HD13 ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.81 -32.66 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.753 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -117.73 -17.37 9.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.61 34.74 11.19 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.92 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 158.48 26.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.738 -1.448 . . . . 0.0 110.909 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.86 119.44 30.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.844 -1.16 . . . . 0.0 111.737 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' VAL . 31.8 ttm105 -86.98 154.54 55.24 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.0 Cg_endo -91.53 137.36 1.98 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.134 1.071 . . . . 0.0 112.151 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.898 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.2 tt -99.74 141.23 22.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 22.2 Cg_endo -43.25 169.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.839 2.359 . . . . 0.0 116.086 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ILE . . . -65.41 150.3 48.56 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 123.528 1.632 . . . . 0.0 115.069 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 14' ' ' SER 0.279 0.9 OUTLIER -51.22 -126.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.462 -2.153 . . . . 0.0 112.783 179.838 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.589 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.7 OUTLIER 34.87 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.211 -0.931 . . . . 0.0 112.468 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -88.9 160.48 17.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.932 -1.105 . . . . 0.0 109.752 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.09 115.21 26.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 111.419 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.3 25.79 0.95 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.849 . . . . 0.0 110.372 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.76 17.23 42.21 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.1 m -94.98 106.94 28.3 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 120.999 -1.295 . . . . 0.0 109.993 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.781 ' HB3' HD11 ' A' ' 15' ' ' ILE . 46.4 Cg_endo -72.22 162.53 41.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.575 1.303 . . . . 0.0 109.734 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.914 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -64.27 92.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.001 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.428 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 31.3 t90 -90.45 -17.23 27.53 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.457 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.8 m-20 -81.65 -35.4 29.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.811 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -82.4 -48.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.854 -0.529 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 41' ' ' ASP . 18.5 mt -70.75 -33.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.155 -0.966 . . . . 0.0 111.16 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -76.8 -45.22 29.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.924 -1.11 . . . . 0.0 110.427 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CD ' ' O ' ' A' ' 43' ' ' ASN . 1.9 mtt180 -52.44 -41.46 63.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.943 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.28 -28.71 34.58 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.107 -0.996 . . . . 0.0 109.066 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.931 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.13 -49.78 76.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -1.0 . . . . 0.0 110.48 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -72.43 -32.35 66.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 111.053 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.85 -42.53 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.103 . . . . 0.0 111.221 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 49.0 m95 -111.01 -27.5 8.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.899 -1.125 . . . . 0.0 111.562 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.7 mt-30 59.48 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.022 -1.049 . . . . 0.0 109.487 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.482 ' HB3' HD13 ' A' ' 6' ' ' LEU . 46.8 Cg_endo -71.37 129.61 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.605 1.319 . . . . 0.0 111.44 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -80.34 -40.21 27.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 110.58 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -132.9 155.16 49.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 109.879 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.761 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.9 mp -133.15 137.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 112.695 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.64 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.916 HG11 ' CD1' ' A' ' 83' ' ' ILE . 74.0 t -131.82 150.73 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.975 -1.703 . . . . 0.0 113.065 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 170.14 121.13 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.245 -0.978 . . . . 0.0 110.833 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.977 ' O ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.08 149.19 97.18 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.891 -1.358 . . . . 0.0 109.535 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.595 ' N ' HD22 ' A' ' 61' ' ' LEU . 44.2 Cg_endo -71.89 135.12 24.95 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.278 1.146 . . . . 0.0 111.323 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 73' ' ' THR . 3.9 mm? -90.03 164.35 14.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -50.89 126.11 15.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.355 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 79.5 mmm -80.98 -43.42 19.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.291 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.43 15.8 26.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 110.315 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.546 ' C ' HG22 ' A' ' 68' ' ' THR . . . -124.88 45.78 1.14 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.546 HG22 ' C ' ' A' ' 67' ' ' GLY . 11.0 t 36.57 -153.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.07 -0.665 . . . . 0.0 111.784 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.36 160.39 14.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 110.256 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.43 155.46 31.67 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.314 -0.866 . . . . 0.0 110.409 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 -6.64 19.48 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.766 1.403 . . . . 0.0 111.22 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -24.56 5.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.613 HG23 HD21 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -54.7 -19.72 6.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 111.127 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.54 -28.87 2.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.932 -1.105 . . . . 0.0 109.822 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -29.02 50.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 108.919 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -64.57 -45.35 87.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.637 -0.665 . . . . 0.0 109.786 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -48.44 81.77 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -25.24 62.8 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.995 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -63.13 -45.51 91.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -62.34 -29.44 70.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.463 -0.773 . . . . 0.0 109.104 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -67.15 -23.25 65.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -56.93 4.04 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 110.45 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.916 ' CD1' HG11 ' A' ' 59' ' ' VAL . 16.2 pt -56.16 -28.82 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.473 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.458 ' HB2' HG11 ' A' ' 91' ' ' VAL . 32.5 t-80 -70.2 -50.99 34.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.345 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.81 -15.55 79.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -74.66 -44.27 51.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.918 -1.342 . . . . 0.0 110.5 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -113.64 -11.09 13.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.394 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.62 48.22 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 89' ' ' VAL . 35.4 m -109.49 153.91 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.636 -0.92 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.55 88.5 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.676 . . . . 0.0 109.768 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.743 HG21 ' CD1' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -88.87 151.05 3.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.087 0.946 . . . . 0.0 111.48 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.36 39.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.892 HD13 ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -101.58 127.4 48.31 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.024 -1.048 . . . . 0.0 109.342 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.838 ' N ' HD22 ' A' ' 93' ' ' LEU . 42.7 t-80 -87.32 108.91 19.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.595 ' OD1' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -82.77 138.15 34.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.34 30.7 7.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.177 -0.952 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -83.75 -21.18 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.115 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.32 -18.53 48.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.262 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 t -54.22 164.36 0.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.083 -1.01 . . . . 0.0 110.499 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -141.09 178.72 7.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.02 152.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.083 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -38.16 90.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.88 99.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.538 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.33 153.69 44.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 p -94.05 17.09 13.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.478 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.64 169.62 11.31 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.83 120.32 8.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -1.188 . . . . 0.0 110.33 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 t80 53.04 35.35 19.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.75 139.11 33.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.17 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.04 95.63 2.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.71 78.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.04 -112.91 0.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -173.37 -176.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -1.222 . . . . 0.0 110.173 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -156.65 73.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 110.37 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.33 61.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 110.343 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -24.52 35.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.77 -173.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.096 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -97.28 -26.06 15.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.189 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 142.38 -115.96 1.0 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER 54.33 -173.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -1.092 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 122' ' ' ASP . 98.8 t 56.57 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 110.627 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' N ' HG12 ' A' ' 121' ' ' VAL . 18.3 p-10 -121.29 158.56 27.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.091 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.07 26.79 5.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.06 -40.07 32.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.5 m -52.91 -23.13 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.966 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -83.84 -55.3 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.065 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.677 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.14 -24.36 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -72.08 -45.53 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.673 HG22 ' HB ' ' A' ' 58' ' ' ILE . 68.0 mt -62.43 -41.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.557 HD22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -56.55 -48.1 78.04 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.195 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -21.59 40.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 0.0 109.965 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 p -70.31 -50.62 37.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.751 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.29 -40.99 78.93 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.139 -0.976 . . . . 0.0 110.111 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -53.45 -31.22 44.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.831 -1.168 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.23 -20.95 43.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.491 -0.755 . . . . 0.0 109.946 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.18 -9.87 22.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -132.5 55.26 0.76 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.202 -1.175 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -86.05 -75.05 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 110.179 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.29 -79.09 0.14 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.8 m -150.37 135.1 17.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.34 . . . . 0.0 112.427 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.069 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -126.7 143.87 51.1 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.912 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -135.72 134.3 38.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.435 -1.416 . . . . 0.0 110.521 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -118.56 123.32 44.77 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HA ' HG22 ' A' ' 17' ' ' VAL . 29.0 m-85 -108.83 129.95 55.4 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.57 0.7 . . . . 0.0 111.789 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.8 t70 -112.65 91.99 3.85 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.895 ' CD2' HD13 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -173.89 -172.93 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.48 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.504 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -144.66 -177.18 19.3 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.618 HG23 ' HE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -71.47 63.36 0.39 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.117 -1.225 . . . . 0.0 111.598 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 12' ' ' THR . 4.4 ptmt 171.57 -27.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.233 -0.917 . . . . 0.0 110.61 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -125.44 143.44 50.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.0 108.756 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.895 HD13 ' CD2' ' A' ' 10' ' ' PHE . 33.5 mm -124.78 97.12 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.55 104.06 0.74 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 104.244 -3.543 . . . . 0.0 104.244 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.92 ' CG1' HD13 ' A' ' 30' ' ' LEU . 38.3 t -134.85 165.8 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 116.623 -2.031 . . . . 0.0 113.688 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.7 131.72 46.42 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.668 HG22 ' CD2' ' A' ' 6' ' ' LEU . 73.7 t -101.51 137.43 29.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 108.082 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.61 136.82 13.87 Favored Glycine 0 N--CA 1.485 1.928 0 O-C-N 120.507 -1.371 . . . . 0.0 110.589 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.64 117.41 30.41 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.161 -1.2 . . . . 0.0 108.04 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' CB ' ' A' ' 5' ' ' LEU . 2.5 mtm180 -90.08 24.51 2.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.343 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.878 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -32.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.407 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.43 -16.82 10.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.486 -0.759 . . . . 0.0 109.99 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 33.54 22.31 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.09 161.55 21.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.982 -1.305 . . . . 0.0 110.807 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.04 122.5 39.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.868 -1.145 . . . . 0.0 112.068 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' VAL . 11.6 ttm180 -87.3 153.11 53.53 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.3 Cg_endo -91.43 139.37 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.132 1.069 . . . . 0.0 112.364 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.92 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.82 142.47 24.68 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.29 167.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.846 2.364 . . . . 0.0 115.993 -174.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.89 143.49 57.91 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 123.234 1.492 . . . . 0.0 114.834 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.7 50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 112.916 -1.947 . . . . 0.0 115.623 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.6 mmtt -131.63 97.43 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.864 -1.147 . . . . 0.0 109.654 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.61 161.09 16.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 110.251 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -85.71 120.57 27.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.876 . . . . 0.0 111.218 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 48.72 25.46 1.01 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -0.979 . . . . 0.0 110.495 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.7 17.28 42.19 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.821 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 21.4 m -98.72 115.72 65.66 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 121.141 -1.211 . . . . 0.0 110.03 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.861 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -69.79 157.7 59.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.433 1.228 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -64.54 91.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.942 -1.099 . . . . 0.0 109.177 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 26.9 t90 -90.94 -16.9 27.29 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -80.38 -34.53 36.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.432 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 mp -81.99 -55.13 8.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.699 -0.625 . . . . 0.0 109.768 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 32.1 mt -59.62 -37.81 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 2.1 tm-20 -72.9 -31.18 64.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.944 -1.097 . . . . 0.0 109.962 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -64.92 -50.66 65.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.952 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.69 -25.02 60.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 109.959 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.944 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.46 -53.75 50.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.104 . . . . 0.0 110.504 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.44 -23.52 63.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.44 -41.22 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 111.346 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CE3' HD23 ' A' ' 48' ' ' LEU . 48.9 m0 -109.08 -17.54 13.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.836 -1.165 . . . . 0.0 111.359 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' LEU . 5.7 mt-30 54.08 97.24 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.15 -0.969 . . . . 0.0 109.835 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.3 Cg_endo -71.56 125.41 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.664 1.349 . . . . 0.0 110.971 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -73.52 -41.91 62.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -138.24 157.87 45.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.031 -1.043 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.724 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.7 mp -132.68 137.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 112.244 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.069 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.86 122.13 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.904 HG21 HD12 ' A' ' 83' ' ' ILE . 76.7 t -133.94 150.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 120.147 -1.596 . . . . 0.0 113.088 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.66 118.22 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.608 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.8 pp -63.66 148.39 94.32 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.44 ' O ' HD12 ' A' ' 61' ' ' LEU . 41.2 Cg_endo -67.09 137.68 45.03 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.582 1.306 . . . . 0.0 110.506 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.741 HD11 ' HB3' ' A' ' 70' ' ' GLN . 62.7 tp -95.11 163.98 13.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 0.0 110.355 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -49.41 139.78 11.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.897 . . . . 0.0 110.43 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.8 tpt -83.11 -43.18 16.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 110.334 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.8 19.27 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.47 55.33 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -1.125 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.32 32.06 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 109.781 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.741 ' HB3' HD11 ' A' ' 63' ' ' LEU . 9.5 tp-100 -97.05 112.22 60.07 Favored Pre-proline 0 C--N 1.303 -1.413 0 O-C-N 121.456 -0.777 . . . . 0.0 109.826 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.38 -6.52 19.1 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.555 1.292 . . . . 0.0 110.411 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tt -53.05 -29.2 28.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.77 -21.25 18.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 111.01 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.05 -30.48 6.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.97 -1.082 . . . . 0.0 109.095 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -30.31 49.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -57.54 -40.43 78.82 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.526 -0.734 . . . . 0.0 109.403 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU . 8.7 mtt180 -68.13 -48.19 66.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.364 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -25.41 65.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.0 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.618 ' HE1' HG23 ' A' ' 12' ' ' THR . 37.3 t80 -59.33 -47.25 86.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -57.87 -31.81 67.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.09 -27.62 67.16 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.539 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -75.88 -57.89 3.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.904 HD12 HG21 ' A' ' 59' ' ' VAL . 20.7 pt -57.4 -32.13 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.176 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 88' ' ' GLY . 24.9 t-80 -65.8 -51.56 58.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.245 -0.91 . . . . 0.0 110.144 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.56 -15.63 73.3 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -71.49 -44.55 64.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.31 . . . . 0.0 110.511 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.691 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -119.17 -10.73 9.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.479 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 74.58 38.82 42.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.8 m -99.24 153.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.593 -0.946 . . . . 0.0 110.785 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -74.86 85.66 2.22 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.636 -0.665 . . . . 0.0 109.681 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.2 p -88.34 151.54 3.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -120.83 158.66 27.11 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 77' ' ' ARG . 8.8 mt -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.539 ' CD2' ' HA ' ' A' ' 129' ' ' ILE . 50.5 t-80 -83.09 112.09 19.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.398 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.77 141.75 34.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -80.5 82.88 6.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -76.0 -29.02 58.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.349 -0.844 . . . . 0.0 110.671 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.13 -41.04 87.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.27 120.11 37.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.068 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 100' ' ' THR . 8.6 t -155.21 69.34 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 0.0 110.729 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 t -94.33 144.34 9.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 7.9 mt-10 -96.93 -40.76 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.654 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 54.53 -148.92 0.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.103 -0.998 . . . . 0.0 109.933 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.13 -43.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 110.321 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -112.92 -23.35 10.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.374 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.94 171.55 28.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 47.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 46.06 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -15.0 51.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.901 . . . . 0.0 110.674 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 107.62 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 110.357 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.54 143.26 26.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.33 155.39 26.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -122.84 34.73 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -128.84 -155.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.74 150.48 30.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -176.2 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.24 -154.08 0.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.968 . . . . 0.0 110.312 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt 55.91 56.37 6.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -159.55 28.41 0.38 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.3 177.35 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -1.116 . . . . 0.0 110.163 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -102.85 154.85 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 110.305 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.282 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.5 m -158.39 24.78 0.24 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.602 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -66.87 -38.88 87.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 110.303 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 28.8 t -53.51 -32.7 51.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.389 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -69.73 -55.73 9.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.652 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.56 -23.87 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.1 mp -73.3 -44.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 9' ' ' ASP . 71.9 mt -60.79 -36.54 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 5' ' ' LEU 0.256 0.4 OUTLIER -64.91 -54.3 32.97 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.414 178.485 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -56.21 -21.78 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 110.039 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -33.08 26.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.635 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -59.04 -38.95 80.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 76.1 m-85 -55.0 -40.45 70.14 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.245 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -23.37 40.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 133' ' ' TYR . 1.9 mt-30 -84.35 -16.75 41.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.389 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.07 -58.82 4.55 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.19 -1.182 . . . . 0.0 110.322 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.313 0.578 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.7 p -128.64 179.4 5.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.175 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . 137.49 -64.1 0.56 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.493 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' ASP . 38.9 m -150.35 141.32 22.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.886 -1.361 . . . . 0.0 112.31 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.83 163.36 25.39 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.437 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.118 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.92 145.22 31.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.192 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.73 124.37 21.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.109 -0.994 . . . . 0.0 108.727 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.777 ' HB2' HG23 ' A' ' 59' ' ' VAL . 73.7 m-85 -120.66 142.5 49.4 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.71 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t0 -106.54 91.35 3.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.669 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -97.34 134.96 39.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.1 160.84 28.56 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 p -47.69 112.24 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.058 -1.26 . . . . 0.0 110.514 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 mtmt 55.29 46.48 23.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.285 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.754 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.48 120.94 14.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.707 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -116.66 93.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 CA-C-O 122.467 1.127 . . . . 0.0 113.924 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.23 104.89 0.84 Allowed Glycine 0 C--N 1.287 -2.169 0 N-CA-C 103.626 -3.79 . . . . 0.0 103.626 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.91 ' CG1' HD13 ' A' ' 30' ' ' LEU . 81.5 t -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 116.49 -2.084 . . . . 0.0 112.819 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.782 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -134.35 138.36 44.85 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 48' ' ' LEU . 33.6 t -100.91 130.45 50.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.584 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.76 136.71 13.69 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.856 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 117.68 34.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.641 ' HB2' HD12 ' A' ' 5' ' ' LEU . 3.2 tpt180 -91.83 35.11 0.97 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.79 0.805 . . . . 0.0 109.967 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.745 ' C ' HD12 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -113.66 -35.07 2.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -118.81 -17.19 9.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.716 . . . . 0.0 109.976 178.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 34.08 7.53 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.13 161.41 21.05 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.996 -1.296 . . . . 0.0 111.221 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -138.45 127.3 23.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 111.161 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 8.0 mmm180 -88.04 154.65 52.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.412 -0.805 . . . . 0.0 109.041 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.26 136.75 2.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.471 1.248 . . . . 0.0 111.356 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.91 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -99.17 144.61 28.55 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' CD ' HD23 ' A' ' 30' ' ' LEU . 17.9 Cg_endo -39.67 165.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.772 2.315 . . . . 0.0 115.756 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.86 142.07 58.56 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.157 1.456 . . . . 0.0 114.355 -175.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.754 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -55.53 51.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.449 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.0 tptm -133.34 98.62 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.75 -1.219 . . . . 0.0 108.96 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.851 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.15 161.6 16.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 110.819 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.77 119.43 24.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.832 . . . . 0.0 111.08 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.18 25.71 1.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 13' ' ' LYS . . . 93.62 14.59 52.69 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.851 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 11.7 m -91.25 111.12 47.05 Favored Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 120.944 -1.327 . . . . 0.0 109.776 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.679 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.4 Cg_endo -70.37 155.87 62.97 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.639 1.336 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.979 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -63.76 91.67 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.897 -1.127 . . . . 0.0 108.579 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.1 t90 -92.41 -22.49 19.62 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.88 -39.28 21.76 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.096 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -70.56 -55.0 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.979 HD12 ' O ' ' A' ' 41' ' ' ASP . 5.9 mt -68.31 -43.02 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.691 -1.256 . . . . 0.0 110.591 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 1.3 tm-20 -54.63 -30.79 55.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.717 -1.239 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.8 mtp180 -66.57 -44.01 83.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.345 -0.847 . . . . 0.0 109.362 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.118 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.63 -27.14 31.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.303 -0.873 . . . . 0.0 109.285 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.74 -53.37 33.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.972 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -80.01 -26.99 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.154 -0.966 . . . . 0.0 111.345 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 25.8 tt0 -79.1 -41.16 29.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.964 -1.085 . . . . 0.0 110.978 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 48' ' ' LEU . 73.4 m95 -103.58 -14.69 16.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.059 -1.026 . . . . 0.0 111.112 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 4' ' ' THR . 2.9 mt-30 51.96 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.951 -1.093 . . . . 0.0 110.112 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.5 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.739 1.389 . . . . 0.0 111.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 4' ' ' THR . 2.3 m-20 -76.77 -43.52 36.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.31 136.82 47.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.661 ' C ' HD13 ' A' ' 58' ' ' ILE . 2.7 mp -129.98 137.43 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.052 -1.03 . . . . 0.0 111.869 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.704 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.21 126.0 74.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' A' ' 8' ' ' PHE . 10.0 p -132.91 150.12 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.579 -1.325 . . . . 0.0 112.289 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.02 3.03 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.909 -1.139 . . . . 0.0 110.377 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 76' ' ' ALA . 1.6 pt? -65.61 148.44 98.13 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.102 -1.234 . . . . 0.0 110.111 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.87 143.31 60.42 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.619 1.326 . . . . 0.0 109.869 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 70' ' ' GLN . 8.8 tp -90.65 154.72 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 24.5 p30 -52.04 152.19 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -12.17 59.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 110.624 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -75.07 -11.33 60.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.069 -1.019 . . . . 0.0 110.539 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.59 46.67 73.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 t -103.08 -161.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.004 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.5 147.64 50.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.038 -1.039 . . . . 0.0 110.285 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.427 ' HG3' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -154.97 68.03 5.38 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.31 -11.32 28.49 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.908 1.478 . . . . 0.0 110.716 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.25 -24.57 57.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.868 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.6 -19.89 6.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 111.532 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -31.41 4.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.829 -1.169 . . . . 0.0 109.536 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.62 63.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.55 ' CB ' HD22 ' A' ' 61' ' ' LEU . . . -58.03 -46.34 85.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -56.42 -48.94 75.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -24.66 64.92 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.147 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 10' ' ' PHE . 5.7 t80 -61.03 -49.73 76.21 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB2' HG13 ' A' ' 59' ' ' VAL . . . -57.29 -33.05 67.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.463 -0.773 . . . . 0.0 109.146 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.47 -23.45 63.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 110.12 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -70.51 -51.6 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.06 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -68.06 -23.75 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.708 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.848 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.5 t-80 -59.07 -57.8 11.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -0.814 . . . . 0.0 110.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.82 -15.63 80.76 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.42 -44.33 91.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.288 . . . . 0.0 110.198 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.693 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -116.13 -14.01 11.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.71 31.06 30.76 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.2 m -95.52 153.2 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -1.039 . . . . 0.0 110.617 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.13 72.66 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 110.255 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -89.51 152.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.999 0.904 . . . . 0.0 111.12 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 162.27 27.82 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.89 143.24 45.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.753 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.485 ' CE1' HG23 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -82.47 104.93 13.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.463 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.6 144.33 49.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.084 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.417 ' CD ' HG21 ' A' ' 73' ' ' THR . 14.5 mp0 -79.8 56.26 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.24 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -78.07 -33.57 50.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.994 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 100' ' ' THR . 10.0 mp -88.64 -40.56 13.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.25 -82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.462 -0.774 . . . . 0.0 110.62 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' LEU . 58.8 p -105.46 112.72 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.297 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.95 152.09 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.009 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 104' ' ' ARG . 22.2 mt-10 -94.88 -24.04 17.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -0.849 . . . . 0.0 110.567 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 54.94 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.498 -0.751 . . . . 0.0 110.341 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -138.11 129.47 27.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.943 -1.098 . . . . 0.0 110.243 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.3 m -109.53 -5.56 15.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.898 . . . . 0.0 110.815 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.14 -64.06 4.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.91 92.39 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -1.164 . . . . 0.0 110.409 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -81.62 149.57 28.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -88.77 122.75 32.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -81.33 158.76 24.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.985 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.83 -171.64 34.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.34 92.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.08 20.81 8.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.123 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -170.36 117.14 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.49 120.65 15.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -109.86 96.67 6.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.001 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -166.06 145.39 6.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.378 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -154.02 -68.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.2 167.66 18.76 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.0 mtpp -137.12 149.45 47.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -1.121 . . . . 0.0 110.318 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 120' ' ' LYS . 93.7 t 55.62 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.453 -0.779 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.88 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.46 25.36 4.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.221 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.628 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -78.97 -31.1 44.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.7 p -54.23 -30.85 51.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.333 -0.854 . . . . 0.0 111.482 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.608 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.03 -56.22 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 109.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.782 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -55.87 -24.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.559 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 124' ' ' ALA . 4.5 mm -71.13 -44.67 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 126' ' ' ALA . 36.3 mt -61.41 -42.0 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.0 OUTLIER -57.7 -58.06 10.01 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.739 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.0 -21.76 65.12 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 108.994 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -58.03 -40.86 81.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.548 -0.72 . . . . 0.0 110.985 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 1.051 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.5 p90 -81.64 -32.64 31.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.317 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.5 m-85 -52.62 -31.8 38.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.985 . . . . 0.0 110.121 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -27.13 38.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -13.84 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.403 -0.811 . . . . 0.0 110.625 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.3 -14.66 73.68 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.049 -1.265 . . . . 0.0 110.201 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.213 0.53 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 69.4 p -154.99 122.61 5.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 110.044 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -158.25 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.742 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.5 m -147.49 138.32 23.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.326 . . . . 0.0 112.243 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.695 0.759 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.38 28.79 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.02 126.73 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.146 -0.971 . . . . 0.0 111.143 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.2 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.4 138.01 58.19 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 123.025 1.393 . . . . 0.0 113.715 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.73 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.03 159.75 17.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.97 . . . . 0.0 110.43 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.08 123.96 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.803 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.96 47.51 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.87 107.71 26.6 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.099 -1.236 . . . . 0.0 110.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.23 157.62 56.75 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.572 1.301 . . . . 0.0 109.082 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.77 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.52 -20.46 54.18 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.371 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -30.94 30.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.67 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.83 -0.543 . . . . 0.0 111.764 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.41 64.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.81 -51.65 8.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 112.302 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.755 -1.216 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.822 -1.174 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.71 136.86 23.94 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.72 1.379 . . . . 0.0 111.439 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.82 -45.1 37.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.403 -0.811 . . . . 0.0 110.103 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 140.35 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.068 . . . . 0.0 109.591 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.74 137.83 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 111.856 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.21 122.46 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -118.3 113.46 37.06 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.609 ' N ' HD22 ' A' ' 61' ' ' LEU . 50.2 Cg_endo -84.07 115.86 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.375 1.197 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' LEU . 52.3 tp -130.56 133.59 46.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -80.47 131.42 35.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.188 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.761 ' HG2' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.28 -44.9 14.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 110.027 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.48 -11.28 15.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.334 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.2 -51.07 0.77 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 6.4 t -105.31 -165.14 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.382 -1.069 . . . . 0.0 109.572 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 68' ' ' THR . 19.1 pt-20 37.87 -157.12 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.165 0.507 . . . . 0.0 111.47 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -176.8 67.12 0.22 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 -30.08 14.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.921 1.485 . . . . 0.0 110.089 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 65' ' ' MET . 1.1 tp -60.08 -30.01 68.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.88 -19.57 18.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.875 . . . . 0.0 111.237 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.28 -33.39 5.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 109.646 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -80.05 -30.3 39.4 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -65.09 -45.05 86.78 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 108.908 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -56.99 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.84 -25.71 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.974 -1.079 . . . . 0.0 109.792 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.71 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.75 -16.29 75.69 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.8 m-85 -119.08 -11.97 9.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.94 31.66 42.79 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.19 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.905 . . . . 0.0 110.773 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.3 125.86 40.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.861 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 -87.97 101.7 14.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 110.445 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.41 143.92 49.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -79.59 57.59 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -63.52 -29.59 70.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 0.0 110.21 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -18.65 65.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.892 . . . . 0.0 110.209 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 100' ' ' THR . 32.5 t -56.88 92.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -157.38 127.73 6.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.165 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.8 152.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.184 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 mt-10 -97.31 -22.9 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 62.14 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.402 -0.811 . . . . 0.0 110.448 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.44 39.75 31.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 17.9 p -114.21 19.41 16.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.905 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.84 -140.64 12.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.99 137.51 39.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 110.272 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.61 39.81 3.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -95.95 -59.17 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -75.75 -60.6 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 110.295 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.06 -53.93 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.84 -94.64 0.09 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 56.0 m-85 -125.75 79.79 1.85 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -1.174 . . . . 0.0 110.362 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 51.78 57.4 6.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.313 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.63 173.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.24 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.15 -46.04 0.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.53 158.06 27.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -153.83 80.35 1.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.18 141.73 10.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -167.86 147.62 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -1.055 . . . . 0.0 110.082 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.32 139.52 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.336 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -173.24 -37.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.89 21.62 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.765 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -21.63 64.49 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -24.36 39.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -13.18 32.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.35 -21.35 59.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.181 -1.188 . . . . 0.0 110.126 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -152.21 138.71 18.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -163.72 81.31 0.12 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp -104.61 107.69 58.75 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -88.43 113.41 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 109.488 -1.004 . . . . 0.0 109.488 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -131.99 131.51 42.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.956 -1.09 . . . . 0.0 110.63 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.99 123.97 29.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.691 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 tpt -84.53 -44.28 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.891 -1.131 . . . . 0.0 109.668 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.42 -2.27 20.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 110.477 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 -25.73 19.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.89 -160.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -1.023 . . . . 0.0 109.742 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.13 163.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.151 -0.968 . . . . 0.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.05 107.37 4.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.94 -6.58 19.4 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.596 1.314 . . . . 0.0 110.754 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -25.08 64.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 0.0 110.572 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.93 -19.06 5.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.301 -0.875 . . . . 0.0 111.412 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . . . -47.31 -35.39 7.89 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -74.67 -27.87 60.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.392 -0.818 . . . . 0.0 109.119 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.79 -50.85 61.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.426 -0.796 . . . . 0.0 109.949 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 74' ' ' ALA . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.44 ' HB2' HG11 ' A' ' 91' ' ' VAL . 1.2 t-80 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 -83.34 120.72 26.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.95 143.24 28.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.29 -0.881 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -74.17 82.93 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.013 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -19.42 39.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.755 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -25.33 64.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.205 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -115.61 88.23 2.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.918 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 m -138.04 -52.14 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.648 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.48 152.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.59 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.63 -45.49 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.805 . . . . 0.0 110.051 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 170.62 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.142 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -117.61 64.5 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 15.43 25.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.96 -76.36 0.67 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 93.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -44.98 5.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -75.39 96.38 3.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -55.98 -28.19 56.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.026 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -98.09 115.15 5.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.98 160.73 10.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 66.8 t80 53.71 35.67 21.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 0.0 110.013 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -61.64 165.43 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.258 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.39 110.6 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 116' ' ' LEU . 2.8 mm? -53.09 107.24 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -170.36 125.65 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -25.89 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.93 77.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -101.19 146.38 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -1.133 . . . . 0.0 110.066 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.16 24.9 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.405 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -87.75 58.24 4.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.995 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m 55.04 29.33 12.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 110.481 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.26 -27.46 42.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 -18.91 43.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.915 . . . . 0.0 110.109 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.51 51.64 56.62 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.155 -1.203 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 17.6 ttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.228 0.537 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER 179.9 -45.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 0.0 109.988 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . 171.62 -79.6 0.09 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.158 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 2' ' ' SER . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -64.81 143.05 98.72 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HG ' ' A' ' 61' ' ' LEU . 42.9 Cg_endo -68.6 148.84 73.22 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.612 1.322 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.21 163.57 12.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.386 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.14 148.67 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -24.3 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -84.49 -11.58 55.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.9 62.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 t -68.97 -172.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -1.195 . . . . 0.0 110.183 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -61.23 125.6 24.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 110.075 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.09 78.65 3.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.689 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.82 -7.69 20.39 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.719 1.379 . . . . 0.0 110.566 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -27.81 12.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.028 -1.045 . . . . 0.0 110.644 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -57.76 -22.08 45.0 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.102 -0.999 . . . . 0.0 110.892 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.75 -30.4 5.58 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.004 -1.06 . . . . 0.0 108.849 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -82.46 -31.49 29.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -59.93 -48.68 80.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.404 -0.81 . . . . 0.0 109.536 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.452 ' CD2' HG12 ' A' ' 91' ' ' VAL . 2.0 t-80 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -91.23 115.28 27.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.11 144.27 55.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -99.06 45.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -87.83 -22.82 24.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.078 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 98' ' ' LEU . 9.9 tt -70.45 -23.75 62.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -98.76 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 m -154.86 63.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -72.52 152.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -86.42 -43.34 12.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.61 111.19 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -152.91 -166.02 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.12 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -25.06 9.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.23 108.26 2.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.24 -161.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.325 -1.103 . . . . 0.0 110.666 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -151.94 175.59 12.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.35 -0.843 . . . . 0.0 110.271 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.89 -64.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -105.64 153.48 21.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.812 . . . . 0.0 110.142 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.76 119.87 0.79 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.72 23.83 11.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -125.32 -38.54 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 0.0 110.086 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -143.93 110.57 5.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 116' ' ' LEU . . . -102.49 -25.28 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -158.75 99.47 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.326 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.9 t30 -158.29 -152.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 120' ' ' LYS . 16.1 mttt 58.02 -84.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.514 -0.742 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' ASN . . . -70.15 66.07 0.71 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 118' ' ' LYS . 29.3 tttt -124.92 -48.33 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.107 . . . . 0.0 110.002 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.2 p -145.19 75.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.089 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.1 142.33 58.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t -176.07 -37.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.96 -22.7 42.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -87.57 12.65 11.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.618 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.67 21.07 3.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.133 -1.216 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.149 0.5 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 0.9 OUTLIER 54.36 -173.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.19 -0.944 . . . . 0.0 110.182 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.05 -61.72 0.65 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.969 -1.312 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.58 127.81 34.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.991 -1.3 . . . . 0.0 112.151 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.83 29.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.748 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.56 32.8 0.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.744 0.783 . . . . 0.0 110.038 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.6 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.6 70.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.65 -53.05 8.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.897 -1.127 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.47 137.6 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.999 -1.063 . . . . 0.0 112.088 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -99.62 114.34 65.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.061 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 51.0 Cg_endo -94.17 112.37 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.164 1.086 . . . . 0.0 109.465 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -132.85 133.13 42.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 110.342 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' A' ' 68' ' ' THR . 26.3 m120 -80.81 125.25 29.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.298 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.3 tpt -82.83 -45.61 14.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 110.214 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -108.09 15.71 24.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.93 19.03 25.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.446 ' N ' ' HB3' ' A' ' 64' ' ' ASN . 6.2 t -165.4 -147.41 0.1 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -1.194 . . . . 0.0 110.057 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.89 165.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 0.0 110.866 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.41 131.71 2.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 109.643 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.02 -12.08 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.316 1.166 . . . . 0.0 110.932 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.49 -27.83 40.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.022 -1.049 . . . . 0.0 110.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.91 -19.7 13.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.18 -0.95 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.89 -34.94 5.88 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -30.78 26.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -61.74 -51.48 68.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.78 . . . . 0.0 109.493 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -22.71 67.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.021 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.428 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.408 ' N ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.34 16.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.32 40.0 41.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.65 154.12 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.565 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 84.71 7.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.495 -0.753 . . . . 0.0 110.246 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 -82.73 117.12 22.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.37 138.48 31.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.006 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.36 28.42 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.367 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -79.69 -41.02 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.803 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 -26.42 21.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.697 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 m 52.92 177.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.492 -0.755 . . . . 0.0 110.493 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.9 p -85.94 130.12 34.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.86 . . . . 0.0 110.106 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.17 152.43 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 2.4 mt-10 -91.42 -35.74 14.19 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.032 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 54.25 -150.72 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -112.15 68.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 p -83.82 -19.74 34.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.354 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.65 129.5 1.54 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.41 59.85 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -1.143 . . . . 0.0 109.922 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 108' ' ' PHE . 79.4 t80 -151.79 64.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.36 -157.65 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.76 -169.57 3.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.57 89.2 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.4 149.3 43.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -103.48 49.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -1.134 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.46 -58.32 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.51 62.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.64 100.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.08 87.77 7.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -122.27 -33.21 3.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.25 -30.2 57.34 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -94.75 -78.14 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -1.067 . . . . 0.0 110.026 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 t 58.31 162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.322 -0.861 . . . . 0.0 110.141 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.79 40.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.417 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m -144.5 -42.85 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.351 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -80.3 -20.65 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -91.76 -21.48 20.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.339 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.25 26.58 64.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.14 -1.212 . . . . 0.0 110.341 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 17.6 ttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.228 0.537 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER 179.9 -45.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 0.0 109.988 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . 171.62 -79.6 0.09 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.158 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 2' ' ' SER . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -64.81 143.05 98.72 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HG ' ' A' ' 61' ' ' LEU . 42.9 Cg_endo -68.6 148.84 73.22 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.612 1.322 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.21 163.57 12.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.386 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.14 148.67 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -24.3 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -84.49 -11.58 55.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.9 62.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 t -68.97 -172.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -1.195 . . . . 0.0 110.183 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -61.23 125.6 24.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 110.075 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.09 78.65 3.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.689 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.82 -7.69 20.39 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.719 1.379 . . . . 0.0 110.566 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -27.81 12.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.028 -1.045 . . . . 0.0 110.644 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -57.76 -22.08 45.0 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.102 -0.999 . . . . 0.0 110.892 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.75 -30.4 5.58 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.004 -1.06 . . . . 0.0 108.849 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -82.46 -31.49 29.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -59.93 -48.68 80.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.404 -0.81 . . . . 0.0 109.536 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.452 ' CD2' HG12 ' A' ' 91' ' ' VAL . 2.0 t-80 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -91.23 115.28 27.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.11 144.27 55.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -99.06 45.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -87.83 -22.82 24.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.078 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 98' ' ' LEU . 9.9 tt -70.45 -23.75 62.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -98.76 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 m -154.86 63.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -72.52 152.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -86.42 -43.34 12.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.164 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.61 111.19 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.123 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -152.91 -166.02 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.12 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -25.06 9.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.23 108.26 2.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.24 -161.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.325 -1.103 . . . . 0.0 110.666 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -151.94 175.59 12.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.35 -0.843 . . . . 0.0 110.271 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.89 -64.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -105.64 153.48 21.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.812 . . . . 0.0 110.142 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.76 119.87 0.79 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.72 23.83 11.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -125.32 -38.54 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 0.0 110.086 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -143.93 110.57 5.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 116' ' ' LEU . . . -102.49 -25.28 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -158.75 99.47 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.326 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.9 t30 -158.29 -152.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 120' ' ' LYS . 16.1 mttt 58.02 -84.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.514 -0.742 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' ASN . . . -70.15 66.07 0.71 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 118' ' ' LYS . 29.3 tttt -124.92 -48.33 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.107 . . . . 0.0 110.002 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.2 p -145.19 75.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.089 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.1 142.33 58.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t -176.07 -37.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.96 -22.7 42.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -87.57 12.65 11.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.618 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.67 21.07 3.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.133 -1.216 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.218 0.532 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.25 119.93 25.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.17 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -165.84 -89.62 0.07 OUTLIER Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp -65.47 149.7 96.84 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 Cg_endo -67.91 147.15 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.595 1.313 . . . . 0.0 110.66 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -91.2 164.75 13.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 110.281 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.655 ' O ' HD12 ' A' ' 63' ' ' LEU . 8.0 m120 -50.64 141.89 11.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.17 -25.97 48.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -4.79 55.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.9 31.71 61.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -179.32 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -1.099 . . . . 0.0 110.21 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.99 119.33 10.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.809 . . . . 0.0 109.927 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -147.36 91.17 5.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 110.002 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.99 -9.24 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.699 1.368 . . . . 0.0 110.457 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -24.08 8.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 110.154 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.09 -21.12 7.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.275 -0.89 . . . . 0.0 110.661 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.53 7.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 108.697 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -78.34 -33.01 49.42 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -57.06 -46.15 82.7 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.345 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 -82.08 110.79 17.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 128.43 34.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.295 -0.878 . . . . 0.0 110.31 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -126.59 48.85 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.979 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -72.91 -30.82 64.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.478 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -78.23 -21.7 49.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.156 -0.965 . . . . 0.0 110.188 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.442 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 1.2 m 49.35 70.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.93 . . . . 0.0 110.728 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m 55.84 103.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.882 . . . . 0.0 110.499 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.46 151.78 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.923 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 104' ' ' ARG . 3.5 tt0 -90.18 -21.45 22.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 55.53 -87.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 110.298 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -83.62 114.55 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -96.27 -7.41 35.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.57 106.86 2.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -173.37 4.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -1.109 . . . . 0.0 110.018 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.71 154.66 17.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -47.1 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.275 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.32 124.51 40.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.38 56.81 2.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.69 -146.98 20.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -72.71 65.79 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -1.127 . . . . 0.0 110.215 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 53.32 -178.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.95 24.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pp -164.74 152.14 11.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.133 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.68 -81.83 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -149.07 145.77 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.56 40.56 1.2 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.04 147.52 32.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -1.13 . . . . 0.0 110.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.69 19.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.446 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -86.57 64.44 8.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t 52.2 33.42 12.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -80.39 -20.95 42.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -78.85 -6.76 56.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 0.0 110.777 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.63 -43.6 3.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.217 -1.167 . . . . 0.0 110.313 -179.909 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.248 0.547 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 10.2 p -172.4 -168.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . 109.33 -46.42 1.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.67 120.07 33.39 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.64 118.09 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 120.756 0.97 . . . . 0.0 110.528 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.4 133.47 47.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.145 -0.972 . . . . 0.0 110.64 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.7 125.71 30.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.2 tpt -83.74 -43.79 15.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.62 19.99 19.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.454 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.66 -39.7 2.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -124.79 -175.19 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.563 -0.963 . . . . 0.0 109.353 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 48.72 -166.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.098 -1.001 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 74.48 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.25 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.05 -24.87 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 110.311 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.2 tp -67.56 -24.91 65.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 0.0 110.648 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.48 -20.59 7.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.147 -0.971 . . . . 0.0 111.254 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.38 -34.22 10.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.989 -1.069 . . . . 0.0 109.324 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -57.63 -47.36 82.42 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 69.6 t60 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 -83.68 100.18 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -99.12 145.65 26.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.264 -0.898 . . . . 0.0 111.287 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.1 55.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.357 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.22 -17.01 38.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 110.987 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -32.48 73.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.068 -1.02 . . . . 0.0 110.371 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.3 t 55.03 171.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.32 -0.863 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 m -122.73 111.24 16.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 151.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 110.108 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -75.98 -43.74 43.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.238 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.63 89.44 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -144.91 -56.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -110.08 -20.79 12.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.38 70.62 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 107' ' ' LEU . 3.1 mm? 53.14 -172.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -102.93 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.141 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 164.75 17.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 110.163 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -151.47 -158.65 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.44 -109.9 0.76 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.65 95.16 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 -64.14 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.204 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -109.43 -178.95 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.159 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.15 123.64 31.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -54.92 41.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.89 163.55 25.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.871 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.79 -43.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.71 124.25 1.35 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 55.76 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -1.08 . . . . 0.0 109.858 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 121' ' ' VAL . 39.0 t -56.17 -65.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.431 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.85 139.63 13.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.43 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t 54.88 31.3 15.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -0.825 . . . . 0.0 110.477 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -72.82 -20.41 61.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.45 -18.45 54.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.533 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -178.81 77.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.447 ' OXT' ' CD1' ' A' ' 138' ' ' TYR . 10.7 t80 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.235 -1.156 . . . . 0.0 109.91 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.109 0.48 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.478 ' CB ' ' HG2' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -129.32 -44.71 1.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.372 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . 170.51 -79.65 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.413 -1.375 . . . . 0.0 110.22 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HG2' ' CB ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 147.62 98.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.23 148.61 44.27 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.895 1.471 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 70' ' ' GLN . 12.7 tp -96.34 160.69 14.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -0.837 . . . . 0.0 109.995 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -75.08 135.53 41.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.164 -0.96 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 -43.35 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.62 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.32 14.31 29.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.77 30.45 9.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.87 -158.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -1.076 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 172.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.793 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.2 tp60 -160.0 80.98 2.41 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.22 -13.99 31.28 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.679 1.357 . . . . 0.0 110.313 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.92 -25.38 63.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.26 -20.35 10.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 111.629 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -36.88 12.31 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.914 -1.116 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -75.33 -27.88 59.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.411 -0.806 . . . . 0.0 108.867 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -61.28 -45.71 93.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.566 -0.709 . . . . 0.0 109.872 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 -89.45 113.87 25.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.3 144.79 56.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.411 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.47 86.92 6.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.65 52.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.608 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -18.72 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.428 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -63.49 -178.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -113.75 161.62 17.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.26 152.71 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.24 -37.8 84.39 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.053 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.95 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.87 . . . . 0.0 110.511 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -73.85 0.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.995 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -98.54 -20.78 16.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.66 58.78 12.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 102.99 4.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.69 115.73 30.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.947 . . . . 0.0 110.108 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 -54.81 19.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.548 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.78 172.02 19.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.282 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 101.22 91.05 2.11 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.37 103.55 1.68 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -56.84 -39.56 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.237 . . . . 0.0 110.167 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.92 146.21 2.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -169.84 141.17 2.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.21 106.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.29 161.92 0.83 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.409 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 174.11 9.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.17 -108.22 3.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -140.72 47.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.9 p -151.45 111.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 110.288 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -106.32 16.79 24.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -78.13 -24.18 47.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -79.43 -17.83 53.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 133' ' ' TYR . 2.6 mm-40 -79.27 -1.55 37.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.05 45.05 0.59 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 25.3 p90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.159 . . . . 0.0 110.242 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.149 0.5 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 0.9 OUTLIER 54.36 -173.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.19 -0.944 . . . . 0.0 110.182 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.05 -61.72 0.65 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.005 -1.291 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.6 127.83 34.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.3 . . . . 0.0 112.196 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.402 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.87 29.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.747 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.61 32.78 0.94 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.7 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.58 70.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.69 -53.06 8.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.858 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.89 -1.131 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.51 137.64 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.999 -1.063 . . . . 0.0 112.044 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -99.62 114.3 65.52 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.085 178.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 51.0 Cg_endo -94.14 112.37 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.225 1.119 . . . . 0.0 109.465 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -132.85 133.13 42.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 110.342 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' A' ' 68' ' ' THR . 26.4 m120 -80.81 125.25 29.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.298 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.3 tpt -82.83 -45.61 14.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 110.214 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -108.09 15.71 24.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.93 19.03 25.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.446 ' N ' ' HB3' ' A' ' 64' ' ' ASN . 6.2 t -165.4 -147.41 0.1 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -1.194 . . . . 0.0 110.057 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.89 165.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 0.0 110.866 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.41 131.71 2.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 109.643 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.02 -12.08 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.316 1.166 . . . . 0.0 110.932 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.5 -27.84 40.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 110.165 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.91 -19.7 13.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.18 -0.95 . . . . 0.0 110.918 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.89 -34.94 5.88 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -30.78 26.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -61.74 -51.48 68.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.78 . . . . 0.0 109.493 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -22.79 67.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 108.996 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 110.428 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.408 ' N ' HG13 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.36 16.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 40.03 41.61 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.66 154.09 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.594 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.81 84.71 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 -82.73 117.12 22.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.37 138.48 31.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.006 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.36 28.42 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.367 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -79.69 -41.02 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.803 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.98 -26.46 21.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.793 . . . . 0.0 109.684 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 m 52.94 177.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.493 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.9 p -85.94 130.12 34.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.86 . . . . 0.0 110.106 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.19 152.46 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.172 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -91.42 -35.74 14.19 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 54.28 -150.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -112.17 68.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 p -83.8 -19.77 34.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.63 129.49 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.36 59.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 0.0 109.953 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 108' ' ' PHE . 79.4 t80 -151.77 64.39 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.335 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.31 -157.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.74 -169.52 3.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.209 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.57 89.2 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.39 149.26 42.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -103.47 49.81 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.091 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.46 -58.32 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.51 62.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.64 100.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.08 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.08 87.77 7.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -122.25 -33.25 3.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.286 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.23 -30.2 57.38 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -94.75 -78.14 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -1.067 . . . . 0.0 110.026 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 t 58.31 162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.322 -0.861 . . . . 0.0 110.141 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.79 40.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.417 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m -144.5 -42.85 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.351 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -80.3 -20.65 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -91.76 -21.48 20.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.339 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.23 26.61 64.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.14 -1.212 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.218 0.532 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.25 119.93 25.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.17 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -165.84 -89.62 0.07 OUTLIER Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp -65.47 149.7 96.84 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 Cg_endo -67.91 147.15 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.595 1.313 . . . . 0.0 110.66 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -91.2 164.75 13.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 110.281 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.655 ' O ' HD12 ' A' ' 63' ' ' LEU . 8.0 m120 -50.64 141.89 11.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.17 -25.97 48.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -4.79 55.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.9 31.71 61.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -179.32 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -1.099 . . . . 0.0 110.21 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.99 119.33 10.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.809 . . . . 0.0 109.927 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -147.36 91.17 5.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 110.002 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.99 -9.24 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.699 1.368 . . . . 0.0 110.457 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -24.08 8.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 110.154 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.09 -21.12 7.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.275 -0.89 . . . . 0.0 110.661 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.53 7.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 108.697 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -78.34 -33.01 49.42 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -57.06 -46.15 82.7 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.345 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 -82.08 110.79 17.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 128.43 34.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.295 -0.878 . . . . 0.0 110.31 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -126.59 48.85 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.979 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -72.91 -30.82 64.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.478 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -78.23 -21.7 49.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.156 -0.965 . . . . 0.0 110.188 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.442 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 1.2 m 49.35 70.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.93 . . . . 0.0 110.728 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m 55.84 103.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.882 . . . . 0.0 110.499 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.46 151.78 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.923 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 104' ' ' ARG . 3.5 tt0 -90.18 -21.45 22.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 55.53 -87.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 110.298 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -83.62 114.55 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -96.27 -7.41 35.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.57 106.86 2.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -173.37 4.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -1.109 . . . . 0.0 110.018 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.71 154.66 17.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -47.1 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.275 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.32 124.51 40.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.38 56.81 2.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.69 -146.98 20.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -72.71 65.79 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -1.127 . . . . 0.0 110.215 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 53.32 -178.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.95 24.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pp -164.74 152.14 11.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.133 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.68 -81.83 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -149.07 145.77 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.56 40.56 1.2 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.04 147.52 32.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -1.13 . . . . 0.0 110.076 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.69 19.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.446 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -86.57 64.44 8.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t 52.2 33.42 12.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -80.39 -20.95 42.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -78.85 -6.76 56.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 0.0 110.777 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.63 -43.6 3.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.217 -1.167 . . . . 0.0 110.313 -179.909 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.248 0.547 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 10.2 p -172.4 -168.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . 109.33 -46.42 1.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.67 120.07 33.39 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.64 118.09 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 120.756 0.97 . . . . 0.0 110.528 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.4 133.47 47.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.145 -0.972 . . . . 0.0 110.64 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.7 125.71 30.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.2 tpt -83.74 -43.79 15.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.62 19.99 19.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.454 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.66 -39.7 2.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -124.79 -175.19 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.563 -0.963 . . . . 0.0 109.353 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 48.72 -166.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.098 -1.001 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 74.48 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.25 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.05 -24.87 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 110.311 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.2 tp -67.56 -24.91 65.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 0.0 110.648 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.48 -20.59 7.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.147 -0.971 . . . . 0.0 111.254 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.38 -34.22 10.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.989 -1.069 . . . . 0.0 109.324 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -57.63 -47.36 82.42 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 69.6 t60 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 -83.68 100.18 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -99.12 145.65 26.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.264 -0.898 . . . . 0.0 111.287 -179.447 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.1 55.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.357 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.22 -17.01 38.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 110.987 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -32.48 73.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.068 -1.02 . . . . 0.0 110.371 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.3 t 55.03 171.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.32 -0.863 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 m -122.73 111.24 16.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 151.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 110.108 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -75.98 -43.74 43.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.238 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.63 89.44 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -144.91 -56.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -110.08 -20.79 12.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.38 70.62 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 107' ' ' LEU . 3.1 mm? 53.14 -172.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -102.93 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.141 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 164.75 17.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 110.163 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -151.47 -158.65 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.44 -109.9 0.76 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.65 95.16 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 -64.14 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.204 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -109.43 -178.95 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.159 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.15 123.64 31.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -54.92 41.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.89 163.55 25.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.871 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.79 -43.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.71 124.25 1.35 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 55.76 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -1.08 . . . . 0.0 109.858 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 121' ' ' VAL . 39.0 t -56.17 -65.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.431 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.85 139.63 13.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.43 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t 54.88 31.3 15.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -0.825 . . . . 0.0 110.477 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -72.82 -20.41 61.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.45 -18.45 54.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.533 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -178.81 77.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.447 ' OXT' ' CD1' ' A' ' 138' ' ' TYR . 10.7 t80 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.235 -1.156 . . . . 0.0 109.91 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.109 0.48 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.478 ' CB ' ' HG2' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -129.32 -44.71 1.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.372 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . 170.51 -79.65 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.413 -1.375 . . . . 0.0 110.22 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HG2' ' CB ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 147.62 98.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.23 148.61 44.27 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.895 1.471 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 70' ' ' GLN . 12.7 tp -96.34 160.69 14.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -0.837 . . . . 0.0 109.995 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -75.08 135.53 41.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.164 -0.96 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 -43.35 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.62 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.32 14.31 29.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.77 30.45 9.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.87 -158.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -1.076 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 172.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.793 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.2 tp60 -160.0 80.98 2.41 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.22 -13.99 31.28 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.679 1.357 . . . . 0.0 110.313 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.92 -25.38 63.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.26 -20.35 10.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 111.629 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -36.88 12.31 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.914 -1.116 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -75.33 -27.88 59.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.411 -0.806 . . . . 0.0 108.867 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -61.28 -45.71 93.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.566 -0.709 . . . . 0.0 109.872 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 -89.45 113.87 25.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.3 144.79 56.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.411 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.47 86.92 6.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.65 52.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.608 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -18.72 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.428 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -63.49 -178.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -113.75 161.62 17.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.26 152.71 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.24 -37.8 84.39 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.053 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.95 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.87 . . . . 0.0 110.511 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -73.85 0.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.995 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -98.54 -20.78 16.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.66 58.78 12.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 102.99 4.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.69 115.73 30.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.947 . . . . 0.0 110.108 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 -54.81 19.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.548 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.78 172.02 19.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.282 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 101.22 91.05 2.11 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.37 103.55 1.68 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -56.84 -39.56 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.237 . . . . 0.0 110.167 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.92 146.21 2.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -169.84 141.17 2.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.21 106.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.29 161.92 0.83 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.409 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 174.11 9.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.17 -108.22 3.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -140.72 47.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.9 p -151.45 111.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 110.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -106.32 16.79 24.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -78.13 -24.18 47.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -79.43 -17.83 53.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 133' ' ' TYR . 2.6 mm-40 -79.27 -1.55 37.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.05 45.05 0.59 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 25.3 p90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.159 . . . . 0.0 110.242 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.559 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 5.4 m -53.93 135.87 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.63 -91.6 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.122 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -64.13 149.15 94.56 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' O ' HD22 ' A' ' 61' ' ' LEU . 39.9 Cg_endo -65.31 149.13 88.74 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.235 1.124 . . . . 0.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 63' ' ' LEU . 1.7 mm? -89.32 164.82 14.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.343 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -47.42 125.83 8.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.857 . . . . 0.0 110.557 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 tpp -72.56 -11.42 60.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 110.661 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -6.37 48.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.072 . . . . 0.0 110.945 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.87 -32.12 6.35 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.43 138.66 9.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.223 -1.163 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -83.88 171.35 13.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.58 128.66 0.66 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.46 -6.24 18.67 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.429 1.226 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -25.17 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.085 -1.009 . . . . 0.0 110.802 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.91 -21.56 11.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.044 -1.035 . . . . 0.0 110.677 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.72 -29.63 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.082 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -31.75 34.13 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . -58.02 -45.71 86.47 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.263 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.01 113.76 27.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 19.4 p-10 -97.29 126.39 42.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.729 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 51.39 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 110.723 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -88.1 -15.04 37.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.411 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -23.17 55.24 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.107 -0.996 . . . . 0.0 110.506 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -63.16 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' THR . 36.2 m -106.02 52.64 0.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.897 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.3 152.07 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.299 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.5 tm-20 -71.17 -28.27 64.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.483 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 56.29 169.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -129.67 22.75 5.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -111.79 2.99 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.43 153.8 17.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -40.92 17.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -1.163 . . . . 0.0 110.189 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -63.13 94.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.954 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.39 140.79 57.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -168.78 117.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.984 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -127.43 153.95 19.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.55 -65.18 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -86.26 91.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.147 . . . . 0.0 110.007 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 118.05 28.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.49 138.06 19.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -156.38 145.52 20.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.0 m-20 52.72 88.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.823 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -131.01 178.99 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.052 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.0 165.91 12.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 124' ' ' ALA . 17.6 mttm -133.4 50.16 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 0.0 110.128 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 m -61.19 -26.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.27 -162.26 0.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.398 -0.814 . . . . 0.0 110.394 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p -84.52 52.47 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.032 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.15 44.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 7.66 45.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.956 . . . . 0.0 110.814 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -145.81 54.39 0.55 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.239 -1.154 . . . . 0.0 110.327 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.559 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 5.4 m -53.93 135.87 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.63 -91.6 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.122 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -64.13 149.15 94.56 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' O ' HD22 ' A' ' 61' ' ' LEU . 39.9 Cg_endo -65.31 149.13 88.74 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.235 1.124 . . . . 0.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 63' ' ' LEU . 1.7 mm? -89.32 164.82 14.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.343 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -47.42 125.83 8.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.857 . . . . 0.0 110.557 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 tpp -72.56 -11.42 60.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 110.661 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -6.37 48.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.072 . . . . 0.0 110.945 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.87 -32.12 6.35 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.43 138.66 9.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.223 -1.163 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -83.88 171.35 13.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.58 128.66 0.66 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.46 -6.24 18.67 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.429 1.226 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -25.17 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.085 -1.009 . . . . 0.0 110.802 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.91 -21.56 11.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.044 -1.035 . . . . 0.0 110.677 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.72 -29.63 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.082 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -31.75 34.13 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . -58.02 -45.71 86.47 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.263 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.01 113.76 27.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 19.4 p-10 -97.29 126.39 42.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.729 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 51.39 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 110.723 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -88.1 -15.04 37.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.411 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -23.17 55.24 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.107 -0.996 . . . . 0.0 110.506 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -63.16 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' THR . 36.2 m -106.02 52.64 0.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.897 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.3 152.07 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.299 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.5 tm-20 -71.17 -28.27 64.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.483 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 56.29 169.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -129.67 22.75 5.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -111.79 2.99 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.43 153.8 17.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -40.92 17.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -1.163 . . . . 0.0 110.189 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -63.13 94.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.954 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.39 140.79 57.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -168.78 117.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.984 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -127.43 153.95 19.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.55 -65.18 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -86.26 91.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.147 . . . . 0.0 110.007 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 118.05 28.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.49 138.06 19.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -156.38 145.52 20.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -179.677 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.0 m-20 52.72 88.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.823 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -131.01 178.99 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.052 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.0 165.91 12.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 124' ' ' ALA . 17.6 mttm -133.4 50.16 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 0.0 110.128 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 m -61.19 -26.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.27 -162.26 0.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.398 -0.814 . . . . 0.0 110.394 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p -84.52 52.47 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.032 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.15 44.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 7.66 45.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.956 . . . . 0.0 110.814 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -145.81 54.39 0.55 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.239 -1.154 . . . . 0.0 110.327 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.241 0.543 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -161.65 147.97 14.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.103 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -172.1 88.42 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.12 113.9 4.26 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.595 -1.532 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.25 -179.88 30.73 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.28 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.85 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.91 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.938 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.82 112.27 23.12 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.424 179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.53 48.36 1.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.411 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.886 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.94 5.68 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.09 162.24 16.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -0.802 . . . . 0.0 109.861 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.77 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.68 25.77 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.371 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.8 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.63 61.08 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.106 -1.232 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.69 155.9 58.09 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.642 1.338 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -65.97 91.72 0.15 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.719 -1.238 . . . . 0.0 109.117 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.5 -17.85 35.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -32.66 33.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.86 29.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.335 0.588 . . . . 0.0 110.291 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.1 mt -70.11 -47.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 110.416 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.79 25.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.8 -5.41 15.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.693 -1.254 . . . . 0.0 111.94 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.58 109.91 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.352 -0.843 . . . . 0.0 109.446 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.06 111.52 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.208 1.11 . . . . 0.0 111.522 -177.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -64.98 149.32 96.86 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.14 149.34 76.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.816 1.43 . . . . 0.0 110.445 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -90.38 164.74 14.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -46.53 150.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.441 -0.787 . . . . 0.0 110.787 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -15.93 63.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.14 -11.45 59.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 110.624 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.59 49.01 81.4 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 -166.22 1.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.226 -1.161 . . . . 0.0 110.239 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.71 114.04 26.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -131.37 120.69 18.08 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.876 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.48 -7.71 21.9 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.481 1.253 . . . . 0.0 111.258 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.86 -26.79 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.969 -1.082 . . . . 0.0 110.232 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.527 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.27 -20.71 19.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.305 -0.872 . . . . 0.0 111.091 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.59 -32.87 8.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.989 -1.069 . . . . 0.0 109.17 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' PHE . 2.1 ttt-85 -75.76 -29.9 58.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . -58.71 -43.19 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 178.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -62.89 -48.66 78.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.04 -25.14 64.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.807 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.06 73.36 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -22.52 62.03 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.518 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -69.91 -57.19 5.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.773 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.71 -28.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.959 -1.088 . . . . 0.0 110.218 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.05 -58.56 4.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.22 -15.85 61.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.26 4.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.68 152.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.175 0.988 . . . . 0.0 112.071 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.34 46.8 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.18 128.38 41.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.02 -1.05 . . . . 0.0 108.855 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 -92.65 132.35 36.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 0.0 110.843 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.52 145.54 54.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.29 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -87.16 -141.57 0.11 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.261 -0.9 . . . . 0.0 109.693 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -11.88 46.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.704 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -17.63 40.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.04 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.82 65.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 110.28 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -143.31 159.59 42.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 p -61.18 152.2 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 110.137 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.0 -32.51 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.5 111.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.38 144.84 42.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 t -91.09 -23.86 20.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.23 -20.96 67.82 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.74 107.94 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -1.194 . . . . 0.0 110.357 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -121.49 116.02 23.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.93 160.33 3.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -103.0 -52.56 3.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.93 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.07 -112.8 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.92 -112.3 3.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 53.86 46.63 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -1.086 . . . . 0.0 110.439 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.469 ' HE ' HD13 ' A' ' 116' ' ' LEU . 3.5 ttp180 -176.16 160.71 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.328 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.07 -57.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' HE ' ' A' ' 114' ' ' ARG . 1.1 mp 53.82 64.7 1.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.88 . . . . 0.0 110.172 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -109.72 49.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.161 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -90.96 79.33 5.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.62 67.21 0.3 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -69.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.134 . . . . 0.0 110.161 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 121' ' ' VAL . 11.8 p -172.82 31.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.413 -0.804 . . . . 0.0 110.169 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -111.02 -178.95 3.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p -109.28 64.93 0.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.28 -17.88 47.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.568 -0.707 . . . . 0.0 111.231 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.489 ' HG2' ' HA ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -75.14 -20.24 59.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.727 -1.233 . . . . 0.0 111.2 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.81 41.58 0.2 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.033 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.158 -1.201 . . . . 0.0 110.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -172.62 160.35 4.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -161.45 84.88 0.11 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.42 56.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.93 134.69 54.72 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.373 -0.829 . . . . 0.0 111.894 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.0 t70 -113.99 92.66 4.05 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.438 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.4 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.94 23.74 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.61 164.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.679 2.253 . . . . 0.0 115.414 -174.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.7 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.877 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.71 28.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.98 30.52 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.55 17.46 66.16 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.877 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -86.91 108.87 20.4 Favored Pre-proline 0 C--N 1.307 -1.256 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.505 1.266 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.4 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.38 -36.5 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.805 178.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.48 -52.74 15.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 109.729 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.84 -43.83 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.995 -1.066 . . . . 0.0 110.488 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.0 tt0 -53.07 -42.8 66.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.953 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.89 -38.27 72.57 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.553 178.983 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.08 133.26 28.32 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.067 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.58 -34.17 60.64 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.664 -0.648 . . . . 0.0 109.848 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.31 157.58 45.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.018 -1.051 . . . . 0.0 110.668 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 8.0 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.04 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp -63.19 149.63 90.66 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.934 -1.333 . . . . 0.0 109.778 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 61' ' ' LEU . 38.1 Cg_endo -64.14 145.82 89.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.655 1.345 . . . . 0.0 111.378 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 ' OE1' ' A' ' 70' ' ' GLN . 2.1 mm? -98.7 164.28 12.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -49.05 149.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.213 -0.93 . . . . 0.0 110.398 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -28.49 69.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.195 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.24 -11.37 59.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.49 27.89 66.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -165.94 0.63 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.081 -1.247 . . . . 0.0 109.912 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.82 154.08 26.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 110.352 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.444 ' OE1' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -157.28 85.12 2.85 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.23 -7.75 22.01 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.712 1.375 . . . . 0.0 110.821 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 mm? -79.57 -24.21 42.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.29 -21.78 10.18 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 111.009 -178.859 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.88 -29.01 4.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 0.0 108.959 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -81.65 -31.82 32.14 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -58.42 -48.41 80.79 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.31 -48.4 81.52 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.475 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -26.27 65.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.805 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.12 94.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.35 -16.53 71.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.64 153.84 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.512 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.39 78.91 8.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.747 . . . . 0.0 110.794 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 -82.68 102.38 11.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.66 144.49 30.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.96 . . . . 0.0 110.095 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.36 79.16 9.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.379 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -83.28 -10.75 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.208 -0.932 . . . . 0.0 110.39 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -17.47 61.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.505 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -50.77 -30.69 14.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.481 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.6 m -72.0 93.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 110.047 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.13 152.6 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.53 -24.49 20.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.388 -0.82 . . . . 0.0 110.356 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -161.34 -52.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -167.8 130.05 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.11 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -114.06 15.58 18.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.02 -175.87 32.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 14.6 mt -61.03 -177.02 0.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -1.164 . . . . 0.0 110.404 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -129.28 144.22 51.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.405 -0.809 . . . . 0.0 109.948 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -153.93 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.467 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -171.8 -41.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.33 -143.67 21.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ARG . . . 102.02 -165.46 17.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 55.3 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.961 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -143.56 -60.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.856 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.32 84.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.81 156.55 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.1 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 110.783 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -89.04 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.05 -129.66 1.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -162.39 161.88 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -1.151 . . . . 0.0 110.229 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.03 127.68 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -101.39 -158.91 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -101.19 16.5 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.59 -38.69 72.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.617 -179.495 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.71 -33.55 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 109.001 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -80.69 -32.14 36.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -78.71 -10.6 59.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 110.615 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.42 -58.71 12.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.112 179.815 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.243 0.544 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 -73.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.75 -86.08 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ASP . 92.0 m -150.82 140.47 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -1.226 . . . . 0.0 112.702 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.127 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.4 136.77 52.31 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.449 -0.782 . . . . 0.0 108.951 178.239 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.02 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.22 144.26 47.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.961 -1.087 . . . . 0.0 108.883 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.579 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . . . -145.32 124.33 12.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 59' ' ' VAL . 3.1 m-85 -117.95 149.95 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.841 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.843 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.3 t0 -121.16 93.8 4.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.1 p90 -174.26 -155.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.113 -1.435 . . . . 0.0 113.705 -177.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . 159.04 159.12 9.47 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p 45.68 -143.78 0.23 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.055 . . . . 0.0 111.394 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 18.9 mttt -81.96 51.99 1.86 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.04 -1.038 . . . . 0.0 111.389 -178.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -142.02 131.49 23.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.682 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.96 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.8 mm -124.62 96.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.16 103.66 0.77 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 103.393 -3.883 . . . . 0.0 103.393 176.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.967 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.48 170.44 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 C-N-CA 116.144 -2.223 . . . . 0.0 114.406 -174.646 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.71 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.66 136.89 52.23 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.306 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 48' ' ' LEU . 13.9 t -106.76 125.04 62.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.83 135.73 13.08 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 118.714 -1.708 . . . . 0.0 111.277 -177.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -96.74 120.57 37.3 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HG2' ' OH ' ' A' ' 133' ' ' TYR . 11.3 mtp180 -91.09 36.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.454 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.89 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 178.171 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.52 -16.52 10.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 178.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.61 35.83 7.68 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.089 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.75 161.21 20.5 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.855 -1.379 . . . . 0.0 111.064 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -124.88 123.29 39.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.046 -1.034 . . . . 0.0 112.375 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 29' ' ' PRO . 24.6 ttt-85 -88.19 146.12 37.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 50.5 Cg_endo -90.74 141.1 3.09 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 O-C-N 122.792 0.891 . . . . 0.0 112.89 -176.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -99.55 139.65 21.04 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.031 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 21.7 Cg_endo -42.65 169.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.013 2.475 . . . . 0.0 115.965 -174.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.62 143.79 57.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.827 -176.181 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.87 53.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.495 -1.684 . . . . 0.0 115.53 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.98 96.24 3.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.829 -1.17 . . . . 0.0 109.273 176.133 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.85 160.86 16.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.577 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -83.81 116.64 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.083 -1.011 . . . . 0.0 111.336 -178.609 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 48.2 27.75 1.37 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 94.81 12.33 55.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 20.5 m -95.47 110.52 51.28 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.022 -1.281 . . . . 0.0 109.631 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HB3' HD11 ' A' ' 15' ' ' ILE . 45.9 Cg_endo -73.53 159.18 46.69 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.472 1.248 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.2 m-20 -63.39 91.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.923 -1.111 . . . . 0.0 108.118 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.45 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 11.4 t-105 -87.69 -16.8 33.31 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.224 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -80.02 -35.07 37.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -74.49 -50.05 28.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.725 -0.61 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 41' ' ' ASP . 12.1 mt -71.23 -43.58 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.907 -1.121 . . . . 0.0 110.466 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 33.8 tp10 -49.2 -43.0 42.0 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.166 -0.959 . . . . 0.0 109.26 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -57.57 -48.22 79.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 6' ' ' LEU . 2.6 mt -59.61 -24.95 64.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.856 178.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.571 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -84.1 -46.8 11.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.621 -0.674 . . . . 0.0 112.136 -178.408 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -50.72 9.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 112.286 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -84.22 -30.63 25.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.046 . . . . 0.0 112.162 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 57.9 m95 -109.12 -30.74 7.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 0.0 111.74 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 54.2 97.07 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.083 -1.011 . . . . 0.0 109.477 -178.589 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -68.6 124.2 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.446 1.235 . . . . 0.0 110.614 -179.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' THR . 3.9 t0 -71.31 -39.0 71.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.53 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HB3' HD23 ' A' ' 5' ' ' LEU . 12.9 tt0 -135.28 154.37 51.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.2 mp -133.94 136.83 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.799 -1.188 . . . . 0.0 112.682 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.127 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.2 113.92 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.073 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 8' ' ' PHE . 2.3 t -134.08 151.58 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.173 -1.579 . . . . 0.0 112.993 -177.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.44 141.32 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.661 177.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -110.21 108.74 58.81 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.539 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.56 ' N ' HD22 ' A' ' 61' ' ' LEU . 51.8 Cg_endo -90.29 113.99 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.216 1.114 . . . . 0.0 110.048 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.3 tp -131.74 132.08 43.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 110.594 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -82.1 125.35 30.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 109.531 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.4 tpp -83.54 -44.81 14.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 110.319 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.69 17.51 22.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.198 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.65 30.61 66.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 t -166.35 -148.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.38 -1.071 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 150.62 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 109.894 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -159.1 98.53 1.63 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.0 110.609 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.0 -8.27 23.24 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.71 1.374 . . . . 0.0 110.524 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -24.12 67.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.144 -0.973 . . . . 0.0 110.531 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -54.24 -19.97 6.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.509 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.73 -26.85 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.019 -1.051 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -33.94 54.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -62.93 -50.15 71.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.583 -0.698 . . . . 0.0 109.748 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.543 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.0 mpt_? -62.77 -45.93 90.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.189 -0.944 . . . . 0.0 109.784 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -56.97 -30.99 64.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.169 -0.957 . . . . 0.0 109.401 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 74.4 t80 -61.6 -38.61 88.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.931 178.553 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -56.72 -33.28 66.34 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -68.89 -22.87 64.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.905 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.67 6.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 91' ' ' VAL . 34.7 pt -59.69 -30.12 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.853 -1.154 . . . . 0.0 109.151 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.441 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -64.37 -58.32 6.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 109.754 179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.43 -16.19 42.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -71.78 -44.82 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -1.225 . . . . 0.0 110.669 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -119.35 -10.62 9.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 110.842 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 42.56 16.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.7 m -104.53 153.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -1.047 . . . . 0.0 110.715 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.07 83.89 2.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 0.0 111.225 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 83' ' ' ILE . 2.8 p -90.76 151.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -121.28 155.29 35.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.92 -0.488 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 77' ' ' ARG . 21.2 mt -92.28 142.68 27.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.041 -1.037 . . . . 0.0 110.621 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.517 ' CG ' HG12 ' A' ' 129' ' ' ILE . 16.4 t-160 -80.76 106.77 13.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.94 144.7 44.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.6 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.8 76.97 0.46 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.875 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -84.32 -4.56 58.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.231 -0.918 . . . . 0.0 110.978 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -28.14 68.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.128 . . . . 0.0 110.579 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 p -62.5 95.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 100' ' ' THR . 7.4 t -83.25 -167.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.897 . . . . 0.0 110.457 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.09 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -21.29 46.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.481 -0.762 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.66 135.34 53.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 0.0 110.209 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.15 167.51 10.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.418 ' OG ' ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -91.33 -12.67 34.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 110.596 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.97 107.91 2.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -107.16 80.97 1.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -1.145 . . . . 0.0 110.584 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.24 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 110.639 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -59.59 160.46 7.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 109.639 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -53.39 39.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.23 150.25 0.25 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.5 87.97 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.418 ' CE2' ' OG ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -175.81 92.9 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.261 -1.14 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.77 66.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -98.79 -36.18 9.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -0.952 . . . . 0.0 110.261 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER 57.17 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.28 -0.888 . . . . 0.0 110.546 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.59 151.85 25.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.124 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -62.37 1.56 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.96 -125.33 6.42 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt 54.97 174.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 122' ' ' ASP . 13.7 p -67.6 167.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 109.989 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -137.75 85.0 2.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.977 . . . . 0.0 110.546 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 m -72.81 -10.06 59.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.342 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.49 60.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.222 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 129' ' ' ILE . 1.5 m -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.807 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.62 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.41 -50.68 8.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.878 -1.139 . . . . 0.0 109.222 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.71 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -60.41 -23.15 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.332 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 128' ' ' ILE . 12.4 mm -70.13 -41.64 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 174.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.843 HD12 ' HB2' ' A' ' 9' ' ' ASP . 38.3 mt -63.92 -35.16 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 176.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.686 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -67.08 -34.61 78.03 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.147 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -20.33 64.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.852 -1.155 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -48.56 26.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -58.15 -40.41 81.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.889 -1.132 . . . . 0.0 109.642 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.61 -45.64 66.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.071 -1.018 . . . . 0.0 109.616 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -80.69 -18.71 47.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.98 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -98.38 11.88 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.28 -42.23 98.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.351 -1.088 . . . . 0.0 110.093 179.886 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.241 0.543 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -161.65 147.97 14.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.103 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -172.1 88.42 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.11 113.87 4.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.554 -1.557 . . . . 0.0 111.027 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.27 -179.86 30.74 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.27 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.825 -179.059 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.88 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.115 -0.99 . . . . 0.0 110.938 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.742 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -113.83 112.33 23.2 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.39 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.56 48.36 1.53 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.411 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.885 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.89 5.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.02 162.24 16.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 109.898 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.71 20.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.156 -0.965 . . . . 0.0 111.154 -178.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.75 25.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.798 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.64 61.05 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.077 -1.249 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.7 155.94 57.99 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.586 1.308 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -66.04 91.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.734 -1.229 . . . . 0.0 109.098 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.47 -17.92 35.1 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.22 -32.66 33.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.95 28.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.317 0.58 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.0 mt -70.04 -47.63 67.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.477 -0.765 . . . . 0.0 110.453 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.82 25.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.77 -5.37 15.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.702 -1.249 . . . . 0.0 111.95 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.59 109.94 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.09 111.52 3.09 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.276 1.145 . . . . 0.0 111.522 -177.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -64.98 149.32 96.86 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.14 149.34 76.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.816 1.43 . . . . 0.0 110.445 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -90.36 164.77 14.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.23 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -46.56 150.43 0.68 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.377 -0.827 . . . . 0.0 110.787 -179.673 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -15.93 63.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.14 -11.45 59.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 110.624 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.56 49.04 80.99 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 -166.22 1.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.226 -1.161 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.68 114.01 26.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -131.35 120.69 18.1 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.48 -7.71 21.9 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.481 1.253 . . . . 0.0 111.258 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.84 -26.79 15.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 110.293 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.527 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.27 -20.71 19.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 111.091 -179.838 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.59 -32.87 8.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.989 -1.069 . . . . 0.0 109.17 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' PHE . 2.1 ttt-85 -75.76 -29.9 58.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.215 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . -58.71 -43.19 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -62.89 -48.69 77.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.0 -25.17 64.37 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 108.815 178.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.07 73.38 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -22.46 62.01 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.56 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -69.91 -57.21 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.68 -28.83 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.934 -1.104 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.06 -58.57 4.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.123 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.2 -15.85 61.51 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.478 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.27 4.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.75 152.52 3.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 122.202 1.001 . . . . 0.0 112.018 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.35 46.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.13 128.37 41.91 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.999 -1.063 . . . . 0.0 108.854 -179.798 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 -92.68 132.35 36.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 110.843 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.52 145.51 54.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.29 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -87.12 -141.6 0.11 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -11.84 46.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.704 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -17.59 40.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.82 65.64 1.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -143.31 159.59 42.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.081 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 p -61.18 152.2 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 110.137 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.0 -32.51 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.49 111.55 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.046 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.43 144.84 42.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 t -91.09 -23.86 20.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.27 -20.88 67.82 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.79 107.94 13.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -121.49 116.02 23.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.95 160.34 3.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.597 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -103.04 -52.53 3.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.04 -112.86 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.86 -112.29 3.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 53.86 46.63 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -1.081 . . . . 0.0 110.439 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.469 ' HE ' HD13 ' A' ' 116' ' ' LEU . 3.5 ttp180 -176.17 160.71 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.363 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.09 -57.47 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' HE ' ' A' ' 114' ' ' ARG . 1.1 mp 53.82 64.69 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.88 . . . . 0.0 110.172 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -109.7 49.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.169 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -90.96 79.33 5.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.63 67.22 0.3 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 -69.27 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -1.134 . . . . 0.0 110.188 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 121' ' ' VAL . 11.8 p -172.82 31.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.413 -0.804 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.0 -178.94 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 110.51 -179.654 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p -109.3 64.93 0.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -81.25 -17.92 47.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.262 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.489 ' HG2' ' HA ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -75.14 -20.24 59.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.727 -1.233 . . . . 0.0 111.2 -178.817 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.81 41.58 0.2 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.033 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.185 -1.185 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -172.62 160.35 4.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -161.45 84.88 0.11 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.47 56.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.99 134.63 54.76 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.357 -0.84 . . . . 0.0 111.863 -178.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.1 t70 -113.92 92.65 4.05 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.5 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.89 23.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.51 164.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.668 2.245 . . . . 0.0 115.462 -174.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.72 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.72 28.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.97 30.51 4.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 110.147 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.56 17.42 66.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.876 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 40.2 m -86.83 108.83 20.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.145 -1.209 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.502 1.264 . . . . 0.0 109.475 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.5 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.4 -36.44 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.834 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.52 -52.74 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.809 -0.557 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.89 -43.77 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.995 -1.066 . . . . 0.0 110.518 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 4.9 tt0 -53.07 -42.84 66.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.918 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.86 -38.27 72.48 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.553 179.007 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.057 -1.027 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.06 133.25 28.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.083 -178.381 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.59 -34.17 60.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.724 -0.61 . . . . 0.0 109.848 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.3 157.57 45.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.018 -1.051 . . . . 0.0 110.623 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.9 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.06 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp -63.23 149.67 90.71 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.969 -1.313 . . . . 0.0 109.779 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 61' ' ' LEU . 38.1 Cg_endo -64.14 145.82 89.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.655 1.345 . . . . 0.0 111.378 -178.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 ' OE1' ' A' ' 70' ' ' GLN . 2.1 mm? -98.7 164.28 12.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -49.05 149.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.213 -0.93 . . . . 0.0 110.398 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -28.49 69.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.195 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.24 -11.37 59.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.49 27.89 66.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -165.94 0.63 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.046 -1.267 . . . . 0.0 109.912 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.82 154.08 26.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 110.352 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.444 ' OE1' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -157.29 85.14 2.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.962 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.23 -7.75 22.01 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.712 1.375 . . . . 0.0 110.821 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 mm? -79.57 -24.21 42.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.31 -21.76 10.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 110.99 -178.859 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.89 -29.01 4.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.017 -1.052 . . . . 0.0 108.959 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -81.63 -31.89 32.18 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -58.38 -48.38 80.82 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.469 -0.769 . . . . 0.0 109.494 179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.37 -48.36 81.61 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.469 179.671 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -26.23 65.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.765 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.15 94.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.3 -16.51 71.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.62 153.85 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.533 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 78.91 8.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.714 . . . . 0.0 110.794 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 -82.68 102.38 11.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.66 144.49 30.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.96 . . . . 0.0 110.095 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.36 79.16 9.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.379 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -83.28 -10.74 58.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.208 -0.932 . . . . 0.0 110.39 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.83 -17.5 61.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 110.483 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -50.77 -30.69 14.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.481 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.6 m -72.0 93.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 110.047 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.17 152.58 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 110.465 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.53 -24.49 20.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 110.356 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -161.34 -52.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -167.8 130.05 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.11 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 p -114.06 15.58 18.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.02 -175.87 32.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 14.6 mt -61.03 -177.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -1.164 . . . . 0.0 110.404 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -129.28 144.19 51.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -153.93 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.467 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -171.8 -41.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.33 -143.67 21.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ARG . . . 102.02 -165.46 17.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 55.3 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.961 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -143.56 -60.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.32 84.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.81 156.55 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.1 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 110.783 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -89.04 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.05 -129.66 1.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -162.41 161.9 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 110.171 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.03 127.68 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -101.39 -158.91 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -101.19 16.5 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.56 -38.72 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.629 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.69 -33.55 64.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.001 179.022 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -80.69 -32.14 36.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -78.71 -10.61 59.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 110.615 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.4 -58.75 12.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.112 179.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.318 0.58 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 68.6 m -143.29 147.03 34.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.079 -1.247 . . . . 0.0 111.699 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -126.79 142.08 51.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.128 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -130.09 144.82 51.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 58' ' ' ILE . . . -153.8 126.01 7.93 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.889 -1.132 . . . . 0.0 110.319 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.905 ' HB2' HG23 ' A' ' 59' ' ' VAL . 1.9 m-85 -123.67 136.5 54.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.305 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 129' ' ' ILE . 12.8 t70 -106.14 96.68 6.64 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.9 p90 -174.16 -159.68 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.55 ' CA ' ' CE2' ' A' ' 79' ' ' PHE . . . -166.26 -148.03 5.41 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.057 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 12' ' ' THR . 78.9 p -37.52 -91.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.655 -0.909 . . . . 0.0 113.098 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.45 49.51 0.94 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.679 -1.263 . . . . 0.0 111.473 -178.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.78 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.94 134.25 27.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 110.373 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 40' ' ' PRO . 32.9 mm -126.39 94.96 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.42 103.94 0.74 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 103.349 -3.901 . . . . 0.0 103.349 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.989 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.0 164.79 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.79 -174.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.806 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.68 129.97 50.62 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.609 HG11 ' HG ' ' A' ' 48' ' ' LEU . 10.9 t -102.48 125.89 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.729 ' HA3' HD12 ' A' ' 5' ' ' LEU . . . -120.59 146.49 17.64 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 118.251 -1.928 . . . . 0.0 112.31 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 21' ' ' GLN . 7.0 pt20 -95.86 121.44 37.59 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.43 ' CD ' ' OH ' ' A' ' 133' ' ' TYR . 0.9 OUTLIER -89.87 31.43 0.96 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.698 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.886 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.97 -32.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -115.92 -17.33 11.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.63 34.43 9.25 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.659 -1.258 . . . . 0.0 109.959 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 161.59 20.4 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.946 -1.326 . . . . 0.0 110.583 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . . . -134.59 135.04 41.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.925 -1.11 . . . . 0.0 112.422 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -98.91 153.72 37.69 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.4 Cg_endo -91.61 134.71 1.59 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.292 1.154 . . . . 0.0 112.094 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.989 HD22 HG13 ' A' ' 17' ' ' VAL . 1.6 tt -99.44 141.26 22.51 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.36 167.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.811 2.341 . . . . 0.0 116.223 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.56 144.84 56.92 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.053 1.406 . . . . 0.0 114.284 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.23 55.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 112.976 -1.92 . . . . 0.0 115.835 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 37.5 tptt -133.73 96.78 3.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.852 -1.155 . . . . 0.0 109.81 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.95 161.14 16.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 39' ' ' THR . 42.7 mt-30 -85.24 120.97 27.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.214 -0.929 . . . . 0.0 111.498 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.26 27.34 1.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.046 -1.034 . . . . 0.0 110.278 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.08 16.82 55.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.796 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.1 m -94.8 109.39 43.57 Favored Pre-proline 0 C--N 1.306 -1.284 0 O-C-N 121.082 -1.246 . . . . 0.0 109.789 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.717 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -68.88 155.92 67.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.572 1.301 . . . . 0.0 109.165 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 45' ' ' ILE . 3.2 m-20 -63.71 91.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.976 -1.077 . . . . 0.0 108.87 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 13.4 t90 -91.95 -21.6 20.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.74 -37.97 26.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.947 . . . . 0.0 109.889 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -73.12 -50.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.736 -0.602 . . . . 0.0 110.045 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 41' ' ' ASP . 20.6 mt -70.34 -49.32 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.952 -1.092 . . . . 0.0 111.025 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -54.06 -32.94 56.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.67 -1.269 . . . . 0.0 109.815 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -61.02 -47.21 87.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.309 -0.87 . . . . 0.0 109.37 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.945 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -82.52 -27.07 31.94 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 109.03 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.875 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -66.16 -54.64 22.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 111.221 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -74.84 -25.82 59.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.941 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -81.26 -38.3 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 0.0 110.771 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.518 ' HB2' HD22 ' A' ' 48' ' ' LEU . 33.9 m95 -109.71 -20.56 12.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.074 -1.016 . . . . 0.0 111.109 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER 56.52 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 46.8 Cg_endo -72.04 134.53 23.5 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.8 1.421 . . . . 0.0 111.117 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.92 -35.8 23.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 110.725 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.58 144.85 50.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 91' ' ' VAL . 5.0 mp -130.02 137.75 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.527 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.54 114.28 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.905 HG23 ' HB2' ' A' ' 8' ' ' PHE . 1.1 p -134.67 151.29 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.229 -1.544 . . . . 0.0 114.008 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 151.16 140.5 3.18 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.297 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.981 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.442 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 3.4 ttm180 -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -56.04 -32.14 63.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.666 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 7.6 m-30 -57.83 -47.72 81.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.026 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' HIS . . . -55.34 -34.69 64.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -80.29 -24.07 40.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 109.198 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 79' ' ' PHE . 2.1 mtt180 -77.3 -56.71 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 91' ' ' VAL . 16.2 pt -62.14 -38.88 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 109.412 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.462 ' N ' HG13 ' A' ' 83' ' ' ILE . 1.9 t60 -58.6 -42.14 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.496 -0.753 . . . . 0.0 109.901 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.72 -16.81 80.41 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -44.82 23.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -1.222 . . . . 0.0 110.433 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.6 -13.15 9.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.01 -1.057 . . . . 0.0 110.881 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 82.24 32.76 27.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.4 m -91.14 153.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.485 -1.009 . . . . 0.0 110.686 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 81.69 6.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.756 . . . . 0.0 110.531 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 57' ' ' ILE . 8.7 p -100.31 152.3 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 153.85 29.78 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.003 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -92.66 138.64 31.32 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.027 -1.046 . . . . 0.0 108.907 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 1.003 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t60 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.786 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.107 0 CA-C-O 121.052 0.453 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -48.57 -29.68 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 0.0 110.9 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.4 p -54.7 -33.39 60.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 111.526 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -77.71 -55.77 5.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.151 . . . . 0.0 109.266 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.806 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -53.47 -24.3 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -76.76 -46.01 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 9' ' ' ASP . 17.0 mt -53.73 -27.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.961 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -67.55 -39.81 84.98 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.894 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -34.18 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -32.35 67.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 t80 -75.11 -54.46 7.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.68 -0.638 . . . . 0.0 109.754 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.961 ' CE2' HD12 ' A' ' 130' ' ' LEU . 25.2 m-85 -52.18 -28.98 20.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.074 -1.016 . . . . 0.0 109.558 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.486 -0.759 . . . . 0.0 109.677 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.7 m -147.5 138.34 23.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.968 -1.313 . . . . 0.0 112.209 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.02 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.02 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HB2' HD12 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.688 0.756 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.4 28.75 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.03 126.7 41.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.124 -0.985 . . . . 0.0 111.155 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.1 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 138.01 58.19 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 123.004 1.383 . . . . 0.0 113.772 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.035 -1.893 . . . . 0.0 115.73 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.05 159.76 17.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.374 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.02 123.92 33.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -0.883 . . . . 0.0 110.821 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -0.93 . . . . 0.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.94 47.59 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.81 107.7 26.46 Favored Pre-proline 0 C--N 1.307 -1.275 0 O-C-N 121.06 -1.259 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.24 157.62 56.71 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.641 1.337 . . . . 0.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.79 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.55 -20.45 54.1 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.359 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -30.89 30.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.837 -0.539 . . . . 0.0 111.764 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.42 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.83 -51.63 8.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.907 -1.121 . . . . 0.0 112.281 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.775 -1.203 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.173 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.74 136.86 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.735 1.387 . . . . 0.0 111.422 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.79 -45.18 37.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 110.074 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 140.3 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.067 . . . . 0.0 109.606 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.7 137.89 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.002 . . . . 0.0 111.856 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.736 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.29 122.42 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -57.02 4.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.78 -25.75 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.068 . . . . 0.0 109.798 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.68 62.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.81 -16.26 75.62 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.7 m-85 -119.1 -11.92 9.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 110.322 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.97 31.62 42.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.17 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.682 -0.893 . . . . 0.0 110.773 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.29 125.83 40.19 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.887 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.208 0.528 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.764 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -21.62 64.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 109.281 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.0 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.96 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.6 m -142.63 134.84 27.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.965 -1.315 . . . . 0.0 112.505 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.073 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -126.31 140.6 52.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.942 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -135.03 134.32 40.3 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.481 -1.387 . . . . 0.0 110.772 179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -118.33 122.96 44.17 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.761 ' HE1' HG23 ' A' ' 57' ' ' ILE . 33.6 m-85 -109.04 131.95 54.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.52 -0.738 . . . . 0.0 111.764 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 18.1 t70 -113.34 93.2 4.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.0 p90 -177.65 -164.57 0.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.244 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.56 168.56 33.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 55.7 p -60.01 77.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.89 -1.359 . . . . 0.0 111.654 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 3.7 mttp 162.67 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.528 -0.733 . . . . 0.0 110.678 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -137.84 142.29 40.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -178.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 40' ' ' PRO . 36.5 mm -122.92 102.22 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.5 103.9 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 104.126 -3.59 . . . . 0.0 104.126 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.898 ' CG1' HD13 ' A' ' 30' ' ' LEU . 39.8 t -135.75 167.13 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 116.713 -1.995 . . . . 0.0 114.091 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.67 131.64 48.03 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.652 HG13 HD11 ' A' ' 6' ' ' LEU . 68.5 t -101.08 135.88 35.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.85 -1.156 . . . . 0.0 108.091 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -111.71 141.03 16.45 Favored Glycine 0 N--CA 1.484 1.85 0 C-N-CA 119.047 -1.549 . . . . 0.0 111.352 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -95.87 112.85 24.47 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -87.58 21.49 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.582 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.891 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.81 -32.66 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.753 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -117.73 -17.37 9.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.61 34.74 11.19 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.92 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 158.48 26.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.738 -1.448 . . . . 0.0 110.909 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.86 119.44 30.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.844 -1.16 . . . . 0.0 111.737 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' VAL . 31.8 ttm105 -86.98 154.54 55.24 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.0 Cg_endo -91.53 137.36 1.98 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.134 1.071 . . . . 0.0 112.151 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.898 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.2 tt -99.74 141.23 22.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 22.2 Cg_endo -43.25 169.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.839 2.359 . . . . 0.0 116.086 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ILE . . . -65.41 150.3 48.56 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 123.528 1.632 . . . . 0.0 115.069 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 14' ' ' SER 0.279 0.9 OUTLIER -51.22 -126.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.462 -2.153 . . . . 0.0 112.783 179.838 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.589 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.7 OUTLIER 34.87 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.211 -0.931 . . . . 0.0 112.468 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -88.9 160.48 17.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.932 -1.105 . . . . 0.0 109.752 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.09 115.21 26.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 111.419 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.3 25.79 0.95 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.849 . . . . 0.0 110.372 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.76 17.23 42.21 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.1 m -94.98 106.94 28.3 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 120.999 -1.295 . . . . 0.0 109.993 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.781 ' HB3' HD11 ' A' ' 15' ' ' ILE . 46.4 Cg_endo -72.22 162.53 41.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.575 1.303 . . . . 0.0 109.734 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.914 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -64.27 92.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.001 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.428 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 31.3 t90 -90.45 -17.23 27.53 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.457 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.8 m-20 -81.65 -35.4 29.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.811 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.0 mp -82.4 -48.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.854 -0.529 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 41' ' ' ASP . 18.5 mt -70.75 -33.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.155 -0.966 . . . . 0.0 111.16 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -76.8 -45.22 29.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.924 -1.11 . . . . 0.0 110.427 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CD ' ' O ' ' A' ' 43' ' ' ASN . 1.9 mtt180 -52.44 -41.46 63.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.943 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.28 -28.71 34.58 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.107 -0.996 . . . . 0.0 109.066 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.931 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.13 -49.78 76.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -1.0 . . . . 0.0 110.48 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -72.43 -32.35 66.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 111.053 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.85 -42.53 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.103 . . . . 0.0 111.221 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 49.0 m95 -111.01 -27.5 8.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.899 -1.125 . . . . 0.0 111.562 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.7 mt-30 59.48 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.022 -1.049 . . . . 0.0 109.487 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.482 ' HB3' HD13 ' A' ' 6' ' ' LEU . 46.8 Cg_endo -71.37 129.61 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.605 1.319 . . . . 0.0 111.44 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -80.34 -40.21 27.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 110.58 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -132.9 155.16 49.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 109.879 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.761 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.9 mp -133.15 137.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 112.695 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.64 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.916 HG11 ' CD1' ' A' ' 83' ' ' ILE . 74.0 t -131.82 150.73 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.975 -1.703 . . . . 0.0 113.065 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 170.14 121.13 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.245 -0.978 . . . . 0.0 110.833 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.799 0 O-C-N 120.891 -1.358 . . . . 0.0 109.535 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.373 0.606 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -48.44 81.77 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -25.24 62.8 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.995 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -63.13 -45.51 91.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -62.34 -29.44 70.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.463 -0.773 . . . . 0.0 109.104 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -67.15 -23.25 65.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -56.93 4.04 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 110.45 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.916 ' CD1' HG11 ' A' ' 59' ' ' VAL . 16.2 pt -56.16 -28.82 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.473 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.458 ' HB2' HG11 ' A' ' 91' ' ' VAL . 32.5 t-80 -70.2 -50.99 34.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.345 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.81 -15.55 79.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -74.66 -44.27 51.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.918 -1.342 . . . . 0.0 110.5 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -113.64 -11.09 13.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.394 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.62 48.22 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 89' ' ' VAL . 35.4 m -109.49 153.91 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.636 -0.92 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.55 88.5 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.676 . . . . 0.0 109.768 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.743 HG21 ' CD1' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -88.87 151.05 3.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.087 0.946 . . . . 0.0 111.48 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.36 39.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.892 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -101.58 127.4 48.31 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.024 -1.048 . . . . 0.0 109.342 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.838 ' N ' HD22 ' A' ' 93' ' ' LEU . 42.7 t-80 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.306 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.309 0.576 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.06 -40.07 32.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.5 m -52.91 -23.13 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.966 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -83.84 -55.3 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.065 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.677 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.14 -24.36 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -72.08 -45.53 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.673 HG22 ' HB ' ' A' ' 58' ' ' ILE . 68.0 mt -62.43 -41.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.557 HD22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -56.55 -48.1 78.04 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.195 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -21.59 40.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 0.0 109.965 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 p -70.31 -50.62 37.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.751 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.29 -40.99 78.93 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.139 -0.976 . . . . 0.0 110.111 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -53.45 -31.22 44.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.831 -1.168 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.491 -0.755 . . . . 0.0 109.946 179.531 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.985 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.8 m -150.37 135.1 17.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.34 . . . . 0.0 112.427 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.069 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -126.7 143.87 51.1 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.912 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -135.72 134.3 38.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.435 -1.416 . . . . 0.0 110.521 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -118.56 123.32 44.77 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HA ' HG22 ' A' ' 17' ' ' VAL . 29.0 m-85 -108.83 129.95 55.4 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.57 0.7 . . . . 0.0 111.789 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.8 t70 -112.65 91.99 3.85 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.895 ' CD2' HD13 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -173.89 -172.93 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.48 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.504 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -144.66 -177.18 19.3 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.618 HG23 ' HE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -71.47 63.36 0.39 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.117 -1.225 . . . . 0.0 111.598 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 12' ' ' THR . 4.4 ptmt 171.57 -27.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.233 -0.917 . . . . 0.0 110.61 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -125.44 143.44 50.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.0 108.756 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.895 HD13 ' CD2' ' A' ' 10' ' ' PHE . 33.5 mm -124.78 97.12 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.55 104.06 0.74 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 104.244 -3.543 . . . . 0.0 104.244 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.92 ' CG1' HD13 ' A' ' 30' ' ' LEU . 38.3 t -134.85 165.8 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 116.623 -2.031 . . . . 0.0 113.688 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.7 131.72 46.42 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.668 HG22 ' CD2' ' A' ' 6' ' ' LEU . 73.7 t -101.51 137.43 29.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 108.082 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.61 136.82 13.87 Favored Glycine 0 N--CA 1.485 1.928 0 O-C-N 120.507 -1.371 . . . . 0.0 110.589 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.64 117.41 30.41 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.161 -1.2 . . . . 0.0 108.04 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' CB ' ' A' ' 5' ' ' LEU . 2.5 mtm180 -90.08 24.51 2.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.343 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.878 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -32.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.407 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.43 -16.82 10.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.486 -0.759 . . . . 0.0 109.99 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 33.54 22.31 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.09 161.55 21.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.982 -1.305 . . . . 0.0 110.807 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.04 122.5 39.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.868 -1.145 . . . . 0.0 112.068 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' VAL . 11.6 ttm180 -87.3 153.11 53.53 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.3 Cg_endo -91.43 139.37 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.132 1.069 . . . . 0.0 112.364 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.92 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.82 142.47 24.68 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.29 167.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.846 2.364 . . . . 0.0 115.993 -174.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.89 143.49 57.91 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 123.234 1.492 . . . . 0.0 114.834 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.7 50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 112.916 -1.947 . . . . 0.0 115.623 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.6 mmtt -131.63 97.43 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.864 -1.147 . . . . 0.0 109.654 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.61 161.09 16.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 110.251 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -85.71 120.57 27.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.876 . . . . 0.0 111.218 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 48.72 25.46 1.01 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -0.979 . . . . 0.0 110.495 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.7 17.28 42.19 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.821 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 21.4 m -98.72 115.72 65.66 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 121.141 -1.211 . . . . 0.0 110.03 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.861 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -69.79 157.7 59.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.433 1.228 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -64.54 91.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.942 -1.099 . . . . 0.0 109.177 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 26.9 t90 -90.94 -16.9 27.29 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -80.38 -34.53 36.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.432 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 mp -81.99 -55.13 8.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.699 -0.625 . . . . 0.0 109.768 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 32.1 mt -59.62 -37.81 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 2.1 tm-20 -72.9 -31.18 64.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.944 -1.097 . . . . 0.0 109.962 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -64.92 -50.66 65.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.952 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.69 -25.02 60.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 109.959 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.944 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.46 -53.75 50.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.104 . . . . 0.0 110.504 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.44 -23.52 63.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.44 -41.22 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 111.346 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CE3' HD23 ' A' ' 48' ' ' LEU . 48.9 m0 -109.08 -17.54 13.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.836 -1.165 . . . . 0.0 111.359 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' LEU . 5.7 mt-30 54.08 97.24 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.15 -0.969 . . . . 0.0 109.835 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.3 Cg_endo -71.56 125.41 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.664 1.349 . . . . 0.0 110.971 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -73.52 -41.91 62.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -138.24 157.87 45.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.031 -1.043 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.724 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.7 mp -132.68 137.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 112.244 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.069 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.86 122.13 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.904 HG21 HD12 ' A' ' 83' ' ' ILE . 76.7 t -133.94 150.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 120.147 -1.596 . . . . 0.0 113.088 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.66 118.22 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.608 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.8 pp . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.519 0.676 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU . 8.7 mtt180 -68.13 -48.19 66.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.364 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -25.41 65.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.0 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.618 ' HE1' HG23 ' A' ' 12' ' ' THR . 37.3 t80 -59.33 -47.25 86.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -57.87 -31.81 67.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.09 -27.62 67.16 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.539 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -75.88 -57.89 3.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.904 HD12 HG21 ' A' ' 59' ' ' VAL . 20.7 pt -57.4 -32.13 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.176 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 88' ' ' GLY . 24.9 t-80 -65.8 -51.56 58.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.245 -0.91 . . . . 0.0 110.144 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.56 -15.63 73.3 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -71.49 -44.55 64.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.31 . . . . 0.0 110.511 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.691 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -119.17 -10.73 9.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.479 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 74.58 38.82 42.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.8 m -99.24 153.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.593 -0.946 . . . . 0.0 110.785 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -74.86 85.66 2.22 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.636 -0.665 . . . . 0.0 109.681 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.2 p -88.34 151.54 3.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -120.83 158.66 27.11 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 77' ' ' ARG . 8.8 mt -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.2 t60 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.398 -179.903 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.249 0.547 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.602 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -66.87 -38.88 87.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 110.303 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 28.8 t -53.51 -32.7 51.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.389 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -69.73 -55.73 9.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.652 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.56 -23.87 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.1 mp -73.3 -44.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 9' ' ' ASP . 71.9 mt -60.79 -36.54 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 5' ' ' LEU 0.256 0.4 OUTLIER -64.91 -54.3 32.97 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.414 178.485 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -56.21 -21.78 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 110.039 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -33.08 26.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.635 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -59.04 -38.95 80.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 76.1 m-85 -55.0 -40.45 70.14 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.245 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' ASP . 38.9 m -150.35 141.32 22.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.886 -1.361 . . . . 0.0 112.31 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.83 163.36 25.39 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.437 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.118 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.92 145.22 31.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.192 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.73 124.37 21.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.109 -0.994 . . . . 0.0 108.727 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.777 ' HB2' HG23 ' A' ' 59' ' ' VAL . 73.7 m-85 -120.66 142.5 49.4 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.71 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t0 -106.54 91.35 3.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.669 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -97.34 134.96 39.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.1 160.84 28.56 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 p -47.69 112.24 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.058 -1.26 . . . . 0.0 110.514 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 mtmt 55.29 46.48 23.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.285 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.754 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.48 120.94 14.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.707 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -116.66 93.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 CA-C-O 122.467 1.127 . . . . 0.0 113.924 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.23 104.89 0.84 Allowed Glycine 0 C--N 1.287 -2.169 0 N-CA-C 103.626 -3.79 . . . . 0.0 103.626 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.91 ' CG1' HD13 ' A' ' 30' ' ' LEU . 81.5 t -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 116.49 -2.084 . . . . 0.0 112.819 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.782 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -134.35 138.36 44.85 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 48' ' ' LEU . 33.6 t -100.91 130.45 50.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.584 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.76 136.71 13.69 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.856 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 117.68 34.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.641 ' HB2' HD12 ' A' ' 5' ' ' LEU . 3.2 tpt180 -91.83 35.11 0.97 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.79 0.805 . . . . 0.0 109.967 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.745 ' C ' HD12 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -113.66 -35.07 2.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -118.81 -17.19 9.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.716 . . . . 0.0 109.976 178.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 34.08 7.53 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.13 161.41 21.05 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.996 -1.296 . . . . 0.0 111.221 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -138.45 127.3 23.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 111.161 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 8.0 mmm180 -88.04 154.65 52.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.412 -0.805 . . . . 0.0 109.041 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.26 136.75 2.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.471 1.248 . . . . 0.0 111.356 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.91 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -99.17 144.61 28.55 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' CD ' HD23 ' A' ' 30' ' ' LEU . 17.9 Cg_endo -39.67 165.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.772 2.315 . . . . 0.0 115.756 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.86 142.07 58.56 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.157 1.456 . . . . 0.0 114.355 -175.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.754 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -55.53 51.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.449 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.0 tptm -133.34 98.62 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.75 -1.219 . . . . 0.0 108.96 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.851 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.15 161.6 16.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 110.819 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.77 119.43 24.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.832 . . . . 0.0 111.08 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.18 25.71 1.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 13' ' ' LYS . . . 93.62 14.59 52.69 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.851 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 11.7 m -91.25 111.12 47.05 Favored Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 120.944 -1.327 . . . . 0.0 109.776 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.679 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.4 Cg_endo -70.37 155.87 62.97 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.639 1.336 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.979 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -63.76 91.67 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.897 -1.127 . . . . 0.0 108.579 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.1 t90 -92.41 -22.49 19.62 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.88 -39.28 21.76 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.096 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -70.56 -55.0 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.979 HD12 ' O ' ' A' ' 41' ' ' ASP . 5.9 mt -68.31 -43.02 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.691 -1.256 . . . . 0.0 110.591 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 1.3 tm-20 -54.63 -30.79 55.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.717 -1.239 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.8 mtp180 -66.57 -44.01 83.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.345 -0.847 . . . . 0.0 109.362 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.118 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.63 -27.14 31.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.303 -0.873 . . . . 0.0 109.285 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.74 -53.37 33.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.972 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -80.01 -26.99 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.154 -0.966 . . . . 0.0 111.345 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 25.8 tt0 -79.1 -41.16 29.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.964 -1.085 . . . . 0.0 110.978 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 48' ' ' LEU . 73.4 m95 -103.58 -14.69 16.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.059 -1.026 . . . . 0.0 111.112 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 4' ' ' THR . 2.9 mt-30 51.96 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.951 -1.093 . . . . 0.0 110.112 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.5 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.739 1.389 . . . . 0.0 111.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 4' ' ' THR . 2.3 m-20 -76.77 -43.52 36.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.31 136.82 47.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.661 ' C ' HD13 ' A' ' 58' ' ' ILE . 2.7 mp -129.98 137.43 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.052 -1.03 . . . . 0.0 111.869 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.704 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.21 126.0 74.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' A' ' 8' ' ' PHE . 10.0 p -132.91 150.12 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.579 -1.325 . . . . 0.0 112.289 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.02 3.03 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.909 -1.139 . . . . 0.0 110.377 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 76' ' ' ALA . 1.6 pt? . . . . . 0 N--CA 1.494 1.754 0 O-C-N 121.102 -1.234 . . . . 0.0 110.111 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.55 ' CB ' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -56.42 -48.94 75.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -24.66 64.92 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.147 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 10' ' ' PHE . 5.7 t80 -61.03 -49.73 76.21 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB2' HG13 ' A' ' 59' ' ' VAL . . . -57.29 -33.05 67.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.463 -0.773 . . . . 0.0 109.146 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.47 -23.45 63.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 110.12 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -70.51 -51.6 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.06 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -68.06 -23.75 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.708 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.848 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.5 t-80 -59.07 -57.8 11.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -0.814 . . . . 0.0 110.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.82 -15.63 80.76 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.42 -44.33 91.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.288 . . . . 0.0 110.198 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.693 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -116.13 -14.01 11.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.71 31.06 30.76 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.2 m -95.52 153.2 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -1.039 . . . . 0.0 110.617 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.13 72.66 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 110.255 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -89.51 152.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.999 0.904 . . . . 0.0 111.12 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 162.27 27.82 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.89 143.24 45.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.753 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.485 ' CE1' HG23 ' A' ' 129' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.463 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.259 0.552 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.628 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -78.97 -31.1 44.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.7 p -54.23 -30.85 51.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.333 -0.854 . . . . 0.0 111.482 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.608 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.03 -56.22 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 109.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.782 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -55.87 -24.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 124' ' ' ALA . 4.5 mm -71.13 -44.67 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 126' ' ' ALA . 36.3 mt -61.41 -42.0 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.0 OUTLIER -57.7 -58.06 10.01 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.739 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.0 -21.76 65.12 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 108.994 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -58.03 -40.86 81.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.548 -0.72 . . . . 0.0 110.985 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 1.051 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.5 p90 -81.64 -32.64 31.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.317 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.5 m-85 -52.62 -31.8 38.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.985 . . . . 0.0 110.121 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.5 m -147.49 138.32 23.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.326 . . . . 0.0 112.243 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HB2' HD12 ' A' ' 5' ' ' LEU . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.695 0.759 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.38 28.79 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.02 126.73 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.146 -0.971 . . . . 0.0 111.143 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.2 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.4 138.01 58.19 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 123.025 1.393 . . . . 0.0 113.715 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.73 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.03 159.75 17.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.97 . . . . 0.0 110.43 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.08 123.96 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.803 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.96 47.51 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.87 107.71 26.6 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.099 -1.236 . . . . 0.0 110.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.23 157.62 56.75 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.572 1.301 . . . . 0.0 109.082 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.77 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.52 -20.46 54.18 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.371 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -30.94 30.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.67 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.83 -0.543 . . . . 0.0 111.764 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.41 64.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.81 -51.65 8.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 112.302 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.755 -1.216 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.822 -1.174 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.71 136.86 23.94 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.72 1.379 . . . . 0.0 111.439 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.82 -45.1 37.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.403 -0.811 . . . . 0.0 110.103 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 140.35 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.068 . . . . 0.0 109.591 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.74 137.83 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 111.856 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.21 122.46 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -56.99 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.84 -25.71 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.974 -1.079 . . . . 0.0 109.792 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.71 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.75 -16.29 75.69 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.8 m-85 -119.08 -11.97 9.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.94 31.66 42.79 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.19 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.905 . . . . 0.0 110.773 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.3 125.86 40.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.861 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 110.445 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.208 0.528 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.765 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -21.63 64.49 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.318 0.58 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.431 ' CB ' ' HG ' ' A' ' 93' ' ' LEU . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.171 0.51 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.005 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.331 0.586 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.333 0.587 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.969 -1.312 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.58 127.81 34.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.991 -1.3 . . . . 0.0 112.151 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.83 29.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.748 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.56 32.8 0.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.744 0.783 . . . . 0.0 110.038 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.6 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.6 70.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.65 -53.05 8.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.897 -1.127 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.47 137.6 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.999 -1.063 . . . . 0.0 112.088 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.061 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -22.71 67.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.021 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.428 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.34 16.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.32 40.0 41.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.65 154.12 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.565 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 84.71 7.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.495 -0.753 . . . . 0.0 110.246 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.279 0.561 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.005 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.331 0.586 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.333 0.587 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.444 0.64 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.297 0.57 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.337 0.589 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HD2' ' OH ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.36 0.6 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.005 -1.291 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.6 127.83 34.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.3 . . . . 0.0 112.196 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.87 29.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.747 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.61 32.78 0.94 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.7 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.58 70.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.69 -53.06 8.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.858 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.89 -1.131 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.51 137.64 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.999 -1.063 . . . . 0.0 112.044 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.085 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -22.79 67.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 108.996 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 110.428 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.36 16.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 40.03 41.61 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.66 154.09 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.594 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.81 84.71 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.279 0.561 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 23' ' ' ILE . . . . . . . . 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp . . . . . 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.444 0.64 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.297 0.57 . . . . 0.0 110.336 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.337 0.589 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' HD2' ' OH ' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' PHE . . . . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.36 0.6 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.287 0.565 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.297 0.57 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.12 113.9 4.26 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.595 -1.532 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.25 -179.88 30.73 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.28 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.85 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.91 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.938 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.588 HE21 HG12 ' A' ' 19' ' ' VAL . 69.8 mm-40 -113.82 112.27 23.12 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.424 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.53 48.36 1.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.411 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.886 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.94 5.68 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.09 162.24 16.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -0.802 . . . . 0.0 109.861 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.77 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.68 25.77 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.371 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.8 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.63 61.08 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.106 -1.232 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.69 155.9 58.09 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.642 1.338 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -65.97 91.72 0.15 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.719 -1.238 . . . . 0.0 109.117 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.5 -17.85 35.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -32.66 33.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.86 29.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.335 0.588 . . . . 0.0 110.291 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.1 mt -70.11 -47.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 110.416 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.79 25.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.8 -5.41 15.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.693 -1.254 . . . . 0.0 111.94 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.58 109.91 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.352 -0.843 . . . . 0.0 109.446 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.06 111.52 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.208 1.11 . . . . 0.0 111.522 -177.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.479 0.657 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -62.89 -48.66 78.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.04 -25.14 64.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.807 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.06 73.36 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -22.52 62.03 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.518 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -69.91 -57.19 5.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.773 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.71 -28.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.959 -1.088 . . . . 0.0 110.218 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.05 -58.56 4.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.22 -15.85 61.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.26 4.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.68 152.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.175 0.988 . . . . 0.0 112.071 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.34 46.8 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.18 128.38 41.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.02 -1.05 . . . . 0.0 108.855 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 0.0 110.843 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.254 0.55 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.568 -0.707 . . . . 0.0 111.231 -179.847 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.42 56.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.93 134.69 54.72 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.373 -0.829 . . . . 0.0 111.894 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.0 t70 -113.99 92.66 4.05 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.438 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.4 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.94 23.74 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.61 164.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.679 2.253 . . . . 0.0 115.414 -174.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.7 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.877 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.71 28.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.98 30.52 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.55 17.46 66.16 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.877 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -86.91 108.87 20.4 Favored Pre-proline 0 C--N 1.307 -1.256 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.505 1.266 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.4 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.38 -36.5 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.805 178.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.48 -52.74 15.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 109.729 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.84 -43.83 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.995 -1.066 . . . . 0.0 110.488 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.0 tt0 -53.07 -42.8 66.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.953 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.89 -38.27 72.57 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.553 178.983 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.08 133.26 28.32 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.067 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.58 -34.17 60.64 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.664 -0.648 . . . . 0.0 109.848 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.31 157.58 45.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.018 -1.051 . . . . 0.0 110.668 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 8.0 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.04 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp . . . . . 0 N--CA 1.494 1.749 0 O-C-N 120.934 -1.333 . . . . 0.0 109.778 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.378 0.609 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.31 -48.4 81.52 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.475 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -26.27 65.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.805 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.12 94.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.35 -16.53 71.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.64 153.84 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.512 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.39 78.91 8.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.747 . . . . 0.0 110.794 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.115 0.483 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.59 -38.69 72.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.617 -179.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.71 -33.55 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 109.001 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ASP . 92.0 m -150.82 140.47 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -1.226 . . . . 0.0 112.702 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.127 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.4 136.77 52.31 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.449 -0.782 . . . . 0.0 108.951 178.239 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.02 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.22 144.26 47.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.961 -1.087 . . . . 0.0 108.883 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.579 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . . . -145.32 124.33 12.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 59' ' ' VAL . 3.1 m-85 -117.95 149.95 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.841 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.843 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.3 t0 -121.16 93.8 4.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.1 p90 -174.26 -155.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.113 -1.435 . . . . 0.0 113.705 -177.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . 159.04 159.12 9.47 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p 45.68 -143.78 0.23 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.055 . . . . 0.0 111.394 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 18.9 mttt -81.96 51.99 1.86 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.04 -1.038 . . . . 0.0 111.389 -178.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -142.02 131.49 23.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.682 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.96 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.8 mm -124.62 96.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.16 103.66 0.77 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 103.393 -3.883 . . . . 0.0 103.393 176.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.967 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.48 170.44 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 C-N-CA 116.144 -2.223 . . . . 0.0 114.406 -174.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.71 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.66 136.89 52.23 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.306 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 48' ' ' LEU . 13.9 t -106.76 125.04 62.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.83 135.73 13.08 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 118.714 -1.708 . . . . 0.0 111.277 -177.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -96.74 120.57 37.3 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HG2' ' OH ' ' A' ' 133' ' ' TYR . 11.3 mtp180 -91.09 36.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.454 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.89 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 178.171 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.52 -16.52 10.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 178.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.61 35.83 7.68 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.089 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.75 161.21 20.5 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.855 -1.379 . . . . 0.0 111.064 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -124.88 123.29 39.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.046 -1.034 . . . . 0.0 112.375 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 29' ' ' PRO . 24.6 ttt-85 -88.19 146.12 37.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 50.5 Cg_endo -90.74 141.1 3.09 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 O-C-N 122.792 0.891 . . . . 0.0 112.89 -176.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -99.55 139.65 21.04 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.031 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 21.7 Cg_endo -42.65 169.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.013 2.475 . . . . 0.0 115.965 -174.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.62 143.79 57.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.827 -176.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.87 53.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.495 -1.684 . . . . 0.0 115.53 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.98 96.24 3.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.829 -1.17 . . . . 0.0 109.273 176.133 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.85 160.86 16.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.577 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -83.81 116.64 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.083 -1.011 . . . . 0.0 111.336 -178.609 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 48.2 27.75 1.37 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 94.81 12.33 55.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 20.5 m -95.47 110.52 51.28 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.022 -1.281 . . . . 0.0 109.631 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HB3' HD11 ' A' ' 15' ' ' ILE . 45.9 Cg_endo -73.53 159.18 46.69 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.472 1.248 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.2 m-20 -63.39 91.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.923 -1.111 . . . . 0.0 108.118 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.45 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 11.4 t-105 -87.69 -16.8 33.31 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.224 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -80.02 -35.07 37.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -74.49 -50.05 28.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.725 -0.61 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 41' ' ' ASP . 12.1 mt -71.23 -43.58 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.907 -1.121 . . . . 0.0 110.466 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 33.8 tp10 -49.2 -43.0 42.0 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.166 -0.959 . . . . 0.0 109.26 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -57.57 -48.22 79.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 6' ' ' LEU . 2.6 mt -59.61 -24.95 64.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.856 178.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -84.1 -46.8 11.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.621 -0.674 . . . . 0.0 112.136 -178.408 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -50.72 9.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 112.286 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -84.22 -30.63 25.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.046 . . . . 0.0 112.162 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 57.9 m95 -109.12 -30.74 7.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 0.0 111.74 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 54.2 97.07 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.083 -1.011 . . . . 0.0 109.477 -178.589 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -68.6 124.2 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.446 1.235 . . . . 0.0 110.614 -179.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' THR . 3.9 t0 -71.31 -39.0 71.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.53 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HB3' HD23 ' A' ' 5' ' ' LEU . 12.9 tt0 -135.28 154.37 51.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.2 mp -133.94 136.83 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.799 -1.188 . . . . 0.0 112.682 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.127 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.2 113.92 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.073 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 8' ' ' PHE . 2.3 t -134.08 151.58 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.173 -1.579 . . . . 0.0 112.993 -177.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.44 141.32 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.661 177.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.328 0.585 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.543 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.0 mpt_? -62.77 -45.93 90.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.189 -0.944 . . . . 0.0 109.784 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -56.97 -30.99 64.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.169 -0.957 . . . . 0.0 109.401 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 74.4 t80 -61.6 -38.61 88.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.931 178.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -56.72 -33.28 66.34 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -68.89 -22.87 64.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.905 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.67 6.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 91' ' ' VAL . 34.7 pt -59.69 -30.12 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.853 -1.154 . . . . 0.0 109.151 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.441 ' HB2' HG11 ' A' ' 91' ' ' VAL . 5.9 t-160 -64.37 -58.32 6.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 109.754 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.43 -16.19 42.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -71.78 -44.82 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -1.225 . . . . 0.0 110.669 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -119.35 -10.62 9.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 110.842 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 42.56 16.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.7 m -104.53 153.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -1.047 . . . . 0.0 110.715 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.07 83.89 2.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 0.0 111.225 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 83' ' ' ILE . 2.8 p -90.76 151.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -121.28 155.29 35.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.92 -0.488 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 77' ' ' ARG . 21.2 mt -92.28 142.68 27.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.041 -1.037 . . . . 0.0 110.621 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.517 ' CG ' HG12 ' A' ' 129' ' ' ILE . 16.4 t-160 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.14 0.495 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.49 60.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.222 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 129' ' ' ILE . 1.5 m -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.807 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.62 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.41 -50.68 8.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.878 -1.139 . . . . 0.0 109.222 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.71 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -60.41 -23.15 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.332 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 128' ' ' ILE . 12.4 mm -70.13 -41.64 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 174.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.843 HD12 ' HB2' ' A' ' 9' ' ' ASP . 38.3 mt -63.92 -35.16 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 176.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.686 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -67.08 -34.61 78.03 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -20.33 64.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.852 -1.155 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -48.56 26.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -58.15 -40.41 81.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.889 -1.132 . . . . 0.0 109.642 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.61 -45.64 66.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.071 -1.018 . . . . 0.0 109.616 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.98 179.37 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.11 113.87 4.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.554 -1.557 . . . . 0.0 111.027 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.27 -179.86 30.74 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.27 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.825 -179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.88 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.115 -0.99 . . . . 0.0 110.938 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.742 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.588 HE21 HG12 ' A' ' 19' ' ' VAL . 69.8 mm-40 -113.83 112.33 23.2 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.39 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.56 48.36 1.53 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.411 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.885 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.89 5.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.02 162.24 16.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 109.898 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.71 20.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.156 -0.965 . . . . 0.0 111.154 -178.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.75 25.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.798 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.64 61.05 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.077 -1.249 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.7 155.94 57.99 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.586 1.308 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -66.04 91.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.734 -1.229 . . . . 0.0 109.098 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.47 -17.92 35.1 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.22 -32.66 33.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.95 28.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.317 0.58 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.0 mt -70.04 -47.63 67.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.477 -0.765 . . . . 0.0 110.453 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.82 25.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.77 -5.37 15.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.702 -1.249 . . . . 0.0 111.95 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.59 109.94 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.09 111.52 3.09 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.276 1.145 . . . . 0.0 111.522 -177.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.479 0.657 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -62.89 -48.69 77.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.0 -25.17 64.37 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 108.815 178.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.07 73.38 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -22.46 62.01 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.56 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -69.91 -57.21 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.68 -28.83 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.934 -1.104 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.06 -58.57 4.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.123 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.2 -15.85 61.51 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.478 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.27 4.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.75 152.52 3.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 122.202 1.001 . . . . 0.0 112.018 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.35 46.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.13 128.37 41.91 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.999 -1.063 . . . . 0.0 108.854 -179.798 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 110.843 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.254 0.55 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.262 -179.853 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.47 56.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.99 134.63 54.76 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.357 -0.84 . . . . 0.0 111.863 -178.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.1 t70 -113.92 92.65 4.05 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.5 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.89 23.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.51 164.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.668 2.245 . . . . 0.0 115.462 -174.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.72 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.72 28.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.97 30.51 4.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 110.147 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.56 17.42 66.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.876 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 40.2 m -86.83 108.83 20.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.145 -1.209 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.502 1.264 . . . . 0.0 109.475 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.5 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.4 -36.44 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.834 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.52 -52.74 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.809 -0.557 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.89 -43.77 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.995 -1.066 . . . . 0.0 110.518 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 4.9 tt0 -53.07 -42.84 66.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.918 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.86 -38.27 72.48 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.553 179.007 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.057 -1.027 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.06 133.25 28.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.083 -178.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.59 -34.17 60.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.724 -0.61 . . . . 0.0 109.848 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.3 157.57 45.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.018 -1.051 . . . . 0.0 110.623 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.9 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.06 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp . . . . . 0 N--CA 1.494 1.77 0 O-C-N 120.969 -1.313 . . . . 0.0 109.779 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.378 0.609 . . . . 0.0 109.494 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.37 -48.36 81.61 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.469 179.671 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -26.23 65.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.765 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.15 94.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.3 -16.51 71.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.62 153.85 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.533 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 78.91 8.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.714 . . . . 0.0 110.794 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.115 0.483 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.56 -38.72 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.629 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.69 -33.55 64.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.001 179.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -152.21 138.71 18.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -163.72 81.31 0.12 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp -104.61 107.69 58.75 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -88.43 113.41 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 109.488 -1.004 . . . . 0.0 109.488 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -131.99 131.51 42.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.956 -1.09 . . . . 0.0 110.63 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.99 123.97 29.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.691 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 tpt -84.53 -44.28 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.891 -1.131 . . . . 0.0 109.668 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.42 -2.27 20.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 110.477 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 -25.73 19.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.89 -160.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -1.023 . . . . 0.0 109.742 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.13 163.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.151 -0.968 . . . . 0.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.05 107.37 4.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.94 -6.58 19.4 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.596 1.314 . . . . 0.0 110.754 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -25.08 64.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 0.0 110.572 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.93 -19.06 5.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.301 -0.875 . . . . 0.0 111.412 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . . . -47.31 -35.39 7.89 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -74.67 -27.87 60.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.392 -0.818 . . . . 0.0 109.119 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.79 -50.85 61.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.426 -0.796 . . . . 0.0 109.949 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 74' ' ' ALA . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 -83.34 120.72 26.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.95 143.24 28.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.29 -0.881 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -74.17 82.93 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.013 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -19.42 39.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.755 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -25.33 64.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.205 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -115.61 88.23 2.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.918 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 m -138.04 -52.14 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.648 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.48 152.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.59 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.63 -45.49 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.805 . . . . 0.0 110.051 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 170.62 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.142 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -117.61 64.5 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 15.43 25.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.96 -76.36 0.67 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 93.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -44.98 5.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -75.39 96.38 3.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -55.98 -28.19 56.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.026 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -98.09 115.15 5.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.98 160.73 10.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 66.8 t80 53.71 35.67 21.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 0.0 110.013 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -61.64 165.43 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.258 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.39 110.6 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 116' ' ' LEU . 2.8 mm? -53.09 107.24 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -170.36 125.65 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -25.89 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.93 77.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -101.19 146.38 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -1.133 . . . . 0.0 110.066 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.16 24.9 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.405 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -87.75 58.24 4.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.995 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m 55.04 29.33 12.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 110.481 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.26 -27.46 42.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 -18.91 43.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.915 . . . . 0.0 110.109 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.51 51.64 56.62 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.155 -1.203 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 ttp . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.26 0.552 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.448 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 1.8 m 58.28 109.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.287 -0.883 . . . . 0.0 110.622 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.41 -92.06 0.09 OUTLIER Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.284 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 68.6 m -143.29 147.03 34.12 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.079 -1.247 . . . . 0.0 111.699 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.94 HD22 ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -126.79 142.08 51.65 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.128 179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.945 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -130.09 144.82 51.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.643 ' HB2' HG12 ' A' ' 58' ' ' ILE . . . -153.8 126.01 7.93 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.889 -1.132 . . . . 0.0 110.319 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.905 ' HB2' HG23 ' A' ' 59' ' ' VAL . 1.9 m-85 -123.67 136.5 54.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.305 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.555 ' HB2' HD12 ' A' ' 129' ' ' ILE . 12.8 t70 -106.14 96.68 6.64 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.629 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.9 p90 -174.16 -159.68 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 118.389 -1.324 . . . . 0.0 113.483 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.55 ' CA ' ' CE2' ' A' ' 79' ' ' PHE . . . -166.26 -148.03 5.41 Favored Glycine 0 N--CA 1.49 2.263 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.057 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 12' ' ' THR . 78.9 p -37.52 -91.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.655 -0.909 . . . . 0.0 113.098 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -99.45 49.51 0.94 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.679 -1.263 . . . . 0.0 111.473 -178.203 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.78 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.94 134.25 27.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 110.373 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.717 HD11 ' CB ' ' A' ' 40' ' ' PRO . 32.9 mm -126.39 94.96 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.42 103.94 0.74 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 103.349 -3.901 . . . . 0.0 103.349 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.989 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.0 164.79 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 C-N-CA 116.563 -2.055 . . . . 0.0 113.79 -174.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.806 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.68 129.97 50.62 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.609 HG11 ' HG ' ' A' ' 48' ' ' LEU . 10.9 t -102.48 125.89 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.729 ' HA3' HD12 ' A' ' 5' ' ' LEU . . . -120.59 146.49 17.64 Favored Glycine 0 N--CA 1.485 1.944 0 C-N-CA 118.251 -1.928 . . . . 0.0 112.31 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.412 ' O ' ' CG ' ' A' ' 21' ' ' GLN . 7.0 pt20 -95.86 121.44 37.59 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -89.87 31.43 0.96 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.698 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.886 HD13 ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.97 -32.62 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.2 m -115.92 -17.33 11.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.196 -0.94 . . . . 0.0 109.805 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.63 34.43 9.25 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.659 -1.258 . . . . 0.0 109.959 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.61 161.59 20.4 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.946 -1.326 . . . . 0.0 110.583 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . . . -134.59 135.04 41.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.925 -1.11 . . . . 0.0 112.422 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -98.91 153.72 37.69 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.4 Cg_endo -91.61 134.71 1.59 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.292 1.154 . . . . 0.0 112.094 -178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.989 HD22 HG13 ' A' ' 17' ' ' VAL . 1.6 tt -99.44 141.26 22.51 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.36 167.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.811 2.341 . . . . 0.0 116.223 -174.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.56 144.84 56.92 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 123.053 1.406 . . . . 0.0 114.284 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.23 55.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 112.976 -1.92 . . . . 0.0 115.835 -179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 37.5 tptt -133.73 96.78 3.75 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.852 -1.155 . . . . 0.0 109.81 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.95 161.14 16.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.297 -0.877 . . . . 0.0 110.044 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 39' ' ' THR . 42.7 mt-30 -85.24 120.97 27.32 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.214 -0.929 . . . . 0.0 111.498 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.26 27.34 1.83 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.046 -1.034 . . . . 0.0 110.278 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.08 16.82 55.29 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.796 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.1 m -94.8 109.39 43.57 Favored Pre-proline 0 C--N 1.306 -1.284 0 O-C-N 121.082 -1.246 . . . . 0.0 109.789 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.717 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -68.88 155.92 67.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.572 1.301 . . . . 0.0 109.165 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 45' ' ' ILE . 3.2 m-20 -63.71 91.02 0.06 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.976 -1.077 . . . . 0.0 108.87 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.445 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 13.4 t90 -91.95 -21.6 20.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -81.74 -37.97 26.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.186 -0.947 . . . . 0.0 109.889 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 44' ' ' ILE . 1.4 mp -73.12 -50.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.736 -0.602 . . . . 0.0 110.045 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 41' ' ' ASP . 20.6 mt -70.34 -49.32 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 120.952 -1.092 . . . . 0.0 111.025 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.7 OUTLIER -54.06 -32.94 56.09 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.67 -1.269 . . . . 0.0 109.815 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -61.02 -47.21 87.5 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.309 -0.87 . . . . 0.0 109.37 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.945 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.52 -27.07 31.94 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.258 -0.901 . . . . 0.0 109.03 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.875 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -66.16 -54.64 22.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.735 -1.228 . . . . 0.0 111.221 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -74.84 -25.82 59.27 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.041 -1.037 . . . . 0.0 110.941 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -81.26 -38.3 27.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.025 -1.047 . . . . 0.0 110.771 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.518 ' HB2' HD22 ' A' ' 48' ' ' LEU . 33.9 m95 -109.71 -20.56 12.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.074 -1.016 . . . . 0.0 111.109 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER 56.52 100.67 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 46.8 Cg_endo -72.04 134.53 23.5 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 O-C-N 123.8 1.421 . . . . 0.0 111.117 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.92 -35.8 23.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.517 -0.739 . . . . 0.0 110.725 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.58 144.85 50.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.146 . . . . 0.0 109.691 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.891 HG22 HG23 ' A' ' 91' ' ' VAL . 5.0 mp -130.02 137.75 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 118.838 -1.145 . . . . 0.0 112.527 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.72 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.54 114.28 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.905 HG23 ' HB2' ' A' ' 8' ' ' PHE . 1.1 p -134.67 151.29 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.229 -1.544 . . . . 0.0 114.008 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 151.16 140.5 3.18 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 119.812 -1.185 . . . . 0.0 111.297 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.049 HD21 HD23 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -103.47 127.21 30.09 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.817 ' N ' HD22 ' A' ' 61' ' ' LEU . 53.5 Cg_endo -90.82 115.63 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.15 1.079 . . . . 0.0 110.695 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.049 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -130.98 132.7 45.2 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.924 -1.11 . . . . 0.0 110.863 179.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -81.86 129.53 34.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.192 -0.942 . . . . 0.0 110.228 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 51.4 tpp -83.7 -45.75 13.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.982 -1.074 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.81 -11.24 15.42 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.202 -0.936 . . . . 0.0 110.451 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.88 -49.18 0.81 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 t -111.45 -176.61 2.99 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.476 -1.014 . . . . 0.0 109.506 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' OE1' ' NH2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 48.91 -155.84 0.08 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.304 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' NE2' ' HB3' ' A' ' 96' ' ' GLU . 0.1 OUTLIER -176.98 77.02 0.25 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 0.0 110.548 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.22 -10.15 25.37 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.865 1.455 . . . . 0.0 110.404 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.663 HD22 ' HB3' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -81.17 -23.85 37.95 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.177 -0.952 . . . . 0.0 110.354 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.56 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -53.93 -21.13 7.23 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.143 -0.973 . . . . 0.0 111.334 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.05 -40.29 30.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.873 -1.142 . . . . 0.0 108.548 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -32.71 71.31 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 79' ' ' PHE . . . -58.47 -37.39 75.4 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.233 -0.917 . . . . 0.0 108.538 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.442 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 3.4 ttm180 -58.46 -41.59 85.54 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -56.04 -32.14 63.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.666 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 76' ' ' ALA . 7.6 m-30 -57.83 -47.72 81.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.918 -1.114 . . . . 0.0 108.026 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' HIS . . . -55.34 -34.69 64.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -80.29 -24.07 40.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.46 -0.775 . . . . 0.0 109.198 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 79' ' ' PHE . 2.1 mtt180 -77.3 -56.71 4.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.764 HD11 HG21 ' A' ' 91' ' ' VAL . 16.2 pt -62.14 -38.88 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 109.412 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.462 ' N ' HG13 ' A' ' 83' ' ' ILE . 1.9 t60 -58.6 -42.14 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.496 -0.753 . . . . 0.0 109.901 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.72 -16.81 80.41 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -44.82 23.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -1.222 . . . . 0.0 110.433 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.5 OUTLIER -119.6 -13.15 9.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.01 -1.057 . . . . 0.0 110.881 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 82.24 32.76 27.76 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.4 m -91.14 153.76 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.485 -1.009 . . . . 0.0 110.686 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.88 81.69 6.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.756 . . . . 0.0 110.531 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.891 HG23 HG22 ' A' ' 57' ' ' ILE . 8.7 p -100.31 152.3 4.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 111.1 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.9 153.85 29.78 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.003 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -92.66 138.64 31.32 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.027 -1.046 . . . . 0.0 108.907 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 1.003 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t60 -80.31 103.31 10.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 0.0 109.786 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.26 145.58 29.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.509 -0.745 . . . . 0.0 110.726 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB3' ' NE2' ' A' ' 70' ' ' GLN . 25.6 mm-40 -129.61 32.79 4.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.405 ' NH2' ' OE1' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -73.08 -4.82 34.99 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.294 -0.879 . . . . 0.0 110.789 -179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -22.35 63.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.922 -1.111 . . . . 0.0 110.29 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.71 63.82 4.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 110.125 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.4 m -94.2 -12.17 28.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 110.635 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 p -55.53 151.4 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.998 -1.064 . . . . 0.0 110.021 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.74 -49.36 4.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 110.415 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 48.61 68.98 0.61 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.266 -0.897 . . . . 0.0 110.479 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.57 62.83 0.61 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 110.257 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.1 t -100.93 4.94 43.03 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 0.0 110.632 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.73 113.21 0.53 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -130.23 136.15 48.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -1.16 . . . . 0.0 109.94 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 107' ' ' LEU . 1.5 m-85 -145.58 100.14 3.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.251 -0.906 . . . . 0.0 110.336 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -92.78 20.66 6.27 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -114.88 165.9 12.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.273 -0.892 . . . . 0.0 110.267 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.11 -91.63 0.1 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.95 126.31 1.1 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -96.09 123.71 39.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -1.119 . . . . 0.0 110.148 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -154.62 71.12 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.194 -0.941 . . . . 0.0 110.203 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.25 -166.04 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.256 -0.903 . . . . 0.0 110.174 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 55.0 mt 53.44 99.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.46 -0.775 . . . . 0.0 110.419 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -151.63 171.77 17.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.159 -0.963 . . . . 0.0 110.239 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 162.96 20.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.196 -0.94 . . . . 0.0 110.115 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -120.5 142.61 15.97 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -116.21 134.1 55.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.237 -1.154 . . . . 0.0 110.407 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.07 111.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.278 -0.889 . . . . 0.0 110.032 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' N ' ' A' ' 124' ' ' ALA . 25.3 m-20 -65.62 -158.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 0.0 110.377 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.06 -60.21 0.37 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 0.0 111.127 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -48.57 -29.68 4.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 0.0 110.9 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 54.4 p -54.7 -33.39 60.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.336 -0.852 . . . . 0.0 111.526 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.653 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -77.71 -55.77 5.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.859 -1.151 . . . . 0.0 109.266 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.806 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -53.47 -24.3 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -76.76 -46.01 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 9' ' ' ASP . 17.0 mt -53.73 -27.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.961 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -67.55 -39.81 84.98 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.894 177.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.93 -34.18 27.5 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.9 -32.35 67.3 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.587 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 1.6 t80 -75.11 -54.46 7.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.68 -0.638 . . . . 0.0 109.754 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.961 ' CE2' HD12 ' A' ' 130' ' ' LEU . 25.2 m-85 -52.18 -28.98 20.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.074 -1.016 . . . . 0.0 109.558 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 -22.55 40.52 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.486 -0.759 . . . . 0.0 109.677 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -79.54 -11.13 59.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.203 -0.936 . . . . 0.0 110.676 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.49 -57.86 3.48 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.307 -1.114 . . . . 0.0 110.207 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.213 0.53 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 69.1 p -154.99 122.61 5.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 110.044 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -158.25 -92.43 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.742 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.7 m -147.5 138.34 23.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.968 -1.313 . . . . 0.0 112.209 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.02 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.02 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.688 0.756 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.4 28.75 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.03 126.7 41.79 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.124 -0.985 . . . . 0.0 111.155 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.1 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 138.01 58.19 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 123.004 1.383 . . . . 0.0 113.772 -175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.035 -1.893 . . . . 0.0 115.73 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.05 159.76 17.41 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.374 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.02 123.92 33.21 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.287 -0.883 . . . . 0.0 110.821 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -0.93 . . . . 0.0 110.061 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.94 47.59 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.81 107.7 26.46 Favored Pre-proline 0 C--N 1.307 -1.275 0 O-C-N 121.06 -1.259 . . . . 0.0 110.07 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.24 157.62 56.71 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.641 1.337 . . . . 0.0 109.082 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.79 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.55 -20.45 54.1 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.359 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -30.89 30.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.63 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.837 -0.539 . . . . 0.0 111.764 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.259 -0.901 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.42 64.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.83 -51.63 8.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.907 -1.121 . . . . 0.0 112.281 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.775 -1.203 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.824 -1.173 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.74 136.86 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.735 1.387 . . . . 0.0 111.422 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.79 -45.18 37.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 0.0 110.074 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.86 140.3 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.067 . . . . 0.0 109.606 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.7 137.89 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.002 . . . . 0.0 111.856 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.736 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.29 122.42 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -118.3 113.46 37.06 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.609 ' N ' HD22 ' A' ' 61' ' ' LEU . 50.2 Cg_endo -84.07 115.86 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.375 1.197 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' LEU . 52.3 tp -130.56 133.59 46.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -80.46 131.4 35.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.207 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.761 ' HG2' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.27 -44.9 14.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.051 -1.031 . . . . 0.0 110.027 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.48 -11.28 15.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.334 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.2 -51.07 0.77 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 6.4 t -105.3 -165.15 1.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.382 -1.069 . . . . 0.0 109.523 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 68' ' ' THR . 19.1 pt-20 37.87 -157.12 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.165 0.507 . . . . 0.0 111.47 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -176.8 67.12 0.22 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 -30.08 14.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.925 1.487 . . . . 0.0 110.089 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 65' ' ' MET . 1.1 tp -60.08 -30.01 68.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.88 -19.57 18.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.875 . . . . 0.0 111.237 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.28 -33.39 5.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 109.646 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -80.05 -30.3 39.4 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -65.09 -45.05 86.78 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 108.908 178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.434 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -57.02 4.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.78 -25.75 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.991 -1.068 . . . . 0.0 109.798 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.68 62.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.81 -16.26 75.62 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.7 m-85 -119.1 -11.92 9.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 110.322 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.97 31.62 42.77 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.17 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.682 -0.893 . . . . 0.0 110.773 -179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.29 125.83 40.19 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.887 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 -87.95 101.66 13.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 110.445 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.35 143.88 50.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.821 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -79.59 57.57 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -63.49 -29.61 70.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 0.0 110.213 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -18.65 65.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.892 . . . . 0.0 110.209 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 100' ' ' THR . 32.5 t -56.88 92.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -157.38 127.73 6.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.165 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.8 152.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.184 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 mt-10 -97.31 -22.9 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 62.14 135.1 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.402 -0.811 . . . . 0.0 110.448 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.42 39.74 31.23 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.196 -0.94 . . . . 0.0 110.294 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 17.9 p -114.21 19.45 16.35 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.905 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.82 -140.69 12.61 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.99 137.51 39.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 110.272 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.57 39.73 3.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -95.91 -59.17 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -75.75 -60.6 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 110.295 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.08 -53.97 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.82 -94.64 0.09 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 56.0 m-85 -125.77 79.86 1.86 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.213 -1.169 . . . . 0.0 110.333 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 51.73 57.39 6.59 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 110.313 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.61 173.48 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 110.27 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.14 -46.04 0.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.259 -0.901 . . . . 0.0 110.187 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.56 158.04 27.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.149 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -153.81 80.34 1.15 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.18 141.73 10.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -167.86 147.62 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -1.055 . . . . 0.0 110.082 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.5 t -64.26 139.48 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.968 . . . . 0.0 110.363 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -173.24 -37.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.908 . . . . 0.0 110.129 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.89 21.62 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.764 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -21.62 64.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.066 -1.021 . . . . 0.0 109.281 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.396 -0.815 . . . . 0.0 110.688 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.0 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -24.36 39.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -13.18 32.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.35 -21.35 59.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.181 -1.188 . . . . 0.0 110.163 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.311 0.577 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -147.77 128.13 13.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.811 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.92 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.6 m -142.63 134.84 27.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.965 -1.315 . . . . 0.0 112.505 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.073 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -126.31 140.6 52.39 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.469 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.942 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -135.03 134.32 40.3 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.481 -1.387 . . . . 0.0 110.772 179.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -118.33 122.96 44.17 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.761 ' HE1' HG23 ' A' ' 57' ' ' ILE . 33.6 m-85 -109.04 131.95 54.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.52 -0.738 . . . . 0.0 111.764 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 18.1 t70 -113.34 93.2 4.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.65 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.0 p90 -177.65 -164.57 0.09 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.91 -1.116 . . . . 0.0 112.244 -178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.56 168.56 33.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.324 -1.911 . . . . 0.0 108.324 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.457 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 55.7 p -60.01 77.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.89 -1.359 . . . . 0.0 111.654 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 3.7 mttp 162.67 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 O-C-N 121.528 -0.733 . . . . 0.0 110.678 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.767 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -137.84 142.29 40.75 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.224 -0.922 . . . . 0.0 109.457 -178.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.781 HD11 ' HB3' ' A' ' 40' ' ' PRO . 36.5 mm -122.92 102.22 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.977 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -129.5 103.9 0.61 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 104.126 -3.59 . . . . 0.0 104.126 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.898 ' CG1' HD13 ' A' ' 30' ' ' LEU . 39.8 t -135.75 167.13 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 116.713 -1.995 . . . . 0.0 114.091 -175.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.67 131.64 48.03 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.652 HG13 HD11 ' A' ' 6' ' ' LEU . 68.5 t -101.08 135.88 35.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 O-C-N 120.85 -1.156 . . . . 0.0 108.091 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -111.71 141.03 16.45 Favored Glycine 0 N--CA 1.484 1.85 0 C-N-CA 119.047 -1.549 . . . . 0.0 111.352 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -95.87 112.85 24.47 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 1.1 ttp180 -87.58 21.49 2.53 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.582 -178.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.891 HD13 ' C ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.81 -32.66 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.753 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.7 OUTLIER -117.73 -17.37 9.89 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.0 110.333 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.61 34.74 11.19 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.92 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 158.48 26.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.738 -1.448 . . . . 0.0 110.909 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.86 119.44 30.53 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.844 -1.16 . . . . 0.0 111.737 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 19' ' ' VAL . 31.8 ttm105 -86.98 154.54 55.24 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.0 Cg_endo -91.53 137.36 1.98 Allowed 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 123.134 1.071 . . . . 0.0 112.151 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.898 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.2 tt -99.74 141.23 22.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 22.2 Cg_endo -43.25 169.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.839 2.359 . . . . 0.0 116.086 -174.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' ILE . . . -65.41 150.3 48.56 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 123.528 1.632 . . . . 0.0 115.069 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 14' ' ' SER 0.279 0.9 OUTLIER -51.22 -126.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-N 112.462 -2.153 . . . . 0.0 112.783 179.838 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.589 ' N ' HG23 ' A' ' 33' ' ' ILE . 0.7 OUTLIER 34.87 88.71 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.211 -0.931 . . . . 0.0 112.468 -178.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -88.9 160.48 17.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.932 -1.105 . . . . 0.0 109.752 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.09 115.21 26.46 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.104 -0.998 . . . . 0.0 111.419 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.3 25.79 0.95 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.849 . . . . 0.0 110.372 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.76 17.23 42.21 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.1 m -94.98 106.94 28.3 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 120.999 -1.295 . . . . 0.0 109.993 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.781 ' HB3' HD11 ' A' ' 15' ' ' ILE . 46.4 Cg_endo -72.22 162.53 41.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.575 1.303 . . . . 0.0 109.734 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.914 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -64.27 92.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.971 -1.081 . . . . 0.0 109.001 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.428 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 31.3 t90 -90.45 -17.23 27.53 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.457 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.8 m-20 -81.65 -35.4 29.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.811 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.629 HD12 ' N ' ' A' ' 44' ' ' ILE . 2.0 mp -82.4 -48.05 18.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.854 -0.529 . . . . 0.0 110.646 -179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 41' ' ' ASP . 18.5 mt -70.75 -33.94 54.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.155 -0.966 . . . . 0.0 111.16 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -76.8 -45.22 29.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.924 -1.11 . . . . 0.0 110.427 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' CD ' ' O ' ' A' ' 43' ' ' ASN . 1.9 mtt180 -52.44 -41.46 63.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.943 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.28 -28.71 34.58 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.107 -0.996 . . . . 0.0 109.066 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.931 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -59.13 -49.78 76.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.101 -1.0 . . . . 0.0 110.48 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -72.43 -32.35 66.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 111.053 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.85 -42.53 39.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.935 -1.103 . . . . 0.0 111.221 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . 49.0 m95 -111.01 -27.5 8.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.899 -1.125 . . . . 0.0 111.562 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' LEU . 1.7 mt-30 59.48 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.022 -1.049 . . . . 0.0 109.487 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.482 ' HB3' HD13 ' A' ' 6' ' ' LEU . 46.8 Cg_endo -71.37 129.61 16.16 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.605 1.319 . . . . 0.0 111.44 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -80.34 -40.21 27.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.527 -0.733 . . . . 0.0 110.58 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -132.9 155.16 49.56 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.926 -1.109 . . . . 0.0 109.879 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.761 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.9 mp -133.15 137.41 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.861 -1.149 . . . . 0.0 112.695 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.073 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.64 116.76 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.916 HG11 ' CD1' ' A' ' 83' ' ' ILE . 74.0 t -131.82 150.73 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 119.975 -1.703 . . . . 0.0 113.065 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 170.14 121.13 0.56 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 120.245 -0.978 . . . . 0.0 110.833 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.977 ' O ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.08 149.19 97.18 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.891 -1.358 . . . . 0.0 109.535 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.595 ' N ' HD22 ' A' ' 61' ' ' LEU . 44.2 Cg_endo -71.89 135.12 24.95 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 123.278 1.146 . . . . 0.0 111.323 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD21 HG23 ' A' ' 73' ' ' THR . 3.9 mm? -90.03 164.35 14.55 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -50.89 126.11 15.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 110.355 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 79.5 mmm -80.98 -43.42 19.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 0.0 110.291 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.43 15.8 26.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 110.315 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.546 ' C ' HG22 ' A' ' 68' ' ' THR . . . -124.88 45.78 1.14 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.546 HG22 ' C ' ' A' ' 67' ' ' GLY . 11.0 t 36.57 -153.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 O-C-N 122.07 -0.665 . . . . 0.0 111.784 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -97.36 160.39 14.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.0 110.256 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -153.43 155.46 31.67 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.314 -0.866 . . . . 0.0 110.409 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.6 -6.64 19.48 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.766 1.403 . . . . 0.0 111.22 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -24.56 5.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.05 . . . . 0.0 110.344 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.613 HG23 HD21 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -54.7 -19.72 6.78 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 111.127 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.54 -28.87 2.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.932 -1.105 . . . . 0.0 109.822 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -29.02 50.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.371 -0.831 . . . . 0.0 108.919 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -64.57 -45.35 87.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.637 -0.665 . . . . 0.0 109.786 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.46 -48.44 81.77 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.204 -0.935 . . . . 0.0 109.54 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.78 -25.24 62.8 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.995 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.53 ' CE2' HG12 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -63.13 -45.51 91.63 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -62.34 -29.44 70.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.463 -0.773 . . . . 0.0 109.104 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -67.15 -23.25 65.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.253 -0.904 . . . . 0.0 109.656 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.66 -56.93 4.04 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.341 -0.85 . . . . 0.0 110.45 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.916 ' CD1' HG11 ' A' ' 59' ' ' VAL . 16.2 pt -56.16 -28.82 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.473 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.458 ' HB2' HG11 ' A' ' 91' ' ' VAL . 32.5 t-80 -70.2 -50.99 34.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.345 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.81 -15.55 79.51 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -74.66 -44.27 51.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.918 -1.342 . . . . 0.0 110.5 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -113.64 -11.09 13.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.238 -0.914 . . . . 0.0 110.394 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.03 43.62 48.22 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.298 -1.921 . . . . 0.0 108.298 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 89' ' ' VAL . 35.4 m -109.49 153.91 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.636 -0.92 . . . . 0.0 110.949 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.55 88.5 0.94 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.618 -0.676 . . . . 0.0 109.768 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.743 HG21 ' CD1' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -88.87 151.05 3.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-O 122.087 0.946 . . . . 0.0 111.48 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.82 130.36 39.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.892 HD13 ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -101.58 127.4 48.31 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.024 -1.048 . . . . 0.0 109.342 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.838 ' N ' HD22 ' A' ' 93' ' ' LEU . 42.7 t-80 -87.32 108.91 19.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.306 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.595 ' OD1' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -82.77 138.15 34.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 110.065 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.34 30.7 7.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.177 -0.952 . . . . 0.0 110.459 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -83.75 -21.18 32.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 110.115 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.32 -18.53 48.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.262 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 t -54.22 164.36 0.67 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.083 -1.01 . . . . 0.0 110.499 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -141.09 178.72 7.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.381 -0.825 . . . . 0.0 110.017 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.7 p -66.02 152.33 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.083 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -38.16 90.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.278 -0.889 . . . . 0.0 110.302 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.88 99.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.204 -0.935 . . . . 0.0 110.538 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.33 153.69 44.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 p -94.05 17.09 13.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.478 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.64 169.62 11.31 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 mt -147.83 120.32 8.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.18 -1.188 . . . . 0.0 110.33 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 t80 53.04 35.35 19.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.2 -0.937 . . . . 0.0 110.3 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -53.75 139.11 33.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.228 -0.92 . . . . 0.0 110.17 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.04 95.63 2.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.71 78.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 149.04 -112.91 0.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -173.37 -176.14 1.27 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.123 -1.222 . . . . 0.0 110.173 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -156.65 73.65 0.78 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.194 -0.941 . . . . 0.0 110.37 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -135.33 61.98 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 110.343 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.11 -24.52 35.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.77 -173.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.225 -0.922 . . . . 0.0 110.096 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -97.28 -26.06 15.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.189 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 142.38 -115.96 1.0 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 0.5 OUTLIER 54.33 -173.67 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -1.092 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.439 HG12 ' N ' ' A' ' 122' ' ' ASP . 98.8 t 56.57 162.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.591 -0.693 . . . . 0.0 110.627 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' N ' HG12 ' A' ' 121' ' ' VAL . 18.3 p-10 -121.29 158.56 27.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 110.091 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.07 26.79 5.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.242 -0.911 . . . . 0.0 110.259 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.72 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.06 -40.07 32.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.242 -0.911 . . . . 0.0 110.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.437 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.5 m -52.91 -23.13 6.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.966 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.713 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -83.84 -55.3 4.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.997 -1.065 . . . . 0.0 109.095 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.677 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.14 -24.36 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 177.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.72 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -72.08 -45.53 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 175.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.673 HG22 ' HB ' ' A' ' 58' ' ' ILE . 68.0 mt -62.43 -41.94 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.557 HD22 HD11 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -56.55 -48.1 78.04 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.195 177.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.59 -21.59 40.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.076 -1.015 . . . . 0.0 109.965 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 p -70.31 -50.62 37.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.751 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -57.29 -40.99 78.93 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.139 -0.976 . . . . 0.0 110.111 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.565 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 8.4 m-85 -53.45 -31.22 44.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.831 -1.168 . . . . 0.0 109.533 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.23 -20.95 43.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.491 -0.755 . . . . 0.0 109.946 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -100.18 -9.87 22.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.539 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -132.5 55.26 0.76 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.202 -1.175 . . . . 0.0 110.223 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -86.05 -75.05 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 110.179 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.29 -79.09 0.14 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.535 ' O ' ' N ' ' A' ' 55' ' ' ASP . 51.8 m -150.37 135.1 17.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.921 -1.34 . . . . 0.0 112.427 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.069 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -126.7 143.87 51.1 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.912 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -135.72 134.3 38.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.435 -1.416 . . . . 0.0 110.521 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -118.56 123.32 44.77 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.767 ' HA ' HG22 ' A' ' 17' ' ' VAL . 29.0 m-85 -108.83 129.95 55.4 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.57 0.7 . . . . 0.0 111.789 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.8 t70 -112.65 91.99 3.85 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.895 ' CD2' HD13 ' A' ' 15' ' ' ILE . 1.0 OUTLIER -173.89 -172.93 0.78 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.686 -1.205 . . . . 0.0 112.48 -177.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.504 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -144.66 -177.18 19.3 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.618 HG23 ' HE1' ' A' ' 79' ' ' PHE . 0.7 OUTLIER -71.47 63.36 0.39 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.117 -1.225 . . . . 0.0 111.598 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 12' ' ' THR . 4.4 ptmt 171.57 -27.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.233 -0.917 . . . . 0.0 110.61 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -125.44 143.44 50.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.0 108.756 -179.327 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.895 HD13 ' CD2' ' A' ' 10' ' ' PHE . 33.5 mm -124.78 97.12 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.55 104.06 0.74 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 104.244 -3.543 . . . . 0.0 104.244 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.92 ' CG1' HD13 ' A' ' 30' ' ' LEU . 38.3 t -134.85 165.8 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 116.623 -2.031 . . . . 0.0 113.688 -175.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.652 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.7 131.72 46.42 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.668 HG22 ' CD2' ' A' ' 6' ' ' LEU . 73.7 t -101.51 137.43 29.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 120.913 -1.117 . . . . 0.0 108.082 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.61 136.82 13.87 Favored Glycine 0 N--CA 1.485 1.928 0 O-C-N 120.507 -1.371 . . . . 0.0 110.589 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.64 117.41 30.41 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.161 -1.2 . . . . 0.0 108.04 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' CB ' ' A' ' 5' ' ' LEU . 2.5 mtm180 -90.08 24.51 2.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.343 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.878 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -32.76 2.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.407 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.43 -16.82 10.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.486 -0.759 . . . . 0.0 109.99 179.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.43 33.54 22.31 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.09 161.55 21.55 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.982 -1.305 . . . . 0.0 110.807 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -122.04 122.5 39.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.868 -1.145 . . . . 0.0 112.068 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 19' ' ' VAL . 11.6 ttm180 -87.3 153.11 53.53 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 49.3 Cg_endo -91.43 139.37 2.36 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 123.132 1.069 . . . . 0.0 112.364 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.92 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.82 142.47 24.68 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 178.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.29 167.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.846 2.364 . . . . 0.0 115.993 -174.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.89 143.49 57.91 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 123.234 1.492 . . . . 0.0 114.834 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.7 50.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 112.916 -1.947 . . . . 0.0 115.623 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.6 mmtt -131.63 97.43 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.864 -1.147 . . . . 0.0 109.654 176.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.821 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.61 161.09 16.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.844 . . . . 0.0 110.251 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.1 OUTLIER -85.71 120.57 27.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.299 -0.876 . . . . 0.0 111.218 -178.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 48.72 25.46 1.01 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -0.979 . . . . 0.0 110.495 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 13' ' ' LYS . . . 93.7 17.28 42.19 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.821 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 21.4 m -98.72 115.72 65.66 Favored Pre-proline 0 C--N 1.308 -1.226 0 O-C-N 121.141 -1.211 . . . . 0.0 110.03 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.861 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.3 Cg_endo -69.79 157.7 59.42 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.433 1.228 . . . . 0.0 109.608 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -64.54 91.26 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.942 -1.099 . . . . 0.0 109.177 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.441 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 26.9 t90 -90.94 -16.9 27.29 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -80.38 -34.53 36.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.161 -0.962 . . . . 0.0 109.432 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.6 mp -81.99 -55.13 8.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.699 -0.625 . . . . 0.0 109.768 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 32.1 mt -59.62 -37.81 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 110.489 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 2.1 tm-20 -72.9 -31.18 64.5 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.944 -1.097 . . . . 0.0 109.962 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -64.92 -50.66 65.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 109.984 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.952 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -73.69 -25.02 60.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.283 -0.886 . . . . 0.0 109.959 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.944 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -62.46 -53.75 50.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.933 -1.104 . . . . 0.0 110.504 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -69.44 -23.52 63.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 110.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.44 -41.22 16.85 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.076 -1.015 . . . . 0.0 111.346 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.742 ' CE3' HD23 ' A' ' 48' ' ' LEU . 48.9 m0 -109.08 -17.54 13.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.836 -1.165 . . . . 0.0 111.359 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 49' ' ' LEU . 5.7 mt-30 54.08 97.24 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.15 -0.969 . . . . 0.0 109.835 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.3 Cg_endo -71.56 125.41 11.16 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.664 1.349 . . . . 0.0 110.971 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.4 OUTLIER -73.52 -41.91 62.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.459 -0.776 . . . . 0.0 110.404 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' NH1' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -138.24 157.87 45.42 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.031 -1.043 . . . . 0.0 110.432 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.724 HG23 ' HE1' ' A' ' 8' ' ' PHE . 4.7 mp -132.68 137.45 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.902 -1.124 . . . . 0.0 112.244 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.069 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -113.86 122.13 67.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.904 HG21 HD12 ' A' ' 83' ' ' ILE . 76.7 t -133.94 150.18 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 120.147 -1.596 . . . . 0.0 113.088 -177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.66 118.22 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.608 ' C ' HD12 ' A' ' 61' ' ' LEU . 3.8 pp -63.66 148.39 94.32 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.44 ' O ' HD12 ' A' ' 61' ' ' LEU . 41.2 Cg_endo -67.09 137.68 45.03 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.582 1.306 . . . . 0.0 110.506 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.741 HD11 ' HB3' ' A' ' 70' ' ' GLN . 62.7 tp -95.11 163.98 13.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.383 -0.823 . . . . 0.0 110.355 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.435 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 0.4 OUTLIER -49.41 139.78 11.31 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.264 -0.897 . . . . 0.0 110.43 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 5.8 tpt -83.11 -43.18 16.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 110.334 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.8 19.27 20.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.178 -0.951 . . . . 0.0 110.391 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -134.47 55.33 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -171.19 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -1.125 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 53.32 32.06 12.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.183 -0.948 . . . . 0.0 109.781 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.741 ' HB3' HD11 ' A' ' 63' ' ' LEU . 9.5 tp-100 -97.05 112.22 60.07 Favored Pre-proline 0 C--N 1.303 -1.413 0 O-C-N 121.456 -0.777 . . . . 0.0 109.826 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.38 -6.52 19.1 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.555 1.292 . . . . 0.0 110.411 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tt -53.05 -29.2 28.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.162 -0.961 . . . . 0.0 110.153 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.77 -21.25 18.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 111.01 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.05 -30.48 6.32 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.97 -1.082 . . . . 0.0 109.095 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -30.31 49.89 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -57.54 -40.43 78.82 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.526 -0.734 . . . . 0.0 109.403 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.625 ' HA ' HD22 ' A' ' 93' ' ' LEU . 8.7 mtt180 -68.13 -48.19 66.08 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.364 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -25.41 65.51 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.0 178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.618 ' HE1' HG23 ' A' ' 12' ' ' THR . 37.3 t80 -59.33 -47.25 86.11 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.572 ' HB3' HD21 ' A' ' 93' ' ' LEU . . . -57.87 -31.81 67.06 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -60.09 -27.62 67.16 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.539 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -75.88 -57.89 3.61 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.295 -0.878 . . . . 0.0 110.607 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.904 HD12 HG21 ' A' ' 59' ' ' VAL . 20.7 pt -57.4 -32.13 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.879 -1.138 . . . . 0.0 110.176 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 88' ' ' GLY . 24.9 t-80 -65.8 -51.56 58.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.245 -0.91 . . . . 0.0 110.144 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.56 -15.63 73.3 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -71.49 -44.55 64.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.31 . . . . 0.0 110.511 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.691 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -119.17 -10.73 9.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.479 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' HIS . . . 74.58 38.82 42.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.8 m -99.24 153.75 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.593 -0.946 . . . . 0.0 110.785 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -74.86 85.66 2.22 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.636 -0.665 . . . . 0.0 109.681 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.2 p -88.34 151.54 3.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.276 -0.89 . . . . 0.0 111.015 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -120.83 158.66 27.11 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.283 0.563 . . . . 0.0 110.246 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.625 HD22 ' HA ' ' A' ' 77' ' ' ARG . 8.8 mt -106.33 125.31 50.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 0.0 110.169 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -83.09 112.09 19.48 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -0.969 . . . . 0.0 110.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.77 141.75 34.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 110.062 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -80.5 82.88 6.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -76.0 -29.02 58.03 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.349 -0.844 . . . . 0.0 110.671 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.13 -41.04 87.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.131 -0.981 . . . . 0.0 110.292 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.27 120.11 37.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 110.068 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 100' ' ' THR . 8.6 t -155.21 69.34 0.71 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 0.0 110.729 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 t -94.33 144.34 9.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 7.9 mt-10 -96.93 -40.76 8.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.914 . . . . 0.0 110.654 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 54.53 -148.92 0.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.103 -0.998 . . . . 0.0 109.933 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.13 -43.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.161 -0.962 . . . . 0.0 110.321 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 t -112.92 -23.35 10.14 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.374 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.94 171.55 28.38 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 47.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.198 -1.178 . . . . 0.0 110.191 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -111.77 46.06 1.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 110.092 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -15.0 51.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.901 . . . . 0.0 110.674 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.64 107.62 12.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 110.357 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.54 143.26 26.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -88.33 155.39 26.06 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -122.84 34.73 5.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -1.136 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -128.84 -155.42 0.7 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.74 150.48 30.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 0.0 110.569 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -176.2 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.243 -0.911 . . . . 0.0 110.276 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -94.24 -154.08 0.4 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.15 -0.968 . . . . 0.0 110.312 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt 55.91 56.37 6.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.0 110.243 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -159.55 28.41 0.38 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -60.3 177.35 0.27 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -1.116 . . . . 0.0 110.163 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -102.85 154.85 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 110.305 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.71 -75.84 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 0.0 110.282 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.5 m -158.39 24.78 0.24 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 0.0 110.212 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.602 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -66.87 -38.88 87.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.224 -0.922 . . . . 0.0 110.303 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 28.8 t -53.51 -32.7 51.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.212 -0.93 . . . . 0.0 110.389 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -69.73 -55.73 9.12 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 108.917 179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.652 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.56 -23.87 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 177.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.1 mp -73.3 -44.82 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.597 HD12 ' HB2' ' A' ' 9' ' ' ASP . 71.9 mt -60.79 -36.54 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 5' ' ' LEU 0.256 0.4 OUTLIER -64.91 -54.3 32.97 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.414 178.485 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.495 ' HA ' ' CD2' ' A' ' 134' ' ' PHE . 0.8 OUTLIER -56.21 -21.78 25.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.399 -0.813 . . . . 0.0 110.039 179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.16 -33.08 26.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.326 -0.859 . . . . 0.0 110.578 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.635 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -59.04 -38.95 80.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.055 -1.028 . . . . 0.0 109.824 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.575 ' CE1' ' CE2' ' A' ' 133' ' ' TYR . 76.1 m-85 -55.0 -40.45 70.14 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.963 -1.095 . . . . 0.0 109.245 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -23.37 40.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.164 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 133' ' ' TYR . 1.9 mt-30 -84.35 -16.75 41.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.0 110.389 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -73.07 -58.82 4.55 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.19 -1.182 . . . . 0.0 110.322 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.313 0.578 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.7 p -128.64 179.4 5.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.175 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . 137.49 -64.1 0.56 Allowed Glycine 0 N--CA 1.488 2.144 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.493 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.448 ' O ' ' N ' ' A' ' 55' ' ' ASP . 38.9 m -150.35 141.32 22.93 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.886 -1.361 . . . . 0.0 112.31 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.051 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.83 163.36 25.39 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.149 -0.969 . . . . 0.0 110.437 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.118 HD21 HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -144.92 145.22 31.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.129 -0.982 . . . . 0.0 109.192 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -137.73 124.37 21.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.109 -0.994 . . . . 0.0 108.727 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.777 ' HB2' HG23 ' A' ' 59' ' ' VAL . 73.7 m-85 -120.66 142.5 49.4 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.149 -1.02 . . . . 0.0 113.71 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 1.4 t0 -106.54 91.35 3.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.669 ' HB2' HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -97.34 134.96 39.91 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -174.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.1 160.84 28.56 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.1 p -47.69 112.24 0.53 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.058 -1.26 . . . . 0.0 110.514 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' CG ' ' HA2' ' A' ' 38' ' ' GLY . 6.1 mtmt 55.29 46.48 23.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 109.285 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.754 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -140.48 120.94 14.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 110.824 -178.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.707 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 39.3 mm -116.66 93.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.839 0 CA-C-O 122.467 1.127 . . . . 0.0 113.924 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.23 104.89 0.84 Allowed Glycine 0 C--N 1.287 -2.169 0 N-CA-C 103.626 -3.79 . . . . 0.0 103.626 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.91 ' CG1' HD13 ' A' ' 30' ' ' LEU . 81.5 t -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 C-N-CA 116.49 -2.084 . . . . 0.0 112.819 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.782 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -134.35 138.36 44.85 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 48' ' ' LEU . 33.6 t -100.91 130.45 50.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.584 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.76 136.71 13.69 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.856 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.45 117.68 34.79 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.641 ' HB2' HD12 ' A' ' 5' ' ' LEU . 3.2 tpt180 -91.83 35.11 0.97 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.79 0.805 . . . . 0.0 109.967 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.745 ' C ' HD12 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -113.66 -35.07 2.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.459 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -118.81 -17.19 9.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.554 -0.716 . . . . 0.0 109.976 178.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.76 34.08 7.53 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.13 161.41 21.05 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.996 -1.296 . . . . 0.0 111.221 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -138.45 127.3 23.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.249 -0.907 . . . . 0.0 111.161 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.454 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 8.0 mmm180 -88.04 154.65 52.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.412 -0.805 . . . . 0.0 109.041 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.26 136.75 2.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.471 1.248 . . . . 0.0 111.356 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.91 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -99.17 144.61 28.55 Favored Pre-proline 0 N--CA 1.492 1.668 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' CD ' HD23 ' A' ' 30' ' ' LEU . 17.9 Cg_endo -39.67 165.32 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.772 2.315 . . . . 0.0 115.756 -175.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.86 142.07 58.56 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.157 1.456 . . . . 0.0 114.355 -175.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.754 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.9 OUTLIER -55.53 51.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.449 -179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.0 tptm -133.34 98.62 4.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.75 -1.219 . . . . 0.0 108.96 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.851 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.15 161.6 16.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.235 -0.916 . . . . 0.0 110.819 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.77 119.43 24.81 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.368 -0.832 . . . . 0.0 111.08 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 49.18 25.71 1.27 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.342 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA2' ' CG ' ' A' ' 13' ' ' LYS . . . 93.62 14.59 52.69 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.851 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 11.7 m -91.25 111.12 47.05 Favored Pre-proline 0 C--N 1.309 -1.175 0 O-C-N 120.944 -1.327 . . . . 0.0 109.776 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.679 ' CB ' HD11 ' A' ' 15' ' ' ILE . 43.4 Cg_endo -70.37 155.87 62.97 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.639 1.336 . . . . 0.0 109.94 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.979 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -63.76 91.67 0.06 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 120.897 -1.127 . . . . 0.0 108.579 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.434 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 15.1 t90 -92.41 -22.49 19.62 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.001 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.88 -39.28 21.76 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.096 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -70.56 -55.0 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.767 -0.583 . . . . 0.0 111.007 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.979 HD12 ' O ' ' A' ' 41' ' ' ASP . 5.9 mt -68.31 -43.02 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.691 -1.256 . . . . 0.0 110.591 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 1.3 tm-20 -54.63 -30.79 55.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.717 -1.239 . . . . 0.0 109.545 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 2.8 mtp180 -66.57 -44.01 83.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.345 -0.847 . . . . 0.0 109.362 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.118 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.63 -27.14 31.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.303 -0.873 . . . . 0.0 109.285 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.74 -53.37 33.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.972 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -80.01 -26.99 39.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.154 -0.966 . . . . 0.0 111.345 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 25.8 tt0 -79.1 -41.16 29.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.964 -1.085 . . . . 0.0 110.978 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.418 ' HB2' HD22 ' A' ' 48' ' ' LEU . 73.4 m95 -103.58 -14.69 16.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.059 -1.026 . . . . 0.0 111.112 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' O ' ' HB ' ' A' ' 4' ' ' THR . 2.9 mt-30 51.96 91.63 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.755 0 O-C-N 120.951 -1.093 . . . . 0.0 110.112 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 45.5 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.739 1.389 . . . . 0.0 111.101 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 4' ' ' THR . 2.3 m-20 -76.77 -43.52 36.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -0.826 . . . . 0.0 110.418 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.31 136.82 47.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.937 -1.102 . . . . 0.0 110.016 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.661 ' C ' HD13 ' A' ' 58' ' ' ILE . 2.7 mp -129.98 137.43 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.052 -1.03 . . . . 0.0 111.869 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.704 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -120.21 126.0 74.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' A' ' 8' ' ' PHE . 10.0 p -132.91 150.12 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.579 -1.325 . . . . 0.0 112.289 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.37 141.02 3.03 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.909 -1.139 . . . . 0.0 110.377 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.55 HD22 ' CB ' ' A' ' 76' ' ' ALA . 1.6 pt? -65.61 148.44 98.13 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.102 -1.234 . . . . 0.0 110.111 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.87 143.31 60.42 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.619 1.326 . . . . 0.0 109.869 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD11 ' HG3' ' A' ' 70' ' ' GLN . 8.8 tp -90.65 154.72 19.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 24.5 p30 -52.04 152.19 3.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.334 -0.854 . . . . 0.0 110.337 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -12.17 59.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 110.624 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -75.07 -11.33 60.07 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.069 -1.019 . . . . 0.0 110.539 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 54.59 46.67 73.4 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 t -103.08 -161.9 0.87 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -1.157 . . . . 0.0 110.004 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.5 147.64 50.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.038 -1.039 . . . . 0.0 110.285 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.427 ' HG3' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -154.97 68.03 5.38 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.31 -11.32 28.49 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.908 1.478 . . . . 0.0 110.716 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.8 mt -75.25 -24.57 57.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.868 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.6 -19.89 6.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 111.532 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -31.41 4.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.829 -1.169 . . . . 0.0 109.536 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -31.62 63.65 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.55 ' CB ' HD22 ' A' ' 61' ' ' LEU . . . -58.03 -46.34 85.48 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -56.42 -48.94 75.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.306 -0.871 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -24.66 64.92 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.147 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 10' ' ' PHE . 5.7 t80 -61.03 -49.73 76.21 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.482 ' HB2' HG13 ' A' ' 59' ' ' VAL . . . -57.29 -33.05 67.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.463 -0.773 . . . . 0.0 109.146 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.47 -23.45 63.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 110.12 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -70.51 -51.6 27.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.221 -0.925 . . . . 0.0 110.06 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.848 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -68.06 -23.75 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.708 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.848 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.5 t-80 -59.07 -57.8 11.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.397 -0.814 . . . . 0.0 110.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.82 -15.63 80.76 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -64.42 -44.33 91.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.01 -1.288 . . . . 0.0 110.198 -179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.693 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -116.13 -14.01 11.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.895 . . . . 0.0 110.137 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.71 31.06 30.76 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.2 m -95.52 153.2 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -1.039 . . . . 0.0 110.617 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.13 72.66 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.568 -0.708 . . . . 0.0 110.255 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.686 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -89.51 152.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 121.999 0.904 . . . . 0.0 111.12 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 162.27 27.82 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.753 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -113.89 143.24 45.01 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.753 179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.485 ' CE1' HG23 ' A' ' 129' ' ' ILE . 0.0 OUTLIER -82.47 104.93 13.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.148 -0.97 . . . . 0.0 110.463 -178.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -71.6 144.33 49.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.084 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.417 ' CD ' HG21 ' A' ' 73' ' ' THR . 14.5 mp0 -79.8 56.26 2.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 110.24 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -78.07 -33.57 50.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.994 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 100' ' ' THR . 10.0 mp -88.64 -40.56 13.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.0 110.078 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.25 -82.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.462 -0.774 . . . . 0.0 110.62 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' LEU . 58.8 p -105.46 112.72 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 110.297 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.95 152.09 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.901 . . . . 0.0 110.009 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 104' ' ' ARG . 22.2 mt-10 -94.88 -24.04 17.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -0.849 . . . . 0.0 110.567 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 54.94 -88.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.498 -0.751 . . . . 0.0 110.341 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.2 OUTLIER -138.11 129.47 27.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.943 -1.098 . . . . 0.0 110.243 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.3 m -109.53 -5.56 15.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.898 . . . . 0.0 110.815 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -54.14 -64.06 4.61 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.91 92.39 3.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -1.164 . . . . 0.0 110.409 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -81.62 149.57 28.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.199 -0.938 . . . . 0.0 110.032 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -88.77 122.75 32.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.87 . . . . 0.0 110.125 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -81.33 158.76 24.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.985 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 91.83 -171.64 34.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.34 92.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.08 20.81 8.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.218 -1.166 . . . . 0.0 110.123 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -170.36 117.14 0.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.911 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.49 120.65 15.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 110.461 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' HA ' HD13 ' A' ' 116' ' ' LEU . 0.7 OUTLIER -109.86 96.67 6.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.27 -0.894 . . . . 0.0 110.001 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -166.06 145.39 6.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.378 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -154.02 -68.8 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 110.374 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.2 167.66 18.76 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.0 mtpp -137.12 149.45 47.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -1.121 . . . . 0.0 110.318 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 120' ' ' LYS . 93.7 t 55.62 104.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.453 -0.779 . . . . 0.0 110.508 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -53.88 -178.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.229 -0.919 . . . . 0.0 110.311 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 53.46 25.36 4.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.221 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.628 ' HA ' HG13 ' A' ' 127' ' ' VAL . . . -78.97 -31.1 44.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.283 -0.886 . . . . 0.0 110.46 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.7 p -54.23 -30.85 51.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.333 -0.854 . . . . 0.0 111.482 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.608 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -84.03 -56.22 3.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 109.295 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.782 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -55.87 -24.28 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 124' ' ' ALA . 4.5 mm -71.13 -44.67 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 126' ' ' ALA . 36.3 mt -61.41 -42.0 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.752 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.0 OUTLIER -57.7 -58.06 10.01 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.739 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.0 -21.76 65.12 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 108.994 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -58.03 -40.86 81.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.548 -0.72 . . . . 0.0 110.985 -179.616 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 1.051 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.5 p90 -81.64 -32.64 31.8 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.317 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.5 m-85 -52.62 -31.8 38.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.125 -0.985 . . . . 0.0 110.121 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.34 -27.13 38.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.775 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -13.84 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.403 -0.811 . . . . 0.0 110.625 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.3 -14.66 73.68 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.049 -1.265 . . . . 0.0 110.201 -179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.213 0.53 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.499 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 69.4 p -154.99 122.61 5.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.0 110.044 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -158.25 -92.44 0.09 OUTLIER Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.742 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.439 ' CG2' ' HA ' ' A' ' 54' ' ' PRO . 99.5 m -147.49 138.32 23.48 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.945 -1.326 . . . . 0.0 112.243 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.047 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -128.16 131.85 48.91 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.219 -0.926 . . . . 0.0 109.325 178.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.021 HD11 HG13 ' A' ' 19' ' ' VAL . 0.7 OUTLIER -128.89 132.73 47.74 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.433 178.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 130' ' ' LEU . . . -121.64 136.71 54.94 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.83 ' HE1' HG23 ' A' ' 57' ' ' ILE . 6.0 m-85 -128.14 149.33 50.47 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.195 -0.941 . . . . 0.0 111.939 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.718 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 4.6 t0 -104.01 93.92 5.12 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 175.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.66 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -99.09 126.37 44.81 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.54 -0.864 . . . . 0.0 112.663 -174.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -141.36 75.82 0.33 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.1 p 44.61 -102.71 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.61 -0.935 . . . . 0.0 111.253 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 70.1 mttt -90.05 45.85 1.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.628 -1.295 . . . . 0.0 110.6 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.843 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.1 p -140.68 129.42 22.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.214 -0.929 . . . . 0.0 110.351 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.851 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.4 mm -119.56 95.79 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.635 ' N ' HD12 ' A' ' 33' ' ' ILE . . . -124.69 111.28 1.53 Allowed Glycine 0 C--N 1.288 -2.102 0 N-CA-C 104.217 -3.553 . . . . 0.0 104.217 177.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 30' ' ' LEU . 65.4 t -140.29 163.24 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 C-N-CA 116.07 -2.252 . . . . 0.0 114.097 -175.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -124.56 130.41 52.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.464 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.021 HG13 HD11 ' A' ' 6' ' ' LEU . 20.1 t -100.34 121.25 50.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.33 136.97 13.97 Favored Glycine 0 N--CA 1.485 1.91 0 C-N-CA 119.117 -1.516 . . . . 0.0 112.626 -175.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.63 120.05 37.3 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 15.3 ttt180 -88.95 25.86 1.7 Allowed 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.695 0.759 . . . . 0.0 109.765 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.25 -37.55 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.55 -16.95 10.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.718 -0.613 . . . . 0.0 110.1 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 89.06 34.92 8.45 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.546 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.82 157.38 28.79 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.886 -1.361 . . . . 0.0 111.127 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.618 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -128.02 126.73 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.146 -0.971 . . . . 0.0 111.143 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.9 OUTLIER -87.32 154.85 54.49 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -89.89 133.73 2.12 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.337 1.178 . . . . 0.0 111.979 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.8 OUTLIER -98.66 144.08 27.49 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.2 Cg_endo -39.63 162.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.578 2.185 . . . . 0.0 115.104 -174.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.4 138.01 58.19 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 123.025 1.393 . . . . 0.0 113.715 -175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.843 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.8 51.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 113.015 -1.902 . . . . 0.0 115.73 -179.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 32' ' ' ALA . 32.3 mmtt -129.55 97.19 4.47 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.884 -1.135 . . . . 0.0 109.183 176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.03 159.75 17.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.97 . . . . 0.0 110.43 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 2.9 tp60 -88.08 123.96 33.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.287 -0.883 . . . . 0.0 110.803 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 49.5 25.59 1.43 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.197 -0.939 . . . . 0.0 110.061 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 90.33 18.96 47.51 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.757 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.2 m -92.87 107.71 26.6 Favored Pre-proline 0 C--N 1.306 -1.285 0 O-C-N 121.099 -1.236 . . . . 0.0 110.054 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.851 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.5 Cg_endo -71.23 157.62 56.75 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.572 1.301 . . . . 0.0 109.082 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.923 ' O ' HD12 ' A' ' 45' ' ' ILE . 32.4 m-20 -64.47 90.77 0.07 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.663 -1.273 . . . . 0.0 108.025 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 45.3 t-105 -77.52 -20.46 54.18 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.371 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.19 -30.94 30.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.67 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.771 HG21 HD21 ' A' ' 30' ' ' LEU . 31.4 mm -71.56 -56.06 11.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.83 -0.543 . . . . 0.0 111.764 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.3 mp -73.29 -37.11 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.769 -1.207 . . . . 0.0 110.642 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 23.3 tt0 -59.61 -31.08 69.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.873 -1.142 . . . . 0.0 109.486 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -70.53 -42.75 70.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.479 -0.763 . . . . 0.0 110.106 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 6' ' ' LEU . 15.1 mt -62.62 -54.21 43.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 111.494 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HA ' ' CD ' ' A' ' 54' ' ' PRO . 2.8 mp -52.61 -42.41 64.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.205 -0.934 . . . . 0.0 111.887 -178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -80.81 -51.65 8.38 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.975 -1.078 . . . . 0.0 112.302 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -84.33 -41.03 17.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.92 -1.113 . . . . 0.0 112.545 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.46 ' CD1' HD23 ' A' ' 48' ' ' LEU . 72.6 m95 -95.72 -28.42 14.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.755 -1.216 . . . . 0.0 112.105 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 48' ' ' LEU . 47.2 mt-30 51.96 91.67 0.07 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 120.822 -1.174 . . . . 0.0 109.887 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.9 Cg_endo -73.71 136.86 23.94 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.72 1.379 . . . . 0.0 111.439 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.6 t70 -75.82 -45.1 37.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.403 -0.811 . . . . 0.0 110.103 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.88 140.35 46.78 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.992 -1.068 . . . . 0.0 109.591 178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.83 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.8 mp -117.74 137.83 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.045 -1.034 . . . . 0.0 111.856 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.735 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -121.21 122.46 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.755 HG22 ' HB2' ' A' ' 8' ' ' PHE . 3.9 t -133.05 150.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 120.501 -1.375 . . . . 0.0 112.339 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 149.99 140.12 3.18 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -118.3 113.46 37.06 Favored Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.269 -1.136 . . . . 0.0 109.27 178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.609 ' N ' HD22 ' A' ' 61' ' ' LEU . 50.2 Cg_endo -84.07 115.86 2.06 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.375 1.197 . . . . 0.0 110.555 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' LEU . 52.3 tp -130.56 133.59 46.33 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 110.284 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -80.47 131.42 35.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.188 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.761 ' HG2' HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.28 -44.9 14.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 110.027 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -107.48 -11.28 15.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 0.0 110.334 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.2 -51.07 0.77 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 6.4 t -105.31 -165.14 1.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.382 -1.069 . . . . 0.0 109.572 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 68' ' ' THR . 19.1 pt-20 37.87 -157.12 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.165 0.507 . . . . 0.0 111.47 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -176.8 67.12 0.22 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.0 -30.08 14.16 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.921 1.485 . . . . 0.0 110.089 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD13 ' HG2' ' A' ' 65' ' ' MET . 1.1 tp -60.08 -30.01 68.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.42 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.602 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.88 -19.57 18.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.299 -0.875 . . . . 0.0 111.237 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.28 -33.39 5.53 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 109.646 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -80.05 -30.3 39.4 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -65.09 -45.05 86.78 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.382 -0.824 . . . . 0.0 108.908 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.432 ' HG2' ' HG ' ' A' ' 93' ' ' LEU . 7.8 mtp180 -55.18 -49.72 71.17 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.724 0.773 . . . . 0.0 109.441 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.45 -25.23 68.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.402 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.586 ' CE1' ' CD1' ' A' ' 10' ' ' PHE . 24.2 t80 -62.96 -45.62 91.58 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.963 -1.095 . . . . 0.0 108.604 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.424 ' CB ' ' HB2' ' A' ' 93' ' ' LEU . . . -54.93 -33.14 61.89 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -68.54 -23.48 64.52 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.225 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -73.9 -56.99 4.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 0.0 110.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.901 HD11 HG21 ' A' ' 91' ' ' VAL . 23.5 pt -57.84 -25.71 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 120.974 -1.079 . . . . 0.0 109.792 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -62.82 -52.71 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.44 -0.788 . . . . 0.0 110.121 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.75 -16.29 75.69 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 17.0 mmt-85 -65.04 -44.38 89.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.014 -1.286 . . . . 0.0 110.151 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.498 ' HB2' HG13 ' A' ' 89' ' ' VAL . 68.8 m-85 -119.08 -11.97 9.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.27 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.94 31.66 42.79 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 87' ' ' PHE . 29.1 m -94.19 153.82 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.905 . . . . 0.0 110.773 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -79.77 81.72 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.542 -0.724 . . . . 0.0 109.684 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.901 HG21 HD11 ' A' ' 83' ' ' ILE . 4.5 p -89.22 152.08 3.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 122.041 0.924 . . . . 0.0 111.232 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 57' ' ' ILE . 18.5 mmtt -124.52 131.24 53.49 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.912 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.3 125.86 40.22 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.126 -0.984 . . . . 0.0 108.861 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.803 ' N ' HD22 ' A' ' 93' ' ' LEU . 9.6 t-160 -87.97 101.7 14.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.361 -0.837 . . . . 0.0 110.445 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.41 143.92 49.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.808 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -79.59 57.59 2.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.176 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -63.52 -29.59 70.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 0.0 110.21 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -18.65 65.48 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.272 -0.892 . . . . 0.0 110.209 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 100' ' ' THR . 32.5 t -56.88 92.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 110.305 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER -157.38 127.73 6.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.165 179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.8 152.24 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.854 . . . . 0.0 110.184 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.7 mt-10 -97.31 -22.9 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 110.215 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 62.14 135.08 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.402 -0.811 . . . . 0.0 110.448 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.44 39.75 31.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 17.9 p -114.21 19.41 16.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.251 -0.905 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.84 -140.64 12.57 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.99 137.51 39.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 110.272 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.61 39.81 3.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 110.24 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -95.95 -59.17 1.91 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.194 -0.941 . . . . 0.0 110.18 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -75.75 -60.6 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 110.295 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.06 -53.93 0.4 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.84 -94.64 0.09 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 56.0 m-85 -125.75 79.79 1.85 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.205 -1.174 . . . . 0.0 110.362 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 51.78 57.4 6.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.226 -0.921 . . . . 0.0 110.313 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.63 173.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.24 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tp -134.15 -46.04 0.78 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.261 -0.9 . . . . 0.0 110.187 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -79.53 158.06 27.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 110.169 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' CG ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -153.83 80.35 1.15 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.158 -0.964 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.18 141.73 10.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -167.86 147.62 4.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -1.055 . . . . 0.0 110.082 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 45.7 t -64.32 139.52 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 110.336 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -173.24 -37.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 110.129 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 54.89 21.62 3.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.279 -0.888 . . . . 0.0 110.406 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.65 -25.01 52.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 110.098 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.436 ' O ' HG13 ' A' ' 129' ' ' ILE . 66.5 m -51.63 -22.57 3.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.285 -0.884 . . . . 0.0 110.694 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.73 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -84.09 -50.48 7.92 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.122 -0.986 . . . . 0.0 108.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.618 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -63.55 -23.86 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 176.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.457 ' HA ' HD13 ' A' ' 128' ' ' ILE . 8.3 mm -66.99 -41.7 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 175.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 126' ' ' ALA . 59.6 mt -65.85 -39.65 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.765 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -56.07 -57.2 13.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -21.63 64.49 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.023 -1.048 . . . . 0.0 109.307 178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.451 ' HB3' ' HA ' ' A' ' 129' ' ' ILE . 1.0 OUTLIER -56.65 -42.35 78.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -0.796 . . . . 0.0 110.688 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 1.047 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -78.94 -31.73 45.22 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.065 -1.454 . . . . 0.0 109.804 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.1 OUTLIER -63.33 -28.65 70.15 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.064 -1.054 . . . . 0.0 109.788 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.62 -24.36 39.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.28 -0.888 . . . . 0.0 109.891 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -13.18 32.69 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.518 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.35 -21.35 59.77 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.181 -1.188 . . . . 0.0 110.126 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 ttp . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.307 0.575 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -152.21 138.71 18.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 110.172 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -163.72 81.31 0.12 Allowed Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 55' ' ' ASP . 78.7 m -66.2 119.49 11.58 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.071 -1.253 . . . . 0.0 110.7 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -124.83 157.71 35.19 Favored 'General case' 0 C--N 1.285 -2.196 0 O-C-N 120.821 -1.174 . . . . 0.0 109.355 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.046 HD21 HD11 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -119.53 160.86 21.61 Favored 'General case' 0 C--N 1.293 -1.881 0 O-C-N 121.039 -1.038 . . . . 0.0 110.715 -177.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 130' ' ' LEU . . . -150.96 122.83 8.12 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.818 ' CD2' HG21 ' A' ' 17' ' ' VAL . 3.1 m-85 -122.61 148.51 45.15 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 118.756 -1.177 . . . . 0.0 112.04 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 10.9 t70 -116.52 94.71 4.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 175.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.842 ' O ' HD23 ' A' ' 61' ' ' LEU . 12.9 p90 -174.27 -158.43 0.08 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.256 -1.378 . . . . 0.0 113.505 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.529 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -174.15 -139.16 2.87 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.8 p -67.31 129.71 40.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -1.201 . . . . 0.0 112.234 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 tttp 52.61 28.26 5.95 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.63 -0.669 . . . . 0.0 112.352 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.77 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.03 128.02 20.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.754 -1.216 . . . . 0.0 110.252 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.943 HD11 ' HB3' ' A' ' 40' ' ' PRO . 39.2 mm -125.96 94.53 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -123.61 102.53 0.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 103.126 -3.99 . . . . 0.0 103.126 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.969 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -140.76 169.36 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 116.462 -2.095 . . . . 0.0 114.071 -174.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -128.46 138.0 52.08 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.053 -0.976 . . . . 0.0 108.473 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.732 HG13 HD21 ' A' ' 6' ' ' LEU . 17.4 t -102.29 133.05 47.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.796 -1.19 . . . . 0.0 108.208 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 5' ' ' LEU . . . -112.33 135.6 12.85 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.978 -1.582 . . . . 0.0 110.337 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.71 112.79 20.95 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.679 -0.894 . . . . 0.0 108.919 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 63.2 mtp180 -87.36 45.9 1.32 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.13 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -114.0 -37.36 2.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 177.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -119.19 -17.33 8.93 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.5 33.27 7.23 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.94 158.65 28.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.719 -1.46 . . . . 0.0 111.94 -178.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -123.31 122.09 37.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.341 -0.849 . . . . 0.0 109.856 178.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 19' ' ' VAL . 4.6 mmt180 -87.0 154.89 55.41 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.272 -0.893 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 53.7 Cg_endo -90.94 136.15 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.237 1.125 . . . . 0.0 111.924 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.969 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.92 140.77 21.78 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.507 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.08 170.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.85 2.367 . . . . 0.0 115.966 -174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.64 145.38 56.27 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.975 1.369 . . . . 0.0 114.23 -175.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.53 57.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 113.138 -1.846 . . . . 0.0 115.405 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -135.15 100.47 4.56 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.938 -1.101 . . . . 0.0 109.592 176.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.423 ' HB1' ' C ' ' A' ' 39' ' ' THR . . . -89.03 162.04 16.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.412 ' O ' ' HB ' ' A' ' 39' ' ' THR . 3.1 mm-40 -83.3 112.8 20.22 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.114 -0.991 . . . . 0.0 112.03 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 46.75 27.41 0.67 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.3 -0.875 . . . . 0.0 110.735 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 101.61 5.5 51.37 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.423 ' C ' ' HB1' ' A' ' 35' ' ' ALA . 6.5 m -102.7 108.05 56.58 Favored Pre-proline 0 C--N 1.309 -1.186 0 O-C-N 120.878 -1.366 . . . . 0.0 109.759 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.943 ' HB3' HD11 ' A' ' 15' ' ' ILE . 44.9 Cg_endo -70.47 156.12 62.17 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.718 1.378 . . . . 0.0 108.926 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.929 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.1 m-20 -64.42 90.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.573 -1.251 . . . . 0.0 107.819 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' N ' ' O ' ' A' ' 40' ' ' PRO . 2.8 t90 -89.32 -22.72 22.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.864 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -82.02 -30.0 31.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.99 0.9 . . . . 0.0 109.073 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.497 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 50.4 mm -73.11 -55.22 13.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.431 0.634 . . . . 0.0 110.443 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 41' ' ' ASP . 7.6 mt -67.47 -49.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.278 -0.889 . . . . 0.0 110.424 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -50.91 -41.45 58.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.906 -1.121 . . . . 0.0 110.807 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 21.9 mtp180 -60.59 -43.11 97.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.151 -0.968 . . . . 0.0 110.52 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.046 HD11 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -82.41 -23.16 35.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.123 -0.986 . . . . 0.0 109.483 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.783 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -73.57 -55.04 6.82 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.0 111.7 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -45.03 22.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.129 -0.982 . . . . 0.0 111.771 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 1.9 tp10 -53.31 -30.37 38.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.959 -1.088 . . . . 0.0 110.274 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.421 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 91.3 m95 -109.73 6.15 23.39 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 110.912 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.0 OUTLIER 65.62 110.23 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 120.925 -1.11 . . . . 0.0 109.549 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 49.4 Cg_endo -72.71 100.16 1.14 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 O-C-N 123.568 1.299 . . . . 0.0 111.496 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.673 ' N ' ' O ' ' A' ' 4' ' ' THR . 30.1 t70 -71.32 -44.2 65.59 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.293 -0.88 . . . . 0.0 110.124 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' N ' ' HB2' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -157.0 150.69 24.48 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.627 -1.296 . . . . 0.0 111.3 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.794 ' C ' HD13 ' A' ' 58' ' ' ILE . 5.3 mp -132.51 137.39 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.974 -1.078 . . . . 0.0 112.67 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.794 HD13 ' C ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -124.16 119.34 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.838 HG11 HD13 ' A' ' 83' ' ' ILE . 72.3 t -132.31 152.46 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.212 -1.555 . . . . 0.0 113.03 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 144.59 141.45 3.73 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.779 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 10' ' ' PHE . 1.7 pp -104.61 107.69 58.75 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.895 -1.356 . . . . 0.0 110.328 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -88.43 113.41 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 109.488 -1.004 . . . . 0.0 109.488 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -131.99 131.51 42.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.956 -1.09 . . . . 0.0 110.63 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.99 123.97 29.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 109.691 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.6 tpt -84.53 -44.28 13.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.891 -1.131 . . . . 0.0 109.668 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.42 -2.27 20.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 110.477 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.86 -25.73 19.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.89 -160.23 0.74 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -1.023 . . . . 0.0 109.742 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.13 163.2 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.151 -0.968 . . . . 0.0 110.665 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -146.05 107.37 4.24 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.94 -6.58 19.4 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 O-C-N 123.596 1.314 . . . . 0.0 110.754 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.28 -25.08 64.08 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 0.0 110.572 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.93 -19.06 5.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.301 -0.875 . . . . 0.0 111.412 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 77' ' ' ARG . . . -47.31 -35.39 7.89 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.006 -1.059 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -74.67 -27.87 60.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.392 -0.818 . . . . 0.0 109.119 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.507 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -66.79 -50.85 61.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.426 -0.796 . . . . 0.0 109.949 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 74' ' ' ALA . 2.0 mtp180 -54.36 -47.48 72.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 110.296 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -27.68 66.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.097 -1.002 . . . . 0.0 110.049 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' CE1' ' CE2' ' A' ' 10' ' ' PHE . 32.0 t80 -62.41 -42.05 99.15 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.333 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -56.86 -35.36 68.8 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -65.14 -23.91 67.26 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.774 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 79' ' ' PHE . 3.7 mtt180 -76.06 -57.8 3.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.178 -0.952 . . . . 0.0 110.824 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.838 HD13 HG11 ' A' ' 59' ' ' VAL . 12.6 pt -55.57 -24.2 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.916 -1.115 . . . . 0.0 110.436 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 5.2 t-160 -70.75 -58.4 3.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.139 -0.976 . . . . 0.0 110.474 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -64.49 -15.67 59.67 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -43.53 56.28 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.095 -1.238 . . . . 0.0 110.76 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.715 ' HB3' HG13 ' A' ' 89' ' ' VAL . 3.5 t80 -116.13 -11.73 11.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.09 -1.006 . . . . 0.0 110.73 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.48 37.32 36.04 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.715 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.3 m -101.13 153.95 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.654 -0.91 . . . . 0.0 110.819 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -76.97 80.45 3.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 0.0 110.394 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.572 HG21 ' CD1' ' A' ' 83' ' ' ILE . 1.4 p -89.55 151.74 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.197 -0.94 . . . . 0.0 111.494 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -130.14 138.6 50.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.5 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.887 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.83 130.85 38.3 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.126 -0.984 . . . . 0.0 108.821 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.864 ' N ' HD22 ' A' ' 93' ' ' LEU . 10.4 t-160 -83.34 120.72 26.21 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.234 -0.917 . . . . 0.0 110.68 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.95 143.24 28.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.29 -0.881 . . . . 0.0 110.18 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -74.17 82.93 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 110.013 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -19.42 39.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 0.0 110.755 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -25.33 64.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 0.0 110.205 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -115.61 88.23 2.84 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.262 -0.899 . . . . 0.0 109.918 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.6 m -138.04 -52.14 0.61 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.925 . . . . 0.0 110.648 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -80.48 152.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.59 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -94.63 -45.49 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.413 -0.805 . . . . 0.0 110.051 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.19 170.62 1.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 110.142 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -117.61 64.5 0.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 65.2 m -106.97 15.43 25.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.96 -76.36 0.67 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 93.42 0.91 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -1.199 . . . . 0.0 110.072 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -44.98 5.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.0 110.199 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -75.39 96.38 3.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.258 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -55.98 -28.19 56.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.026 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -98.09 115.15 5.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.98 160.73 10.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.483 ' CG ' ' O ' ' A' ' 113' ' ' TYR . 66.8 t80 53.71 35.67 21.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 0.0 110.013 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -61.64 165.43 5.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.258 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.39 110.6 0.89 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 110.029 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 116' ' ' LEU . 2.8 mm? -53.09 107.24 0.21 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.234 -0.916 . . . . 0.0 110.096 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -170.36 125.65 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.279 -0.888 . . . . 0.0 110.256 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.99 -25.89 11.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 110.132 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 152.93 77.69 0.02 OUTLIER Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -101.19 146.38 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -1.133 . . . . 0.0 110.066 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.16 24.9 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.405 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -87.75 58.24 4.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.995 . . . . 0.0 110.26 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB3' ' N ' ' A' ' 17' ' ' VAL . 2.5 m 55.04 29.33 12.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.263 -0.898 . . . . 0.0 110.481 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.779 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -67.61 -30.55 70.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 110.087 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.434 ' O ' ' HB ' ' A' ' 128' ' ' ILE . 8.5 m -61.9 -31.35 71.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 109.999 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.726 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -69.8 -55.66 9.24 Favored 'General case' 0 C--O 1.199 -1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 108.938 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.741 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -54.29 -23.22 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 176.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.779 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -75.95 -45.38 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.54 HG22 ' HB ' ' A' ' 58' ' ' ILE . 50.6 mt -58.73 -40.0 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 7' ' ' ALA 0.253 1.2 tm? -61.77 -54.82 37.12 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.548 -1.205 . . . . 0.0 107.812 178.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.14 -21.76 35.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -36.85 62.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.877 . . . . 0.0 110.349 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.749 ' CE2' HD11 ' A' ' 5' ' ' LEU . 0.1 OUTLIER -66.21 -36.53 83.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.964 -1.085 . . . . 0.0 109.753 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.402 ' CZ ' ' OH ' ' A' ' 133' ' ' TYR . 11.5 m-85 -56.04 -26.03 47.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.056 -1.028 . . . . 0.0 109.427 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -79.26 -27.46 42.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 -18.91 43.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.915 . . . . 0.0 110.109 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.51 51.64 56.62 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.155 -1.203 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 17.6 ttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.228 0.537 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER 179.9 -45.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 0.0 109.988 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . 171.62 -79.6 0.09 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.158 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 2' ' ' SER . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -64.81 143.05 98.72 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HG ' ' A' ' 61' ' ' LEU . 42.9 Cg_endo -68.6 148.84 73.22 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.612 1.322 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.21 163.57 12.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.386 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.14 148.67 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -24.3 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -84.49 -11.58 55.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.9 62.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 t -68.97 -172.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -1.195 . . . . 0.0 110.183 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -61.23 125.6 24.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 110.075 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.09 78.65 3.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.689 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.82 -7.69 20.39 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.719 1.379 . . . . 0.0 110.566 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -27.81 12.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.028 -1.045 . . . . 0.0 110.644 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -57.76 -22.08 45.0 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.102 -0.999 . . . . 0.0 110.892 -179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.75 -30.4 5.58 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.004 -1.06 . . . . 0.0 108.849 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -82.46 -31.49 29.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -59.93 -48.68 80.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.404 -0.81 . . . . 0.0 109.536 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -91.23 115.28 27.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.11 144.27 55.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -99.06 45.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -87.83 -22.82 24.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.078 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 98' ' ' LEU . 9.9 tt -70.45 -23.75 62.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -98.76 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 m -154.86 63.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -72.52 152.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -86.42 -43.34 12.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.164 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.61 111.19 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -152.91 -166.02 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.12 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -25.06 9.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.23 108.26 2.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.24 -161.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.325 -1.103 . . . . 0.0 110.666 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -151.94 175.59 12.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.35 -0.843 . . . . 0.0 110.271 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.89 -64.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -105.64 153.48 21.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.812 . . . . 0.0 110.142 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.76 119.87 0.79 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.72 23.83 11.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -125.32 -38.54 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 0.0 110.086 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -143.93 110.57 5.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 116' ' ' LEU . . . -102.49 -25.28 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -158.75 99.47 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.326 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.9 t30 -158.29 -152.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 120' ' ' LYS . 16.1 mttt 58.02 -84.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.514 -0.742 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' ASN . . . -70.15 66.07 0.71 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 118' ' ' LYS . 29.3 tttt -124.92 -48.33 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.107 . . . . 0.0 110.002 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.2 p -145.19 75.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.089 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.1 142.33 58.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t -176.07 -37.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.96 -22.7 42.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -87.57 12.65 11.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.618 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.67 21.07 3.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.133 -1.216 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.149 0.5 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 0.9 OUTLIER 54.36 -173.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.19 -0.944 . . . . 0.0 110.182 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.05 -61.72 0.65 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.969 -1.312 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.58 127.81 34.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.991 -1.3 . . . . 0.0 112.151 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.83 29.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.748 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.56 32.8 0.94 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.744 0.783 . . . . 0.0 110.038 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.6 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.6 70.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.65 -53.05 8.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 0.0 110.883 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.897 -1.127 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.47 137.6 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.999 -1.063 . . . . 0.0 112.088 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -99.62 114.34 65.55 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.061 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 51.0 Cg_endo -94.17 112.37 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.164 1.086 . . . . 0.0 109.465 179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -132.85 133.13 42.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 110.342 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' A' ' 68' ' ' THR . 26.3 m120 -80.81 125.25 29.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.298 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.3 tpt -82.83 -45.61 14.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 110.214 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -108.09 15.71 24.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.93 19.03 25.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.446 ' N ' ' HB3' ' A' ' 64' ' ' ASN . 6.2 t -165.4 -147.41 0.1 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -1.194 . . . . 0.0 110.057 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.89 165.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 0.0 110.866 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -164.41 131.71 2.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 109.643 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.02 -12.08 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.316 1.166 . . . . 0.0 110.932 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.49 -27.83 40.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.022 -1.049 . . . . 0.0 110.224 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.91 -19.7 13.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.18 -0.95 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.89 -34.94 5.88 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -30.78 26.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -61.74 -51.48 68.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.78 . . . . 0.0 109.493 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.06 -22.71 67.05 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 109.021 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.374 -0.829 . . . . 0.0 110.428 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.34 16.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.32 40.0 41.91 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.889 -1.685 . . . . 0.0 108.889 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.65 154.12 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.565 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.84 84.71 7.28 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.495 -0.753 . . . . 0.0 110.246 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 -82.73 117.12 22.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.37 138.48 31.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.006 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.36 28.42 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.367 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -79.69 -41.02 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.803 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 -26.42 21.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.697 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 m 52.92 177.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.492 -0.755 . . . . 0.0 110.493 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.9 p -85.94 130.12 34.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.86 . . . . 0.0 110.106 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.17 152.43 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.145 -0.972 . . . . 0.0 110.2 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 2.4 mt-10 -91.42 -35.74 14.19 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.032 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 54.25 -150.72 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 110.027 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -112.15 68.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 p -83.82 -19.74 34.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.354 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.65 129.5 1.54 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.41 59.85 1.59 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -1.143 . . . . 0.0 109.922 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.456 ' O ' ' CD2' ' A' ' 108' ' ' PHE . 79.4 t80 -151.79 64.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.36 -157.65 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.241 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.76 -169.57 3.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.57 89.2 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.4 149.3 43.0 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -103.48 49.84 0.82 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -1.134 . . . . 0.0 110.143 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.46 -58.32 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.51 62.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.64 100.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.08 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.08 87.77 7.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.919 . . . . 0.0 110.25 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -122.27 -33.21 3.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.293 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.25 -30.2 57.34 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -94.75 -78.14 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -1.067 . . . . 0.0 110.026 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 t 58.31 162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.322 -0.861 . . . . 0.0 110.141 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.79 40.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.417 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m -144.5 -42.85 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.351 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -80.3 -20.65 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -91.76 -21.48 20.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.339 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.25 26.58 64.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.14 -1.212 . . . . 0.0 110.341 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 17.6 ttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.228 0.537 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.486 ' N ' ' HG2' ' A' ' 22' ' ' ARG . 0.4 OUTLIER 179.9 -45.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.309 -0.869 . . . . 0.0 109.988 -179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.403 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . 171.62 -79.6 0.09 OUTLIER Glycine 0 N--CA 1.486 2.005 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.158 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.432 ' HB ' ' HA ' ' A' ' 54' ' ' PRO . 96.7 m -146.78 134.31 20.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.933 -1.333 . . . . 0.0 112.341 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.056 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.99 142.58 51.2 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.042 HD11 HG13 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -132.75 135.03 45.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.483 -1.385 . . . . 0.0 110.835 179.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.517 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.4 124.83 46.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.546 -0.721 . . . . 0.0 109.69 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 17' ' ' VAL . 20.0 m-85 -111.98 134.23 53.66 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 111.18 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.802 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 21.3 t70 -111.76 93.33 4.41 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.897 ' HD2' HD13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -175.96 -159.06 0.06 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 118.447 -1.301 . . . . 0.0 113.111 -177.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 79' ' ' PHE . . . -170.72 -150.07 6.78 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 79' ' ' PHE . 1.6 p -71.66 141.82 49.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.956 -1.32 . . . . 0.0 111.535 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.23 8.19 3.24 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.561 -0.712 . . . . 0.0 112.48 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.52 129.28 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.638 -1.289 . . . . 0.0 110.834 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.897 HD13 ' HD2' ' A' ' 10' ' ' PHE . 35.7 mm -125.46 96.05 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.433 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -126.93 103.27 0.65 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 103.543 -3.823 . . . . 0.0 103.543 176.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.987 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.32 170.85 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 116.235 -2.186 . . . . 0.0 114.591 -174.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.571 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -126.32 137.89 53.53 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.393 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 6' ' ' LEU . 39.5 t -102.37 125.5 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.09 136.02 13.27 Favored Glycine 0 N--CA 1.482 1.72 0 C-N-CA 118.401 -1.857 . . . . 0.0 111.185 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -94.95 114.24 26.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HG2' ' N ' ' A' ' 2' ' ' SER . 5.8 ttt180 -87.43 34.64 0.7 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.689 0.757 . . . . 0.0 110.019 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 HG22 ' N ' ' A' ' 24' ' ' THR . 0.9 OUTLIER -111.03 -43.44 5.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 179.039 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.417 ' N ' HG22 ' A' ' 23' ' ' ILE . 27.9 m -118.02 -17.38 9.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.832 -0.542 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 97.16 35.59 5.23 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.992 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 160.67 21.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.577 -1.543 . . . . 0.0 111.443 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.627 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.08 140.5 52.84 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.119 0.961 . . . . 0.0 111.916 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.445 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -100.31 153.82 37.54 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 52.6 Cg_endo -90.62 130.55 1.56 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 123.235 1.124 . . . . 0.0 111.429 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.987 HD22 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -98.51 141.63 23.25 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' CD ' HD23 ' A' ' 30' ' ' LEU . 18.8 Cg_endo -39.79 164.29 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.846 2.364 . . . . 0.0 115.852 -174.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.19 143.24 58.04 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.883 -175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.89 51.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 113.376 -1.738 . . . . 0.0 115.536 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -129.86 95.4 3.95 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.698 -1.251 . . . . 0.0 109.746 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.4 161.03 16.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.28 -0.888 . . . . 0.0 109.779 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 1.6 mm-40 -92.23 119.64 32.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.033 -1.042 . . . . 0.0 111.408 -178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 47.62 29.73 1.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.0 110.67 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.1 14.42 56.16 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.536 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.09 105.94 19.96 Favored Pre-proline 0 C--N 1.307 -1.261 0 O-C-N 120.985 -1.303 . . . . 0.0 109.68 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.674 ' CB ' HD11 ' A' ' 15' ' ' ILE . 42.0 Cg_endo -68.88 159.83 52.24 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.572 1.301 . . . . 0.0 109.493 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.954 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.5 m-20 -64.0 91.2 0.07 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.0 -1.062 . . . . 0.0 109.048 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.43 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 68.7 t-105 -93.44 -17.36 23.56 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' HB3' HD12 ' A' ' 44' ' ' ILE . 4.2 t30 -80.79 -39.69 26.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -0.868 . . . . 0.0 109.343 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -75.86 -54.03 14.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.854 -0.529 . . . . 0.0 110.142 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.954 HD12 ' O ' ' A' ' 41' ' ' ASP . 19.5 mt -62.03 -39.28 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 110.792 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -66.31 -34.87 78.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.843 -1.16 . . . . 0.0 110.42 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -65.58 -42.18 92.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.271 -0.893 . . . . 0.0 110.327 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.977 ' O ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.15 -23.91 37.95 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.189 -0.944 . . . . 0.0 109.35 -179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.863 ' N ' HD13 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -62.33 -52.13 64.87 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.002 -1.061 . . . . 0.0 111.016 179.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -76.2 -29.49 57.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 111.474 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.45 -35.67 46.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.592 ' HB2' HD22 ' A' ' 48' ' ' LEU . 24.4 m95 -109.53 -20.21 12.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.069 -1.019 . . . . 0.0 111.272 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.41 ' O ' ' HB ' ' A' ' 4' ' ' THR . 28.8 mt-30 53.64 89.17 0.11 Allowed Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.023 -1.048 . . . . 0.0 109.753 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.7 Cg_endo -68.61 129.81 19.58 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.807 1.425 . . . . 0.0 111.471 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 4' ' ' THR . 17.6 t0 -86.95 -38.39 16.7 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 111.056 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.8 mt-10 -132.34 157.3 44.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.823 -1.173 . . . . 0.0 110.032 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.617 HG22 HG23 ' A' ' 59' ' ' VAL . 4.7 mp -133.21 137.17 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.982 -1.074 . . . . 0.0 112.538 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.056 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.21 116.84 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.918 HG21 HD12 ' A' ' 83' ' ' ILE . 53.1 t -133.36 150.75 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 120.037 -1.665 . . . . 0.0 113.301 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.4 123.57 0.68 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.2 OUTLIER -64.81 143.05 98.72 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.272 . . . . 0.0 108.782 178.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' HG ' ' A' ' 61' ' ' LEU . 42.9 Cg_endo -68.6 148.84 73.22 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.612 1.322 . . . . 0.0 110.571 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.21 163.57 12.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.263 -0.898 . . . . 0.0 110.386 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.14 148.67 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.188 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.37 -24.3 62.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -84.49 -11.58 55.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.11 21.9 62.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.9 t -68.97 -172.89 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.168 -1.195 . . . . 0.0 110.183 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -61.23 125.6 24.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.0 110.075 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -158.09 78.65 3.35 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.207 -0.933 . . . . 0.0 110.689 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.82 -7.69 20.39 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.719 1.379 . . . . 0.0 110.566 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.64 -27.81 12.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.028 -1.045 . . . . 0.0 110.644 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.491 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -57.76 -22.08 45.0 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.102 -0.999 . . . . 0.0 110.892 -179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.75 -30.4 5.58 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.004 -1.06 . . . . 0.0 108.849 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -82.46 -31.49 29.4 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -59.93 -48.68 80.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.404 -0.81 . . . . 0.0 109.536 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' HA ' HD21 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -61.13 -48.85 79.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -66.79 -25.47 66.48 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.078 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.599 ' HD2' HG23 ' A' ' 12' ' ' THR . 10.3 t80 -67.69 -39.27 84.46 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 83' ' ' ILE . . . -57.97 -34.82 70.35 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -75.2 -22.93 57.64 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.313 -0.867 . . . . 0.0 109.005 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -57.13 5.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.781 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.918 HD12 HG21 ' A' ' 59' ' ' VAL . 29.4 pt -56.17 -30.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 109.468 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.428 ' N ' HG13 ' A' ' 83' ' ' ILE . 3.5 t-160 -59.46 -56.99 15.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.584 -0.698 . . . . 0.0 110.129 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.34 -16.59 79.81 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -43.35 99.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.005 -1.291 . . . . 0.0 109.624 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE2' HD23 ' A' ' 49' ' ' LEU . 5.7 t80 -119.09 -12.79 9.44 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.319 -0.863 . . . . 0.0 110.244 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.39 41.96 10.96 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.629 -1.788 . . . . 0.0 108.629 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' A' ' 57' ' ' ILE . 30.9 m -114.8 153.8 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.578 -0.954 . . . . 0.0 110.869 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.7 99.85 4.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.615 -0.678 . . . . 0.0 110.214 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.878 HG21 HD11 ' A' ' 83' ' ' ILE . 5.9 p -89.12 152.22 3.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.293 -0.879 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.92 135.07 55.03 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.243 0.544 . . . . 0.0 110.081 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -95.22 128.42 42.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.219 -0.926 . . . . 0.0 110.539 -179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -91.23 115.28 27.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.257 -0.902 . . . . 0.0 110.286 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.11 144.27 55.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -0.942 . . . . 0.0 110.291 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -99.06 45.11 1.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.394 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -87.83 -22.82 24.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 110.078 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD23 ' O ' ' A' ' 98' ' ' LEU . 9.9 tt -70.45 -23.75 62.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.305 -0.872 . . . . 0.0 110.437 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 m -98.76 43.14 1.07 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 110.34 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.4 m -154.86 63.54 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.204 -0.935 . . . . 0.0 110.111 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.0 p -72.52 152.23 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.25 -0.906 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 52.9 tt0 -86.42 -43.34 12.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.439 -0.788 . . . . 0.0 110.164 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.61 111.19 1.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.845 . . . . 0.0 110.123 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -152.91 -166.02 2.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 110.12 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.84 -25.06 9.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.23 108.26 2.72 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt 50.24 -161.73 0.06 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.325 -1.103 . . . . 0.0 110.666 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -151.94 175.59 12.34 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.35 -0.843 . . . . 0.0 110.271 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -162.89 -64.53 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.289 -0.882 . . . . 0.0 110.101 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -105.64 153.48 21.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.4 -0.812 . . . . 0.0 110.142 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -172.76 119.87 0.79 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -114.72 23.83 11.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -125.32 -38.54 2.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.305 -1.115 . . . . 0.0 110.086 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -143.93 110.57 5.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.827 ' O ' HD12 ' A' ' 116' ' ' LEU . . . -102.49 -25.28 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 110.301 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 115' ' ' ALA . 0.3 OUTLIER -158.75 99.47 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.898 . . . . 0.0 110.326 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 119' ' ' GLY . 3.9 t30 -158.29 -152.44 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 110.22 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 120' ' ' LYS . 16.1 mttt 58.02 -84.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.514 -0.742 . . . . 0.0 110.423 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 117' ' ' ASN . . . -70.15 66.07 0.71 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 118' ' ' LYS . 29.3 tttt -124.92 -48.33 1.76 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -1.107 . . . . 0.0 110.002 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.2 p -145.19 75.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.089 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.1 142.33 58.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.275 -0.891 . . . . 0.0 110.293 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 5.2 t -176.07 -37.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.206 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -73.06 -26.27 61.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 110.252 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.0 t -51.63 -24.68 5.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.304 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.802 ' HB2' ' HB3' ' A' ' 9' ' ' ASP . . . -84.45 -50.8 7.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.28 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.627 HG13 ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -60.88 -22.98 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HA ' HD13 ' A' ' 128' ' ' ILE . 9.1 mm -70.55 -43.56 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.609 HG22 ' HB ' ' A' ' 58' ' ' ILE . 53.7 mt -62.57 -39.11 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.678 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -61.87 -33.55 74.39 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.07 -21.43 63.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.137 . . . . 0.0 109.794 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -72.58 -47.82 44.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 110.827 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.681 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.36 -39.71 88.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.853 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.678 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.8 m-85 -54.06 -34.1 59.17 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.835 -1.166 . . . . 0.0 109.62 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -79.96 -22.7 42.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.436 -0.79 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -87.57 12.65 11.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 110.618 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.67 21.07 3.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.133 -1.216 . . . . 0.0 110.309 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.218 0.532 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.25 119.93 25.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.17 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -165.84 -89.62 0.07 OUTLIER Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp -65.47 149.7 96.84 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 Cg_endo -67.91 147.15 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.595 1.313 . . . . 0.0 110.66 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -91.2 164.75 13.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 110.281 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.655 ' O ' HD12 ' A' ' 63' ' ' LEU . 26.6 m-80 -50.64 141.89 11.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.17 -25.97 48.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -4.79 55.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.9 31.71 61.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -179.32 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -1.099 . . . . 0.0 110.21 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.99 119.33 10.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.809 . . . . 0.0 109.927 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.36 91.17 5.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 110.002 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.99 -9.24 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.699 1.368 . . . . 0.0 110.457 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -24.08 8.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 110.154 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.09 -21.12 7.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.275 -0.89 . . . . 0.0 110.661 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.53 7.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 108.697 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -78.34 -33.01 49.42 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -57.06 -46.15 82.7 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.345 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 -82.08 110.79 17.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 128.43 34.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.295 -0.878 . . . . 0.0 110.31 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -126.59 48.85 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.979 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -72.91 -30.82 64.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.478 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -78.23 -21.7 49.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.156 -0.965 . . . . 0.0 110.188 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.442 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 1.2 m 49.35 70.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.93 . . . . 0.0 110.728 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m 55.84 103.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.882 . . . . 0.0 110.499 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.46 151.78 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.923 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 104' ' ' ARG . 3.5 tt0 -90.18 -21.45 22.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 55.53 -87.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 110.298 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -83.62 114.55 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -96.27 -7.41 35.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.57 106.86 2.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -173.37 4.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -1.109 . . . . 0.0 110.018 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.71 154.66 17.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -47.1 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.275 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.32 124.51 40.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.38 56.81 2.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.69 -146.98 20.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -72.71 65.79 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -1.127 . . . . 0.0 110.215 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 53.32 -178.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.95 24.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pp -164.74 152.14 11.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.133 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.68 -81.83 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -149.07 145.77 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.56 40.56 1.2 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.04 147.52 32.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -1.13 . . . . 0.0 110.076 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.69 19.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.446 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -86.57 64.44 8.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t 52.2 33.42 12.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -80.39 -20.95 42.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -78.85 -6.76 56.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 0.0 110.777 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.63 -43.6 3.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.217 -1.167 . . . . 0.0 110.313 -179.909 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.248 0.547 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 10.2 p -172.4 -168.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . 109.33 -46.42 1.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.67 120.07 33.39 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.64 118.09 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 120.756 0.97 . . . . 0.0 110.528 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.4 133.47 47.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.145 -0.972 . . . . 0.0 110.64 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.7 125.71 30.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.2 tpt -83.74 -43.79 15.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.62 19.99 19.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.454 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.66 -39.7 2.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -124.79 -175.19 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.563 -0.963 . . . . 0.0 109.353 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 48.72 -166.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.098 -1.001 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 74.48 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.25 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.05 -24.87 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 110.311 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.2 tp -67.56 -24.91 65.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 0.0 110.648 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.48 -20.59 7.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.147 -0.971 . . . . 0.0 111.254 -179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.38 -34.22 10.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.989 -1.069 . . . . 0.0 109.324 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -57.63 -47.36 82.42 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 -83.68 100.18 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -99.12 145.65 26.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.264 -0.898 . . . . 0.0 111.287 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.1 55.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.357 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.22 -17.01 38.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 110.987 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -32.48 73.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.068 -1.02 . . . . 0.0 110.371 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.3 t 55.03 171.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.32 -0.863 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 m -122.73 111.24 16.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 151.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 110.108 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -75.98 -43.74 43.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.238 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.63 89.44 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -144.91 -56.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -110.08 -20.79 12.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.38 70.62 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 107' ' ' LEU . 3.1 mm? 53.14 -172.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -102.93 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.141 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 164.75 17.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 110.163 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.47 -158.65 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.44 -109.9 0.76 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.65 95.16 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 -64.14 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.204 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -109.43 -178.95 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.159 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.15 123.64 31.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -54.92 41.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.89 163.55 25.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.871 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.79 -43.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.71 124.25 1.35 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 55.76 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -1.08 . . . . 0.0 109.858 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 121' ' ' VAL . 39.0 t -56.17 -65.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.431 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.85 139.63 13.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.43 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t 54.88 31.3 15.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -0.825 . . . . 0.0 110.477 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -72.82 -20.41 61.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.45 -18.45 54.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.533 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -178.81 77.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.447 ' OXT' ' CD1' ' A' ' 138' ' ' TYR . 10.7 t80 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.235 -1.156 . . . . 0.0 109.91 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.109 0.48 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.478 ' CB ' ' HG2' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -129.32 -44.71 1.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.372 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . 170.51 -79.65 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.413 -1.375 . . . . 0.0 110.22 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HG2' ' CB ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 147.62 98.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.23 148.61 44.27 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.895 1.471 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 70' ' ' GLN . 12.7 tp -96.34 160.69 14.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -0.837 . . . . 0.0 109.995 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -75.08 135.53 41.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.164 -0.96 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 -43.35 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.62 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.32 14.31 29.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.77 30.45 9.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.87 -158.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -1.076 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 172.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.793 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.2 tp60 -160.0 80.98 2.41 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.22 -13.99 31.28 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.679 1.357 . . . . 0.0 110.313 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.92 -25.38 63.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.26 -20.35 10.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 111.629 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -36.88 12.31 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.914 -1.116 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -75.33 -27.88 59.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.411 -0.806 . . . . 0.0 108.867 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -61.28 -45.71 93.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.566 -0.709 . . . . 0.0 109.872 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 -89.45 113.87 25.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.3 144.79 56.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.411 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.47 86.92 6.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.65 52.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.608 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -18.72 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.428 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -63.49 -178.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -113.75 161.62 17.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.26 152.71 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.24 -37.8 84.39 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.053 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.95 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.87 . . . . 0.0 110.511 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -73.85 0.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.995 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -98.54 -20.78 16.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.66 58.78 12.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 102.99 4.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.69 115.73 30.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.947 . . . . 0.0 110.108 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 -54.81 19.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.548 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.78 172.02 19.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.282 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 101.22 91.05 2.11 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.37 103.55 1.68 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -56.84 -39.56 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.237 . . . . 0.0 110.167 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.92 146.21 2.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -169.84 141.17 2.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.21 106.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.29 161.92 0.83 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.409 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 174.11 9.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.17 -108.22 3.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -140.72 47.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.9 p -151.45 111.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 110.288 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -106.32 16.79 24.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -78.13 -24.18 47.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -79.43 -17.83 53.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 133' ' ' TYR . 2.6 mm-40 -79.27 -1.55 37.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.05 45.05 0.59 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 25.3 p90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.159 . . . . 0.0 110.242 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.149 0.5 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 0.9 OUTLIER 54.36 -173.41 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.19 -0.944 . . . . 0.0 110.182 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.05 -61.72 0.65 Allowed Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 55' ' ' ASP . 90.8 m -148.41 138.89 22.72 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.005 -1.291 . . . . 0.0 111.597 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.08 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.77 147.6 50.79 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.063 -1.023 . . . . 0.0 110.87 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.755 HD21 HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -129.98 136.61 49.62 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.581 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -131.16 124.08 29.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 0.0 110.229 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.845 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.8 m-85 -112.22 144.54 41.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.873 0.844 . . . . 0.0 112.094 -178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.6 t70 -128.22 93.33 3.63 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' SER . 15.3 p90 -177.16 -159.05 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.501 -1.28 . . . . 0.0 113.583 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.535 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -173.94 -137.99 2.56 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.0 p -68.6 127.83 34.45 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.991 -1.3 . . . . 0.0 112.196 -178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.4 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER 55.56 27.94 11.12 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 112.286 178.402 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -141.18 128.91 21.59 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.818 -1.176 . . . . 0.0 110.021 179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.697 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 46.8 mm -126.85 98.61 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.15 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -127.18 109.57 1.09 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 104.014 -3.634 . . . . 0.0 104.014 176.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.924 ' CG1' HD13 ' A' ' 30' ' ' LEU . 76.0 t -140.52 166.89 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 116.381 -2.128 . . . . 0.0 114.273 -175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.06 131.58 50.89 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.205 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.877 ' CG1' HD22 ' A' ' 48' ' ' LEU . 5.2 t -99.62 125.38 53.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.73 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -112.66 136.94 13.87 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.929 -1.605 . . . . 0.0 112.655 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.01 114.87 29.36 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.747 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -90.61 32.78 0.94 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.744 0.783 . . . . 0.0 110.009 -178.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.02 -37.01 2.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.155 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 23' ' ' ILE . 37.8 m -117.13 -17.19 10.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.462 -0.774 . . . . 0.0 109.747 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.473 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 91.34 34.53 7.45 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.807 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.85 161.07 21.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.788 -1.419 . . . . 0.0 111.143 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.537 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -131.49 125.94 33.71 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.351 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -87.56 154.09 53.41 Favored Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -90.73 135.44 2.0 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.323 1.17 . . . . 0.0 112.407 -177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.924 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.85 142.9 25.4 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 20.5 Cg_endo -42.01 164.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.587 2.191 . . . . 0.0 115.11 -175.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.65 143.93 57.58 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.848 1.309 . . . . 0.0 113.979 -176.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -54.19 53.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 113.515 -1.675 . . . . 0.0 115.448 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.6 98.03 4.54 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.688 -1.258 . . . . 0.0 109.016 176.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.89 157.92 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.56 118.45 23.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.227 -0.921 . . . . 0.0 111.119 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 48.16 29.87 1.97 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.299 -0.876 . . . . 0.0 110.446 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.64 15.6 54.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 22.8 m -94.19 109.49 42.68 Favored Pre-proline 0 C--N 1.308 -1.236 0 O-C-N 121.054 -1.262 . . . . 0.0 110.032 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.686 ' CB ' HD11 ' A' ' 15' ' ' ILE . 45.0 Cg_endo -71.6 157.93 54.79 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 O-C-N 123.544 1.286 . . . . 0.0 109.608 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.967 ' O ' HD12 ' A' ' 45' ' ' ILE . 94.6 m-20 -64.27 92.21 0.08 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.886 -1.134 . . . . 0.0 108.63 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.531 ' CD1' ' HG3' ' A' ' 46' ' ' GLU . 8.0 t-105 -90.25 -20.47 22.95 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -81.42 -42.23 20.71 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.839 0.828 . . . . 0.0 109.883 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 47' ' ' ARG . 1.4 mp -69.76 -55.19 15.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.673 -0.642 . . . . 0.0 111.084 -178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.967 HD12 ' O ' ' A' ' 41' ' ' ASP . 10.7 mt -64.0 -35.14 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.802 -1.186 . . . . 0.0 110.604 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.531 ' HG3' ' CD1' ' A' ' 42' ' ' TRP . 4.6 mm-40 -53.54 -43.94 68.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.949 -1.094 . . . . 0.0 109.4 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 44' ' ' ILE . 11.5 mtp180 -60.35 -41.26 93.27 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.504 -0.748 . . . . 0.0 110.008 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.877 HD22 ' CG1' ' A' ' 19' ' ' VAL . 22.5 mt -64.85 -29.58 70.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 0.0 110.442 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' CD1' HG22 ' A' ' 45' ' ' ILE . 5.7 mp -76.69 -53.06 8.5 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.139 -0.975 . . . . 0.0 110.858 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -80.49 -37.51 31.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.176 -0.952 . . . . 0.0 111.426 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 14.7 tt0 -84.54 -41.59 16.33 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.89 -1.131 . . . . 0.0 111.805 -178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.541 ' HD1' HD23 ' A' ' 48' ' ' LEU . 52.7 m95 -103.11 -24.67 13.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.912 -1.117 . . . . 0.0 111.248 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 51.48 87.02 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.861 -1.15 . . . . 0.0 109.916 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 47.6 Cg_endo -73.22 128.18 12.7 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.719 1.378 . . . . 0.0 110.721 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -70.76 -43.95 67.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.384 -0.822 . . . . 0.0 110.136 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -134.27 138.99 45.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.87 -1.144 . . . . 0.0 109.637 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.612 ' C ' HD13 ' A' ' 58' ' ' ILE . 4.7 mp -124.51 137.64 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.999 -1.063 . . . . 0.0 112.044 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.703 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -116.9 122.23 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.845 HG22 ' HB2' ' A' ' 8' ' ' PHE . 54.9 t -133.11 151.36 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.588 -1.32 . . . . 0.0 112.344 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 148.16 142.12 3.6 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.184 -1.007 . . . . 0.0 110.81 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -99.62 114.3 65.52 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.14 -1.212 . . . . 0.0 109.085 178.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 51.0 Cg_endo -94.14 112.37 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.225 1.119 . . . . 0.0 109.465 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.6 HD23 HD21 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -132.85 133.13 42.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.051 -1.03 . . . . 0.0 110.342 179.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.446 ' HB3' ' N ' ' A' ' 68' ' ' THR . 26.4 m120 -80.81 125.25 29.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.032 -1.043 . . . . 0.0 109.298 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.3 tpt -82.83 -45.61 14.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.925 -1.11 . . . . 0.0 110.214 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -108.09 15.71 24.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.93 19.03 25.43 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.446 ' N ' ' HB3' ' A' ' 64' ' ' ASN . 6.2 t -165.4 -147.41 0.1 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -1.194 . . . . 0.0 110.057 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -55.89 165.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 0.0 110.866 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' NE2' ' O ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -164.41 131.71 2.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.413 -0.805 . . . . 0.0 109.643 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.02 -12.08 25.74 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.316 1.166 . . . . 0.0 110.932 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.5 -27.84 40.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.022 -1.049 . . . . 0.0 110.165 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.91 -19.7 13.09 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.18 -0.95 . . . . 0.0 110.918 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -46.89 -34.94 5.88 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.186 -0.946 . . . . 0.0 109.328 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -30.78 26.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB3' HG22 ' A' ' 73' ' ' THR . . . -61.74 -51.48 68.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.451 -0.78 . . . . 0.0 109.493 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.7 mtp85 -59.88 -48.43 81.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.133 -0.979 . . . . 0.0 109.158 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -57.37 -28.86 63.55 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.371 -0.831 . . . . 0.0 109.457 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 76' ' ' ALA . 23.5 t80 -60.24 -42.86 96.17 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.898 -1.121 . . . . 0.0 108.415 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.679 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -55.38 -36.64 66.6 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -22.79 67.08 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.591 -0.843 . . . . 0.0 108.996 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -58.47 3.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.391 -0.818 . . . . 0.0 110.428 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 59' ' ' VAL . 24.6 pt -60.88 -33.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.969 -1.082 . . . . 0.0 109.924 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 89' ' ' VAL . 7.8 t-160 -56.66 -58.23 8.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.279 -0.888 . . . . 0.0 110.123 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.79 -16.29 72.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -44.04 21.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.937 -1.331 . . . . 0.0 110.552 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.76 -12.36 16.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.153 -0.967 . . . . 0.0 110.59 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 40.03 41.61 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CD2' ' A' ' 84' ' ' HIS . 34.9 m -112.66 154.09 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.475 -1.014 . . . . 0.0 110.594 -179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.81 84.71 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.455 -0.778 . . . . 0.0 110.246 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.706 HG21 HD11 ' A' ' 83' ' ' ILE . 1.4 p -89.78 151.6 3.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 111.287 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 29.9 mttt -116.52 158.06 24.24 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.679 ' CD2' ' HB3' ' A' ' 80' ' ' ALA . 35.5 mt -92.0 139.49 30.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.928 -1.108 . . . . 0.0 110.635 -179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.49 ' CG ' HG12 ' A' ' 129' ' ' ILE . 76.6 t60 -82.73 117.12 22.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.314 -0.867 . . . . 0.0 109.852 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -86.37 138.48 31.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 110.006 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.36 28.42 6.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -0.917 . . . . 0.0 110.367 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -79.69 -41.02 27.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.803 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.98 -26.46 21.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.432 -0.793 . . . . 0.0 109.684 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.3 m 52.94 177.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.425 -0.797 . . . . 0.0 110.493 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.9 p -85.94 130.12 34.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.86 . . . . 0.0 110.106 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.19 152.46 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.172 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -91.42 -35.74 14.19 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.032 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 54.28 -150.7 0.39 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.211 -0.931 . . . . 0.0 110.018 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -112.17 68.33 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.171 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.3 p -83.8 -19.77 34.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.63 129.49 1.54 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.36 59.86 1.59 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.228 -1.16 . . . . 0.0 109.953 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 108' ' ' PHE . 79.4 t80 -151.77 64.39 0.86 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.335 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -167.31 -157.68 0.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.211 -0.931 . . . . 0.0 110.241 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -153.74 -169.52 3.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.209 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -155.57 89.2 0.12 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -60.39 149.26 42.99 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -103.47 49.81 0.82 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.091 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.46 -58.32 2.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.263 -0.898 . . . . 0.0 110.39 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.51 62.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.258 -0.901 . . . . 0.0 110.262 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -174.64 100.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.08 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -86.08 87.77 7.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.25 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -122.25 -33.25 3.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.282 -0.886 . . . . 0.0 110.286 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.23 -30.2 57.38 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -94.75 -78.14 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.386 -1.067 . . . . 0.0 110.026 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 t 58.31 162.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.322 -0.861 . . . . 0.0 110.141 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -173.79 40.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.417 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.3 m -144.5 -42.85 0.25 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.986 . . . . 0.0 110.351 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -59.98 -24.49 64.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 0.0 110.485 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' A' ' 128' ' ' ILE . 68.1 m -51.63 -32.51 29.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.162 -0.961 . . . . 0.0 110.479 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 17' ' ' VAL . . . -71.14 -42.99 68.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.264 -0.897 . . . . 0.0 109.417 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.654 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -67.83 -23.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 176.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 125' ' ' SER . 1.2 mp -70.25 -42.28 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 9' ' ' ASP . 54.9 mt -62.0 -40.48 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.735 HD22 ' HE2' ' A' ' 133' ' ' TYR . 1.1 tm? -61.05 -58.3 8.96 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 134' ' ' PHE . 14.6 tt0 -61.47 -21.15 63.92 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.126 -0.984 . . . . 0.0 108.866 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 129' ' ' ILE . 0.2 OUTLIER -55.55 -43.71 76.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.521 -0.737 . . . . 0.0 110.61 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 1.08 ' CE2' HD22 ' A' ' 5' ' ' LEU . 4.1 p90 -80.13 -32.37 39.0 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.409 -1.316 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 0.6 OUTLIER -58.28 -34.78 70.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.937 . . . . 0.0 109.682 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -80.3 -20.65 43.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.251 -0.905 . . . . 0.0 110.372 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -91.76 -21.48 20.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.258 -0.901 . . . . 0.0 110.339 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.23 26.61 64.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.14 -1.212 . . . . 0.0 110.341 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 ttt . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.218 0.532 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.25 119.93 25.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.229 -0.919 . . . . 0.0 110.17 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 22' ' ' ARG . . . -165.84 -89.62 0.07 OUTLIER Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' ASP . 86.9 m -150.43 133.34 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.894 -1.357 . . . . 0.0 112.273 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.079 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -127.59 142.32 51.4 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.029 HD11 HG13 ' A' ' 19' ' ' VAL . 0.9 OUTLIER -132.63 133.83 44.11 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.43 -1.419 . . . . 0.0 110.832 178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -118.44 133.54 55.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.524 -0.735 . . . . 0.0 109.036 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.807 ' HE1' HG23 ' A' ' 57' ' ' ILE . 4.8 m-85 -124.6 148.98 47.54 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.379 -0.826 . . . . 0.0 111.565 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 20.4 t0 -104.69 92.67 4.38 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.64 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.19 127.91 38.94 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.689 -175.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.12 156.42 25.0 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 12' ' ' THR . 59.5 p -48.84 116.02 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.856 -1.379 . . . . 0.0 110.535 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 53.28 44.2 30.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.801 ' HB3' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -140.57 126.0 18.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.413 -0.804 . . . . 0.0 110.369 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.714 ' C ' ' HA ' ' A' ' 33' ' ' ILE . 34.8 mm -120.64 95.45 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.036 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.431 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.27 110.28 1.32 Allowed Glycine 0 C--N 1.287 -2.177 0 N-CA-C 103.878 -3.689 . . . . 0.0 103.878 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.955 ' CG1' HD13 ' A' ' 30' ' ' LEU . 74.5 t -139.77 166.11 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 116.165 -2.214 . . . . 0.0 114.042 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.673 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -129.86 131.21 46.02 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.78 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.029 HG13 HD11 ' A' ' 6' ' ' LEU . 25.9 t -100.92 121.47 51.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -108.47 135.96 13.19 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 118.344 -1.884 . . . . 0.0 111.456 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.43 ' NE2' ' HB ' ' A' ' 26' ' ' THR . 6.4 pm0 -95.83 116.59 29.13 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' ' H ' ' A' ' 3' ' ' GLY . 0.1 OUTLIER -86.62 23.05 1.74 Allowed 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.43 0.633 . . . . 0.0 110.356 -178.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -101.99 -36.03 4.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -117.77 -17.37 9.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.714 -0.616 . . . . 0.0 110.215 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' CE1' ' A' ' 134' ' ' PHE . . . 89.99 33.69 8.78 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.795 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HB ' ' NE2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -120.73 161.33 21.63 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.85 -1.383 . . . . 0.0 111.026 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -119.17 156.21 30.25 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.976 -1.077 . . . . 0.0 111.61 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.493 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.06 153.09 47.17 Favored Pre-proline 0 C--N 1.3 -1.548 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.1 Cg_endo -91.7 126.83 0.99 Allowed 'Trans proline' 0 C--N 1.3 -1.98 0 O-C-N 123.253 1.133 . . . . 0.0 112.103 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.955 HD13 ' CG1' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -98.57 142.98 25.5 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.97 162.8 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.592 2.195 . . . . 0.0 115.205 -174.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.41 140.16 58.84 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.849 1.309 . . . . 0.0 113.936 -175.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 14' ' ' SER . 0.6 OUTLIER -53.59 51.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 113.245 -1.798 . . . . 0.0 115.684 -179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.45 107.17 8.32 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.976 -1.077 . . . . 0.0 108.333 176.036 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.655 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.75 155.5 19.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.759 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB ' ' A' ' 39' ' ' THR . 2.1 mt-30 -83.96 118.84 24.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.511 -0.743 . . . . 0.0 110.527 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.28 25.87 3.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.114 -0.991 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 90.96 17.57 50.87 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.655 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 18.3 m -94.35 110.74 50.4 Favored Pre-proline 0 C--N 1.307 -1.254 0 O-C-N 121.078 -1.248 . . . . 0.0 110.124 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.682 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.33 157.37 59.49 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.567 1.298 . . . . 0.0 109.205 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.916 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -64.16 91.0 0.07 Allowed 'General case' 0 C--N 1.307 -1.247 0 O-C-N 120.839 -1.163 . . . . 0.0 108.964 179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 10.1 t-105 -90.45 -18.79 24.76 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HB3' HD12 ' A' ' 44' ' ' ILE . 0.8 OUTLIER -82.0 -39.63 23.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.888 . . . . 0.0 109.579 179.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.603 ' N ' HD12 ' A' ' 44' ' ' ILE . 2.5 mp -73.55 -54.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.852 -0.53 . . . . 0.0 110.468 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.916 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -64.79 -42.27 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.979 -1.076 . . . . 0.0 110.621 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.7 tt0 -60.08 -38.53 83.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.912 -1.118 . . . . 0.0 109.003 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.4 mtp-105 -56.39 -40.59 74.86 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.025 HD13 HD21 ' A' ' 6' ' ' LEU . 17.3 mt -74.08 -40.73 62.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 110.103 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 HG22 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -65.54 -43.69 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.385 -0.822 . . . . 0.0 111.407 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.15 -52.24 7.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.178 -0.951 . . . . 0.0 112.379 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -83.55 -41.25 18.13 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.921 -1.112 . . . . 0.0 112.544 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.538 ' HD1' HD23 ' A' ' 48' ' ' LEU . 34.9 m95 -92.12 -27.02 17.99 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.736 -1.228 . . . . 0.0 111.535 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 50.0 87.99 0.12 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.888 -1.132 . . . . 0.0 110.191 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' CD ' ' HA ' ' A' ' 49' ' ' LEU . 46.1 Cg_endo -72.63 134.49 22.27 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.639 1.336 . . . . 0.0 110.665 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 4' ' ' THR . 31.8 t70 -78.63 -32.9 47.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.465 -0.772 . . . . 0.0 110.79 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HB3' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -132.47 153.23 51.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.914 -1.116 . . . . 0.0 110.399 -179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.807 HG23 ' HE1' ' A' ' 8' ' ' PHE . 3.6 mp -132.81 137.29 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.898 -1.126 . . . . 0.0 112.312 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.079 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.82 122.2 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.884 HG21 ' CD1' ' A' ' 83' ' ' ILE . 9.6 t -134.5 150.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 120.168 -1.582 . . . . 0.0 112.484 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 164.73 135.14 1.77 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.3 pp -65.47 149.7 96.84 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.267 -1.137 . . . . 0.0 109.862 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' O ' HD12 ' A' ' 61' ' ' LEU . 40.6 Cg_endo -67.91 147.15 73.88 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.595 1.313 . . . . 0.0 110.66 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.655 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -91.2 164.75 13.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 110.281 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.655 ' O ' HD12 ' A' ' 63' ' ' LEU . 26.6 m-80 -50.64 141.89 11.92 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -0.908 . . . . 0.0 110.443 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.17 -25.97 48.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.0 110.234 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.21 -4.79 55.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.9 31.71 61.5 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -179.32 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.332 -1.099 . . . . 0.0 110.21 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -64.99 119.33 10.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -0.809 . . . . 0.0 109.927 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.36 91.17 5.11 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 0.0 110.002 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.99 -9.24 25.57 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.699 1.368 . . . . 0.0 110.457 179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -24.08 8.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.991 . . . . 0.0 110.154 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.472 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.09 -21.12 7.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.275 -0.89 . . . . 0.0 110.661 -179.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.53 7.1 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 108.697 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -78.34 -33.01 49.42 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.498 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -57.06 -46.15 82.7 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.522 -0.736 . . . . 0.0 109.345 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 96.1 mtt180 -60.21 -48.1 83.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.397 -0.814 . . . . 0.0 109.21 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -25.09 65.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.346 -0.846 . . . . 0.0 108.826 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.577 ' CE1' ' CG ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -56.84 -55.86 28.98 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 108.915 179.092 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.82 -31.73 66.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.556 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -68.59 -22.46 64.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.109 -0.994 . . . . 0.0 109.767 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -57.13 4.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 110.35 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.884 ' CD1' HG21 ' A' ' 59' ' ' VAL . 30.9 pt -60.69 -28.08 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 110.101 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -63.75 -58.15 7.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.232 -0.918 . . . . 0.0 110.081 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.24 -15.72 65.93 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -43.81 62.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -1.207 . . . . 0.0 110.593 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' HB3' HG13 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -117.68 -10.98 10.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.025 . . . . 0.0 110.774 -179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.62 43.72 22.94 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.234 -1.946 . . . . 0.0 108.234 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.7 m -104.47 153.99 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.62 -0.929 . . . . 0.0 110.781 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -83.35 73.96 10.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.643 -0.66 . . . . 0.0 110.165 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.681 HG23 HG22 ' A' ' 57' ' ' ILE . 4.9 p -89.94 152.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.239 -0.913 . . . . 0.0 111.157 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.41 148.05 35.15 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.897 HD22 ' N ' ' A' ' 94' ' ' HIS . 0.0 OUTLIER -98.74 131.87 44.55 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.164 -0.96 . . . . 0.0 109.034 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.897 ' N ' HD22 ' A' ' 93' ' ' LEU . 2.1 t-80 -82.08 110.79 17.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.167 -0.958 . . . . 0.0 109.982 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 128.43 34.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.295 -0.878 . . . . 0.0 110.31 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -126.59 48.85 2.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.979 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -72.91 -30.82 64.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.478 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -78.23 -21.7 49.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.156 -0.965 . . . . 0.0 110.188 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.442 ' N ' ' HG ' ' A' ' 98' ' ' LEU . 1.2 m 49.35 70.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.93 . . . . 0.0 110.728 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.0 m 55.84 103.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.288 -0.882 . . . . 0.0 110.499 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -89.46 151.78 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.923 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 104' ' ' ARG . 3.5 tt0 -90.18 -21.45 22.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 0.0 110.522 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 55.53 -87.97 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 110.298 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -83.62 114.55 21.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -96.27 -7.41 35.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.174 -0.954 . . . . 0.0 110.763 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -75.57 106.86 2.19 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.28 -173.37 4.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.315 -1.109 . . . . 0.0 110.018 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.71 154.66 17.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.953 . . . . 0.0 110.048 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -47.1 29.06 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.185 -0.947 . . . . 0.0 110.275 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.32 124.51 40.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 0.0 110.232 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 82.38 56.81 2.75 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -92.69 -146.98 20.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -72.71 65.79 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -1.127 . . . . 0.0 110.215 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 53.32 -178.81 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.293 -0.879 . . . . 0.0 110.119 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.95 24.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 pp -164.74 152.14 11.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.133 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -140.68 -81.83 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 0.0 110.172 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -149.07 145.77 27.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 110.178 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -143.56 40.56 1.2 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.04 147.52 32.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -1.13 . . . . 0.0 110.076 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.69 19.83 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.446 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -86.57 64.44 8.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.2 t 52.2 33.42 12.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 110.336 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -73.98 -34.75 64.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.412 ' O ' HG13 ' A' ' 129' ' ' ILE . 13.5 t -52.21 -22.44 4.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.853 . . . . 0.0 110.511 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.631 ' HA ' HD12 ' A' ' 129' ' ' ILE . . . -83.87 -53.71 5.4 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.228 -0.92 . . . . 0.0 109.064 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.673 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -58.4 -23.08 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 177.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.714 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -68.66 -43.27 83.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 105.283 -2.117 . . . . 0.0 105.283 175.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 126' ' ' ALA . 75.8 mt -63.33 -36.9 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 176.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.594 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.25 -46.55 86.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -57.27 -21.15 32.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.83 -1.169 . . . . 0.0 110.026 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.407 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.3 p -73.24 -54.29 8.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 111.137 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.619 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -52.66 -40.25 62.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.791 -1.193 . . . . 0.0 109.89 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.594 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.7 m-85 -53.26 -36.26 60.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.077 -1.015 . . . . 0.0 109.455 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -80.39 -20.95 42.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.474 -0.766 . . . . 0.0 110.152 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -78.85 -6.76 56.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 0.0 110.777 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -95.63 -43.6 3.35 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.217 -1.167 . . . . 0.0 110.313 -179.909 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.248 0.547 . . . . 0.0 110.185 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' ARG . 10.2 p -172.4 -168.66 0.55 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.213 -0.929 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' N ' ' HB3' ' A' ' 22' ' ' ARG . . . 109.33 -46.42 1.17 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' ASP . 27.8 m -147.18 134.01 20.12 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.953 -1.322 . . . . 0.0 111.959 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.086 HD22 ' CE2' ' A' ' 133' ' ' TYR . 0.2 OUTLIER -128.28 164.08 23.36 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.111 -0.993 . . . . 0.0 110.188 178.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -147.11 135.33 21.61 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.937 -1.102 . . . . 0.0 110.418 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' N ' HD12 ' A' ' 6' ' ' LEU . . . -123.97 124.45 42.61 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.921 ' CE2' HG11 ' A' ' 17' ' ' VAL . 5.5 t80 -129.68 141.2 50.95 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.677 -1.209 . . . . 0.0 113.203 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -105.95 95.5 5.83 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.452 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.693 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -96.58 130.74 43.71 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.784 -176.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -136.59 156.9 23.37 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' LYS . 17.3 p -49.44 117.16 2.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.952 -1.322 . . . . 0.0 110.392 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' A' ' 38' ' ' GLY . 7.6 tttt 54.64 41.82 31.67 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.794 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -141.46 130.22 22.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.319 -0.863 . . . . 0.0 111.313 -178.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.83 HD11 ' CB ' ' A' ' 40' ' ' PRO . 39.3 mm -122.87 92.68 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.165 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -125.28 103.43 0.72 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 103.985 -3.646 . . . . 0.0 103.985 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.054 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.46 169.8 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 116.337 -2.145 . . . . 0.0 113.751 -174.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -125.0 142.61 51.37 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.892 ' CG1' HD21 ' A' ' 48' ' ' LEU . 63.6 t -101.36 142.66 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' A' ' 130' ' ' LEU . . . -122.72 136.87 10.91 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.745 -1.693 . . . . 0.0 111.538 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.83 113.67 27.31 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.671 ' HB2' HD12 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -89.23 24.76 2.07 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.532 0.682 . . . . 0.0 110.694 -178.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.892 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -113.49 -34.37 2.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.273 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' HD13 ' A' ' 23' ' ' ILE . 50.8 m -113.5 -16.61 12.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.846 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 134' ' ' PHE . . . 84.92 33.32 18.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.63 159.19 25.8 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.066 -1.255 . . . . 0.0 110.627 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -128.46 125.97 39.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.216 -0.927 . . . . 0.0 110.891 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -87.46 154.71 54.04 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.8 133.32 1.37 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.057 1.03 . . . . 0.0 111.515 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.054 HD22 HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -99.62 140.69 21.78 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.94 167.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.957 2.438 . . . . 0.0 116.051 -174.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.77 138.99 58.71 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.053 1.406 . . . . 0.0 114.402 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.794 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.93 51.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 113.153 -1.839 . . . . 0.0 115.847 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -129.84 93.9 3.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.81 -1.181 . . . . 0.0 109.857 176.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.774 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.77 161.59 15.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.394 -0.816 . . . . 0.0 110.021 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.45 ' CG ' ' HB ' ' A' ' 39' ' ' THR . 9.8 pt20 -99.07 130.0 45.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.963 -1.086 . . . . 0.0 111.567 -179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 50.92 24.4 1.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.063 -1.023 . . . . 0.0 110.365 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' N ' ' HD2' ' A' ' 13' ' ' LYS . . . 88.58 22.01 41.72 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.774 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 5.6 m -95.3 105.72 21.66 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.309 -1.112 . . . . 0.0 110.325 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.83 ' CB ' HD11 ' A' ' 15' ' ' ILE . 44.8 Cg_endo -71.48 159.12 52.31 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 108.629 -1.335 . . . . 0.0 108.629 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.965 ' O ' HD12 ' A' ' 45' ' ' ILE . 25.3 m-20 -63.72 91.17 0.06 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.736 -1.227 . . . . 0.0 108.563 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.433 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 77.8 t90 -78.46 -20.92 49.92 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.212 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -82.01 -28.8 32.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.534 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.754 HG21 HD21 ' A' ' 30' ' ' LEU . 34.5 mm -75.69 -56.26 9.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.797 -0.564 . . . . 0.0 111.72 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.965 HD12 ' O ' ' A' ' 41' ' ' ASP . 2.7 mt -71.69 -34.33 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.911 -1.118 . . . . 0.0 110.399 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.8 tp10 -57.12 -43.95 82.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.893 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.4 ttt85 -56.33 -48.24 77.15 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.347 -0.846 . . . . 0.0 109.281 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.892 HD21 ' CG1' ' A' ' 19' ' ' VAL . 1.2 mt -59.18 -40.55 86.04 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.326 -0.859 . . . . 0.0 110.903 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.62 HD21 HG11 ' A' ' 89' ' ' VAL . 2.5 mp -66.16 -54.79 21.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.323 -0.86 . . . . 0.0 112.002 -178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -81.44 -38.96 25.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.028 -1.045 . . . . 0.0 112.285 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -84.25 -41.2 17.15 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.944 -1.098 . . . . 0.0 112.617 -177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -107.04 -20.04 13.43 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.723 -1.236 . . . . 0.0 111.97 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER 52.26 89.21 0.1 Allowed Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 120.781 -1.2 . . . . 0.0 109.401 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.474 ' HG2' HD11 ' A' ' 57' ' ' ILE . 43.3 Cg_endo -70.01 125.71 12.32 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.69 1.363 . . . . 0.0 111.122 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' THR . 35.8 t70 -71.95 -44.88 62.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.369 -0.832 . . . . 0.0 110.24 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' O ' HD23 ' A' ' 5' ' ' LEU . 55.4 mt-10 -140.78 131.65 25.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.996 -1.065 . . . . 0.0 109.726 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.734 HG23 ' HB3' ' A' ' 6' ' ' LEU . 2.7 mp -123.72 136.18 61.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 111.851 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -112.43 118.84 58.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 178.275 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.793 HG23 ' HB3' ' A' ' 8' ' ' PHE . 13.2 p -132.02 150.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.686 -1.259 . . . . 0.0 113.225 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 139.06 151.98 5.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -117.67 120.07 33.39 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.034 -1.274 . . . . 0.0 110.654 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.64 118.09 1.23 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 C-N-CA 120.756 0.97 . . . . 0.0 110.528 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.9 tp -129.4 133.47 47.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.145 -0.972 . . . . 0.0 110.64 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -80.7 125.71 30.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.24 -0.913 . . . . 0.0 109.879 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.2 tpt -83.74 -43.79 15.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.219 -0.925 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.62 19.99 19.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.231 -0.918 . . . . 0.0 110.454 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.66 -39.7 2.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.5 t -124.79 -175.19 3.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.563 -0.963 . . . . 0.0 109.353 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 48.72 -166.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.098 -1.001 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 74.48 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.085 -1.009 . . . . 0.0 110.25 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.05 -24.87 14.53 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.8 1.421 . . . . 0.0 110.311 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.2 tp -67.56 -24.91 65.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 0.0 110.648 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.48 -20.59 7.96 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.147 -0.971 . . . . 0.0 111.254 -179.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.38 -34.22 10.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.989 -1.069 . . . . 0.0 109.324 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -30.84 59.74 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -57.63 -47.36 82.42 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HA ' ' HG ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.37 -50.22 72.19 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.375 -0.828 . . . . 0.0 109.246 179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mttm -67.03 -24.97 66.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.648 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.576 ' CZ ' ' CD1' ' A' ' 10' ' ' PHE . 0.7 OUTLIER -57.29 -56.46 21.57 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 83' ' ' ILE . . . -53.6 -34.82 59.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.627 -0.671 . . . . 0.0 109.658 178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -35.35 65.13 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.205 -0.934 . . . . 0.0 109.674 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.38 -56.79 5.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.387 -0.82 . . . . 0.0 109.914 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 80' ' ' ALA . 3.5 mt -55.5 -38.23 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.878 . . . . 0.0 109.29 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.432 ' HB2' ' CG1' ' A' ' 91' ' ' VAL . 19.8 t-80 -56.2 -57.59 11.55 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.468 0.652 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.39 -14.84 80.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.19 -44.38 88.6 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.955 -1.32 . . . . 0.0 109.827 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.656 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -118.95 -12.02 9.61 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.101 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.86 39.54 46.91 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 87' ' ' PHE . 35.1 m -103.58 153.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.695 -0.886 . . . . 0.0 110.978 -179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.94 69.38 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.637 -0.664 . . . . 0.0 109.961 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.599 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -88.68 152.39 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.894 0.854 . . . . 0.0 110.93 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -124.93 160.4 28.97 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.303 0.573 . . . . 0.0 109.889 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.91 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -102.9 131.64 49.68 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.969 . . . . 0.0 109.526 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.889 ' N ' HD22 ' A' ' 93' ' ' LEU . 8.1 t-80 -83.68 100.18 10.7 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.155 -0.965 . . . . 0.0 109.705 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.456 ' OD2' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -99.12 145.65 26.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.264 -0.898 . . . . 0.0 111.287 -179.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.1 55.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 109.357 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.22 -17.01 38.59 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.394 -0.816 . . . . 0.0 110.987 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -32.48 73.28 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.068 -1.02 . . . . 0.0 110.371 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.3 t 55.03 171.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.32 -0.863 . . . . 0.0 110.485 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 66.8 m -122.73 111.24 16.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.309 -0.869 . . . . 0.0 110.216 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 151.64 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 0.0 110.108 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -75.98 -43.74 43.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.238 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.63 89.44 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -144.91 -56.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.291 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 p -110.08 -20.79 12.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -79.38 70.62 2.79 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.473 ' HA ' HD13 ' A' ' 107' ' ' LEU . 3.1 mm? 53.14 -172.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.173 . . . . 0.0 110.17 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -102.93 -58.55 1.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.141 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.75 164.75 17.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 110.163 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.47 -158.65 0.93 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.327 -0.858 . . . . 0.0 110.223 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.44 -109.9 0.76 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.65 95.16 0.18 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.52 -64.14 1.14 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -1.147 . . . . 0.0 110.204 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -109.43 -178.95 3.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 0.0 110.159 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.15 123.64 31.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 110.347 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -54.92 41.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.303 -0.873 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -78.89 163.55 25.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.871 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.79 -43.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 0.0 110.556 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -158.71 124.25 1.35 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.28 55.76 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -1.08 . . . . 0.0 109.858 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 121' ' ' VAL . 39.0 t -56.17 -65.39 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.871 . . . . 0.0 110.431 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -157.85 139.63 13.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.0 110.43 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 17' ' ' VAL . 25.1 t 54.88 31.3 15.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -0.825 . . . . 0.0 110.477 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.737 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -79.58 -37.45 36.29 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 6.4 m -51.61 -28.52 14.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.226 -0.922 . . . . 0.0 111.275 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.08 -55.04 4.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.987 -1.071 . . . . 0.0 109.615 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.74 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.3 -24.27 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 177.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.737 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -74.76 -44.87 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.526 ' CG2' ' HB ' ' A' ' 58' ' ' ILE . 12.6 mt -58.64 -38.9 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.671 HD22 ' HE2' ' A' ' 133' ' ' TYR . 0.7 OUTLIER -61.05 -58.49 8.16 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.552 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -21.13 62.71 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.404 -0.918 . . . . 0.0 108.767 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 0.1 OUTLIER -60.24 -41.08 92.41 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.474 -0.767 . . . . 0.0 111.071 -179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 1.086 ' CE2' HD22 ' A' ' 5' ' ' LEU . 2.1 p90 -80.76 -34.02 34.57 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 118.34 -1.344 . . . . 0.0 110.273 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 133' ' ' TYR . 1.1 m-85 -58.06 -30.17 65.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 109.642 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -72.82 -20.41 61.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.863 . . . . 0.0 110.051 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -78.45 -18.45 54.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.533 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -178.81 77.01 0.07 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.447 ' OXT' ' CD1' ' A' ' 138' ' ' TYR . 10.7 t80 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.235 -1.156 . . . . 0.0 109.91 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.109 0.48 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.478 ' CB ' ' HG2' ' A' ' 22' ' ' ARG . 0.1 OUTLIER -129.32 -44.71 1.25 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -0.945 . . . . 0.0 110.372 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' C ' ' HB3' ' A' ' 22' ' ' ARG . . . 170.51 -79.65 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.413 -1.375 . . . . 0.0 110.22 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' ASP . 60.3 m -149.66 135.5 18.66 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.811 -1.405 . . . . 0.0 112.667 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.032 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.69 138.01 52.66 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.079 HD21 HD13 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -130.77 134.06 46.54 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.565 -1.334 . . . . 0.0 110.295 178.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB2' HG13 ' A' ' 58' ' ' ILE . . . -120.57 124.4 45.21 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.437 -0.789 . . . . 0.0 109.174 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.973 ' HB2' HG23 ' A' ' 59' ' ' VAL . 3.0 m-30 -108.07 147.12 31.64 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 110.697 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 126' ' ' ALA . 8.6 t0 -129.0 92.85 3.47 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.0 p90 -173.99 -164.69 0.21 Allowed 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.483 -1.287 . . . . 0.0 112.459 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . 175.1 156.14 13.82 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.2 p 44.64 -145.3 0.13 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.499 -1.001 . . . . 0.0 111.439 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 5.1 ptmt -77.04 51.69 0.83 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 111.634 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.788 ' OG ' HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.43 128.19 20.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.815 HG21 ' OD2' ' A' ' 41' ' ' ASP . 40.4 mm -125.88 98.13 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.227 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -127.97 103.8 0.65 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 103.932 -3.667 . . . . 0.0 103.932 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.006 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -142.1 168.21 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 C-N-CA 115.811 -2.356 . . . . 0.0 115.167 -174.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -117.07 144.02 45.12 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.516 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.032 HG13 HD11 ' A' ' 6' ' ' LEU 0.261 48.7 t -114.16 123.82 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 177.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.553 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -110.28 140.33 15.83 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 118.586 -1.768 . . . . 0.0 112.041 -177.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -95.34 115.75 27.86 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HG2' ' CB ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -89.99 24.4 2.45 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.819 -178.218 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.896 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.87 -33.24 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.042 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 -16.98 10.24 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.186 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 35.35 9.57 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.521 -1.323 . . . . 0.0 110.874 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.3 159.19 24.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.775 -1.427 . . . . 0.0 111.101 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -125.44 117.98 24.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.019 -1.05 . . . . 0.0 111.759 179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 19' ' ' VAL . 14.0 ttm180 -86.88 152.09 53.18 Favored Pre-proline 0 C--N 1.303 -1.416 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 176.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -91.33 142.06 2.89 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 O-C-N 123.075 1.04 . . . . 0.0 113.119 -177.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.006 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -100.32 143.39 26.44 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 177.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.87 165.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.833 2.356 . . . . 0.0 115.733 -174.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.46 144.31 57.28 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.417 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.788 HD11 ' OG ' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.94 52.01 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -179.152 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' ALA . 12.0 mmtm -132.13 97.33 4.11 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.532 -1.355 . . . . 0.0 109.459 176.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.18 159.97 17.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.828 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' THR . 0.6 OUTLIER -86.98 120.35 28.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.108 -0.995 . . . . 0.0 111.456 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 46.6 30.4 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.303 -0.873 . . . . 0.0 110.857 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 93.08 15.08 53.32 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.772 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 23.5 m -96.18 108.32 40.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 O-C-N 121.064 -1.256 . . . . 0.0 109.811 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.734 ' HB3' HD11 ' A' ' 15' ' ' ILE . 42.9 Cg_endo -70.34 161.73 44.94 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.618 1.325 . . . . 0.0 109.484 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 45' ' ' ILE . 11.5 m-20 -64.14 91.68 0.07 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.017 -1.052 . . . . 0.0 109.408 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.446 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 79.3 t90 -92.58 -16.7 25.35 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' ILE . 29.5 t30 -79.81 -37.08 35.96 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.244 -0.91 . . . . 0.0 109.333 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.9 mp -78.13 -54.87 11.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.337 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 41' ' ' ASP . 22.1 mt -61.16 -34.82 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.026 -1.046 . . . . 0.0 110.177 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.446 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 12.2 tp10 -60.55 -46.01 91.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 109.361 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.41 ' O ' ' CB ' ' A' ' 51' ' ' GLU . 3.8 mtp180 -53.65 -39.62 65.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.575 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.079 HD13 HD21 ' A' ' 6' ' ' LEU . 10.3 mt -73.5 -24.99 60.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.316 -0.865 . . . . 0.0 110.094 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -77.03 -56.21 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 111.763 -178.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -82.11 -37.31 26.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.15 -0.969 . . . . 0.0 111.611 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -83.81 -41.22 17.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.157 -0.965 . . . . 0.0 111.933 -178.259 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 47.9 m95 -104.81 -23.62 13.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.839 -1.163 . . . . 0.0 111.494 -178.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 53.76 92.53 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.996 -1.065 . . . . 0.0 109.342 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 42.8 Cg_endo -67.39 124.5 12.15 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.685 1.36 . . . . 0.0 111.275 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 4' ' ' THR . 7.0 t0 -70.12 -41.13 74.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.406 -0.809 . . . . 0.0 109.504 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.22 156.33 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.186 -0.946 . . . . 0.0 109.972 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.5 mp -132.47 137.38 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.753 -1.217 . . . . 0.0 112.276 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.032 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -118.37 116.05 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.973 HG23 ' HB2' ' A' ' 8' ' ' PHE . 4.6 p -131.48 150.9 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.502 0 O-C-N 120.004 -1.685 . . . . 0.0 113.525 -178.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 172.77 126.3 0.89 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.344 -0.931 . . . . 0.0 110.838 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.541 HD23 ' O ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -65.03 147.62 98.38 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.159 -1.2 . . . . 0.0 109.64 179.174 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.23 148.61 44.27 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.895 1.471 . . . . 0.0 111.02 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 70' ' ' GLN . 12.7 tp -96.34 160.69 14.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.361 -0.837 . . . . 0.0 109.995 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -75.08 135.53 41.19 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.164 -0.96 . . . . 0.0 110.255 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -83.24 -43.35 16.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.29 -0.881 . . . . 0.0 110.62 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.32 14.31 29.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.092 -1.005 . . . . 0.0 110.841 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -97.77 30.45 9.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.87 -158.0 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.371 -1.076 . . . . 0.0 110.273 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -50.43 172.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.793 ' HB3' HD11 ' A' ' 63' ' ' LEU . 33.2 tp60 -160.0 80.98 2.41 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.368 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.22 -13.99 31.28 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.679 1.357 . . . . 0.0 110.313 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.92 -25.38 63.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.133 -0.979 . . . . 0.0 110.244 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -55.26 -20.35 10.84 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.253 -0.905 . . . . 0.0 111.629 -179.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.77 -36.88 12.31 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.914 -1.116 . . . . 0.0 109.648 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -75.33 -27.88 59.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.411 -0.806 . . . . 0.0 108.867 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 73' ' ' THR . . . -61.28 -45.71 93.33 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.566 -0.709 . . . . 0.0 109.872 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -62.74 -48.37 79.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.9 . . . . 0.0 109.718 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 tttp -65.37 -25.6 67.64 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.106 -0.996 . . . . 0.0 109.314 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 87.3 t80 -64.3 -38.48 91.18 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.938 -1.105 . . . . 0.0 108.131 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.73 76.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.09 -23.02 67.17 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -57.81 4.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.541 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.773 HD13 ' N ' ' A' ' 84' ' ' HIS . 0.0 OUTLIER -55.99 -24.18 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 C-N-CA 118.679 -1.209 . . . . 0.0 108.585 179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.773 ' N ' HD13 ' A' ' 83' ' ' ILE . 1.9 t60 -74.06 -58.03 3.57 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.197 -0.939 . . . . 0.0 110.043 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.24 -15.7 61.37 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -44.55 50.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.085 -1.244 . . . . 0.0 110.561 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -115.64 -11.27 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.054 -1.029 . . . . 0.0 110.799 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.43 35.35 42.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.454 ' H ' HG22 ' A' ' 89' ' ' VAL . 26.7 m -95.41 153.79 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.965 . . . . 0.0 110.609 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.66 87.57 3.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.488 -0.758 . . . . 0.0 109.929 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG22 HG12 ' A' ' 59' ' ' VAL . 4.3 p -89.22 152.6 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 122.019 0.914 . . . . 0.0 111.381 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -128.91 139.8 51.96 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 121.175 0.512 . . . . 0.0 109.938 179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mt -92.9 128.23 38.68 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.22 -0.925 . . . . 0.0 110.455 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.45 ' ND1' HG12 ' A' ' 129' ' ' ILE . 19.3 t-80 -89.45 113.87 25.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.3 144.79 56.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.411 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -90.47 86.92 6.57 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.0 110.198 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -21.65 52.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.286 -0.884 . . . . 0.0 110.608 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.09 -18.72 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.163 -0.961 . . . . 0.0 110.428 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 7.7 t -63.49 -178.64 0.29 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.183 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -113.75 161.62 17.29 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.296 -0.877 . . . . 0.0 110.423 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.5 p -81.26 152.71 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.24 -37.8 84.39 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.053 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 49.95 -173.32 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.307 -0.87 . . . . 0.0 110.511 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -73.85 0.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.995 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 75.0 m -98.54 -20.78 16.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.229 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.66 58.78 12.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 102.99 4.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.354 -1.086 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.69 115.73 30.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.186 -0.947 . . . . 0.0 110.108 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.46 -54.81 19.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 0.0 110.548 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -155.78 172.02 19.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.282 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 101.22 91.05 2.11 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -110.37 103.55 1.68 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -56.84 -39.56 74.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.237 . . . . 0.0 110.167 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.92 146.21 2.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.409 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -169.84 141.17 2.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.244 -0.91 . . . . 0.0 110.172 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -175.21 106.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 110.228 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.29 161.92 0.83 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.409 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.22 174.11 9.33 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.891 . . . . 0.0 110.401 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -108.17 -108.22 3.22 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -140.72 47.9 1.74 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -1.164 . . . . 0.0 110.152 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 121' ' ' VAL . 7.9 p -151.45 111.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 110.288 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -106.32 16.79 24.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 110.306 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.6 m -78.13 -24.18 47.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 0.0 110.094 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.01 61.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.984 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 129' ' ' ILE . 7.8 t -52.75 -31.24 37.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 110.192 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -80.73 -52.5 7.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.274 -0.891 . . . . 0.0 109.402 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.715 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.65 -23.11 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 128' ' ' ILE . 3.9 mm -70.11 -43.99 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 175.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 58' ' ' ILE . 64.2 mt -62.07 -38.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.688 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.99 -33.67 76.25 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 127' ' ' VAL . 6.2 mt-10 -69.78 -21.24 63.43 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.991 -1.068 . . . . 0.0 109.483 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -72.76 -47.84 43.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.422 -0.799 . . . . 0.0 111.1 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -60.89 -39.94 91.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.868 -1.145 . . . . 0.0 110.089 -179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.688 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.53 -42.62 64.55 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.885 -1.135 . . . . 0.0 109.857 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -79.43 -17.83 53.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 110.447 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 133' ' ' TYR . 2.6 mm-40 -79.27 -1.55 37.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.121 -0.987 . . . . 0.0 110.971 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -153.05 45.05 0.59 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 138' ' ' TYR . 25.3 p90 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.231 -1.159 . . . . 0.0 110.242 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.559 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 5.4 m -53.93 135.87 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.63 -91.6 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.122 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -64.13 149.15 94.56 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' O ' HD22 ' A' ' 61' ' ' LEU . 39.9 Cg_endo -65.31 149.13 88.74 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.235 1.124 . . . . 0.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 63' ' ' LEU . 1.7 mm? -89.32 164.82 14.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.343 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -47.42 125.83 8.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.857 . . . . 0.0 110.557 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 tpp -72.56 -11.42 60.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 110.661 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -6.37 48.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.072 . . . . 0.0 110.945 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.87 -32.12 6.35 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.43 138.66 9.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.223 -1.163 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -83.88 171.35 13.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.58 128.66 0.66 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.46 -6.24 18.67 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.429 1.226 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -25.17 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.085 -1.009 . . . . 0.0 110.802 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.91 -21.56 11.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.044 -1.035 . . . . 0.0 110.677 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.72 -29.63 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.082 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -31.75 34.13 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . -58.02 -45.71 86.47 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.263 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.01 113.76 27.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 19.4 p-10 -97.29 126.39 42.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.729 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 51.39 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 110.723 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -88.1 -15.04 37.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.411 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -23.17 55.24 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.107 -0.996 . . . . 0.0 110.506 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -63.16 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' THR . 36.2 m -106.02 52.64 0.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.897 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.3 152.07 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.299 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.5 tm-20 -71.17 -28.27 64.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.483 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 56.29 169.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -129.67 22.75 5.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -111.79 2.99 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.43 153.8 17.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -40.92 17.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -1.163 . . . . 0.0 110.189 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -63.13 94.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.954 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.39 140.79 57.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -168.78 117.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.984 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -127.43 153.95 19.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.55 -65.18 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -86.26 91.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.147 . . . . 0.0 110.007 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 118.05 28.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.49 138.06 19.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -156.38 145.52 20.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -179.677 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.0 m-20 52.72 88.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.823 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -131.01 178.99 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.052 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.0 165.91 12.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 124' ' ' ALA . 17.6 mttm -133.4 50.16 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 0.0 110.128 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 m -61.19 -26.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.27 -162.26 0.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.398 -0.814 . . . . 0.0 110.394 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p -84.52 52.47 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.032 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.15 44.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 7.66 45.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.956 . . . . 0.0 110.814 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -145.81 54.39 0.55 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.239 -1.154 . . . . 0.0 110.327 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.275 0.559 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 22' ' ' ARG . 5.4 m -53.93 135.87 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -161.63 -91.6 0.08 OUTLIER Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.122 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 55' ' ' ASP . 47.6 m -147.45 134.75 20.63 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.078 -1.248 . . . . 0.0 111.851 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -127.75 132.54 49.54 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.814 -1.179 . . . . 0.0 109.407 178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.027 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.32 133.53 53.43 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.684 -1.26 . . . . 0.0 109.843 177.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.616 ' HB1' HG22 ' A' ' 129' ' ' ILE . . . -111.67 124.45 52.34 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' HB2' HG23 ' A' ' 59' ' ' VAL . 56.6 m-85 -108.82 128.96 55.35 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 111.749 -178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 126' ' ' ALA . 16.3 t70 -116.29 92.39 3.87 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.625 ' HB2' ' O ' ' A' ' 14' ' ' SER . 8.2 p90 -174.42 -166.91 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.322 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' PHE . . . -159.98 -145.42 4.27 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.113 -1.041 . . . . 0.0 110.913 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -36.22 -98.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.722 -0.87 . . . . 0.0 112.978 -178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.02 50.61 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.489 -1.382 . . . . 0.0 110.807 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.761 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -140.88 133.65 28.89 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.083 -1.011 . . . . 0.0 110.517 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.77 HD11 ' HB3' ' A' ' 40' ' ' PRO . 47.4 mm -127.1 95.83 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.41 102.62 0.61 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 103.727 -3.749 . . . . 0.0 103.727 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.016 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.27 170.23 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 116.326 -2.15 . . . . 0.0 113.758 -175.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.72 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.81 140.23 52.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.178 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.027 HG13 HD11 ' A' ' 6' ' ' LEU . 19.3 t -101.86 124.52 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.487 ' H ' HD12 ' A' ' 6' ' ' LEU . . . -109.9 138.32 14.78 Favored Glycine 0 N--CA 1.484 1.873 0 C-N-CA 119.052 -1.547 . . . . 0.0 111.202 -177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.27 115.87 28.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 4.6 ttt85 -90.98 23.25 3.27 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.841 -0.743 . . . . 0.0 110.263 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.902 ' CD1' HG23 ' A' ' 24' ' ' THR . 0.0 OUTLIER -114.4 -33.61 2.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.17 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.902 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -117.24 -16.87 10.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -0.804 . . . . 0.0 110.104 179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.07 34.96 10.15 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.861 -1.162 . . . . 0.0 110.788 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.14 158.8 25.2 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.834 -1.391 . . . . 0.0 110.997 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -131.89 130.88 42.2 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 0.0 111.704 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -100.27 155.54 36.28 Favored Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 50.6 Cg_endo -90.21 135.43 2.23 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.305 1.161 . . . . 0.0 111.998 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.016 HD22 HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -99.26 143.49 26.51 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.477 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 18.7 Cg_endo -40.25 164.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.845 2.363 . . . . 0.0 115.923 -174.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.48 143.2 58.08 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.125 -1.398 . . . . 0.0 113.728 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.11 50.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -179.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 32' ' ' ALA . 1.3 tppt? -132.83 96.03 3.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.565 -1.334 . . . . 0.0 109.561 176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.6 161.57 16.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.355 -0.84 . . . . 0.0 110.127 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 39' ' ' THR . 30.5 mt-30 -88.07 122.02 31.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.0 111.543 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t70 48.19 31.18 2.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.176 -0.952 . . . . 0.0 110.475 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 40' ' ' PRO . . . 86.89 19.05 57.02 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.758 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -95.51 103.71 13.5 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.243 -1.151 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.77 ' HB3' HD11 ' A' ' 15' ' ' ILE . 43.5 Cg_endo -70.09 162.85 40.71 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.532 1.28 . . . . 0.0 109.509 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.943 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -64.11 90.53 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.918 -1.114 . . . . 0.0 108.416 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.421 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 30.1 t90 -90.13 -19.81 23.85 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.74 -41.68 26.16 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.831 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 30' ' ' LEU . 0.3 OUTLIER -77.55 -44.91 29.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 O-C-N 121.311 -0.868 . . . . 0.0 110.589 -179.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.943 HD12 ' O ' ' A' ' 41' ' ' ASP . 36.7 mt -67.87 -35.09 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.682 -1.261 . . . . 0.0 109.514 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' TRP . 65.1 tt0 -57.81 -38.85 76.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 108.532 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -59.94 -45.45 92.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 109.78 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.98 HD13 HD21 ' A' ' 6' ' ' LEU . 18.4 mt -65.81 -23.82 66.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.935 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 1.3 mp -79.63 -53.39 6.88 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 111.817 -178.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -80.03 -48.26 13.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.034 -1.041 . . . . 0.0 112.102 -178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.68 -41.53 37.76 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.853 -1.154 . . . . 0.0 111.748 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.52 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 48.0 m95 -97.54 -33.86 11.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.867 -1.146 . . . . 0.0 111.018 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 55.32 93.6 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.382 -179.291 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 47.0 Cg_endo -72.29 129.59 15.16 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.706 1.371 . . . . 0.0 111.102 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 4' ' ' THR . 0.7 OUTLIER -70.27 -40.71 74.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.528 -0.732 . . . . 0.0 109.631 179.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.42 ' C ' HD12 ' A' ' 57' ' ' ILE . 3.7 tt0 -145.82 156.66 43.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.002 -1.061 . . . . 0.0 109.164 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 91' ' ' VAL . 5.1 mp -133.48 136.22 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.743 -1.223 . . . . 0.0 112.233 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.982 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -108.45 112.38 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.462 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 8' ' ' PHE . 12.5 p -132.76 151.6 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.426 -1.421 . . . . 0.0 113.968 -176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 163.32 135.04 1.74 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.327 -1.109 . . . . 0.0 110.327 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.743 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -64.13 149.15 94.56 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.04 -1.271 . . . . 0.0 110.096 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' O ' HD22 ' A' ' 61' ' ' LEU . 39.9 Cg_endo -65.31 149.13 88.74 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.235 1.124 . . . . 0.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 63' ' ' LEU . 1.7 mm? -89.32 164.82 14.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.872 . . . . 0.0 110.343 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -47.42 125.83 8.76 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.328 -0.857 . . . . 0.0 110.557 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.2 tpp -72.56 -11.42 60.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.522 -0.736 . . . . 0.0 110.661 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.57 -6.37 48.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.984 -1.072 . . . . 0.0 110.945 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.87 -32.12 6.35 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -48.43 138.66 9.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.223 -1.163 . . . . 0.0 110.437 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -83.88 171.35 13.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.905 . . . . 0.0 110.241 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.58 128.66 0.66 Allowed Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.151 -0.968 . . . . 0.0 110.482 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.46 -6.24 18.67 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.429 1.226 . . . . 0.0 110.591 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.15 -25.17 4.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.085 -1.009 . . . . 0.0 110.802 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.462 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.91 -21.56 11.98 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.044 -1.035 . . . . 0.0 110.677 -179.552 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.72 -29.63 4.67 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.059 -1.025 . . . . 0.0 109.082 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.11 -31.75 34.13 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB2' HD11 ' A' ' 61' ' ' LEU . . . -58.02 -45.71 86.47 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.495 -0.753 . . . . 0.0 109.263 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -62.81 -47.6 82.75 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.474 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -67.34 -25.46 66.01 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.207 -0.933 . . . . 0.0 109.153 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.401 ' CZ ' ' C ' ' A' ' 11' ' ' GLY . 27.0 t80 -63.31 -43.75 96.92 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -55.58 -40.15 71.61 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.15 -23.77 65.79 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.065 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.24 -57.36 7.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.851 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.8 HD12 HG21 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -66.61 -22.84 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.489 179.009 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.545 ' N ' HD13 ' A' ' 83' ' ' ILE . 3.7 t-160 -61.03 -58.66 7.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.255 -0.903 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.33 -15.83 75.11 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -43.59 73.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.983 -1.304 . . . . 0.0 110.508 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.427 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 75.5 m-85 -114.86 -10.37 12.36 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.916 . . . . 0.0 110.404 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.8 45.91 15.61 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.49 153.9 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.48 -1.012 . . . . 0.0 110.697 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.7 83.14 5.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.614 -0.679 . . . . 0.0 110.307 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.8 HG21 HD12 ' A' ' 83' ' ' ILE . 2.0 p -89.23 151.12 3.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.131 -0.981 . . . . 0.0 111.086 -179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -117.54 159.38 22.96 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.817 ' N ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.7 140.04 53.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 118.943 -1.103 . . . . 0.0 111.23 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -106.01 113.76 27.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.223 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 19.4 p-10 -97.29 126.39 42.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 110.729 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 51.39 98.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.395 -0.816 . . . . 0.0 110.723 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -88.1 -15.04 37.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 110.411 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.99 -23.17 55.24 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.107 -0.996 . . . . 0.0 110.506 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 p -63.16 -23.35 67.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.076 -1.015 . . . . 0.0 110.084 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 100' ' ' THR . 36.2 m -106.02 52.64 0.72 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 109.897 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.4 p -70.3 152.07 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 110.299 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.5 tm-20 -71.17 -28.27 64.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.327 -0.858 . . . . 0.0 110.483 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 102' ' ' GLU . . . 56.29 169.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.316 -0.865 . . . . 0.0 110.174 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -129.67 22.75 5.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.029 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.7 m -111.79 2.99 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.641 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -56.43 153.8 17.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -40.92 17.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -1.163 . . . . 0.0 110.189 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -63.13 94.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 109.954 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.39 140.79 57.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.539 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -168.78 117.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.984 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -127.43 153.95 19.37 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.55 -65.18 0.13 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -86.26 91.32 8.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -1.147 . . . . 0.0 110.007 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.55 118.05 28.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.179 -0.951 . . . . 0.0 110.431 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.49 138.06 19.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.814 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -156.38 145.52 20.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.097 -1.002 . . . . 0.0 110.615 -179.677 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.446 ' N ' HD23 ' A' ' 116' ' ' LEU . 5.0 m-20 52.72 88.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 0.0 110.823 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 pttp -131.01 178.99 6.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.153 -0.967 . . . . 0.0 110.052 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.0 165.91 12.15 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 124' ' ' ALA . 17.6 mttm -133.4 50.16 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.43 -1.041 . . . . 0.0 110.128 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 25.3 m -61.19 -26.86 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 110.252 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.27 -162.26 0.88 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.398 -0.814 . . . . 0.0 110.394 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.464 ' CB ' ' N ' ' A' ' 17' ' ' VAL . 2.0 p -84.52 52.47 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 0.0 110.032 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.732 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -60.04 -45.24 93.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 129' ' ' ILE . 26.1 m -51.07 -29.38 12.84 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 111.191 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.666 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.35 -55.45 4.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.943 -1.098 . . . . 0.0 109.822 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.72 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -54.24 -23.93 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.3 mp -73.57 -45.79 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.616 HG22 ' HB1' ' A' ' 7' ' ' ALA . 29.5 mt -59.18 -37.21 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -63.57 -31.33 72.46 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.967 179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -73.62 -21.79 60.2 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.833 -1.167 . . . . 0.0 109.761 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 129' ' ' ILE . 1.3 m -74.15 -44.05 55.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 110.664 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.723 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -61.91 -41.43 97.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.912 -1.118 . . . . 0.0 109.15 179.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.7 m-85 -53.89 -32.62 53.89 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.956 -1.09 . . . . 0.0 109.201 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.15 44.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.419 -0.8 . . . . 0.0 110.046 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.55 7.66 45.99 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.171 -0.956 . . . . 0.0 110.814 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -145.81 54.39 0.55 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.239 -1.154 . . . . 0.0 110.327 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.241 0.543 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -161.65 147.97 14.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.103 -179.994 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -172.1 88.42 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.12 113.9 4.26 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 120.595 -1.532 . . . . 0.0 111.039 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.25 -179.88 30.73 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.28 68.25 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.85 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.91 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.173 -0.955 . . . . 0.0 110.938 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.588 HE21 HG12 ' A' ' 19' ' ' VAL . 69.8 mm-40 -113.82 112.27 23.12 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.424 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.53 48.36 1.54 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.411 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.886 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.94 5.68 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.8 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.09 162.24 16.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -0.802 . . . . 0.0 109.861 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.77 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 111.117 -178.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.68 25.77 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.371 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.8 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.63 61.08 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.106 -1.232 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.69 155.9 58.09 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.642 1.338 . . . . 0.0 109.202 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.689 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -65.97 91.72 0.15 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.719 -1.238 . . . . 0.0 109.117 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.5 -17.85 35.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -32.66 33.21 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.86 29.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.335 0.588 . . . . 0.0 110.291 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.1 mt -70.11 -47.64 66.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 110.416 -179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.79 25.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.439 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.8 -5.41 15.57 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.693 -1.254 . . . . 0.0 111.94 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.58 109.91 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.352 -0.843 . . . . 0.0 109.446 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.06 111.52 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.208 1.11 . . . . 0.0 111.522 -177.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -64.98 149.32 96.86 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.14 149.34 76.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.816 1.43 . . . . 0.0 110.445 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -90.38 164.74 14.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.245 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -46.53 150.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.441 -0.787 . . . . 0.0 110.787 -179.652 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -15.93 63.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.14 -11.45 59.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 110.624 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.59 49.01 81.4 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 -166.22 1.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.226 -1.161 . . . . 0.0 110.239 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.71 114.04 26.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 0.0 110.219 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -131.37 120.69 18.08 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.359 -0.838 . . . . 0.0 109.876 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.48 -7.71 21.9 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.481 1.253 . . . . 0.0 111.258 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.86 -26.79 15.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.969 -1.082 . . . . 0.0 110.232 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.527 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.27 -20.71 19.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.305 -0.872 . . . . 0.0 111.091 -179.825 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.59 -32.87 8.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.989 -1.069 . . . . 0.0 109.17 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' PHE . 2.1 ttt-85 -75.76 -29.9 58.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . -58.71 -43.19 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 178.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -62.89 -48.66 78.02 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.04 -25.14 64.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.274 -0.891 . . . . 0.0 108.807 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.06 73.36 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -22.52 62.03 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.518 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -69.91 -57.19 5.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.773 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.71 -28.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.959 -1.088 . . . . 0.0 110.218 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.05 -58.56 4.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.144 179.925 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.22 -15.85 61.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.26 4.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.68 152.49 3.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-O 122.175 0.988 . . . . 0.0 112.071 -179.045 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.34 46.8 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.18 128.38 41.97 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.02 -1.05 . . . . 0.0 108.855 -179.803 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 -92.65 132.35 36.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 0.0 110.843 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.52 145.54 54.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.29 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -87.16 -141.57 0.11 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.261 -0.9 . . . . 0.0 109.693 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -11.88 46.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.704 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -17.63 40.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.04 . . . . 0.0 110.476 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.82 65.66 1.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.15 -0.969 . . . . 0.0 110.28 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -143.31 159.59 42.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.081 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 p -61.18 152.2 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 110.137 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.0 -32.51 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.5 111.49 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.082 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.38 144.84 42.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 -179.753 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 t -91.09 -23.86 20.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.23 -20.96 67.82 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.74 107.94 13.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -1.194 . . . . 0.0 110.357 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -121.49 116.02 23.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.93 160.33 3.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.566 -179.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -103.0 -52.56 3.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.93 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.07 -112.8 0.52 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.92 -112.3 3.66 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 53.86 46.63 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -1.086 . . . . 0.0 110.439 179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.469 ' HE ' HD13 ' A' ' 116' ' ' LEU . 3.5 ttp180 -176.16 160.71 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.328 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.07 -57.43 0.72 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 0.0 110.345 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' HE ' ' A' ' 114' ' ' ARG . 1.1 mp 53.82 64.7 1.74 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.88 . . . . 0.0 110.172 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -109.72 49.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.231 -0.918 . . . . 0.0 110.161 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -90.96 79.33 5.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.62 67.21 0.3 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.73 -69.22 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.134 . . . . 0.0 110.161 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 121' ' ' VAL . 11.8 p -172.82 31.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.413 -0.804 . . . . 0.0 110.169 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -111.02 -178.95 3.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 110.468 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p -109.28 64.93 0.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.28 -17.88 47.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.568 -0.707 . . . . 0.0 111.231 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.489 ' HG2' ' HA ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -75.14 -20.24 59.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.727 -1.233 . . . . 0.0 111.2 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.81 41.58 0.2 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.033 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.158 -1.201 . . . . 0.0 110.507 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -172.62 160.35 4.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -161.45 84.88 0.11 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.42 56.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.93 134.69 54.72 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.373 -0.829 . . . . 0.0 111.894 -178.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.0 t70 -113.99 92.66 4.05 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.438 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.4 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.94 23.74 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.8 Cg_endo -41.61 164.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.679 2.253 . . . . 0.0 115.414 -174.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.7 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.877 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.71 28.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.98 30.52 4.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.185 -0.947 . . . . 0.0 110.116 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.55 17.46 66.16 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.877 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 39.7 m -86.91 108.87 20.4 Favored Pre-proline 0 C--N 1.307 -1.256 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.505 1.266 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.4 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.38 -36.5 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.805 178.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.48 -52.74 15.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.776 -0.578 . . . . 0.0 109.729 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.84 -43.83 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.995 -1.066 . . . . 0.0 110.488 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 5.0 tt0 -53.07 -42.8 66.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.953 179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.89 -38.27 72.57 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.553 178.983 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.018 -1.051 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.08 133.26 28.32 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.067 -178.381 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.58 -34.17 60.64 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.664 -0.648 . . . . 0.0 109.848 178.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.31 157.58 45.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.018 -1.051 . . . . 0.0 110.668 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 8.0 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.04 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp -63.19 149.63 90.66 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.934 -1.333 . . . . 0.0 109.778 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 61' ' ' LEU . 38.1 Cg_endo -64.14 145.82 89.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.655 1.345 . . . . 0.0 111.378 -178.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 ' OE1' ' A' ' 70' ' ' GLN . 2.1 mm? -98.7 164.28 12.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -49.05 149.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.213 -0.93 . . . . 0.0 110.398 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -28.49 69.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.195 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.24 -11.37 59.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.49 27.89 66.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -165.94 0.63 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.081 -1.247 . . . . 0.0 109.912 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.82 154.08 26.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 110.352 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.444 ' OE1' HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -157.28 85.12 2.85 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.872 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.23 -7.75 22.01 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.712 1.375 . . . . 0.0 110.821 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 mm? -79.57 -24.21 42.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.29 -21.78 10.18 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 111.009 -178.859 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.88 -29.01 4.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.076 -1.015 . . . . 0.0 108.959 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -81.65 -31.82 32.14 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -58.42 -48.41 80.79 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.432 -0.792 . . . . 0.0 109.494 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.31 -48.4 81.52 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.475 179.642 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -26.27 65.42 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.805 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.12 94.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.35 -16.53 71.23 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.64 153.84 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.512 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.39 78.91 8.11 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.504 -0.747 . . . . 0.0 110.794 -179.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 -82.68 102.38 11.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.66 144.49 30.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.96 . . . . 0.0 110.095 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.36 79.16 9.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.379 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -83.28 -10.75 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.208 -0.932 . . . . 0.0 110.39 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.81 -17.47 61.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.039 -1.038 . . . . 0.0 110.505 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -50.77 -30.69 14.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.481 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.6 m -72.0 93.71 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 110.047 179.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.13 152.6 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.53 -24.49 20.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.388 -0.82 . . . . 0.0 110.356 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -161.34 -52.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -167.8 130.05 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.11 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.2 p -114.06 15.58 18.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.02 -175.87 32.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 14.6 mt -61.03 -177.02 0.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -1.164 . . . . 0.0 110.404 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -129.28 144.22 51.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.405 -0.809 . . . . 0.0 109.948 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -153.93 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.467 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -171.8 -41.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.33 -143.67 21.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ARG . . . 102.02 -165.46 17.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 55.3 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.961 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -143.56 -60.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.856 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.32 84.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.81 156.55 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.1 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 110.783 179.43 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -89.04 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.05 -129.66 1.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.9 tttp -162.39 161.88 27.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -1.151 . . . . 0.0 110.229 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.03 127.68 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -101.39 -158.91 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -101.19 16.5 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.59 -38.69 72.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.617 -179.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.71 -33.55 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.025 -1.047 . . . . 0.0 109.001 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -80.69 -32.14 36.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -78.71 -10.6 59.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 110.615 -179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.42 -58.71 12.58 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.112 179.815 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.243 0.544 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 -73.84 0.27 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.929 . . . . 0.0 110.256 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.75 -86.08 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 55' ' ' ASP . 92.0 m -150.82 140.47 21.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.116 -1.226 . . . . 0.0 112.702 -179.241 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.127 HD21 HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.4 136.77 52.31 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.449 -0.782 . . . . 0.0 108.951 178.239 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.02 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.22 144.26 47.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 120.961 -1.087 . . . . 0.0 108.883 179.687 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.579 ' HB2' ' CG1' ' A' ' 58' ' ' ILE . . . -145.32 124.33 12.8 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.927 -1.108 . . . . 0.0 109.225 179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 59' ' ' VAL . 3.1 m-85 -117.95 149.95 40.06 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.841 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.843 ' HB2' HD12 ' A' ' 129' ' ' ILE . 10.3 t0 -121.16 93.8 4.14 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.1 p90 -174.26 -155.22 0.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 118.113 -1.435 . . . . 0.0 113.705 -177.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . 159.04 159.12 9.47 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 -178.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p 45.68 -143.78 0.23 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.055 . . . . 0.0 111.394 179.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 18.9 mttt -81.96 51.99 1.86 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.04 -1.038 . . . . 0.0 111.389 -178.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.809 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -142.02 131.49 23.79 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.964 -1.085 . . . . 0.0 109.682 179.933 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.96 HD11 ' HB3' ' A' ' 40' ' ' PRO . 31.8 mm -124.62 96.89 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -178.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.16 103.66 0.77 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 103.393 -3.883 . . . . 0.0 103.393 176.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.967 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.48 170.44 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 C-N-CA 116.144 -2.223 . . . . 0.0 114.406 -174.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.71 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -127.66 136.89 52.23 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.306 -179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 48' ' ' LEU . 13.9 t -106.76 125.04 62.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -110.83 135.73 13.08 Favored Glycine 0 N--CA 1.485 1.928 0 C-N-CA 118.714 -1.708 . . . . 0.0 111.277 -177.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -96.74 120.57 37.3 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' HG2' ' OH ' ' A' ' 133' ' ' TYR . 11.3 mtp180 -91.09 36.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.454 -179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.89 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -114.45 -39.77 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 178.171 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.47 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.52 -16.52 10.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.884 178.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.61 35.83 7.68 Favored Glycine 0 N--CA 1.493 2.451 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.089 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.75 161.21 20.5 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.855 -1.379 . . . . 0.0 111.064 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -124.88 123.29 39.6 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.046 -1.034 . . . . 0.0 112.375 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.515 ' HG3' ' HD2' ' A' ' 29' ' ' PRO . 24.6 ttt-85 -88.19 146.12 37.5 Favored Pre-proline 0 C--N 1.3 -1.557 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 176.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.515 ' HD2' ' HG3' ' A' ' 28' ' ' ARG . 50.5 Cg_endo -90.74 141.1 3.09 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 O-C-N 122.792 0.891 . . . . 0.0 112.89 -176.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.967 HD22 HG13 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -99.55 139.65 21.04 Favored Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.031 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 21.7 Cg_endo -42.65 169.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.013 2.475 . . . . 0.0 115.965 -174.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.62 143.79 57.67 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.291 -1.322 . . . . 0.0 113.827 -176.181 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.809 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -53.87 53.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 113.495 -1.684 . . . . 0.0 115.53 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -132.98 96.24 3.73 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.829 -1.17 . . . . 0.0 109.273 176.133 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.639 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.85 160.86 16.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.577 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -83.81 116.64 22.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.083 -1.011 . . . . 0.0 111.336 -178.609 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 48.2 27.75 1.37 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.192 -0.942 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 13' ' ' LYS . . . 94.81 12.33 55.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.639 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 20.5 m -95.47 110.52 51.28 Favored Pre-proline 0 C--N 1.308 -1.212 0 O-C-N 121.022 -1.281 . . . . 0.0 109.631 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HB3' HD11 ' A' ' 15' ' ' ILE . 45.9 Cg_endo -73.53 159.18 46.69 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.472 1.248 . . . . 0.0 109.922 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.779 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.2 m-20 -63.39 91.58 0.05 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.923 -1.111 . . . . 0.0 108.118 179.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.45 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 11.4 t-105 -87.69 -16.8 33.31 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.224 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -80.02 -35.07 37.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.013 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.579 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.8 mp -74.49 -50.05 28.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.725 -0.61 . . . . 0.0 110.361 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.779 HD12 ' O ' ' A' ' 41' ' ' ASP . 12.1 mt -71.23 -43.58 74.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.907 -1.121 . . . . 0.0 110.466 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 33.8 tp10 -49.2 -43.0 42.0 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.166 -0.959 . . . . 0.0 109.26 179.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 34.9 mtp180 -57.57 -48.22 79.94 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.92 HD13 HD21 ' A' ' 6' ' ' LEU . 2.6 mt -59.61 -24.95 64.24 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.192 -0.943 . . . . 0.0 109.856 178.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.571 ' CD1' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -84.1 -46.8 11.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.621 -0.674 . . . . 0.0 112.136 -178.408 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -50.72 9.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.041 -1.037 . . . . 0.0 112.286 -178.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -84.22 -30.63 25.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.027 -1.046 . . . . 0.0 112.162 -177.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 57.9 m95 -109.12 -30.74 7.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 0.0 111.74 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER 54.2 97.07 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.083 -1.011 . . . . 0.0 109.477 -178.589 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 43.3 Cg_endo -68.6 124.2 11.3 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.446 1.235 . . . . 0.0 110.614 -179.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 4' ' ' THR . 3.9 t0 -71.31 -39.0 71.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 110.53 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.57 ' HB3' HD23 ' A' ' 5' ' ' LEU . 12.9 tt0 -135.28 154.37 51.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.231 -0.918 . . . . 0.0 110.567 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 4.2 mp -133.94 136.83 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.799 -1.188 . . . . 0.0 112.682 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.127 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -120.2 113.92 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.073 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 8' ' ' PHE . 2.3 t -134.08 151.58 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 120.173 -1.579 . . . . 0.0 112.993 -177.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 149.44 141.32 3.41 Favored Glycine 0 N--CA 1.488 2.155 0 C-N-CA 119.771 -1.204 . . . . 0.0 111.661 177.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -110.21 108.74 58.81 Favored Pre-proline 0 N--CA 1.493 1.689 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.539 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.56 ' N ' HD22 ' A' ' 61' ' ' LEU . 51.8 Cg_endo -90.29 113.99 0.5 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.216 1.114 . . . . 0.0 110.048 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 63' ' ' LEU . 16.3 tp -131.74 132.08 43.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 110.594 179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -82.1 125.35 30.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 109.531 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 39.4 tpp -83.54 -44.81 14.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 110.319 -179.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.69 17.51 22.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.198 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.65 30.61 66.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.9 t -166.35 -148.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.38 -1.071 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.06 150.62 5.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.06 -1.025 . . . . 0.0 109.894 179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -159.1 98.53 1.63 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.0 -1.062 . . . . 0.0 110.609 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.0 -8.27 23.24 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.71 1.374 . . . . 0.0 110.524 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.03 -24.12 67.39 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.144 -0.973 . . . . 0.0 110.531 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -54.24 -19.97 6.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.509 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -47.73 -26.85 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.019 -1.051 . . . . 0.0 109.538 179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -33.94 54.04 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 73' ' ' THR . . . -62.93 -50.15 71.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.583 -0.698 . . . . 0.0 109.748 179.073 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.543 ' HB3' HD13 ' A' ' 93' ' ' LEU . 3.0 mpt_? -62.77 -45.93 90.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.189 -0.944 . . . . 0.0 109.784 179.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -56.97 -30.99 64.57 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.169 -0.957 . . . . 0.0 109.401 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.506 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 74.4 t80 -61.6 -38.61 88.2 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.85 -1.14 . . . . 0.0 107.931 178.553 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.539 ' HB3' ' CD2' ' A' ' 93' ' ' LEU . . . -56.72 -33.28 66.34 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -68.89 -22.87 64.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.724 -0.79 . . . . 0.0 108.905 178.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -57.67 6.34 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.39 -0.819 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 91' ' ' VAL . 34.7 pt -59.69 -30.12 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 120.853 -1.154 . . . . 0.0 109.151 179.215 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.441 ' HB2' HG11 ' A' ' 91' ' ' VAL . 5.9 t-160 -64.37 -58.32 6.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.529 -0.732 . . . . 0.0 109.754 179.426 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.43 -16.19 42.3 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -71.78 -44.82 63.35 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.117 -1.225 . . . . 0.0 110.669 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HB3' HG13 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -119.35 -10.62 9.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.074 -1.016 . . . . 0.0 110.842 -179.81 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 42.56 16.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.637 HG13 ' HB3' ' A' ' 87' ' ' PHE . 34.7 m -104.53 153.94 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.421 -1.047 . . . . 0.0 110.715 -179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.07 83.89 2.93 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.593 -0.692 . . . . 0.0 111.225 -179.03 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.713 HG21 HD11 ' A' ' 83' ' ' ILE . 2.8 p -90.76 151.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.122 -0.986 . . . . 0.0 111.334 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -121.28 155.29 35.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.92 -0.488 . . . . 0.0 109.843 179.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.543 HD13 ' HB3' ' A' ' 77' ' ' ARG . 21.2 mt -92.28 142.68 27.19 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.041 -1.037 . . . . 0.0 110.621 -179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.517 ' CG ' HG12 ' A' ' 129' ' ' ILE . 16.4 t-160 -80.76 106.77 13.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 109.567 179.285 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -58.94 144.7 44.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 110.6 -179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -69.8 76.97 0.46 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.319 -0.863 . . . . 0.0 109.875 179.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -84.32 -4.56 58.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.231 -0.918 . . . . 0.0 110.978 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -28.14 68.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.128 . . . . 0.0 110.579 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.6 p -62.5 95.54 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.115 -0.991 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 100' ' ' THR . 7.4 t -83.25 -167.83 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.897 . . . . 0.0 110.457 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.09 152.77 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 0.0 110.441 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.19 -21.29 46.56 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.481 -0.762 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.66 135.34 53.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 0.0 110.209 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.15 167.51 10.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.942 . . . . 0.0 110.304 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.418 ' OG ' ' CE2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -91.33 -12.67 34.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 0.0 110.596 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.97 107.91 2.75 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -107.16 80.97 1.48 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -1.145 . . . . 0.0 110.584 -179.697 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 60.24 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.379 -0.826 . . . . 0.0 110.639 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -59.59 160.46 7.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.961 -1.087 . . . . 0.0 109.639 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -53.39 39.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.23 150.25 0.25 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.5 87.97 0.13 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.418 ' CE2' ' OG ' ' A' ' 105' ' ' SER . 0.2 OUTLIER -175.81 92.9 0.05 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.261 -1.14 . . . . 0.0 110.05 -179.885 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.77 66.53 1.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -98.79 -36.18 9.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -0.952 . . . . 0.0 110.261 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER 57.17 165.5 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.28 -0.888 . . . . 0.0 110.546 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.59 151.85 25.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 110.124 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.68 -62.37 1.56 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 117.96 -125.33 6.42 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt 54.97 174.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -1.168 . . . . 0.0 110.028 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 122' ' ' ASP . 13.7 p -67.6 167.77 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.932 . . . . 0.0 109.989 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.479 ' N ' HG22 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -137.75 85.0 2.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.138 -0.977 . . . . 0.0 110.546 -179.887 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 1.5 m -72.81 -10.06 59.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.097 -1.002 . . . . 0.0 110.342 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.49 60.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.222 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.435 ' O ' HG13 ' A' ' 129' ' ' ILE . 1.5 m -50.67 -22.75 2.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.807 -179.427 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.62 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -82.41 -50.68 8.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.878 -1.139 . . . . 0.0 109.222 179.329 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.71 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -60.41 -23.15 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 177.332 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 128' ' ' ILE . 12.4 mm -70.13 -41.64 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 174.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.843 HD12 ' HB2' ' A' ' 9' ' ' ASP . 38.3 mt -63.92 -35.16 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 176.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.686 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -67.08 -34.61 78.03 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.97 -20.33 64.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.852 -1.155 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -48.56 26.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.646 ' CE2' HD12 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -58.15 -40.41 81.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.889 -1.132 . . . . 0.0 109.642 -179.853 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.686 ' CE2' HD12 ' A' ' 130' ' ' LEU . 8.4 m-85 -52.61 -45.64 66.67 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.071 -1.018 . . . . 0.0 109.616 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -80.69 -18.71 47.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.299 -0.876 . . . . 0.0 109.98 179.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -98.38 11.88 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 110.584 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.28 -42.23 98.67 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.351 -1.088 . . . . 0.0 110.093 179.886 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 tpt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.241 0.543 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -161.65 147.97 14.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 110.103 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -172.1 88.42 0.08 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 55' ' ' ASP . 52.4 m -65.11 113.87 4.24 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 120.554 -1.557 . . . . 0.0 111.027 -178.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.051 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.21 134.35 55.09 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.176 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.8 ' CD2' HG22 ' A' ' 19' ' ' VAL . 1.2 mp -124.37 133.32 53.46 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.534 178.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -109.24 122.55 47.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.687 ' CD2' HG21 ' A' ' 17' ' ' VAL . 48.7 m-85 -108.95 140.77 41.98 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.529 -0.732 . . . . 0.0 111.733 -178.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 9.9 t70 -126.02 91.35 3.36 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 176.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' HB2' ' O ' ' A' ' 14' ' ' SER . 12.9 p90 -176.95 -163.68 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.321 -177.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.495 ' N ' ' CD2' ' A' ' 10' ' ' PHE . . . -155.27 -179.86 30.74 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 13' ' ' LYS . 48.4 p -65.27 68.29 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.697 -1.473 . . . . 0.0 111.825 -179.059 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 12' ' ' THR . 8.6 mttt 167.88 -26.4 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.115 -0.99 . . . . 0.0 110.938 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.742 ' HB2' HD11 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -129.19 146.81 51.03 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.246 -0.909 . . . . 0.0 109.774 -178.113 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.877 HD11 ' CB ' ' A' ' 40' ' ' PRO . 43.7 mm -126.13 93.46 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . . . -124.58 101.87 0.68 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 103.941 -3.664 . . . . 0.0 103.941 177.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.908 HG13 HD22 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -141.4 163.89 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 116.177 -2.209 . . . . 0.0 113.994 -174.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.676 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -122.73 134.85 54.44 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.8 HG22 ' CD2' ' A' ' 6' ' ' LEU . 54.9 t -101.85 146.44 10.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 27' ' ' ALA . . . -118.78 136.11 11.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.588 HE21 HG12 ' A' ' 19' ' ' VAL . 69.8 mm-40 -113.83 112.33 23.2 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.463 -1.022 . . . . 0.0 109.39 179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 67.5 mtp180 -90.56 48.36 1.53 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.36 -0.936 . . . . 0.0 109.411 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.885 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -116.53 -42.08 3.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 104.907 -2.257 . . . . 0.0 104.907 177.158 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.816 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -117.39 -17.35 10.12 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.274 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.78 32.99 7.66 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.106 -0.996 . . . . 0.0 110.96 179.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.53 156.22 36.08 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.766 -1.432 . . . . 0.0 111.564 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 20' ' ' GLY . . . -110.12 121.99 46.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.038 -1.039 . . . . 0.0 110.09 178.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 19' ' ' VAL . 21.0 ttm180 -85.92 153.54 57.58 Favored Pre-proline 0 N--CA 1.489 1.49 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' N ' ' HG2' ' A' ' 28' ' ' ARG . 51.0 Cg_endo -92.69 136.67 1.47 Allowed 'Trans proline' 0 C--N 1.301 -1.945 0 O-C-N 123.157 1.082 . . . . 0.0 112.178 -178.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.908 HD22 HG13 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.61 140.21 21.43 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 177.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CD ' HD23 ' A' ' 30' ' ' LEU . 19.4 Cg_endo -40.84 168.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.157 2.571 . . . . 0.0 116.153 -174.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 34' ' ' LYS . . . -64.58 144.63 57.07 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 123.32 1.534 . . . . 0.0 114.462 -175.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 14' ' ' SER . 0.5 OUTLIER -55.87 51.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 112.93 -1.941 . . . . 0.0 115.585 -179.454 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' ALA . 3.2 tmtt? -131.69 101.89 5.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.716 -1.24 . . . . 0.0 109.506 176.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.798 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -89.02 162.24 16.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.431 -0.793 . . . . 0.0 109.898 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.13 114.71 20.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.156 -0.965 . . . . 0.0 111.154 -178.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 49.75 25.76 1.63 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.336 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.13 13.51 39.14 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.798 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 17.5 m -101.96 117.64 61.05 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 121.077 -1.249 . . . . 0.0 110.143 -179.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.877 ' CB ' HD11 ' A' ' 15' ' ' ILE . 46.9 Cg_endo -71.7 155.94 57.99 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.586 1.308 . . . . 0.0 109.193 179.275 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 45' ' ' ILE . 1.7 m-20 -66.04 91.75 0.16 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.734 -1.229 . . . . 0.0 109.098 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 90.8 t90 -85.47 -17.92 35.1 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.22 -32.66 33.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 122.121 0.962 . . . . 0.0 108.788 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' CG1' ' HB3' ' A' ' 41' ' ' ASP . 37.3 mm -75.44 -48.95 28.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-O 121.317 0.58 . . . . 0.0 110.207 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 41' ' ' ASP . 38.0 mt -70.04 -47.63 67.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.477 -0.765 . . . . 0.0 110.453 -179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.413 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 1.3 tt0 -55.72 -31.01 62.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.173 -0.954 . . . . 0.0 109.674 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -66.27 -48.06 71.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 110.473 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 HD12 HD21 ' A' ' 6' ' ' LEU . 20.1 mt -66.52 -41.96 88.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 110.34 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.548 HD13 HG22 ' A' ' 45' ' ' ILE . 3.8 mp -63.45 -45.19 92.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 111.67 -178.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -73.84 -40.45 63.3 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 0.0 111.895 -178.623 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.91 -31.82 25.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.774 -1.204 . . . . 0.0 112.055 -178.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 53' ' ' GLN . 31.6 m95 -109.77 -5.37 15.6 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.702 -1.249 . . . . 0.0 111.95 -178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.441 ' O ' ' HB ' ' A' ' 4' ' ' THR . 79.3 mt-30 57.59 109.94 0.02 OUTLIER Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.362 -0.836 . . . . 0.0 109.429 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.923 ' HB2' HD11 ' A' ' 57' ' ' ILE . 43.9 Cg_endo -71.09 111.52 3.09 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.276 1.145 . . . . 0.0 111.522 -177.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 4' ' ' THR . 9.0 t70 -70.28 -43.47 70.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.229 -0.92 . . . . 0.0 109.402 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.968 ' O ' HD13 ' A' ' 57' ' ' ILE . 11.0 mt-10 -149.17 156.91 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.507 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.7 mm -130.81 136.96 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.722 -1.236 . . . . 0.0 111.656 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.051 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -115.74 123.52 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 79' ' ' PHE . 97.0 t -134.58 151.03 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.2 -1.562 . . . . 0.0 113.083 -177.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 168.24 114.44 0.3 Allowed Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.063 178.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -64.98 149.32 96.86 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.761 -1.435 . . . . 0.0 109.812 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.14 149.34 76.4 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.816 1.43 . . . . 0.0 110.445 -179.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 64' ' ' ASN . 1.4 pp -90.36 164.77 14.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 110.23 -179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -46.56 150.43 0.68 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.377 -0.827 . . . . 0.0 110.787 -179.673 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -15.93 63.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.14 -11.45 59.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.07 -1.019 . . . . 0.0 110.624 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 58.56 49.04 80.99 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 -166.22 1.06 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.226 -1.161 . . . . 0.0 110.239 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.68 114.01 26.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.245 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 -131.35 120.69 18.1 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.39 -0.819 . . . . 0.0 109.876 179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.48 -7.71 21.9 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.481 1.253 . . . . 0.0 111.258 -179.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 tt -52.84 -26.79 15.71 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 110.293 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.527 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -56.27 -20.71 19.8 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.265 -0.897 . . . . 0.0 111.091 -179.838 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.59 -32.87 8.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.989 -1.069 . . . . 0.0 109.17 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' PHE . 2.1 ttt-85 -75.76 -29.9 58.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.215 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' HB2' HD22 ' A' ' 61' ' ' LEU . . . -58.71 -43.19 90.03 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.402 -0.811 . . . . 0.0 109.462 178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -62.89 -48.69 77.91 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 109.191 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.0 -25.17 64.37 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 108.815 178.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' CG1' ' A' ' 59' ' ' VAL . 2.9 t80 -64.95 -40.69 95.39 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 91' ' ' VAL . . . -59.46 -35.07 73.38 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -22.46 62.01 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.56 178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -69.91 -57.21 5.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.773 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 91' ' ' VAL . 2.7 pp -59.68 -28.83 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.934 -1.104 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.598 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -67.06 -58.57 4.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.142 -0.974 . . . . 0.0 110.123 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.2 -15.85 61.51 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -70.08 -44.25 69.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.114 -1.227 . . . . 0.0 110.732 -179.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 16.3 t80 -119.15 -14.1 9.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.03 -1.044 . . . . 0.0 110.672 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.0 45.69 6.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.478 HG11 ' CD2' ' A' ' 49' ' ' LEU . 36.0 m -112.65 153.54 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.497 -1.002 . . . . 0.0 110.672 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.8 92.27 4.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.466 -0.772 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.052 HG21 HD11 ' A' ' 83' ' ' ILE . 4.8 p -95.75 152.52 3.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 122.202 1.001 . . . . 0.0 112.018 -179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.83 130.35 46.81 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.89 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -95.13 128.37 41.91 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.999 -1.063 . . . . 0.0 108.854 -179.798 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.845 ' N ' HD22 ' A' ' 93' ' ' LEU . 1.5 m170 -92.68 132.35 36.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 110.843 -179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.52 145.51 54.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.29 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -87.12 -141.6 0.11 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -11.84 46.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.113 -0.992 . . . . 0.0 110.704 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -17.59 40.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.046 -1.034 . . . . 0.0 110.465 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.82 65.64 1.14 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 110.299 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.9 p -143.31 159.59 42.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.081 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 104' ' ' ARG . 1.2 p -61.18 152.2 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.149 -0.97 . . . . 0.0 110.137 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -76.0 -32.51 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.49 111.55 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.046 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' HB2' HG11 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -113.43 144.84 42.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.0 110.237 -179.792 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.2 t -91.09 -23.86 20.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -65.27 -20.88 67.82 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.79 107.94 13.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -1.2 . . . . 0.0 110.357 -179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -121.49 116.02 23.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.346 -0.846 . . . . 0.0 109.978 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.95 160.34 3.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.309 -0.869 . . . . 0.0 110.597 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -103.04 -52.53 3.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 109.893 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.04 -112.86 0.52 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -106.86 -112.29 3.66 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.276 -1.529 . . . . 0.0 109.276 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 53.86 46.63 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.362 -1.081 . . . . 0.0 110.439 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.469 ' HE ' HD13 ' A' ' 116' ' ' LEU . 3.5 ttp180 -176.17 160.71 2.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.129 -0.982 . . . . 0.0 110.363 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.09 -57.47 0.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.214 -0.929 . . . . 0.0 110.34 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' HE ' ' A' ' 114' ' ' ARG . 1.1 mp 53.82 64.69 1.75 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -0.88 . . . . 0.0 110.172 -179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -109.7 49.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 110.169 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -90.96 79.33 5.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -155.63 67.22 0.3 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 -69.27 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -1.134 . . . . 0.0 110.188 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 121' ' ' VAL . 11.8 p -172.82 31.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.413 -0.804 . . . . 0.0 110.169 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -111.0 -178.94 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 110.51 -179.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.9 p -109.3 64.93 0.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.146 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.8 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -64.27 -24.82 67.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 129' ' ' ILE . 8.1 m -57.94 -36.02 71.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 110.662 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.659 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -71.21 -55.65 7.67 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.234 -0.916 . . . . 0.0 109.642 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.676 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -55.16 -23.18 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.248 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.8 HD13 ' O ' ' A' ' 124' ' ' ALA . 1.2 mp -73.26 -46.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 174.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' ' 58' ' ' ILE . 71.1 mt -58.91 -35.81 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 176.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.638 HD13 ' O ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -68.34 -33.71 74.78 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.202 178.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.8 -21.83 59.08 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.929 -1.107 . . . . 0.0 109.384 178.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.6 m -77.58 -32.68 53.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 110.433 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -70.99 -41.26 71.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.951 -1.093 . . . . 0.0 109.107 179.713 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.54 ' CE2' ' CD1' ' A' ' 130' ' ' LEU . 8.5 m-85 -57.45 -33.87 68.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.842 -1.161 . . . . 0.0 109.022 178.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -81.25 -17.92 47.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 111.262 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.489 ' HG2' ' HA ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER -75.14 -20.24 59.5 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.727 -1.233 . . . . 0.0 111.2 -178.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -169.81 41.58 0.2 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.033 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.185 -1.185 . . . . 0.0 110.572 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.238 0.542 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -172.62 160.35 4.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.168 -0.957 . . . . 0.0 110.338 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 22' ' ' ARG . . . -161.45 84.88 0.11 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.642 ' O ' ' N ' ' A' ' 55' ' ' ASP . 96.1 m -65.72 114.47 5.03 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.429 -1.63 . . . . 0.0 110.153 -179.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.021 HD21 HD11 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -119.64 133.3 55.7 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 120.835 -1.165 . . . . 0.0 108.124 179.752 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.065 HD11 HG13 ' A' ' 19' ' ' VAL . 1.1 mp -124.2 133.69 53.48 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.781 -1.168 . . . . 0.0 110.808 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -112.93 130.47 56.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.726 ' HB2' HG22 ' A' ' 59' ' ' VAL . 5.2 m-85 -115.99 134.63 54.76 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.357 -0.84 . . . . 0.0 111.863 -178.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 33.1 t70 -113.92 92.65 4.05 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.657 ' HB2' ' O ' ' A' ' 14' ' ' SER . 9.8 p90 -176.36 -161.32 0.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.481 -1.288 . . . . 0.0 113.283 -178.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.489 ' HA2' ' CE2' ' A' ' 79' ' ' PHE . . . -158.71 -177.93 32.25 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 12' ' ' THR . 10.2 t -68.64 62.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.78 -1.424 . . . . 0.0 111.572 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 12' ' ' THR . 0.0 OUTLIER 179.48 -31.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.058 -1.026 . . . . 0.0 110.976 179.503 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HB2' ' A' ' 10' ' ' PHE . 1.6 p -129.1 149.54 50.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.388 -0.82 . . . . 0.0 109.672 -178.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 40' ' ' PRO . 35.6 mm -126.14 99.13 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.264 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' C ' HG23 ' A' ' 17' ' ' VAL . . . -125.59 111.47 1.49 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 176.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.922 ' CG1' HD13 ' A' ' 30' ' ' LEU . 58.4 t -140.82 162.36 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 116.04 -2.264 . . . . 0.0 114.882 -175.027 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.745 ' HB2' ' N ' ' A' ' 127' ' ' VAL . . . -118.14 133.65 55.71 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.796 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.065 HG13 HD11 ' A' ' 6' ' ' LEU 0.258 46.6 t -101.97 127.2 55.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 177.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 5' ' ' LEU . . . -109.53 135.33 12.8 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 118.791 -1.671 . . . . 0.0 109.033 -178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 112.56 23.71 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.688 -0.889 . . . . 0.0 110.066 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 40.5 mtp-105 -90.49 49.24 1.65 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.174 0.987 . . . . 0.0 108.738 178.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.875 ' C ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -117.53 -45.28 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.191 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.672 HG23 ' CD1' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -117.96 -17.31 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.885 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.58 33.68 7.0 Favored Glycine 0 N--CA 1.499 2.848 0 O-C-N 121.054 -1.028 . . . . 0.0 111.098 179.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 160.09 28.25 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.765 -1.432 . . . . 0.0 111.872 -178.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HB1' HG13 ' A' ' 127' ' ' VAL . . . -112.93 125.91 54.9 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.023 -1.048 . . . . 0.0 110.491 178.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.547 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -86.53 153.64 55.93 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.645 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ARG . 51.5 Cg_endo -91.02 134.84 1.79 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.267 1.141 . . . . 0.0 112.258 -177.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.922 HD13 ' CG1' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -99.23 141.89 23.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.951 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' HG ' ' A' ' 30' ' ' LEU . 19.9 Cg_endo -41.51 164.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.668 2.245 . . . . 0.0 115.462 -174.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.72 141.29 58.83 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 123.303 1.525 . . . . 0.0 114.283 -175.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.671 ' HA ' ' C ' ' A' ' 15' ' ' ILE . 0.9 OUTLIER -56.86 46.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 112.882 -1.963 . . . . 0.0 115.501 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.78 93.07 3.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 176.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.876 ' HB1' ' O ' ' A' ' 39' ' ' THR . . . -88.93 161.36 16.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.326 -0.859 . . . . 0.0 111.05 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' O ' ' CB ' ' A' ' 39' ' ' THR . 0.8 OUTLIER -85.24 121.72 28.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.433 -0.792 . . . . 0.0 111.298 -179.018 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 49.97 30.51 4.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 110.147 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.56 17.42 66.2 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.876 ' O ' ' HB1' ' A' ' 35' ' ' ALA . 40.2 m -86.83 108.83 20.1 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 121.145 -1.209 . . . . 0.0 109.57 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.679 ' HB3' HD11 ' A' ' 15' ' ' ILE . 41.3 Cg_endo -67.32 153.62 76.46 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.502 1.264 . . . . 0.0 109.475 179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -63.44 90.96 0.05 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.994 -1.066 . . . . 0.0 108.455 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' GLU . 49.5 t-105 -89.03 -17.02 30.22 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.165 179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -79.4 -36.44 39.12 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.212 -0.93 . . . . 0.0 108.834 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' N ' HD12 ' A' ' 44' ' ' ILE . 1.7 mp -77.52 -52.74 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.809 -0.557 . . . . 0.0 109.729 179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 41' ' ' ASP . 48.5 mt -62.89 -43.77 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.995 -1.066 . . . . 0.0 110.518 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' CB ' ' O ' ' A' ' 42' ' ' TRP . 4.9 tt0 -53.07 -42.84 66.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.012 -1.055 . . . . 0.0 108.918 179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -56.86 -38.27 72.48 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.553 179.007 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 6' ' ' LEU . 9.4 mt -77.79 -23.6 49.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.285 -0.884 . . . . 0.0 110.601 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -83.26 -54.25 5.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.057 -1.027 . . . . 0.0 111.854 -178.717 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -80.21 -40.81 26.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.054 -1.029 . . . . 0.0 111.703 -178.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 3.3 tt0 -83.38 -36.69 24.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.974 -1.079 . . . . 0.0 111.408 -178.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.638 ' HB3' HG21 ' A' ' 4' ' ' THR . 19.4 m95 -104.91 -31.09 9.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.908 -1.12 . . . . 0.0 111.307 -179.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 55.04 91.1 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.921 -1.112 . . . . 0.0 109.001 -178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 49' ' ' LEU . 44.3 Cg_endo -68.06 133.25 28.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.711 1.374 . . . . 0.0 112.083 -178.381 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.642 ' N ' ' O ' ' A' ' 4' ' ' THR . 5.8 t70 -75.59 -34.17 60.63 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.724 -0.61 . . . . 0.0 109.848 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.985 ' O ' HD13 ' A' ' 57' ' ' ILE . 5.0 mt-10 -141.3 157.57 45.04 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.018 -1.051 . . . . 0.0 110.623 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 56' ' ' GLU . 7.9 mm -131.95 137.95 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.905 -1.122 . . . . 0.0 112.132 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 1.021 HD11 HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -122.8 116.35 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.016 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.95 HG11 HD13 ' A' ' 83' ' ' ILE . 54.1 t -134.46 150.29 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.049 -1.657 . . . . 0.0 113.2 -177.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 9' ' ' ASP . . . 166.65 127.06 0.87 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 76' ' ' ALA . 3.5 pp -63.23 149.67 90.71 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 120.969 -1.313 . . . . 0.0 109.779 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.528 ' O ' HD12 ' A' ' 61' ' ' LEU . 38.1 Cg_endo -64.14 145.82 89.74 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.655 1.345 . . . . 0.0 111.378 -178.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.444 HD11 ' OE1' ' A' ' 70' ' ' GLN . 2.1 mm? -98.7 164.28 12.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.513 -0.742 . . . . 0.0 110.159 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -49.05 149.87 1.78 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.213 -0.93 . . . . 0.0 110.398 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -28.49 69.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 110.195 -179.974 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.24 -11.37 59.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.21 -0.931 . . . . 0.0 110.743 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.49 27.89 66.61 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.02 -165.94 0.63 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.046 -1.267 . . . . 0.0 109.912 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.82 154.08 26.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.171 -0.956 . . . . 0.0 110.352 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.444 ' OE1' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -157.29 85.14 2.85 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.962 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.23 -7.75 22.01 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.712 1.375 . . . . 0.0 110.821 -179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 mm? -79.57 -24.21 42.23 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.042 -1.036 . . . . 0.0 110.404 -179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -54.31 -21.76 10.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 110.99 -178.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -48.89 -29.01 4.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.017 -1.052 . . . . 0.0 108.959 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -81.63 -31.89 32.18 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 61' ' ' LEU . . . -58.38 -48.38 80.82 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.469 -0.769 . . . . 0.0 109.494 179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.439 ' CG ' ' HG ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -61.37 -48.36 81.61 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.469 179.671 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -66.25 -25.32 66.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.461 -0.895 . . . . 0.0 109.613 179.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.489 ' CE2' ' HA2' ' A' ' 11' ' ' GLY . 56.6 t80 -66.35 -40.25 89.69 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 118.578 -1.249 . . . . 0.0 108.156 178.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.91 67.28 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.49 -26.23 65.36 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.765 178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.77 -58.03 4.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.205 -0.935 . . . . 0.0 110.308 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.95 HD13 HG11 ' A' ' 59' ' ' VAL . 22.8 pt -56.98 -33.78 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.979 -1.076 . . . . 0.0 109.85 179.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.449 ' ND1' HG12 ' A' ' 91' ' ' VAL . 3.6 t-160 -60.49 -45.15 94.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.544 -0.723 . . . . 0.0 110.078 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -82.3 -16.51 71.4 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -63.5 -45.86 88.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.999 -1.295 . . . . 0.0 110.195 -179.804 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.77 ' CD2' HD22 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -120.88 -13.14 8.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 110.809 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.41 39.48 8.32 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 87' ' ' PHE . 31.6 m -98.62 153.85 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.584 -0.95 . . . . 0.0 110.533 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.4 78.91 8.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.558 -0.714 . . . . 0.0 110.794 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 83' ' ' ILE . 9.9 p -98.78 152.82 4.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 122.037 0.922 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 157.22 37.34 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.886 ' O ' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -96.42 128.56 43.46 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 120.945 -1.097 . . . . 0.0 109.129 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.84 ' N ' HD22 ' A' ' 93' ' ' LEU . 3.9 t60 -82.68 102.38 11.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.845 . . . . 0.0 110.52 -179.632 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.66 144.49 30.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.96 . . . . 0.0 110.095 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -86.36 79.16 9.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.937 . . . . 0.0 110.379 -179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -83.28 -10.74 58.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.208 -0.932 . . . . 0.0 110.39 179.767 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.7 mt -73.83 -17.5 61.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.041 -1.037 . . . . 0.0 110.483 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -50.77 -30.69 14.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.151 -0.968 . . . . 0.0 110.481 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.6 m -72.0 93.74 1.41 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 110.047 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.17 152.58 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 0.0 110.465 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.53 -24.49 20.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 110.356 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -161.34 -52.17 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.228 -0.92 . . . . 0.0 110.058 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -167.8 130.05 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.333 -0.855 . . . . 0.0 110.11 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.1 p -114.06 15.58 18.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 110.635 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 154.02 -175.87 32.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 14.6 mt -61.03 -177.01 0.07 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.221 -1.164 . . . . 0.0 110.404 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -129.28 144.19 51.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.342 -0.849 . . . . 0.0 109.966 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.63 -153.93 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 110.467 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -171.8 -41.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 -179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.33 -143.67 21.16 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 114' ' ' ARG . . . 102.02 -165.46 17.37 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 55.3 -86.63 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.566 -0.961 . . . . 0.0 110.688 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 112' ' ' GLY . 0.5 OUTLIER -143.56 -60.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.924 -1.11 . . . . 0.0 110.541 -179.856 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 53.32 84.27 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.116 -0.99 . . . . 0.0 110.029 -179.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.81 156.55 16.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 110.49 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.8 t30 55.1 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.332 -0.855 . . . . 0.0 110.783 179.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -89.04 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.05 -129.66 1.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -162.41 161.9 27.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 110.171 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.4 t -126.03 127.68 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 110.217 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -101.39 -158.91 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.884 . . . . 0.0 110.061 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.0 p -101.19 16.5 25.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.186 -0.946 . . . . 0.0 110.317 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.468 ' O ' HD13 ' A' ' 128' ' ' ILE . . . -72.38 -29.12 63.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.948 . . . . 0.0 110.019 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.3 m -59.29 -21.01 59.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.859 . . . . 0.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' VAL . . . -83.02 -51.42 7.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.27 -0.894 . . . . 0.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.745 ' N ' ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -58.44 -23.64 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 177.493 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.468 HD13 ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -69.46 -43.82 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.52 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.62 HG22 ' HB ' ' A' ' 58' ' ' ILE . 61.5 mt -64.43 -37.21 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 176.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.588 HD12 ' CE2' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -60.56 -42.45 96.62 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.372 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.64 -21.14 64.13 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.741 -1.225 . . . . 0.0 109.377 178.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 133' ' ' TYR . 1.8 p -69.37 -54.22 15.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.417 -0.802 . . . . 0.0 111.323 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.613 ' CZ ' ' HG ' ' A' ' 5' ' ' LEU . 0.1 OUTLIER -56.56 -38.72 72.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.882 -1.137 . . . . 0.0 109.629 -179.495 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.588 ' CE2' HD12 ' A' ' 130' ' ' LEU . 7.6 m-85 -55.69 -33.55 64.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.974 -1.079 . . . . 0.0 109.001 179.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -80.69 -32.14 36.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.588 -0.695 . . . . 0.0 110.24 179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -78.71 -10.61 59.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 110.615 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.4 -58.75 12.41 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.112 179.815 . . . . . . . . 0 0 . 1 stop_ save_